
<html lang="en"     class="pb-page"  data-request-id="caeaa1b6-70ce-420c-8c9d-f34b5ca5607b"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";article:article:10.1021/jm8008597;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2009.52.issue-5;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Covalent Modifiers: An Orthogonal Approach to Drug Design" /></meta><meta name="dc.Creator" content="Michele H.  Potashman" /></meta><meta name="dc.Creator" content="Mark E.  Duggan" /></meta><meta name="dc.Publisher" content=" American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="February 9, 2009" /></meta><meta name="dc.Type" content="review-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm8008597" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2009 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm8008597" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm8008597" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm8008597" /></link>
        
    
    

<title>Covalent Modifiers: An Orthogonal Approach to Drug Design | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm8008597" /></meta><meta property="og:title" content="Covalent Modifiers: An Orthogonal Approach to Drug Design" /></meta><meta property="og:image" content="https://pubs.acs.org/pb-assets/images/CoverImages_2by1Scaled/jmcmar-1595795902140.png" /></meta><meta property="og:description" content="" /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm8008597"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm8008597">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-14/achre4.2021.54.issue-14/20210720/achre4.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-29/aamick.2021.13.issue-29/20210728/aamick.2021.13.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-14/acncdm.2021.12.issue-14/20210721/acncdm.2021.12.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-7/amlcef.2021.3.issue-7/20210705/amlcef.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-29/acsodf.2021.6.issue-29/20210727/acsodf.2021.6.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-29/ascecg.2021.9.issue-29/20210726/ascecg.2021.9.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-29/ancham.2021.93.issue-29/20210727/ancham.2021.93.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-29/bichaw.2021.60.issue-29/20210727/bichaw.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-27/cgeabj.2021.99.issue-27/20210726-01/cgeabj.2021.99.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-7/cgdefu.2021.21.issue-7/20210707/cgdefu.2021.21.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-14/esthag.2021.55.issue-14/20210720/esthag.2021.55.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-29/iecred.2021.60.issue-29/20210728/iecred.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-14/inocaj.2021.60.issue-14/20210719/inocaj.2021.60.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-29/jafcau.2021.69.issue-29/20210728/jafcau.2021.69.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-29/jacsat.2021.143.issue-29/20210728/jacsat.2021.143.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-7/jamsef.2021.32.issue-7/20210707/jamsef.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-29/langd5.2021.37.issue-29/20210727/langd5.2021.37.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-7/mpohbp.2021.18.issue-7/20210705/mpohbp.2021.18.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm8008597&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm8008597&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm8008597&amp;href=/doi/10.1021/jm8008597" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2009</span><span class="cit-fg-volume">, 52</span><span class="cit-fg-issue">, 5</span><span class="cit-fg-pageRange">, 1231-1246</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/52/5" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><span class="content-navigation__contentType">Perspective</span><a href="/doi/10.1021/jm801278g" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Covalent Modifiers: An Orthogonal Approach to Drug Design</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michele+H.++Potashman">Michele H. Potashman</a></span><span class="author-xref-symbol "><sup>*</sup></span></span></li><span class="comma-separator"> and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mark+E.++Duggan">Mark E. Duggan</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol "><sup>§</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info"><span class="aff-text">Department of Medicinal Chemistry, Amgen Inc., One Kendall Square, Building 1000, Cambridge, Massachusetts 02139</span></div><div class="corresp-info"><strong>*</strong> To whom correspondence should be addressed. For M.H.P.: phone, (617) 444-5010; fax, (617) 577-9288; e-mail, <a href="/cdn-cgi/l/email-protection#34595d575c5158514474555953515a1a575b59"><span class="__cf_email__" data-cfemail="b4d9ddd7dcd1d8d1c4f4d5d9d3d1da9ad7dbd9">[email protected]</span></a>. For M.E.D.: phone, (617) 583-1983; e-mail, <a href="/cdn-cgi/l/email-protection#402d21322b002c292e2b2d25242923292e256e232f2d"><span class="__cf_email__" data-cfemail="4b262a39200b27222520262e2f222822252e65282426">[email protected]</span></a></div><div class="corresp-fn" id="afn1">§Current address: Link Medicine Inc., 161 First Street, Cambridge, MA 02142.</div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm8008597&amp;href=/doi/10.1021%2Fjm8008597" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2009</span></span><span class="cit-volume">, 52</span><span class="cit-issue">, 5</span><span class="cit-pageRange">, 1231–1246</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">February 9, 2009</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>11 July 2008</li><li><span class="item_label"><b>Published</b> online</span>9 February 2009</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 12 March 2009</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm8008597" title="DOI URL">https://doi.org/10.1021/jm8008597</a></div><div class="article_header-article-copyright"><strong>Copyright © 2009 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D1231%26pageCount%3D16%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DMichele%2BH.%2BPotashman%252C%2BMark%2BE.%2BDuggan%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D52%26issueNum%3D5%26contentID%3Djm8008597%26title%3DCovalent%2BModifiers%253A%2BAn%2BOrthogonal%2BApproach%2Bto%2BDrug%2BDesign%26numPages%3D16%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D1246%26publicationDate%3DMarch%2B2009">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm8008597"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">14802</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">250</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm8008597" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Covalent Modifiers: An Orthogonal Approach to Drug Design&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Michele&quot;,&quot;last_name&quot;:&quot;H. Potashman&quot;},{&quot;first_name&quot;:&quot;Mark&quot;,&quot;last_name&quot;:&quot;E. Duggan&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2009&quot;,&quot;month&quot;:&quot;02&quot;,&quot;day&quot;:&quot;09&quot;,&quot;issue&quot;:&quot;5&quot;,&quot;volume&quot;:&quot;52&quot;,&quot;pages&quot;:&quot;1231-1246&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm8008597&quot;},&quot;abstract&quot;:&quot;&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm8008597&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm8008597" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm8008597&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm8008597" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm8008597&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm8008597" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm8008597&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm8008597&amp;href=/doi/10.1021/jm8008597" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm8008597" /></input><a href="/doi/pdf/10.1021/jm8008597" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (985 KB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm8008597&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm8008597%26sid%3Dliteratum%253Aachs%26pmid%3D19203292%26genre%3Darticle%26aulast%3DPotashman%26date%3D2009%26atitle%3DCovalent%2BModifiers%253A%2BAn%2BOrthogonal%2BApproach%2Bto%2BDrug%2BDesign%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D52%26issue%3D5%26spage%3D1231%26epage%3D1246%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292547" title="Adducts">Adducts</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=290831" title="Monomers">Monomers</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/52/5" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_34751" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_34751" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">In an effort to discover small molecule drug candidates with attractive toxicity profiles, the pharmaceutical industry has predominantly sought compounds that modulate target proteins through noncovalent interactions. Therefore, high throughput screening strategies and screening collections have been tailored to identify leads that display this binding profile. Scientists will often disregard or filter out screening hits containing potentially reactive functionality or compounds that exhibit noncompetitive kinetics (due to either covalent or noncovalent interactions). This is not surprising, as it is well-known that indiscriminant reactivity can result in covalent binding to proteins, DNA, and glutathione (GSH<a class="ref internalNav" href="#fnabbrev" aria-label="a">a</a>), <div class="NLM_fn" id="fnabbrev">a<p class="last">Abbreviations: GSH, glutathione; AChE, acetylcholinesterase; PLP, pyridoxal 5′-phosphate; GABA-AT, γ-aminobutyric acid aminotransferase; PPIs, proton pump inhibitors; ID-I, type 1 thyroxine 5′-deiodinase; (HCV)NS3·4A, hepatitis C virus NS3 serine protease, EGFR or erB1, epidermal growth factor receptor; HER-2 or erB1, human epidermal growth factor receptor 2; MAO-B, monoamine oxidase B; DPP-IV, dipeptidyl peptidase; GLP-1, glucagon-like peptide 1; Cat K, cathepsin K.</p></div> which can herald unfavorable toxicological outcomes.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> These toxicological events may occur either acutely or as a delayed response due to either immunological or histological factors (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>).<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> In the case of immunological (allergic) response, either a drug−protein complex or a degradation product of such a complex can act as a stimulant for the immune system (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>). Even when compounds present no grave toxicological outcome in preclinical models, idiosyncratic reactions can be manifested in human clinical trials or arise once the entity is exposed to a larger patient pool. Unfortunately, predicting life-threatening idiosyncratic adverse events in humans at the preclinical stage has been evasive. As a result, there is often resistance toward the development of drugs containing modestly reactive functionality, even when the reactivity is confined to the biochemical target.</div><figure id="fig1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/medium/jm-2008-008597_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/large/jm-2008-008597_0003.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Postulated mechanism for drug hypersensitivity reactions. This pathway can be achieved by either a reactive parent compound or a metabolite.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/large/jm-2008-008597_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8008597&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">It is widely acknowledged that nonspecific covalent binding should be avoided or minimized when optimizing drug properties. In fact, the industry now monitors for levels of metabolic activation at the preclinical stage to eliminate potential development candidates that furnish undesirable levels of drug−protein complexes as a strategy to reduce the potential for organ toxicity or idiosyncratic reactions.<a onclick="showRef(event, 'cit1a'); return false;" href="javascript:void(0);" class="ref cit1a">(1a)</a> There are examples where covalent drug (or metabolite)−protein adducts do not lead to toxicity, such as is observed with 3′-hydroxyacetanilide, the meta-isomer of acetaminophen.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> However, since it is difficult to predict physiological responses to a drug−protein adduct, nonspecific covalent binding is undesired.</div><div class="NLM_p">Alternatively, there are instances where controlled, target-specific covalent modification has proven useful. In most instances this has not been the strategy but rather discovered in hindsight. In ideal cases the covalent modifier is typically poorly reactive with solution nucleophiles under physiological conditions but yet upon appropriate positioning will selectively react with a nucleophile within the target protein.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> Herein, we review a variety of examples in which therapeutic targets are covalently bound by small-molecule drugs or by compounds in advanced clinical development. The covalent interactions can be either reversible or irreversible, depending on the reaction partners.</div><div class="NLM_p last">The drugs within this review contain functionality ranging from potentially reactive with solution nucleophiles, as in the case of an epoxide or activated ester, to less-reactive functionality that react upon target binding, such as carbamates and nitriles. Where known, we include the proposed mechanisms of inhibition, crystal structures, and models illustrating the binding mode, as well as biochemical proof of covalent inhibition and information on the reversibility of binding. Finally, in the <a class="ref internalNav" href="#sec4" aria-label="Perspective">Perspective</a> section we suggest medicinal chemistry strategies that enable rational approaches to therapeutics that bind through targeted covalent interactions.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Methods and Materials</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_68234" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_68234" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Method of Analysis</h3><div class="NLM_p">This review article focuses on small molecule drugs and late stage clinical candidates that modify their target protein through a covalent interaction. The targets and compounds presented herein are restricted to those that have published biochemical proof of covalent target modulation. Alternatively, when crystal structures and proposed binding models are convincing of covalent inhibition, those examples are included as well. Proposed or studied chemical mechanisms have been included when documented. The reversibility of the covalent adduction is mentioned, if known. In this discussion, reversibility refers to the event where drug dissociates from the protein as the parent form or as a modified derivative. If there is no mechanism for the removal of the covalent drug-derived moiety or if that removal is not detected, the process is classified as irreversible. However, compounds with slow off-rates due to exclusively noncovalent interactions (such as strong van der Waals interactions, strong metal chelators,<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> or irreversible reorganization of the protein upon substrate binding<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a>) have not been included in this discussion. Although noncovalent binders that exhibit slow off-rates may display overall pharmacodynamic properties commensurate with a covalent inhibitor, these compounds have been excluded from this review.</div><div class="NLM_p last">In addition to covalent adduction by the parent compound, several examples of covalent modification by a major metabolite are presented. In these cases, the parent compound prodrug<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> is inactive and the observed pharmacodynamic activity results from a defined metabolite.</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Scope</h3><div class="NLM_p">As there exists no comprehensive source systematically detailing the chemical mechanism of action for marketed drugs or any formalized means of classifying drug mechanism at the target level, the data presented in this review have been gathered from several sources. The database and literature searches conducted were broad in scope; however, it is possible that some drugs may have been overlooked.</div><div class="NLM_p">Marketed or investigational drugs that bind the therapeutic target covalently were identified by searching the following major sources: (a) electronic databases such as the Food and Drug Administration (FDA) drug labels, European Medicines Evaluation Agency (EMEA) drug labels, Scifinder (CAS database), IDdb (Investigational Drugs database), Physicians Desk Reference (PDR); (b) published literature (including several review articles)<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> and presentations at national chemistry meetings, such as the American Chemical Society meetings.</div><div class="NLM_p">Because of the lack of complete information on the total number of drug targets for which therapeutic agents exist or a comprehensive list of targets that form covalently bound drug adducts, no attempt was made to analyze the frequency or advantage of covalent inhibition with respect to noncovalent inhibition. Additionally, the overall success rate of covalent, target-bound drugs has not been evaluated. While there have been numerous drugs withdrawn from the market or withdrawn from clinical investigation,<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> there is no systematic analysis of the mechanism leading to the toxicological event. There are several examples, however, that suggest that withdrawal is due to a promiscuous reactive metabolite, such as amineptine and sulfamethoxazole.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a></div><div class="NLM_p last">The purpose of this study was to examine known covalent target-modifying small molecule drugs and attempt to glean the characteristics of successful strategies from them. This review consists of a survey of covalently modified drug targets and reviews the types of chemical reactions employed therein. A critical eye has been given to identifying where covalent inhibition may be appropriately applied to early stage drug discovery programs.</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i5">Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_18171" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_18171" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Small molecule drugs and late stage clinical candidates that modulate their targets through covalent interactions can be divided into different categories as depicted in Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>. These molecules react via one of the following reaction types: acylation, alkylation, metal/metalloid binding, disulfide/seleno bond formation, hemiketal formation, Michael addition, and the Pinner reaction. In most instances the small molecule interacts directly with its target while a subset of molecules undergo a transformation before reacting. These molecules display both reversible and irreversible binding characteristics, as well as slow release from the enzyme. The structures of the small molecules (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>) are as diverse as the numerous clinical indications that these therapeutics target.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Targets, Indications, and Mechanism of Action of Covalently Interacting Small Molecules</div></div></div><div class="scrollable-table-wrap"><table class="table frame_topbot"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead valign="middle"><tr valign="top"><th align="center" valign="middle">mechanism</th><th align="center" valign="middle">target</th><th align="center" valign="middle">indication</th><th align="center" valign="middle">name of drug or representative drug<a class="ref internalNav" href="#tbl2-fn1" aria-label="a">a</a></th><th align="center" valign="middle">reacting functionality</th><th align="center" valign="middle">reversibility</th><th align="center" valign="middle">dose (mg)<a class="ref internalNav" href="#tbl2-fn2" aria-label="b">b</a></th></tr></thead><tbody><tr valign="top"><td align="left" valign="top">acylation</td><td align="left" valign="top">serine-type <span class="smallcaps smallerCapital">d</span>-Ala-<span class="smallcaps smallerCapital">d</span>-Ala carboxypeptidase</td><td align="left" valign="top">bacterial infection</td><td align="left" valign="top">amoxicillin<a class="ref internalNav" href="#tbl2-fn3" aria-label="c">c</a></td><td align="left" valign="top">β-lactam</td><td align="left" valign="top">irreversible</td><td align="left" valign="top">100−500</td></tr><tr valign="top"><td align="left" valign="top"> </td><td align="left" valign="top">triacylglycerol lipase</td><td align="left" valign="top">obesity</td><td align="left" valign="top">orlistat</td><td align="left" valign="top">lactone</td><td align="left" valign="top">reversible</td><td align="left" valign="top">360</td></tr><tr valign="top"><td align="left" valign="top"> </td><td align="left" valign="top">acetylcholinesterase</td><td align="left" valign="top">Alzheimer’s</td><td align="left" valign="top">rivastigmine</td><td align="left" valign="top">carbamate</td><td align="left" valign="top">reversible</td><td align="left" valign="top">6−12</td></tr><tr valign="top"><td align="left" valign="top"> </td><td align="left" valign="top">β-lactamase</td><td align="left" valign="top">bacterial infection</td><td align="left" valign="top">clavulanate<a class="ref internalNav" href="#tbl2-fn3" aria-label="c">c</a></td><td align="left" valign="top">β-lactam</td><td align="left" valign="top">irreversible</td><td align="left" valign="top">500</td></tr><tr valign="top"><td align="left" valign="top"> </td><td align="left" valign="top">prostaglandin endoperoxidase synthase</td><td align="left" valign="top">pain</td><td align="left" valign="top">aspirin</td><td align="left" valign="top">ester</td><td align="left" valign="top">reversible</td><td align="left" valign="top">1000</td></tr><tr valign="top"><td align="left" valign="top"> </td><td align="left" valign="top">vitamin K epoxide reductase (warfarin-sensitive)</td><td align="left" valign="top">anticoagulant</td><td align="left" valign="top">warfarin</td><td align="left" valign="top">coumarin</td><td align="left" valign="top"> </td><td align="left" valign="top">2−10</td></tr><tr valign="top"><td align="left" valign="top"> </td><td align="left" valign="top">enol−acyl carrier protein reductase</td><td align="left" valign="top">bacterial infection (tuberculosis)</td><td align="left" valign="top"><i>isoniazid</i></td><td align="left" valign="top">hydrazide<a class="ref internalNav" href="#tbl2-fn4" aria-label="d">d</a></td><td align="left" valign="top">irreversible</td><td align="left" valign="top">300</td></tr><tr valign="top"><td align="left" valign="top"> </td><td align="left" valign="top">aldehyde dehydrogenase</td><td align="left" valign="top">alcoholism</td><td align="left" valign="top"><i>disulfiram</i></td><td align="left" valign="top">disulfide</td><td align="left" valign="top">irreversible</td><td align="left" valign="top">500<a class="ref internalNav" href="#tbl2-fn5" aria-label="e">e</a></td></tr><tr valign="top"><td align="left" valign="top">alkylation</td><td align="left" valign="top">UDP-<i>N</i>-acetylglucosamine-1-carboxyvinyltransferase</td><td align="left" valign="top">bacterial infection</td><td align="left" valign="top">fosfomycin</td><td align="left" valign="top">epoxide</td><td align="left" valign="top"> </td><td align="left" valign="top">3000</td></tr><tr valign="top"><td align="left" valign="top"> </td><td align="left" valign="top">alanine racemase</td><td align="left" valign="top">bacterial infection (tuberculosis)</td><td align="left" valign="top"><span class="smallcaps smallerCapital">d</span>-cycloserine</td><td align="left" valign="top">amine<a class="ref internalNav" href="#tbl2-fn4" aria-label="d">d</a></td><td align="left" valign="top"> </td><td align="left" valign="top">>250</td></tr><tr valign="top"><td align="left" valign="top"> </td><td align="left" valign="top">GABA-AT<a class="ref internalNav" href="#tbl2-fn6" aria-label="f">f</a></td><td align="left" valign="top">epilepsy</td><td align="left" valign="top">vigabatrin</td><td align="left" valign="top">amine<a class="ref internalNav" href="#tbl2-fn4" aria-label="d">d</a></td><td align="left" valign="top">irreversible</td><td align="left" valign="top">3000<a class="ref internalNav" href="#tbl2-fn5" aria-label="e">e</a></td></tr><tr valign="top"><td align="left" valign="top">metal/metalloid binding</td><td align="left" valign="top">aromatase</td><td align="left" valign="top">breast cancer</td><td align="left" valign="top"><i>exemstane</i><a class="ref internalNav" href="#tbl2-fn3" aria-label="c">c</a></td><td align="left" valign="top">methyl</td><td align="left" valign="top">irreversible</td><td align="left" valign="top">25</td></tr><tr valign="top"><td align="left" valign="top"> </td><td align="left" valign="top">proteasome</td><td align="left" valign="top">multiple myeloma</td><td align="left" valign="top">bortezomib</td><td align="left" valign="top">boronic acid</td><td align="left" valign="top">reversible</td><td align="left" valign="top">3</td></tr><tr valign="top"><td align="left" valign="top">disulfide bond formation</td><td align="left" valign="top">H<sup>+</sup>/K<sup>+</sup> ATPase</td><td align="left" valign="top">gastresophageal reflux disease</td><td align="left" valign="top"><i>omeprazole</i><a class="ref internalNav" href="#tbl2-fn3" aria-label="c">c</a></td><td align="left" valign="top">sulfenamide</td><td align="left" valign="top">irreversible</td><td align="left" valign="top">20</td></tr><tr valign="top"><td align="left" valign="top"> </td><td align="left" valign="top">P2Y12 purinoceptor antagonist</td><td align="left" valign="top">platelet aggregation inhibitor</td><td align="left" valign="top"><i>clopidogrel</i></td><td align="left" valign="top">thiol</td><td align="left" valign="top">irreversible</td><td align="left" valign="top">75</td></tr><tr valign="top"><td align="left" valign="top">(seleno-enzyme)</td><td align="left" valign="top">thyroxine 5′-deiodinase (type 1)</td><td align="left" valign="top">hyperthyroidism</td><td align="left" valign="top">propylthiouracil</td><td align="left" valign="top">thiourea</td><td align="left" valign="top"> </td><td align="left" valign="top">450</td></tr><tr valign="top"><td align="left" valign="top">hemiketal formation</td><td align="left" valign="top">serine protease hepatitis C virus NS3<a class="ref internalNav" href="#tbl2-fn7" aria-label="g">g</a></td><td align="left" valign="top">viral infection</td><td align="left" valign="top">VX-950 (<b>1q</b>)</td><td align="left" valign="top">ketoamide</td><td align="left" valign="top">reversible</td><td align="left" valign="top">n/a</td></tr><tr valign="top"><td align="left" valign="top">Michael addition</td><td align="left" valign="top">ribonucleoside diphosphate reductase</td><td align="left" valign="top">cancer</td><td align="left" valign="top"><i>gemcitabine</i><a class="ref internalNav" href="#tbl2-fn3" aria-label="c">c</a></td><td align="left" valign="top">vinyl ketone</td><td align="left" valign="top"> </td><td align="left" valign="top">≥150−000<a class="ref internalNav" href="#tbl2-fn8" aria-label="h">h</a></td></tr><tr valign="top"><td align="left" valign="top"> </td><td align="left" valign="top">thymidylate synthase</td><td align="left" valign="top">cancer</td><td align="left" valign="top">floxuridine<a class="ref internalNav" href="#tbl2-fn3" aria-label="c">c</a></td><td align="left" valign="top">unsaturated amide</td><td align="left" valign="top">reversible</td><td align="left" valign="top">0.1−0.6 (mg/kg)/d</td></tr><tr valign="top"><td align="left" valign="top"> </td><td align="left" valign="top">ErbB1/2<a class="ref internalNav" href="#tbl2-fn7" aria-label="g">g</a></td><td align="left" valign="top">cancer (NSCLC)</td><td align="left" valign="top">HKI-272 (<b>1t</b>)</td><td align="left" valign="top">unsaturated amide</td><td align="left" valign="top">irreversible</td><td align="left" valign="top">n/a</td></tr><tr valign="top"><td align="left" valign="top"> </td><td align="left" valign="top">5-α-reductase</td><td align="left" valign="top">benign prostatic hyperplasia</td><td align="left" valign="top">finasteride<a class="ref internalNav" href="#tbl2-fn3" aria-label="c">c</a></td><td align="left" valign="top">unsaturated amide<a class="ref internalNav" href="#tbl2-fn4" aria-label="d">d</a></td><td align="left" valign="top">reversible</td><td align="left" valign="top">5</td></tr><tr valign="top"><td align="left" valign="top"> </td><td align="left" valign="top">MAO-B</td><td align="left" valign="top">Parkinson’s disease<a class="ref internalNav" href="#tbl2-fn9" aria-label="i">i</a></td><td align="left" valign="top"><i>selegiline</i><a class="ref internalNav" href="#tbl2-fn3" aria-label="c">c</a></td><td align="left" valign="top">aceylenic imine<a class="ref internalNav" href="#tbl2-fn4" aria-label="d">d</a></td><td align="left" valign="top">irreversible</td><td align="left" valign="top">1</td></tr><tr valign="top"><td align="left" valign="top">Pinner reaction</td><td align="left" valign="top">DPP IV<a class="ref internalNav" href="#tbl2-fn7" aria-label="g">g</a></td><td align="left" valign="top">diabetes</td><td align="left" valign="top">vildagliptin</td><td align="left" valign="top">nitrile</td><td align="left" valign="top">reversible</td><td align="left" valign="top">100</td></tr><tr valign="top"><td align="left" valign="top"> </td><td align="left" valign="top">cathepsin K<a class="ref internalNav" href="#tbl2-fn7" aria-label="g">g</a></td><td align="left" valign="top">osteoporosis</td><td align="left" valign="top">odanacatib</td><td align="left" valign="top">nitrile</td><td align="left" valign="top">reversible</td><td align="left" valign="top">10−50<a class="ref internalNav" href="#tbl2-fn10" aria-label="j">j</a></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl2-fn1"><div class="footnote" id="tbl2-fn1"><sup>a</sup><p class="last">Prodrugs are indicated in italics.</p></div><div class="footnote" id="tbl2-fn2"><sup>b</sup><p class="last">As determined from the FDA label or other medical references.</p></div><div class="footnote" id="tbl2-fn3"><sup>c</sup><p class="last">Because of the large number of drugs developed for these targets, one representative drug is indicated in the table.</p></div><div class="footnote" id="tbl2-fn4"><sup>d</sup><p class="last">Indicates functionality covalently modified by the cofactor.</p></div><div class="footnote" id="tbl2-fn5"><sup>e</sup><p class="last">Estimated dose.</p></div><div class="footnote" id="tbl2-fn6"><sup>f</sup><p class="last">Approved in Canada, U.K., and Mexico.</p></div><div class="footnote" id="tbl2-fn7"><sup>g</sup><p class="last">Under clinical investigation.</p></div><div class="footnote" id="tbl2-fn8"><sup>h</sup><p class="last">Dose = 1000 mg/m<sup>2</sup> weekly. The average body surface area of a person is approximately 1.5−2 mm<sup>2</sup>.</p></div><div class="footnote" id="tbl2-fn9"><sup>i</sup><p class="last">Several irreversible MAO inhibitors are on the market for the treatment of depression.</p></div><div class="footnote" id="tbl2-fn10"><sup>j</sup><p class="last">Weekly dose used in the clinical trial “MK0822 (Odanacatib) Late Phase II Dose-Finding Study” described at <a href="http://www.clinicaltrials.gov" class="extLink">www.clinicaltrials.gov</a>.</p></div></div></div><figure id="fig2" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/medium/jm-2008-008597_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/large/jm-2008-008597_0004.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Chemical structures of the compounds described in Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>. Structures in green indicate prodrugs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/large/jm-2008-008597_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8008597&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7">I Acylation Mechanisms</h3><div id="sec3_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i8" class="anchor-spacer"></div><h4 class="article-section__title" id="_i8"> Triacylglycerol Lipase</h4><div class="NLM_p">Orlistat (<b>1a</b>) affects obesity management by inhibiting the body’s ability to metabolize dietary fats. Triacylglycerol lipase, a serine hydrolase, is secreted from the pancreas. Orlistat inhibits triacyglycerol lipase covalently by reversibly binding to the active site serine, with assistance from the histidine and aspartate residues comprising the catalytic triad (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>).<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> The detailed mechanism has been elucidated from in vitro degradation studies of <sup>14</sup>C-labeled orlistat bound to porcine pancreatic lipase. Animal studies indicate that orlistat is minimally absorbed from the gastrointestinal tract, with negligible concentrations in the plasma. Since orlistat is a potent inhibitor of a large number lipases, localization of the drug’s action to the lumen while minimizing systemic exposure is key to the overall safe profile of the drug.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a></div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/medium/jm-2008-008597_0021.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/large/jm-2008-008597_0021.jpeg" id="gs1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Depiction of the Reversible Inhibition of Triacylglycerol Lipase by Orlistat<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/large/jm-2008-008597_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8008597&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>The catalytic triad (Asp176, His263, and Ser152) is also illustrated.</p></p></figure></div><div id="sec3_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i10" class="anchor-spacer"></div><h4 class="article-section__title" id="_i10"> Serine-Type <span class="smallcaps smallerCapital">d</span>-Ala-<span class="smallcaps smallerCapital">d</span>-ala Carboxypeptidase</h4><div class="NLM_p">Drugs targeting serine-type <span class="smallcaps smallerCapital">d</span>-ala-<span class="smallcaps smallerCapital">d</span>-ala carboxypeptidase are used as broad-spectrum antibacterial agents. Serine-type <span class="smallcaps smallerCapital">d</span>-ala-<span class="smallcaps smallerCapital">d</span>-ala carboxypeptidase is a serine protease involved in bacterial synthesis of the peptidoglycan layer in the cell wall. β-Lactam antibiotics are thus effective at weakening the cell wall of the bacterium, resulting in osmotic lysis and cell death. All β-lactam antibiotics irreversibly acylate the active site serine forming a serine-ester linked adduct <b>3</b> (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>).<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> There are many β-lactam-derived antibiotics on the market targeting serine-type <span class="smallcaps smallerCapital">d</span>-ala-<span class="smallcaps smallerCapital">d</span>-ala carboxypeptidase, including amoxicillin (<b>1b</b>), ampicillin, and penicillin (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>). Although this drug class is generally well tolerated, the rate of allergic reaction can occur in as high as 18% of patients.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Interestingly, it has been shown that factors in the serum facilitate the covalent binding of penicillin to serum proteins rather than inherent reactivity of the β-lactam with the proteins directly.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> Most certainly, the short treatment period aids in the tolerability of these agents.</div><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/medium/jm-2008-008597_0022.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/large/jm-2008-008597_0022.jpeg" id="gs2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Depiction of the Acylation of Serine-Type <span class="smallcaps smallerCapital">d</span>-Ala-<span class="smallcaps smallerCapital">d</span>-ala Carboxypeptidase by Amoxicillin</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/large/jm-2008-008597_0022.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8008597&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/medium/jm-2008-008597_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/large/jm-2008-008597_0005.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Examples of some β-lactam inhibitors of serine-type <span class="smallcaps smallerCapital">d</span>-ala-<span class="smallcaps smallerCapital">d</span>-ala carboxypeptidase.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/large/jm-2008-008597_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8008597&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="secLacta" class="NLM_sec NLM_sec_level_3"><div id="ac_i12" class="anchor-spacer"></div><h4 class="article-section__title" id="_i12"> β-Lactamase</h4><div class="NLM_p">β-Lactamase inhibitors are used in conjunction with serine-type <span class="smallcaps smallerCapital">d</span>-ala-<span class="smallcaps smallerCapital">d</span>-ala carboxypeptidase inhibitors to treat bacterial infection. Bacteria produce the serine hydrolase β-lactamase to hydrolyze carboxypeptidase inhibitors, forming a hydrolytically labile, fast turnover serine-ester linked adduct.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> However, reactions between β-lactamase and specific β-lactamase inhibitors such as clavulanate (<b>1c</b>) form kinetically stable irreversible adducts (<b>4</b>), functionally inactivating the bacterial resistance mechanism (Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>). There are several β-lactamase inhibitors on the market with the similar chemotypes including clavulanate (<b>1c</b>), tazobactam, and sulbactam (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>).</div><figure id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/medium/jm-2008-008597_0023.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/large/jm-2008-008597_0023.jpeg" id="gs3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Depiction of the Acylation of β-Lactamase by Clavulanate</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/large/jm-2008-008597_0023.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8008597&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/medium/jm-2008-008597_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/large/jm-2008-008597_0006.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Examples of some β-lactam inhibitors of β-lactamase.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/large/jm-2008-008597_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8008597&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i14" class="anchor-spacer"></div><h4 class="article-section__title" id="_i14"> Acetylcholinesterase</h4><div class="NLM_p">Acetylcholinesterase (AChE) inhibitors are used to treat neurological diseases, including Alzheimer’s disease, by preventing the breakdown of acetylcholine and therefore preserving synaptically relevant concentrations of this key neurotransmitter. Rivastigmine (<b>1d</b>) is a slow-binding, reversible<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> inhibitor of the serine hydrolase, AChE. Crystallographic data of rivastigmine bound to <i>Torpedo californica</i> AChE show the formation of the active site serine−carbamate adduct, assisted by other members of the catalytic triad. The leaving group phenol is retained in the “anionic site” of the enzyme in proximity to the site of adduction.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a></div><div class="NLM_p">Apart from the covalently bound rivastigmine (<b>1d</b>), donepezil and galantamine are competitive inhibitors of AChE also marketed to treat Alzheimer’s disease (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>). On the basis of analysis of the side effects observe for each of these drugs, there does not seem to be a significant safety drawback to using a covalent versus noncovalent AChE inhibitor.</div><figure id="fig5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/medium/jm-2008-008597_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/large/jm-2008-008597_0007.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Covalent and competitive AChE inhibitors used to treat Alzheimer’s disease.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/large/jm-2008-008597_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8008597&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i15" class="anchor-spacer"></div><h4 class="article-section__title" id="_i15"> Prostaglandin Endoperoxidase Synthase</h4><div class="NLM_p last">Aspirin (acetylsalicyclic acid, <b>1e</b>) is a widely used prostaglandin endoperoxidase synthase (cyclooxygenase) inhibitor. The primary indication is pain management, but at low doses aspirin is also widely used for cardiovascular benefit.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> Incubation and further degradation studies of [<sup>3</sup>H]aspirin with prostaglandin endoperoxidase synthase indicate that aspirin irreversibly acylates an active site serine.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> Adverse events associated with aspirin use include an increased risk of gastrointestinal bleeding<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> and the development of Reye’s syndrome in children. Although there are many known noncovalently bound cyclooxygenase inhibitors, aspirin is the only covalent modifier on the market.</div></div><div id="sec3_1_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i16" class="anchor-spacer"></div><h4 class="article-section__title" id="_i16"> Vitamin-K Epoxide Reductase (Warfarin-Sensitive)</h4><div class="NLM_p">Thromboembolic disease is a condition derived from formation of blood clots that obstruct blood flow. Warfarin (<b>1f</b>) is an oral anticoagulant used for the treatment of venous and arterial thromboembolic disorders. Since Warfarin-treated microsomes do not recover vitamin K epoxide reductase activity after being washed, it has been concluded that the binding is irreversible.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> Although the mechanism of covalent binding is not well elucidated, a proposed mechanism involves opening of the coumarin ring by either a cysteine or neighboring (unidentified) nucleophilic residue (Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>).<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a></div><figure id="sch4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/medium/jm-2008-008597_0024.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/large/jm-2008-008597_0024.jpeg" id="gs4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Proposed Mechanism for the Inhibition of Vitamin K Epoxide Reductase by Warfarin</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/large/jm-2008-008597_0024.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8008597&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_1_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i18" class="anchor-spacer"></div><h4 class="article-section__title" id="_i18"> Enol−Acyl Carrier Protein Reductase</h4><div class="NLM_p">Enol−acyl carrier protein reductase is an NADH-dependent enzyme essential for mycolic acid biosynthesis, an important component for the synthesis of mycobacterial cell walls. The enol−acyl carrier protein reductase inhibitor isoniazid (<b>1g</b>) is a first-line antituberculous agent used in the treatment of tuberculosis. In the proposed mechanism, catalase peroxidase converts isoniazid to a reactive isonicotinic acyl anion (<b>5</b>), which attacks NAD (<b>6</b>) to generate the isonicotinic acyl−NADH adduct (<b>7</b>) (Scheme <a class="ref internalNav" href="#sch5" aria-label="5">5</a>).<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> Whether the mechanism proceeds through a cationic or radical pathway, isoniazid forms a reversible enzyme-bound cofactor adduct (<b>7</b>), as determined by X-ray crystallography and mass spectrometry.</div><figure id="sch5" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/medium/jm-2008-008597_0025.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/large/jm-2008-008597_0025.jpeg" id="gs5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Proposed Mechanism for Formation of the Isoniazid−NADP Adduct</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/large/jm-2008-008597_0025.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8008597&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Isoniazid is a known CYP inhibitor<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> and is associated with liver injury ranging from minor nonspecific changes in hepatic structure to fulminant hepatic failure.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> The liver damage is proposed to occur through a metabolite, acylhydrazine, which is a different chemical species from the acyl intermediate <b>5</b> generated for covalent adduction. Although liver damage can be a serious effect of treatment, there is a medical need warranting the continued use of this drug.</div></div><div id="sec3_1_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> Aldehyde Dehydrogenase</h4><div class="NLM_p">The aldehyde dehydrogenase inhibitor disulfiram (<b>1h</b>) is used to treat alcohol abuse by causing a buildup of acetaldehyde, a metabolite of ethanol.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> Elevated levels of acetaldehyde result in a phenotype similar to that of an allergic reaction, with nasal congestion and flushing, therefore deterring alcohol consumption. Disulfiram is a time-dependent irreversible inhibitor of aldehyde dehydrogenase.</div><div class="NLM_p">Disulfiram, which acts as a prodrug, is believed to inhibit the enzyme by the mechanism shown in Scheme <a class="ref internalNav" href="#sch6" aria-label="6">6</a>. The disulfide bond is cleaved and methylated to give the methyl dithioate (<b>8</b>). Compound <b>8</b> is oxidized to the methylsulfinyl methanethioamide (<b>9</b>), which forms an adduct with Cys302 (<b>10</b>). Two adducts have been isolated, indicating covalent modification by both the dialkyl (<b>10</b>) and monoalkylated intermediates (<b>10′</b>).<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a></div><figure id="sch6" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/medium/jm-2008-008597_0026.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/large/jm-2008-008597_0026.jpeg" id="gs6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Inhibition of Aldehyde Dehydrogenase by Disulfiram</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/large/jm-2008-008597_0026.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8008597&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22">II Alkylation Mechanisms</h3><div class="NLM_p">Several alkylation mechanisms have been used to achieve covalent modulation; however, preactivation of the substrate prior to the alkylation event is required.</div><div id="sec3_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> UDP-<i>N</i>-Acetylglucosamine Enol−Pyruvyl Transferase</h4><div class="NLM_p last">UDP-<i>N</i>-acetylglucosamine enol−pyruvyl transferase (or MurA) is an integral protein to the synthesis of peptidoglycans required for bacterial cell wall synthesis. Naturally occurring fosfomycin (<b>1i</b>) is a broad-spectrum antibiotic used to treat urinary tract infections. As determined by X-ray crystallography, fosfomycin irreversibly inhibits MurA by alkylating the catalytically important Cys115.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> Crystallographic studies have also shown a large protein conformational change upon binding fosfomycin. It is proposed that this conformational change facilitates nucleophilic attack on the epoxide by Cys115 to generate the enzyme-bound inhibitor.</div></div><div id="sec3_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> Alanine Racemase</h4><div class="NLM_p">Alanine racemase is a pyridoxal 5′-phosphate (PLP) assisted enzyme that catalyzes the conversion of <span class="smallcaps smallerCapital">l</span>-alanine to <span class="smallcaps smallerCapital">d</span>-alanine, a constituent required for the synthesis of the peptidoglycan layer of the bacterial cell wall. <span class="smallcaps smallerCapital">d</span>-Cycloserine (<b>1j</b>) is a broad-spectrum antibiotic used as a second-line treatment of tuberculosis. <span class="smallcaps smallerCapital">d</span>-Cycloserine irreversibly inhibits alanine racemase by covalently modifying the PLP cofactor, with subsequent noncovalent enzymatic binding of the PLP−cycloserine adduct <b>14</b> (Scheme <a class="ref internalNav" href="#sch7" aria-label="7">7</a>).<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> The irreversible inhibition was determined from enzyme−substrate time-dependent inactivation studies. The inhibition mode was determined by a crystal structure of adduct <b>14</b> bound to the enzyme. A proposed mechanism for formation of adduct <b>14</b> involves the initial formation of an iminium species between the aldehyde of PLP and Lys 39 (<b>11</b>). Subsequent transamination with <span class="smallcaps smallerCapital">d</span>-cycloserine <b>1j</b> followed by tautomerization and deprotonation forms a stable aromatic isoxazole moiety (<b>14</b> in Scheme <a class="ref internalNav" href="#sch7" aria-label="7">7</a>). Although <span class="smallcaps smallerCapital">d</span>-cycloserine acts as an irreversible inhibitor of many PLP-dependent enzymes and is thus a less selective drug, there is a medical need warranting continued use.</div><figure id="sch7" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/medium/jm-2008-008597_0027.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/large/jm-2008-008597_0027.jpeg" id="gs7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 7. Mechanism for Formation of the PLP−Cycloserine Adduct <b>14</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/large/jm-2008-008597_0027.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8008597&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> γ-Aminobutyric Acid Aminotransferase</h4><div class="NLM_p">γ-Aminobutyric acid aminotransferase (or GABA-AT) is a PLP-dependent enzyme that catalyzes the catabolism of the inhibitory neurotransmitter GABA. Vigabatrin <b>1k</b> irreversibly inhibits GABA-AT and is used (with restriction) to treat epilepsy in adults and children in Canada, the U.K., and Mexico, as it is associated with visual field defects in ∼40% of patients with long-term use.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> Likely because of the long-term effects on the retina, the FDA has not approved its use for epilepsy. However, vigabatrin is currently under phase II investigation for treatment of cocaine addiction at lower doses.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> Although vigabatrin is sold as a racemate, the (<i>S</i>)-enantiomer is the eutomer.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a></div><div class="NLM_p">Incubation of GABA-AT (isolated from a pig liver) with a radiolabeled vigabatrin confirms the irreverisbile binding and identified the site of modification at the lysine that normally binds the cofactor.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> After denaturation of the inactivated enzyme, the PLP cofactor was modified to pyridoxamine phosphate. Although the proposed mechanism of irreversible inhibition involves the PLP cofactor (Scheme <a class="ref internalNav" href="#sch8" aria-label="8">8</a>), it is proposed to occur by a mechanism different from that of <span class="smallcaps smallerCapital">d</span>-cycloserine with PLP<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> (Scheme <a class="ref internalNav" href="#sch7" aria-label="7">7</a>). It is postulated that vigabatrin forms an iminium species with PLP and tautomerizes to an activated enamine type species <b>15</b>. Lysine addition to the β-carbon and hydrolysis of the resulting iminium afford the covalent adduct <b>16</b> with simultaneous formation of pyridoxamine phosphate.</div><figure id="sch8" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Scheme 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/medium/jm-2008-008597_0028.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/large/jm-2008-008597_0028.jpeg" id="gs8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 8. Proposed Mechanism of Adduct Formation of Vigabatrin with PLP</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/large/jm-2008-008597_0028.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8008597&amp;id=sch8"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28">III Metal/Metalloid Binding</h3><div id="sec3_3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> Aromatase</h4><div class="NLM_p">Estrogen plays an important role in breast cancer development. Aromatase, a member of the iron-containing CYP superfamily, is an enzyme that aromatizes androgens to estrogens. The lowering of circulating estrogen levels by use of aromatase inhibitors, such as exemstane (<b>1l</b>), is one treatment strategy employed for breast cancer therapy. The steroidal inhibitor <b>1l</b> is a time-dependent inhibitor of aromatase.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> The mechanism for irreversible inhibition of exemstane is not known, but the mechanism with the preferred endogenous ligand, androstenedione, has been studied (Scheme <a class="ref internalNav" href="#sch9" aria-label="9">9</a>).<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> Androstenedione is oxidized to hydroperoxy alcohol, which binds to iron, forming a peroxy−enzyme intermediate <b>17</b>. Adduct <b>17</b> is then oxidized and aromatized to the phenol <b>18</b>, generating estrone. Although the final oxidation step’s details remain to be completely elucidated, it is known that aromatization proceeds with loss of the C19 carbon atom as formic acid. On the basis of the structural similarities between exemstane and the endogenous ligand androstenedione, a similar mechanism can be proposed where upon formation of the exemstane peroxy-iron intermediate (analogous to <b>17</b>) aromatization does not occur, leading to irreversible inhibition (not depicted).</div><figure id="sch9" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Scheme 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/medium/jm-2008-008597_0029.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/large/jm-2008-008597_0029.jpeg" id="gs9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 9. Inhibition of Aromatase by the Endogenous Ligand Androstenedione</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/large/jm-2008-008597_0029.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8008597&amp;id=sch9"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_3_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> Proteasomes</h4><div class="NLM_p">Cells regulate protein concentration and control the degradation of misfolded proteins by large protein complexes called proteasomes. Proteasomal inhibition by bortezomib (<b>1m</b>) is a mechanism for the treatment of blood cancers, multiple myeloma, and mantle cell lymphoma. Under physiological conditions, bortezomib primarily targets the proteasomal β5 active site of the 20S proteasome. The crystal structure of bortezomib with yeast 20S proteasome indicates a tetrahedral adduct between bortezomib and the active site threonine, while the free amino group of the threonine hydrogen-bonds to an acidic boronate hydroxyl group (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>).<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> The tetrahedral boronate adduct is further stabilized by a hydrogen bonding interaction between the second acidic hydroxyl boronate moiety with a neighboring glycine (stabilizing the oxyanion hole). This formation of a tetrahedral adduct is analogous to the action of the α-ketoamide VX-950 (<b>1q</b>) protease inhibitor.</div><figure id="fig6" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/medium/jm-2008-008597_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/large/jm-2008-008597_0008.jpeg" id="gr16" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Representation of the binding of bortezomib (shown in blue) in the active site of yeast 20S proteaseome. Hydrogen bonds are indicated by the dashed lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/large/jm-2008-008597_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8008597&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32">IV Disulfide Bond Formation</h3><div id="seciv_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> H<sup>+</sup>/K<sup>+</sup> ATPase</h4><div class="NLM_p">Proton transport by the gastric H<sup>+</sup>/K<sup>+</sup> ATPase is the final step in gastric acid secretion. Proton pump inhibitors (PPIs) such as omeprazole <b>1n</b>, esomeprazole, or lansoprazole (Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>) are used to treat gastresophageal reflux disease. Experiments with several radiolabeled PPIs indicate covalent inhibition of gastric ATPase via disulfide formation with one or more cysteine residues.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> The mechanism of PPI inhibition has been extensively studied.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> As illustrated with omeprazole, this class of inhibitors are prodrugs that transform under the acidic conditions on the stomach to a spiro intermediate <b>19</b> that undergoes aromatization to a sulfenic acid <b>20</b> followed by dehydration to a tetracyclic sulfeneamide <b>21</b>. Compound <b>21</b> reacts irreversibly with a cysteine to form the disulfide adduct <b>22</b> (Scheme <a class="ref internalNav" href="#sch10" aria-label="10">10</a>). The unstable reactive intermediate (<b>20</b> or <b>21</b>) is generated at the site of action, so the compound is efficacious and systemic exposure is not achieved.</div><figure id="fig7" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/medium/jm-2008-008597_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/large/jm-2008-008597_0009.jpeg" id="gr17" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. H<sup>+</sup>/K<sup>+</sup> ATPase inhibitors omeprazole <b>1n</b>, esomeprazole, and lansoprazole.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/large/jm-2008-008597_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8008597&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="sch10" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Scheme 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/medium/jm-2008-008597_0030.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/large/jm-2008-008597_0030.jpeg" id="gs10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 10. Inhibition of H<sup>+</sup>/K<sup>+</sup> ATPase by Omeprazole</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/large/jm-2008-008597_0030.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8008597&amp;id=sch10"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_4_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> P2Y<sub>12</sub> Purinoceptor</h4><div class="NLM_p">Platelet aggregation in occluded arteries can lead to stroke and myocardial infactions. Clopidogrel (<b>1o</b>) is a prodrug whose active metabolite inhibits platelet aggregation by irreversibly inhibiting the P2Y<sub>12</sub> purinoceptor. The irreversibility of the active metabolite <b>24</b> has been determined in platelet binding studies.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> In the proposed mechanism, clopidogrel is oxidized by cytochrome P<sub>450</sub> 1A to a 2-oxo-thiophene <b>23</b> with hydrolysis to a ring-opened carboxylic acid bearing thiol <b>24</b> (Scheme <a class="ref internalNav" href="#sch11" aria-label="11">11</a>). It is proposed that <b>24</b> forms covalent adduct <b>25</b> via a disulfide bridge with a cysteine.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a></div><figure id="sch11" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Scheme 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/medium/jm-2008-008597_0031.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/large/jm-2008-008597_0031.jpeg" id="gs11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 11. Proposed Mechanism of Clopidogrel Inhibition of P2Y<sub>12</sub> Purinoceptor</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/large/jm-2008-008597_0031.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8008597&amp;id=sch11"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_4_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> Thyroxine 5′-Deiodinase (Type 1)</h4><div class="NLM_p">Hyperthyroidism is caused by excess thyroid hormone production resulting in an overactive metabolism. Type 1 thyroxine 5′-deiodinase (or ID-I) is a seleno−enzyme involved in the regulation of thyroid activity. Propylthiouracil (or PTU, <b>1p</b>) irreversibly inhibits thyroxine 5′-deiodinase<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> by formation of a covalent enzyme−Se−PTU adduct (Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a>).<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a></div><figure id="fig8" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/medium/jm-2008-008597_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/large/jm-2008-008597_0010.jpeg" id="gr20" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Thyroxine 5′-deiodinase−PTU adduct.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/large/jm-2008-008597_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8008597&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38">V Hemiacetal Formation</h3><div id="sec3_5_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> Serine Protease Hepatitis C Virus NS3</h4><div class="NLM_p">Viral hepatitis causes acute inflammation to the liver tissue, which if left untreated can lead to a chronic condition that may progress toward liver cirrhosis or hepatocellular carcinoma.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> The hepatitis C virus NS3 serine protease ((HCV) NS3·4A) is proposed to be responsible for the virus’ RNA replication.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> VX-950 (<b>1q</b>) is currently under phase II investigation as a reversible (HCV) NS3·4A inhibitor. On the basis of modeling studies, <b>1q</b> is proposed to inhibit serine protease hepatitis C virus NS3 by formation of a reversible covalent bond between the active site Ser139 and the ketoamide warhead (Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a>).<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a></div><figure id="fig9" data-index="19" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/medium/jm-2008-008597_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/large/jm-2008-008597_0011.jpeg" id="gr21" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Proposed <b>1q</b>−protein hemiketal adduct.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/large/jm-2008-008597_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8008597&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40">VI Michael Addition</h3><div id="sec3_6_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> Ribonucleoside Diphosphate Reductase</h4><div class="NLM_p">Ribonucleoside diphosphate reductase is an enzyme catalyzing the formation of 2′-deoxyribonucletides ultimately used in DNA synthesis. Inhibitors of ribonucleoside diphosphate reductase, such as gemicitabine (<b>1r</b>), cladribine, or fludarabine (Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a>) are used to treat pancreatic and non-small-cell lung cancers. Studies have shown that the diphosphate of gemicitabine irreversibly inactivates the target in a time- and concentration-dependent manner in vitro.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> Although the site of covalent modification on the protein is unknown, gemicitabine reacts with a cysteine to generate the covalent adduct <b>28</b> via the vinyl ketone <b>27</b> (Scheme <a class="ref internalNav" href="#sch12" aria-label="12">12</a>).<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a></div><figure id="fig10" data-index="20" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/medium/jm-2008-008597_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/large/jm-2008-008597_0012.jpeg" id="gr22" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Ribonucleoside diphosphate reductase inhibitors gemcitabine (<b>1r)</b>, cladribine, and fludarabine.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/large/jm-2008-008597_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8008597&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="sch12" data-index="21" class="article__inlineFigure"><h2 class="fig-label">Scheme 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/medium/jm-2008-008597_0032.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/large/jm-2008-008597_0032.jpeg" id="gs12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 12. Proposed Mechanism for the Inhibition of Ribonucleoside Diphosphate Reductase by Gemcitabine</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/large/jm-2008-008597_0032.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8008597&amp;id=sch12"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_6_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> Thymidylate Synthase</h4><div class="NLM_p">Thymidylate synthase generates thymidine monophosphate, which is subsequently phosphorylated and used in DNA synthesis and repair. Several uracil-derived inhibitors of thymidlate synthase including floxuridine (<b>1s</b>), capecitabine, and fluorouracil (Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a>) are used in the treatment of cancers. There is biochemical and spectral evidence that floxuridine binds covalently to thymidylate synthase in the presence of the cofactor CH<sub>2</sub>FAH<sub>4</sub>.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> Although it is known that the cofactor is converted to a different chemical species, the exact structure has not been elucidated. A proposed mechanism to account for the cofactor modification and the covalent enzymatic binding is depicted in Scheme <a class="ref internalNav" href="#sch13" aria-label="13">13</a>. The reversible addition of a cysteine to the 6-position of the fluorouracil core (generating <b>29</b>) is followed by reaction of the enolate with the cofactor (generating <b>30</b>, Scheme <a class="ref internalNav" href="#sch13" aria-label="13">13</a>).</div><figure id="fig11" data-index="22" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/medium/jm-2008-008597_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/large/jm-2008-008597_0013.jpeg" id="gr24" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Thymidylate synthase inhibitors floxuridine <b>1s</b>, capecitabine, and fluorouracil.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/large/jm-2008-008597_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8008597&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="sch13" data-index="23" class="article__inlineFigure"><h2 class="fig-label">Scheme 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/medium/jm-2008-008597_0033.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/large/jm-2008-008597_0033.jpeg" id="gs13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 13. Proposed Inhibition of Thymidylate Synthase by Floxuridine<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/large/jm-2008-008597_0033.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8008597&amp;id=sch13"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>CH<sub>2</sub>FAH<sub>4</sub> denotes the cofactor 5,10-CH<sub>2</sub>FAH<sub>4</sub>.</p></p></figure></div><div id="sec3_6_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> Epidermal Growth Factor Receptors</h4><div class="NLM_p">Epidermal growth factor receptor (EGFR or erbB1) and human epidermal growth factor receptor 2 (HER-2 or erbB2) are receptor tyrosine kinases whose overexpression is associated with a number of cancers. HKI-272 (<b>1t</b>) is currently under phase II clinical investigation as an irreversible dual erbB1/2 inhibitor for the treatment of non-small-cell lung cancers.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> The irreversibility of this chemotype has been demonstrated with an analogous compound, 2-<i>E</i>-<i>N</i>-[4-[(3-chloro-4-fluorophenyl)amino]-3-cyano-7-ethoxy-6-quinolinyl]-4-(dimethylamino)-2-butenamide (EKB-569, an earlier clinical candidate) by incorporation of the compound into the EGFR protein upon incubation with A431 cells.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> Interestingly, EKB-569 was also shown to undergo Michael addition reaction of glutathione (19% conversion).<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a></div><div class="NLM_p">The proposed binding model of <b>1t</b> in HER-2 indicates that the Cys805 is 3.43 Å away from Michael acceptor β-carbon and is easily accessible for covalent interaction (Figure <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">12</a>). The sulfhydryl hydrogen and the nitrogen of the dimethylamino group are situated for intramolecular catalysis.<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> It is postulated that the Michael addition is accelerated because of the entropic effect of having the reactive center, nucleophile, and base catalyst in proximity.</div><figure id="fig12" data-index="24" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/medium/jm-2008-008597_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/large/jm-2008-008597_0014.jpeg" id="gr26" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. Schematic representation of the key interactions in the proposed binding model of <b>1t</b> (shown in blue) bound to EGFR. Bonding distances (Å) are indicated by the dotted lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/large/jm-2008-008597_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8008597&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">There are currently two noncovalent EGFR inhibitors on the market, gefitinib and erlotinibm, and one noncovalent erbB2 inhibitor, lapatinib (Figure <a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">13</a>). In addition to maintaining activity against mutations,<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> covalent modification of the target is proposed to be beneficial over competitive inhibition because irreversible inhibition can occur in the presence of millimolar adenosine triphosphate levels within the cell and inhibition can only be overcome by new synthesis of the target, resulting in a sustained effect.<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a></div><figure id="fig13" data-index="25" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/medium/jm-2008-008597_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/large/jm-2008-008597_0015.jpeg" id="gr27" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. EGFR inhibitors gefitinib and erlotinib and ErbB2 inhibitor lapatinib.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/large/jm-2008-008597_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8008597&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_6_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> 5-α-Reductase</h4><div class="NLM_p">5-α-Reductase is an NADPH-dependent enzyme that catalyzes the reduction of testosterone to dihydrotestosterone, the more potent androgen implicated in the development of enlarged prostates. Inhibitors of 5-α-reductase, such as finasteride (<b>1u</b>) and dutasteride (Figure <a data-tab="pane-pcw-Figures" href="#fig14" id="" class=" internalNav">14</a>), are used for the treatment of benign prostatic hyperplasia. <b>1u</b> covalently inhibits 5-α-reductase by forming a reversible, enzyme bound adduct with the NADP cofactor (<b>32</b>). Hydride addition to the β-carbon of the vinylogous amide affords the dihydrofinasteride enolate <b>31</b>, which attacks NADP<sup>+</sup>, forming the NADP−dihydrofinasteride adduct <b>32</b> (Scheme <a class="ref internalNav" href="#sch14" aria-label="14">14</a>).<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a></div><figure id="fig14" data-index="26" class="article__inlineFigure"><h2 class="fig-label">Figure 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/medium/jm-2008-008597_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/large/jm-2008-008597_0016.jpeg" id="gr28" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 14. 5-α-Reductase inhibitors finasteride (<b>1u</b>) and dutasteride.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/large/jm-2008-008597_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8008597&amp;id=fig14"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="sch14" data-index="27" class="article__inlineFigure"><h2 class="fig-label">Scheme 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/medium/jm-2008-008597_0034.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/large/jm-2008-008597_0034.jpeg" id="gs14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 14. Proposed Mechanism of Inhibition of 5-α-Reductase by Finasteride<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/large/jm-2008-008597_0034.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8008597&amp;id=sch14"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>PADRP = phosphoadenosine diphosphoribose.</p></p></figure></div><div id="sec3_6_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> Monoamine Oxidase B</h4><div class="NLM_p">Monoamine oxidase B (MAO-B) is an enzyme that is located in the mitochondrial membrane and is responsible for catalyzing the oxidative deamination of biogenic amines. Selegiline (<b>1v</b>) and rasagiline (Figure <a data-tab="pane-pcw-Figures" href="#fig15" id="" class=" internalNav">15</a>) are used to treat Parkinson’s disease by irreversibly inhibiting MAO-B and therefore inhibiting MAO-B mediated degradation of dopamine postsynaptic release.<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> A covalent adduct with selegiline has been isolated and demonstrated to proceed through the isolloxazone moiety of the FAD cofactor (covalently attached via the C8 to a cysteine, as determined by absorption spectral analysis) (<b>36</b> in Scheme <a class="ref internalNav" href="#sch15" aria-label="15">15</a>).<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> The proposed mechanism for the formation of <b>36</b> involves an initial single electron transfer (SET) to the flavin to generate an aminium radical <b>33</b>. Subsequent steps have been suggested to occur either by Michael addition to the vinylogous iminiumyl cation intermediate (<b>35</b> as depicted in Scheme <a class="ref internalNav" href="#sch15" aria-label="15">15</a>) or by a radical coupling mechanism.<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a> Both mechanisms result in a Michael-type adduct <b>36</b>.</div><figure id="fig15" data-index="28" class="article__inlineFigure"><h2 class="fig-label">Figure 15</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/medium/jm-2008-008597_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/large/jm-2008-008597_0017.jpeg" id="gr30" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 15. MAO-B inhibitors selegiline <b>1v</b> and rasagiline used to treat Alzheimer’s disease.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/large/jm-2008-008597_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8008597&amp;id=fig15"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="sch15" data-index="29" class="article__inlineFigure"><h2 class="fig-label">Scheme 15</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/medium/jm-2008-008597_0035.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/large/jm-2008-008597_0035.jpeg" id="gs15" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 15. One of the Proposed Mechanisms for Formation of the FAD−Selegiline Adduct (Bound through N5 of the Isolloxazone Moiety)<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/large/jm-2008-008597_0035.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8008597&amp;id=sch15"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>MAO-F indicates the MAO−flavin moiety.</p></p></figure></div></div><div id="sec3_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50">VII Pinner Reaction</h3><div id="sec3_7_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> Dipeptidyl Peptidase IV</h4><div class="NLM_p">Diabetes is a disease involving the improper synthesis or use of insulin. Dipeptidyl peptidase IV (DPP-IV) is a serine protease that degrades the incretin hormone glucagon-like peptide 1 (GLP-1), a peptide required for the glucose-dependent regulation of insulin. Inhibition of DPP-IV by vildagliptin (<b>1w</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig16" id="" class=" internalNav">16</a>), approved for use in Europe and under phase III investigation, or saxagliptin increases the level of active GLP-1, resulting in improved glucose tolerance. On the basis of the crystal structures of chemically related pyrrolidine nitriles with DPP-IV, it is believed that vildagliptin forms a reversible covalent imidate ester adduct with the active site serine (Ser610) likely assisted by protonation by a neighboring residue (Figure <a data-tab="pane-pcw-Figures" href="#fig17" id="" class=" internalNav">17</a>).<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a></div><figure id="fig16" data-index="30" class="article__inlineFigure"><h2 class="fig-label">Figure 16</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/medium/jm-2008-008597_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/large/jm-2008-008597_0018.jpeg" id="gr32" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 16. DPP-IV inhibitors vildagliptin (<b>1w</b>), saxagliptin, and sitagliptin.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/large/jm-2008-008597_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8008597&amp;id=fig16"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig17" data-index="31" class="article__inlineFigure"><h2 class="fig-label">Figure 17</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/medium/jm-2008-008597_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/large/jm-2008-008597_0019.jpeg" id="gr33" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 17. Representation of the crystal structure of a pyrrolidine nitrile bound to DPP-IV. It is predicted that vildagliptin and other pyrollidine nitriles bind in a similar fashion.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/large/jm-2008-008597_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8008597&amp;id=fig17"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">A noncovalent DPP IV inhibitor, sitagliptin, was recently approved for use in the U.S. Sitagliptin binds to the same region of the protein as the pyrollidine nitrile compounds, with the amide carbonyl of sitagliptin binding to Tyr547.<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a></div></div><div id="sec3_7_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> Cathepsin K</h4><div class="NLM_p">Cathepsin K (Cat K) is a lysosomal cysteine protease fundamentally involved in osteoclast mediated degradation of the bone. Inhibition of Cat K is proposed to aid in the prevention and progression of osteoporosis. Odanacatib (<b>1x</b>), currently under phase III clinical investigation, is described as a reversible covalent Cat K inhibitor.<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> A published crystal structure of a chemically similar dipeptidic nitrile indicates a covalent bond between the nitrile and the active site Cys25 (Figure <a data-tab="pane-pcw-Figures" href="#fig18" id="" class=" internalNav">18</a>).<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> The resulting thioimidate NH hydrogen-bonds with a neighboring carbonyl group.</div><figure id="fig18" data-index="32" class="article__inlineFigure"><h2 class="fig-label">Figure 18</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/medium/jm-2008-008597_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/large/jm-2008-008597_0020.jpeg" id="gr34" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 18. Schematic representation of the binding mode of a related Cat K inhibitor, shown in blue (based on the crystal structure). Hydrogen bonds are indicated by dotted lines, and values are given in angstrom.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/large/jm-2008-008597_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8008597&amp;id=fig18"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i53">Perspective</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_48162" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_48162" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The examples presented herein provide strong evidence that covalent modifiers can be safe and effective therapeutics. While in many instances the mechanism of inhibition was determined after efficacy was realized, one could adopt a covalent modifier approach from the beginning of a program. One key success factor for this approach is the proper selection of the warhead moiety. Although there are examples of compounds containing very active functionality, such as apirin <b>1e</b> (activated ester) and fosfomycin <b>1i</b> (epoxide), a majority of the successful drugs contain functionality whose reactivity is attenuated to achieve targeted modulation. For example, the binding of rivastigmine <b>1d</b> to acetylcholinesterase activates the carbamate toward cleavage by the active site serine of the catalytic triad. Another elegant example is finasteride <b>1u</b>, which acts as a selective hydride acceptor from NADPH only when bound to 5α-reductase.<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> In addition, the Cat K inhibitor odanacatib <b>1x</b> highlights the reversible nucleophilic addition of an active site thiol to a nitrile. These examples illustrate how the location of the warhead within a structural motif can deliver both the desired therapeutic effect and safety profile.</div><div class="NLM_p">Additionally, the prodrug approach is also valid but arguably more challenging. There are several drugs that utilize a masked warhead as the electrophilic component such as the H<sup>+</sup>/K<sup>+</sup> ATPase inhibitors (exemplified by omeprazole <b>1n</b>), where the reactive species is generated in the acidic environment of the stomach where the drug exercises its antisecretory effect. This target-localized formation of the reactive intermediate reduces systemic exposure and potential for off-target toxicities.<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> The blockbuster drug clopidogrel <b>1o</b> is converted to an active metabolite that is hypothesized to react preferentially with P2Y<sub>12</sub> to prevent stoke.</div><div class="NLM_p">Whether these successful drugs were discovered serendipitously or by design, we can use the insight provided by the available mechanistic and/or structural information to enable future de novo design of selective covalent modifiers. Paramount for success is the availability of detailed structural information on protein−ligand interaction, such as that derived from of X-ray crystallography, to facilitate the refinement of compound design and warhead placement. This approach is elegantly illustrated by the EGFR inhibitor <b>1t</b>, where an appropriately placed Michael acceptor reacts readily with a nucleophilic amino acid side chain when facilitated by assistance from an internal basic amine moiety.</div><div class="NLM_p">A systematic review of the known covalently modulated targets reveals several trends (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>, Charts <a class="ref internalNav" href="#cht1" aria-label="1">1</a> and <a class="ref internalNav" href="#cht2" aria-label="2">2</a>). It is no surprise that the most prevalent covalently modified targets identified are enzymes (Chart <a class="ref internalNav" href="#cht1" aria-label="1">1</a>). As a subset of the overall targets, the cysteine and serine residues are primarily modified, with few examples of other nucleophilic amino acid residues (Chart <a class="ref internalNav" href="#cht2" aria-label="2">2</a>). Among the enzymes, proteases or hydrolases appear frequently. In addition, cofactor mediated enzymes are also represented. These data indicate that cofactor mediated enzymes or enzymes bearing an active site cysteine or serine represent attractive targets for covalent modification.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Targets of Covalent Inhibition</div></div></div><div class="scrollable-table-wrap"><table class="table frame_topbot"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead valign="middle"><tr valign="top"><th align="center" valign="middle">target type</th><th align="center" valign="middle">target</th><th align="center" valign="middle">functionality covalently modified by the protein</th></tr></thead><tbody><tr valign="top"><td align="left" valign="top">serine proteases</td><td align="left" valign="top">serine-type-<span class="smallcaps smallerCapital">d</span>-Ala-<span class="smallcaps smallerCapital">d</span>-Ala carboxypeptidase</td><td align="left" valign="top">β-lactam</td></tr><tr valign="top"><td align="left" valign="top"> </td><td align="left" valign="top">triacylglycerol lipase</td><td align="left" valign="top">lactone</td></tr><tr valign="top"><td align="left" valign="top"> </td><td align="left" valign="top">DPP IV</td><td align="left" valign="top">nitrile</td></tr><tr valign="top"><td align="left" valign="top"> </td><td align="left" valign="top">serine protease hepatitis C virus NS3</td><td align="left" valign="top">ketoamide</td></tr><tr valign="top"><td align="left" valign="top">serine hydrolases</td><td align="left" valign="top">acetylcholinesterase</td><td align="left" valign="top">carbamate</td></tr><tr valign="top"><td align="left" valign="top"> </td><td align="left" valign="top">β-lactamase</td><td align="left" valign="top">β-lactam</td></tr><tr valign="top"><td align="left" valign="top">miscellaneous serine-containing enzymes</td><td align="left" valign="top">prostaglandin endoperoxidase synthase</td><td align="left" valign="top">ester</td></tr><tr valign="top"><td align="left" valign="top">cysteine proteases</td><td align="left" valign="top">cathepsin K</td><td align="left" valign="top">nitrile</td></tr><tr valign="top"><td align="left" valign="top">cysteine-containing enzymes</td><td align="left" valign="top">aldehyde dehydrogenase</td><td align="left" valign="top">disulfide</td></tr><tr valign="top"><td align="left" valign="top"> </td><td align="left" valign="top">H<sup>+</sup>/K<sup>+</sup> ATPase</td><td align="left" valign="top">sulfenamide</td></tr><tr valign="top"><td align="left" valign="top"> </td><td align="left" valign="top">UDP-<i>N</i>-acetylglucosamine-1-carboxyvinyltransferase</td><td align="left" valign="top">epoxide</td></tr><tr valign="top"><td align="left" valign="top"> </td><td align="left" valign="top">vitamin K epoxide reductase (warfarin-sensitive)</td><td align="left" valign="top">coumarin</td></tr><tr valign="top"><td align="left" valign="top"> </td><td align="left" valign="top">ribonucleoside diphosphate reductase</td><td align="left" valign="top">vinyl ketone</td></tr><tr valign="top"><td align="left" valign="top"> </td><td align="left" valign="top">EGFR</td><td align="left" valign="top">unsaturated amide</td></tr><tr valign="top"><td align="left" valign="top"> </td><td align="left" valign="top">thymidylate synthase</td><td align="left" valign="top">unsaturated amide</td></tr><tr valign="top"><td align="left" valign="top">cysteine-containing GPCRs</td><td align="left" valign="top">P2Y12 purinoceptor antagonist</td><td align="left" valign="top">thiol</td></tr><tr valign="top"><td align="left" valign="top"> </td><td align="left" valign="top">5-α-reductase</td><td align="left" valign="top">unsaturated amide</td></tr><tr valign="top"><td align="left" valign="top"> </td><td align="left" valign="top">enol−acyl carrier protein reductase</td><td align="left" valign="top">hydrazide</td></tr><tr valign="top"><td align="left" valign="top">cofactor mediated enzymes</td><td align="left" valign="top">MAO-B</td><td align="left" valign="top">aceylenic imine</td></tr><tr valign="top"><td align="left" valign="top"> </td><td align="left" valign="top">alanine racemase</td><td align="left" valign="top">amine</td></tr><tr valign="top"><td align="left" valign="top"> </td><td align="left" valign="top">GABA-AT</td><td align="left" valign="top">amine</td></tr><tr valign="top"><td align="left" valign="top">seleno-enzyme</td><td align="left" valign="top">thyroxine 5′-deiodinase (type 1)</td><td align="left" valign="top">thiourea</td></tr><tr valign="top"><td align="left" valign="top">metal-containing enzyme (Fe)</td><td align="left" valign="top">aromatase</td><td align="left" valign="top">methyl</td></tr><tr valign="top"><td align="left" valign="top">other</td><td align="left" valign="top">proteasome</td><td align="left" valign="top">boronic acid</td></tr></tbody></table></div></div><figure id="cht1" data-index="33" class="article__inlineFigure"><h2 class="fig-label">Chart 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/medium/jm-2008-008597_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/large/jm-2008-008597_0001.jpeg" id="gc1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 1. Graphical Representation of the Diversity of Target Types</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/large/jm-2008-008597_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8008597&amp;id=cht1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="cht2" data-index="34" class="article__inlineFigure"><h2 class="fig-label">Chart 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/medium/jm-2008-008597_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/large/jm-2008-008597_0002.jpeg" id="gc2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 2. Breakdown of Protein Functionality Modified by Covalent Drug</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/large/jm-2008-008597_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8008597&amp;id=cht2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The strategy to drug a target through employing covalent modifying approach could provide advantages under certain scenarios. There is typically a cost to improving the potency of lead structures that bind through noncovalent interactions. This endeavor must balance increases in molecule weight, lipophilicity, and hydrogen bonding functionality that can be detrimental to other important properties such as pharmacokinetics and ancillary pharmacology. In contrast, when a significant amount of binding energy is derived from the drug−protein covalent bond, there should be a reduction in the number noncovalent interactions needed to achieve desired potency. In the case of irreversible binders, drug concentrations in systemic circulation need only be available for a long enough period to achieve target coverage, potentially deemphasizing the need for a high, prolonged systemic drug load and therefore potentially mitigating off-target activity.<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a> Also, the half-life of the compound need not be long in order to achieve once a day or twice a day dosing. Certainly, reversible noncovalent inhibitors that display slow off-rates would also provide a similar benefit. While there will always be a healthy debate about pursuing molecules that bind covalently, this risk may be minimized by pursuing covalent modifiers that would be administered acutely or to patients with a life threatening disease.</div><div class="NLM_p">Analysis of the pharmacodynamic needs of a particular therapy may lead one to consider irreversible covalent inhibition. For many diseases pharmacodynamic activity is correlated to the degree of target inhibition or occupancy. For therapies that require a high target occupancy for effective treatment, such as cancer or antibacterial therapeutics (where in the absence of high target coverage mutations may occur),<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a> irreversible covalent modulation could be the most effective means of treatment.</div><div class="NLM_p">Conversely, there are therapeutic axes that would not benefit from complete covalent inhibition, wherein the complete shutdown of a primary pathway would lead to on-target toxicities. In these instances, irreversible covalent inhibition may not be appropriate. For example, in the case of warfarin, it is known that using the drug for an extended period of time (or at a high dose) can cause fatal bleeding. For this reason, warfarin is recommended for short-term use; when warfarin is used for long-term thrombosis therapy, patients are closely monitored. That said, the industry is still searching for a safe and effective alternative to warfarin.</div><div class="NLM_p">Whether medicinal chemists pursue covalent or noncovalent modifiers, compounds should be selective for the desired target. This selectivity encompasses related pharmacological targets, as well as other endogenous nucleophilic moieties such as proteins, peptides (such as glutathione), and DNA. In any drug discovery program ancillary pharmacology studies are conducted to assess the potential liability for observing off-target toxicities in addition to in vitro safety studies. While selectivity criteria are identical for programs striving to develop either a covalent or noncovalent modifier, one might consider conducting studies to determine promiscuous binding earlier in a program utilizing a potentially reactive functional group.</div><div class="NLM_p">It is interesting to consider how an organization might become better positioned to exploit covalent modification as a more general approach to drug discovery. For instance, one may consider building a focused screening set that would be populated with low molecular weight compounds that possess “low to moderately” reactive functionality. A lead identified from this collection could be optimized with information from crystallography and modeling studies. Medicinal chemists could further “fine-tune” reactivity, if needed, so covalent adduction is confined to the target protein. Of course opinions regarding an acceptable level of reactivity for a lead structure will always be defined differently throughout the industry. In addition, identification of functional groups beyond those mentioned in this review that selectively form covalent adducts could further enable this strategy.</div><div class="NLM_p">There are a number of covalent modifiers in preclinical or early clinical investigation that will continue to offer insight to this drug discovery strategy, including ones that target the caspases,<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(69)</a> MMP13,<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a> thyroid hormone receptor,<a onclick="showRef(event, 'ref71'); return false;" href="javascript:void(0);" class="ref ref71">(71)</a> and FAAH.<a onclick="showRef(event, 'ref72'); return false;" href="javascript:void(0);" class="ref ref72">(72)</a> Certainly, the presence of small screening or fragment sets comprising compounds with low to moderately reactive functionality will be crucial for providing starting points. Alternatively, one could look to strategically position a warhead within a lead compound. Hopefully, the compilation of examples in this review will inspire drug discovery scientists to consider pursuing covalent modifiers in the future.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Toxicological Effects That Can Result from Covalent Binding</div></div></div><div class="scrollable-table-wrap"><table class="table frame_topbot"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead valign="middle"><tr valign="top"><th align="center" valign="middle">response</th><th align="center" valign="middle">comments</th><th align="center" valign="middle">immune mediated</th><th align="center" valign="middle">direct effect on cellular function</th></tr></thead><tbody><tr valign="top"><td align="left" valign="top">anaphylaxis</td><td align="left" valign="top">Immediate response upon secondary exposure to antigen. Cause: rapid histamine release with accompanying vasodilation, blood pressuredrop.</td><td align="left" valign="top">yes</td><td align="left" valign="top">no</td></tr><tr valign="top"><td align="left" valign="top">blood dyscrasis</td><td align="left" valign="top">Relatively uncommon. Manifests as aplastic anemia, agranulocytosis, hemolytic anemia.</td><td align="left" valign="top">yes</td><td align="left" valign="top">no</td></tr><tr valign="top"><td align="left" valign="top">hepatic reactions</td><td align="left" valign="top">Range of responses from elevated serum transaminase levels (e.g., ALT, AST) to liver failure. Rarely associated with hypersensitivity.</td><td align="left" valign="top">yes</td><td align="left" valign="top">yes</td></tr><tr valign="top"><td align="left" valign="top">cutaneous reactions</td><td align="left" valign="top">Responses range from mild (rash) to severe (Stevens−Johnson syndrome, toxic necrolysis). Included are delayed-type hypersensitivity reactions (DHR) and phototoxicity.</td><td align="left" valign="top">yes</td><td align="left" valign="top">no</td></tr></tbody></table></div></div></div><div class="NLM_back"><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_46715" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_46715" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michele H. Potashman</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry, Amgen Inc., One Kendall Square, Building 1000, Cambridge, Massachusetts 02139</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#adc0c4cec5c8c1c8ddedccc0cac8c383cec2c08dc0ccdfc6edc1c4c3c6c0c8c9c4cec4c3c883cec2c0"><span class="__cf_email__" data-cfemail="533e3a303b363f362313323e34363d7d303c3e">[email protected]</span> <span class="__cf_email__" data-cfemail="e885899a83a884818683858d8c818b81868dc68b8785">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mark E. Duggan</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry, Amgen Inc., One Kendall Square, Building 1000, Cambridge, Massachusetts 02139</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#fc91959f949990998cbc9d919b9992d29f9391dc919d8e97bc90959297919998959f959299d29f9391"><span class="__cf_email__" data-cfemail="b9d4d0dad1dcd5dcc9f9d8d4dedcd797dad6d4">[email protected]</span> <span class="__cf_email__" data-cfemail="b4d9d5c6dff4d8dddadfd9d1d0ddd7dddad19ad7dbd9">[email protected]</span></a></span></div></li></ul></li><li><ul></ul></li><li></li><li></li><li></li></ul></div><div class="testing" data-doi="10.1021/jm8008597" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="bio" rid="ath1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="biographies">Biographies</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_02040" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_02040" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><figure id="ath1" data-index="35" class="article__inlineFigure"><h2 class="fig-label">Michele H. Potashman</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8008597&amp;id="><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Michele H. Potashman</b> earned a B.A. degree in Chemistry (with honors) from the University of Pennsylvania in 1997 and a Ph.D. in Organic Chemistry in 2002 from the Massachusetts Institute of Technology under the guidance of Professor Stephen L. Buchwald. In 2002, she began her professional career at Amgen in Cambridge, MA. She is currently a Senior Scientist in the medicinal chemistry group focused on the discovery of novel agents for the treatment of cancer.</p></figure></div><div class="bio" rid="ath2"><figure id="ath2" data-index="36" class="article__inlineFigure"><h2 class="fig-label">Mark E. Duggan</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8008597&amp;id="><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Mark E. Duggan</b> has over 20 years of experience in the pharmaceutical and biotechnology industry. Prior to joining Link Medicine as Vice President of Chemistry, Mark was Head of the Cambridge Massachusetts Medicinal Chemistry Department of Amgen. Before that, he spent 18 years at Merck & Co. where he was engaged in drug discovery projects in the areas of cardiovascular disease, bone biology, endocrinology, oncology, and neuroscience. Mark is a co-inventor of the antithrombotic agent, Aggrastat. He has authored over 50 publications and is an inventor on 52 patents. Mark holds a Bachelors degree in Chemistry from The Pennsylvania State University and a Ph.D. in Organic Chemistry from University of Pennsylvania under the tutelage of Professor K. C. Nicolaou.</p></figure></div><div class="ack"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i58">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_52657" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_52657" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank J. C. Harmange, Richard Lewis, Yohannes Teffera, and Alan Cheng for fruitful discussions. In addition, we acknowledge Alessandro Boezio’s contribution to the orlistat portion of this review.</p></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i61">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_54014" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_54014" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 72 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Evans, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watt, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicoll-Griffith, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baillie, T. A.</span><span> </span><span class="NLM_article-title">Drug−Protein Adducts. An Industry Perspective on Minimizing the Potential for Drug Bioactivation in Drug Discovery and Development</span> <span class="citation_source-journal">Chem. Res. Toxocol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">3</span><span class="NLM_x">–</span> <span class="NLM_lpage">16</span></span><div class="citationLinks">[<a href="/doi/10.1021/tx034170b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=32&amp;doi=10.1021%2Fjm8008597&amp;key=1%3ACAS%3A528%3ADC%252BD3sXps1ymtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2004&pages=3-16&author=D.+C.+Evansauthor=A.+P.+Wattauthor=D.+A.+Nicoll-Griffithauthor=T.+A.+Baillie&title=Drug%E2%88%92Protein+Adducts.+An+Industry+Perspective+on+Minimizing+the+Potential+for+Drug+Bioactivation+in+Drug+Discovery+and+Development"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1aR"><div class="casContent"><span class="casTitleNuber">1a</span><div class="casTitle"><span class="NLM_cas:atitle">Drug-Protein Adducts: An Industry Perspective on Minimizing the Potential for Drug Bioactivation in Drug Discovery and Development</span></div><div class="casAuthors">Evans, David C.; Watt, Alan P.; Nicoll-Griffith, Deborah A.; Baillie, Thomas A.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">3-16</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  It is generally accepted that there is neither a well-defined nor a consistent link between the formation of drug-protein adducts and organ toxicity.  Because the potential does exist, however, for these processes to be causally related, the general strategy at Merck Research Labs. has been to minimize reactive metabolite formation to the extent possible by appropriate structural modification during the lead optimization stage.  This requires a flexible approach to defining bioactivation issues in a variety of metab. vectors and typically involves the initial use of small mol. trapping agents to define the potential for bioactivation.  At some point, however, there is a requirement to synthesize a radiolabeled tracer and to undertake covalent binding studies in vitro, usually in liver microsomal (and sometimes hepatocyte) prepns. from preclin. species and human, and also in vivo, typically in the rat.  This paper serves to provide one pragmatic approach to addressing the issue of bioactivation from an industry viewpoint based on protocols adopted by Merck Research Labs.  The availability of a dedicated Labeled Compd. Synthesis group, coupled to a close working relationship between Drug Metab. and Medicinal Chem., represents a framework within which this perspective becomes viable; the overall aim is to bring safer drugs to patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOsPmSgJDD8rVg90H21EOLACvtfcHk0lgs_GRaMS_-GA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXps1ymtbg%253D&md5=9ab130c5462b2245e2f4c783afb01d1d</span></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=10.1021%2Ftx034170b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx034170b%26sid%3Dliteratum%253Aachs%26aulast%3DEvans%26aufirst%3DD.%2BC.%26aulast%3DWatt%26aufirst%3DA.%2BP.%26aulast%3DNicoll-Griffith%26aufirst%3DD.%2BA.%26aulast%3DBaillie%26aufirst%3DT.%2BA.%26atitle%3DDrug%25E2%2588%2592Protein%2520Adducts.%2520An%2520Industry%2520Perspective%2520on%2520Minimizing%2520the%2520Potential%2520for%2520Drug%2520Bioactivation%2520in%2520Drug%2520Discovery%2520and%2520Development%26jtitle%3DChem.%2520Res.%2520Toxocol.%26date%3D2004%26volume%3D17%26spage%3D3%26epage%3D16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit1b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Kalgutkar, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardner, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Obach, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaffer, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Callegari, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henne, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mutlib, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dalvie, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Donnel, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harriman, S. P.</span><span> </span><span class="NLM_article-title">A Comprehensive Listing of Bioactivation Pathways of Organic Functional Groups</span> <span class="citation_source-journal">Curr. Drug Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">161</span><span class="NLM_x">–</span> <span class="NLM_lpage">225</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=16&amp;doi=10.1021%2Fjm8008597&amp;key=10.2174%2F1389200054021799" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=8&amp;doi=10.1021%2Fjm8008597&amp;key=15975040" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=32&amp;doi=10.1021%2Fjm8008597&amp;key=1%3ACAS%3A528%3ADC%252BD2MXkvF2is7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2005&pages=161-225&author=A.+S.+Kalgutkarauthor=I.+Gardnerauthor=R.+S.+Obachauthor=C.+L.+Shafferauthor=E.+Callegariauthor=K.+R.+Henneauthor=A.+E.+Mutlibauthor=D.+K.+Dalvieauthor=J.+S.+Leeauthor=Y.+Nakaiauthor=J.+P.+O%E2%80%99Donnelauthor=J.+Boerauthor=S.+P.+Harriman&title=A+Comprehensive+Listing+of+Bioactivation+Pathways+of+Organic+Functional+Groups"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1bR"><div class="casContent"><span class="casTitleNuber">1b</span><div class="casTitle"><span class="NLM_cas:atitle">A comprehensive listing of bioactivation pathways of organic functional groups</span></div><div class="casAuthors">Kalgutkar, Amit S.; Gardner, Iain; Obach, R. Scott; Shaffer, Christopher L.; Callegari, Ernesto; Henne, Kirk R.; Mutlib, Abdul E.; Dalvie, Deepak K.; Lee, Jae S.; Nakai, Yasuhiro; O'Donnell, John P.; Boer, Jason; Harriman, Shawn P.</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Metabolism</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">161-225</span>CODEN:
                <span class="NLM_cas:coden">CDMUBU</span>;
        ISSN:<span class="NLM_cas:issn">1389-2002</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The occurrence of idiosyncratic adverse drug reactions during late clin. trials or after a drug has been released can lead to a severe restriction in its use and even in its withdrawal.  Metabolic activation of relatively inert functional groups to reactive electrophilic intermediates is considered to be an obligatory event in the etiol. of many drug-induced adverse reactions.  Therefore, a thorough examn. of the biochem. reactivity of functional groups/structural motifs in all new drug candidates is essential from a safety standpoint.  A major theme attempted in this review is the comprehensive cataloging of all of the known bioactivation pathways of functional groups or structural motifs commonly utilized in drug design efforts.  Potential strategies in the detection of reactive intermediates in biochem. systems are also discussed.  The intention of this review is not to "black list" functional groups or to immediately discard compds. based on their potential to form reactive metabolites, but rather to serve as a resource describing the structural diversity of these functionalities as well as exptl. approaches that could be taken to evaluate whether a "structural alert" in a new drug candidate undergoes bioactivation to reactive metabolites.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOVj7cmxfwXrVg90H21EOLACvtfcHk0ljOJeO7V3CdnA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXkvF2is7k%253D&md5=b16dfc2de97c40a11218ecc3043bed66</span></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=10.2174%2F1389200054021799&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1389200054021799%26sid%3Dliteratum%253Aachs%26aulast%3DKalgutkar%26aufirst%3DA.%2BS.%26aulast%3DGardner%26aufirst%3DI.%26aulast%3DObach%26aufirst%3DR.%2BS.%26aulast%3DShaffer%26aufirst%3DC.%2BL.%26aulast%3DCallegari%26aufirst%3DE.%26aulast%3DHenne%26aufirst%3DK.%2BR.%26aulast%3DMutlib%26aufirst%3DA.%2BE.%26aulast%3DDalvie%26aufirst%3DD.%2BK.%26aulast%3DLee%26aufirst%3DJ.%2BS.%26aulast%3DNakai%26aufirst%3DY.%26aulast%3DO%25E2%2580%2599Donnel%26aufirst%3DJ.%2BP.%26aulast%3DBoer%26aufirst%3DJ.%26aulast%3DHarriman%26aufirst%3DS.%2BP.%26atitle%3DA%2520Comprehensive%2520Listing%2520of%2520Bioactivation%2520Pathways%2520of%2520Organic%2520Functional%2520Groups%26jtitle%3DCurr.%2520Drug%2520Metab.%26date%3D2005%26volume%3D6%26spage%3D161%26epage%3D225" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit1c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Liebler, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guengerich, F. P.</span><span> </span><span class="NLM_article-title">Elucidating Mechanisms of Drug-Induced Toxicity</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">410</span><span class="NLM_x">–</span> <span class="NLM_lpage">420</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=16&amp;doi=10.1021%2Fjm8008597&amp;key=10.1038%2Fnrd1720" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=8&amp;doi=10.1021%2Fjm8008597&amp;key=15864270" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=32&amp;doi=10.1021%2Fjm8008597&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjs1OktL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2005&pages=410-420&author=D.+C.+Lieblerauthor=F.+P.+Guengerich&title=Elucidating+Mechanisms+of+Drug-Induced+Toxicity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1cR"><div class="casContent"><span class="casTitleNuber">1c</span><div class="casTitle"><span class="NLM_cas:atitle">Elucidating mechanisms of drug-induced toxicity</span></div><div class="casAuthors">Liebler, Daniel C.; Guengerich, F. Peter</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">410-420</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The early and high-throughput application of assays for non-genetic toxicity is of great interest to the pharmaceutical industry, although few systems have been validated as being of good predictive value.  New technologies could enable toxicity to be studied in the context of systems biol.  An important factor to be considered is the metab. of drugs to reactive intermediates.  Chem. reactions of these with cell and tissue nucleophiles are relatively well understood, but predicting how biol. modifications will affect signaling and regulatory networks remains a challenge.  Some of these pathways could be useful as sentinels for toxicity.  This article will cover some examples of drug toxicity and the prospects for future technol. development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAyrioYqM9jLVg90H21EOLACvtfcHk0ljOJeO7V3CdnA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjs1OktL0%253D&md5=3339fb52b3c68682033ad0334de15cae</span></div><a href="/servlet/linkout?suffix=cit1c&amp;dbid=16384&amp;doi=10.1038%2Fnrd1720&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd1720%26sid%3Dliteratum%253Aachs%26aulast%3DLiebler%26aufirst%3DD.%2BC.%26aulast%3DGuengerich%26aufirst%3DF.%2BP.%26atitle%3DElucidating%2520Mechanisms%2520of%2520Drug-Induced%2520Toxicity%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2005%26volume%3D4%26spage%3D410%26epage%3D420" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit1d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Wiliams, D. P.</span><span> </span><span class="NLM_article-title">Toxicophores: Investigations in Drug Safety</span> <span class="citation_source-journal">Toxicology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">226</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">11</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=226&publication_year=2006&pages=1-11&author=D.+P.+Wiliams&title=Toxicophores%3A+Investigations+in+Drug+Safety"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWiliams%26aufirst%3DD.%2BP.%26atitle%3DToxicophores%253A%2520Investigations%2520in%2520Drug%2520Safety%26jtitle%3DToxicology%26date%3D2006%26volume%3D226%26spage%3D1%26epage%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit1e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Park, B., K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pirmohamed, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitteringham, N., R.</span><span> </span><span class="NLM_article-title">Role of Drug Disposition in Drug Hypersensitivity: A Chemical, Molecular and Clinical Perspective</span> <span class="citation_source-journal">Chem. Res. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">969</span><span class="NLM_x">–</span> <span class="NLM_lpage">988</span></span><div class="citationLinks">[<a href="/doi/10.1021/tx980058f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=1998&pages=969-988&author=B.%2C+K.+Parkauthor=M.+Pirmohamedauthor=N.%2C+R.+Kitteringham&title=Role+of+Drug+Disposition+in+Drug+Hypersensitivity%3A+A+Chemical%2C+Molecular+and+Clinical+Perspective"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1e&amp;dbid=16384&amp;doi=10.1021%2Ftx980058f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx980058f%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DB.%252C%2BK.%26aulast%3DPirmohamed%26aufirst%3DM.%26aulast%3DKitteringham%26aufirst%3DN.%252C%2BR.%26atitle%3DRole%2520of%2520Drug%2520Disposition%2520in%2520Drug%2520Hypersensitivity%253A%2520A%2520Chemical%252C%2520Molecular%2520and%2520Clinical%2520Perspective%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D1998%26volume%3D11%26spage%3D969%26epage%3D988" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Naisbitt, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gordon, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pirmohamed, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, K. B.</span><span> </span><span class="NLM_article-title">Immunological Principles of Adverse Drug Reactions</span> <span class="citation_source-journal">Drug Safety</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">483</span><span class="NLM_x">–</span> <span class="NLM_lpage">507</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2000&pages=483-507&author=D.+J.+Naisbittauthor=S.+F.+Gordonauthor=M.+Pirmohamedauthor=K.+B.+Park&title=Immunological+Principles+of+Adverse+Drug+Reactions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNaisbitt%26aufirst%3DD.%2BJ.%26aulast%3DGordon%26aufirst%3DS.%2BF.%26aulast%3DPirmohamed%26aufirst%3DM.%26aulast%3DPark%26aufirst%3DK.%2BB.%26atitle%3DImmunological%2520Principles%2520of%2520Adverse%2520Drug%2520Reactions%26jtitle%3DDrug%2520Safety%26date%3D2000%26volume%3D23%26spage%3D483%26epage%3D507" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit2b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Leubke, R.; House, R.; Kimber, I.</span><span> </span><span class="NLM_article-title">Drug Allergy in Immunotoxicology and Immunopharmacology</span>. In  <span class="citation_source-book">Target Organs Toxicology Series</span>, 3rd ed.; <span class="NLM_publisher-name">CRC Press</span>: <span class="NLM_publisher-loc">Boca Raton, FL</span>,<span class="NLM_x"> </span><span class="NLM_year">2007</span><span class="NLM_x">; </span>Chapter 36, pp  <span class="NLM_fpage">623</span>− <span class="NLM_lpage">632</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&pages=623-632&author=R.+Leubke&author=R.+House&author=I.+Kimber&title=Target+Organs+Toxicology+Series"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DLeubke%26aufirst%3DR.%26atitle%3DDrug%2520Allergy%2520in%2520Immunotoxicology%2520and%2520Immunopharmacology%26btitle%3DTarget%2520Organs%2520Toxicology%2520Series%26pub%3DCRC%2520Press%26date%3D2007%26spage%3D623%26epage%3D632" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Tirmenstein, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, S. D.</span><span> </span><span class="NLM_article-title">Subcellular Finding and Effects on Calcium Homeostasis Produced by Acetaminophen and a Nonhepatotoxic Regioisomer, 3′-Hydroxyacetanilide, in Mouse Liver</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">264</span><span class="NLM_x">, </span> <span class="NLM_fpage">9814</span><span class="NLM_x">–</span> <span class="NLM_lpage">9819</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=264&publication_year=1989&pages=9814-9819&author=M.+A.+Tirmensteinauthor=S.+D.+Nelson&title=Subcellular+Finding+and+Effects+on+Calcium+Homeostasis+Produced+by+Acetaminophen+and+a+Nonhepatotoxic+Regioisomer%2C+3%E2%80%B2-Hydroxyacetanilide%2C+in+Mouse+Liver"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTirmenstein%26aufirst%3DM.%2BA.%26aulast%3DNelson%26aufirst%3DS.%2BD.%26atitle%3DSubcellular%2520Finding%2520and%2520Effects%2520on%2520Calcium%2520Homeostasis%2520Produced%2520by%2520Acetaminophen%2520and%2520a%2520Nonhepatotoxic%2520Regioisomer%252C%25203%25E2%2580%25B2-Hydroxyacetanilide%252C%2520in%2520Mouse%2520Liver%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1989%26volume%3D264%26spage%3D9814%26epage%3D9819" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit3b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Cohen, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pumford, N. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khairallah, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boekelheide, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pohl, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amouzadeh, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hinson, J. A.</span><span> </span><span class="NLM_article-title">Selective Protein Covalent Binding and Target Organ Toxicity</span> <span class="citation_source-journal">Toxicol. Appl. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">143</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">12</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=16&amp;doi=10.1021%2Fjm8008597&amp;key=10.1006%2Ftaap.1996.8074" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=8&amp;doi=10.1021%2Fjm8008597&amp;key=9073586" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=32&amp;doi=10.1021%2Fjm8008597&amp;key=1%3ACAS%3A528%3ADyaK2sXhvVSjs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=143&publication_year=1997&pages=1-12&author=S.+D.+Cohenauthor=N.+R.+Pumfordauthor=E.+A.+Khairallahauthor=K.+Boekelheideauthor=L.+R.+Pohlauthor=H.+R.+Amouzadehauthor=J.+A.+Hinson&title=Selective+Protein+Covalent+Binding+and+Target+Organ+Toxicity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3bR"><div class="casContent"><span class="casTitleNuber">3b</span><div class="casTitle"><span class="NLM_cas:atitle">Selective protein covalent binding and target organ toxicity</span></div><div class="casAuthors">Cohen, Steven D.; Pumford, Neil R.; Khairallah, Edward A.; Boekelheide, Kim; Pohl, Lance R.; Amouzadeh, H. R.; Hinson, Jack A.</div><div class="citationInfo"><span class="NLM_cas:title">Toxicology and Applied Pharmacology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">143</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-12</span>CODEN:
                <span class="NLM_cas:coden">TXAPA9</span>;
        ISSN:<span class="NLM_cas:issn">0041-008X</span>.
    
            (<span class="NLM_cas:orgname">Academic</span>)
        </div><div class="casAbstract">A review and discussion with many refs.  Protein covalent binding by xenobiotic metabolites has long been assocd. with target organ toxicity but mechanistic involvement of such binding has not been widely demonstrated.  Modern biochem., mol., and immunochem. approaches have facilitated identification of specific protein targets of xenobiotic covalent binding.  Such studies have revealed that protein covalent binding is not random, but rather selective with respect to the proteins targeted.  Selective binding to specific cellular target proteins may better correlate with toxicity than total protein covalent binding.  Current research is directed at characterizing and identifying the targeted proteins and clarifying the effect of such binding on their structure, function, and potential roles in target organ toxicity.  The approaches employed to detect and identify the targeted proteins are described.  Metabolites of acetaminophen, halothane, and 2,5-hexanedione form covalently bound adducts to recently identified protein targets.  The selective binding may influence homeostatic or other cellular responses which in turn contribute to drug toxicity, hypersensitivity, or autoimmunity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGps8YnY6hReKLVg90H21EOLACvtfcHk0lh_bL-surTxHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXhvVSjs74%253D&md5=819153f53ae0570c3a1af4e95e6a6af9</span></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=10.1006%2Ftaap.1996.8074&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Ftaap.1996.8074%26sid%3Dliteratum%253Aachs%26aulast%3DCohen%26aufirst%3DS.%2BD.%26aulast%3DPumford%26aufirst%3DN.%2BR.%26aulast%3DKhairallah%26aufirst%3DE.%2BA.%26aulast%3DBoekelheide%26aufirst%3DK.%26aulast%3DPohl%26aufirst%3DL.%2BR.%26aulast%3DAmouzadeh%26aufirst%3DH.%2BR.%26aulast%3DHinson%26aufirst%3DJ.%2BA.%26atitle%3DSelective%2520Protein%2520Covalent%2520Binding%2520and%2520Target%2520Organ%2520Toxicity%26jtitle%3DToxicol.%2520Appl.%2520Pharmacol.%26date%3D1997%26volume%3D143%26spage%3D1%26epage%3D12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><div class="note"><p class="first last">As the FDA does not require data on covalent binding studies with serum proteins or assessments of intrinsic reactivity with nucleophiles such as glutathione, there is little, if any, information available on these properties of the approved or investigational drugs.</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=As+the+FDA+does+not+require+data+on+covalent+binding+studies+with+serum+proteins+or+assessments+of+intrinsic+reactivity+with+nucleophiles+such+as+glutathione%2C+there+is+little%2C+if+any%2C+information+available+on+these+properties+of+the+approved+or+investigational+drugs."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><div class="note"><p class="first last">A drug that binds by strong metal chelation is allopurinol, the xanthine oxidase (molybdenum) chelator. Allopurinol is oxidized to the active form alloxanthine, which tightly binds to the partially reduced molybdenum center of the enzyme. This event makes binding functionally irreversible, however, through a dative bond.</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=A+drug+that+binds+by+strong+metal+chelation+is+allopurinol%2C+the+xanthine+oxidase+%28molybdenum%29+chelator.+Allopurinol+is+oxidized+to+the+active+form+alloxanthine%2C+which+tightly+binds+to+the+partially+reduced+molybdenum+center+of+the+enzyme.+This+event+makes+binding+functionally+irreversible%2C+however%2C+through+a+dative+bond."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5a"><span><span class="NLM_contrib-group">Truglio, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Theis, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leimkuhler, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rappa, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajagopalan, K. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kisker, C.</span><span> </span><span class="NLM_article-title">Crystal Structures of the Active and Alloxanthine-Inhibited Forms of Xanthine Dehydrogenase from <i>Rhodobacter capsulatus</i></span> <span class="citation_source-journal">Structure</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">115</span><span class="NLM_x">–</span> <span class="NLM_lpage">125</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2002&pages=115-125&author=J.+J.+Truglioauthor=K.+Theisauthor=S.+Leimkuhlerauthor=R.+Rappaauthor=K.+V.+Rajagopalanauthor=C.+Kisker&title=Crystal+Structures+of+the+Active+and+Alloxanthine-Inhibited+Forms+of+Xanthine+Dehydrogenase+from+Rhodobacter+capsulatus"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTruglio%26aufirst%3DJ.%2BJ.%26aulast%3DTheis%26aufirst%3DK.%26aulast%3DLeimkuhler%26aufirst%3DS.%26aulast%3DRappa%26aufirst%3DR.%26aulast%3DRajagopalan%26aufirst%3DK.%2BV.%26aulast%3DKisker%26aufirst%3DC.%26atitle%3DCrystal%2520Structures%2520of%2520the%2520Active%2520and%2520Alloxanthine-Inhibited%2520Forms%2520of%2520Xanthine%2520Dehydrogenase%2520from%2520Rhodobacter%2520capsulatus%26jtitle%3DStructure%26date%3D2002%26volume%3D10%26spage%3D115%26epage%3D125" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="note"><p class="first last">For other references, see the following:</p></div><div class="NLM_citation" id="cit5c"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Rastelli, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Costantino, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albasani, A.</span><span> </span><span class="NLM_article-title">A Model of the Interaction of Substrates and Inhibitors with Xanthine Oxidase</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">119</span><span class="NLM_x">, </span> <span class="NLM_fpage">3007</span><span class="NLM_x">–</span> <span class="NLM_lpage">3016</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja962309h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=1997&pages=3007-3016&author=G.+Rastelliauthor=L.+Costantinoauthor=A.+Albasani&title=A+Model+of+the+Interaction+of+Substrates+and+Inhibitors+with+Xanthine+Oxidase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5c&amp;dbid=16384&amp;doi=10.1021%2Fja962309h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja962309h%26sid%3Dliteratum%253Aachs%26aulast%3DRastelli%26aufirst%3DG.%26aulast%3DCostantino%26aufirst%3DL.%26aulast%3DAlbasani%26aufirst%3DA.%26atitle%3DA%2520Model%2520of%2520the%2520Interaction%2520of%2520Substrates%2520and%2520Inhibitors%2520with%2520Xanthine%2520Oxidase%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1997%26volume%3D119%26spage%3D3007%26epage%3D3016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5d"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Spector, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johns, D. G.</span><span> </span><span class="NLM_article-title">Stoichiometric Inhibition of Reduced Xanthine Oxidase by Hydrioyrazolo[3,4-<i>d</i>]pyrimidines</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1970</span><span class="NLM_x">, </span> <span class="NLM_volume">245</span><span class="NLM_x">, </span> <span class="NLM_fpage">5079</span><span class="NLM_x">–</span> <span class="NLM_lpage">5085</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=245&publication_year=1970&pages=5079-5085&author=T.+Spectorauthor=D.+G.+Johns&title=Stoichiometric+Inhibition+of+Reduced+Xanthine+Oxidase+by+Hydrioyrazolo%5B3%2C4-d%5Dpyrimidines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSpector%26aufirst%3DT.%26aulast%3DJohns%26aufirst%3DD.%2BG.%26atitle%3DStoichiometric%2520Inhibition%2520of%2520Reduced%2520Xanthine%2520Oxidase%2520by%2520Hydrioyrazolo%255B3%252C4-d%255Dpyrimidines%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1970%26volume%3D245%26spage%3D5079%26epage%3D5085" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><div class="note"><p class="first last">For example, see the following:</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=For+example%2C+see+the+following%3A"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6a"><span><span class="NLM_contrib-group">Furman, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">St. Clair, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spector, T.</span><span> </span><span class="NLM_article-title">Acyclovir Triphosphate Is a Suicide Inactivator of the Herpes Simplex Virus DNA Polymerase</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1984</span><span class="NLM_x">, </span> <span class="NLM_volume">259</span><span class="NLM_x">, </span> <span class="NLM_fpage">9575</span><span class="NLM_x">–</span> <span class="NLM_lpage">9579</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=259&publication_year=1984&pages=9575-9579&author=P.+A.+Furmanauthor=M.+H.+St.+Clairauthor=T.+Spector&title=Acyclovir+Triphosphate+Is+a+Suicide+Inactivator+of+the+Herpes+Simplex+Virus+DNA+Polymerase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFurman%26aufirst%3DP.%2BA.%26aulast%3DSt.%2BClair%26aufirst%3DM.%2BH.%26aulast%3DSpector%26aufirst%3DT.%26atitle%3DAcyclovir%2520Triphosphate%2520Is%2520a%2520Suicide%2520Inactivator%2520of%2520the%2520Herpes%2520Simplex%2520Virus%2520DNA%2520Polymerase%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1984%26volume%3D259%26spage%3D9575%26epage%3D9579" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><div class="note"><p class="first last">For a review of prodrugs, see the following:</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=For+a+review+of+prodrugs%2C+see+the+following%3A"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit7a"><span><span class="NLM_contrib-group">Ettmayer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amidon, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clement, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Testa, B.</span><span> </span><span class="NLM_article-title">Lessons Learned from Marketed and Investigational Prodrugs</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">2393</span><span class="NLM_x">–</span> <span class="NLM_lpage">2404</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0303812" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=32&amp;doi=10.1021%2Fjm8008597&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjtVSqsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=2393-2404&author=P.+Ettmayerauthor=G.+L.+Amidonauthor=B.+Clementauthor=B.+Testa&title=Lessons+Learned+from+Marketed+and+Investigational+Prodrugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7aR"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Lessons Learned from Marketed and Investigational Prodrugs</span></div><div class="casAuthors">Ettmayer, Peter; Amidon, Gordon L.; Clement, Bernd; Testa, Bernard</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2393-2404</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  This article provide arguments and guidelines for the early recourse to, and successful application of, a prodrug strategy in drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpw0Hg--zru8LVg90H21EOLACvtfcHk0lh_bL-surTxHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjtVSqsbY%253D&md5=839aadef2d64e14b5e311c2e8e8d9b83</span></div><a href="/servlet/linkout?suffix=cit7a&amp;dbid=16384&amp;doi=10.1021%2Fjm0303812&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0303812%26sid%3Dliteratum%253Aachs%26aulast%3DEttmayer%26aufirst%3DP.%26aulast%3DAmidon%26aufirst%3DG.%2BL.%26aulast%3DClement%26aufirst%3DB.%26aulast%3DTesta%26aufirst%3DB.%26atitle%3DLessons%2520Learned%2520from%2520Marketed%2520and%2520Investigational%2520Prodrugs%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D2393%26epage%3D2404" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="note"><p class="first last">An overview of enzymes targeted by covalent modulators can be found in</p></div><div class="NLM_citation" id="cit8a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Robertson, J. G.</span><span> </span><span class="NLM_article-title">Mechanistic Basis of Enzyme−Target Drugs</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">5561</span><span class="NLM_x">–</span> <span class="NLM_lpage">5571</span><div class="note"><p class="first last">including supplemental data</p></div></span><div class="citationLinks">[<a href="/doi/10.1021/bi050247e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2005&pages=5561-5571&author=J.+G.+Robertson&title=Mechanistic+Basis+of+Enzyme%E2%88%92Target+Drugs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8a&amp;dbid=16384&amp;doi=10.1021%2Fbi050247e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi050247e%26sid%3Dliteratum%253Aachs%26aulast%3DRobertson%26aufirst%3DJ.%2BG.%26atitle%3DMechanistic%2520Basis%2520of%2520Enzyme%25E2%2588%2592Target%2520Drugs%26jtitle%3DBiochemistry%26date%3D2005%26volume%3D44%26spage%3D5561%26epage%3D5571" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit8b"><span><div class="note"><p class="first last">For a general review covering irreversible inhibitors, see review chapter:</p></div><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Tipton, K. F.</span> <span class="citation_source-book">Enzymes: Irreversible Inhibition in Handbook of Proteins</span>; <span class="NLM_publisher-name">John Wiley & Sons Ltd.</span>: <span class="NLM_publisher-loc">Chichester, U.K.</span>,<span class="NLM_x"> </span><span class="NLM_year">2007</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">490</span>− <span class="NLM_lpage">503</span>. <div class="note"><p class="first last">Target-specific reviews include the following:</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&pages=490-503&author=K.+F.+Tipton&title=Enzymes%3A+Irreversible+Inhibition+in+Handbook+of+Proteins"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DTipton%26aufirst%3DK.%2BF.%26btitle%3DEnzymes%253A%2520Irreversible%2520Inhibition%2520in%2520Handbook%2520of%2520Proteins%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%2520Ltd%26date%3D2007%26spage%3D490%26epage%3D503" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit8c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Powers, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asgian, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ekici, O. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, K. E.</span><span> </span><span class="NLM_article-title">Irreversible Inhibitors of Serine, Cysteine, and Threonine Proteases</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">4639</span><span class="NLM_x">–</span> <span class="NLM_lpage">4750</span></span><div class="citationLinks">[<a href="/doi/10.1021/cr010182v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref8/cit8c&amp;dbid=32&amp;doi=10.1021%2Fjm8008597&amp;key=1%3ACAS%3A528%3ADC%252BD38XosFSnsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2002&pages=4639-4750&author=J.+C.+Powersauthor=J.+L.+Asgianauthor=O.+D.+Ekiciauthor=K.+E.+James&title=Irreversible+Inhibitors+of+Serine%2C+Cysteine%2C+and+Threonine+Proteases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8cR"><div class="casContent"><span class="casTitleNuber">8c</span><div class="casTitle"><span class="NLM_cas:atitle">Irreversible inhibitors of serine, cysteine, and threonine proteases</span></div><div class="casAuthors">Powers, James C.; Asgian, Juliana L.; Ekici, Oezlem Dogan; James, Karen Ellis</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">4639-4750</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Topics discussed include alkylating, acylating, phosphonylating, and sulfonylating agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGorivaxGhmhirVg90H21EOLACvtfcHk0lhf08Tut7wN1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XosFSnsr4%253D&md5=eb21ff0297b87537a7d459c92f13c75d</span></div><a href="/servlet/linkout?suffix=cit8c&amp;dbid=16384&amp;doi=10.1021%2Fcr010182v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr010182v%26sid%3Dliteratum%253Aachs%26aulast%3DPowers%26aufirst%3DJ.%2BC.%26aulast%3DAsgian%26aufirst%3DJ.%2BL.%26aulast%3DEkici%26aufirst%3DO.%2BD.%26aulast%3DJames%26aufirst%3DK.%2BE.%26atitle%3DIrreversible%2520Inhibitors%2520of%2520Serine%252C%2520Cysteine%252C%2520and%2520Threonine%2520Proteases%26jtitle%3DChem.%2520Rev.%26date%3D2002%26volume%3D102%26spage%3D4639%26epage%3D4750" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit8d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Bridges, A. J.</span><span> </span><span class="NLM_article-title">The Rationale and Strategy Used To Develop a Series of Highly Potent, Irreversible, Inhibitors of the Epidermal Growth Factor Receptor Family of Tyrosine Kinase</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">825</span><span class="NLM_x">–</span> <span class="NLM_lpage">843</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8d&amp;dbid=8&amp;doi=10.1021%2Fjm8008597&amp;key=10495354" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8d&amp;dbid=32&amp;doi=10.1021%2Fjm8008597&amp;key=1%3ACAS%3A528%3ADyaK1MXlvFWqtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1999&pages=825-843&author=A.+J.+Bridges&title=The+Rationale+and+Strategy+Used+To+Develop+a+Series+of+Highly+Potent%2C+Irreversible%2C+Inhibitors+of+the+Epidermal+Growth+Factor+Receptor+Family+of+Tyrosine+Kinase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8dR"><div class="casContent"><span class="casTitleNuber">8d</span><div class="casTitle"><span class="NLM_cas:atitle">The rationale and strategy used to develop a series of highly potent, irreversible, inhibitors of the Epidermal Growth Factor receptor family of tyrosine kinases</span></div><div class="casAuthors">Bridges, A. J.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">825-843</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers</span>)
        </div><div class="casAbstract">A review with 122 refs.  The Epidermal Growth Factor receptor (EGFr) was one of the first oncogenes identified, and it, or its ligands Epidermal Growth Factor (EGF) and Transforming Growth Factor α (TGFα) are overexpressed in most clin. tumors.  As EGF and TGFα are potent mitogens, it appeared that inhibition of EGFr signaling would be a viable anti-proliferative strategy.  Screening found several classes of EGFr inhibitor, one of which, the indolinethiones was developed.  The SAR, in common with that of other first generation tyrosine kinase (TK) inhibitors was flat, and potency was poor.  Rescreening in presence of a thiol, to remove chem. reactive species, identified only two leads, a pyridopyrimidine and a quinazoline.  These were developed into a very broad class of EGFr inhibitors, with great potency and selectivity for EGFr, but poor physicochem. properties, and little if any in vivo anti-tumor activity.  Meanwhile the complex role of other members of the EGFr TK family in oncogenesis, was becoming apparent, suggesting that the whole EGFr family should be inhibited.  The difficulty of finding potent compds. with acceptable pharmacokinetics also suggested that irreversible inhibitors of the TK might produce better in vivo profiles.  Modeling suggested that the unusual Cys773 residue might be reached from the 6/7-positions of quinazoline and pyridopyrimidine inhibitors.  Inhibitors with acrylamides at these positions proved to be irreversible alkylating agents for both EGFr and erbB-2 with cellular inhibitory activities in the low nanomolar range, and very potent in vivo antitumor activity.  Optimized inhibitors had exceptionally potent oral antitumor activity, with negligible cytotoxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCfxlExE175LVg90H21EOLACvtfcHk0lhf08Tut7wN1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXlvFWqtb8%253D&md5=36f387aecf4c6e676591383bf25a10ca</span></div><a href="/servlet/linkout?suffix=cit8d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBridges%26aufirst%3DA.%2BJ.%26atitle%3DThe%2520Rationale%2520and%2520Strategy%2520Used%2520To%2520Develop%2520a%2520Series%2520of%2520Highly%2520Potent%252C%2520Irreversible%252C%2520Inhibitors%2520of%2520the%2520Epidermal%2520Growth%2520Factor%2520Receptor%2520Family%2520of%2520Tyrosine%2520Kinase%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D1999%26volume%3D6%26spage%3D825%26epage%3D843" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit8e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Ghisa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wenz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thorpe, C.</span><span> </span><span class="NLM_article-title">Suicide Substrates as Irreversible Inhibitors of Flavoenzymes</span> <span class="citation_source-journal">Enzyme Inhib., Proc. Meet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1980</span><span class="NLM_x">, </span> <span class="NLM_fpage">43</span><span class="NLM_x">–</span> <span class="NLM_lpage">60</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1980&pages=43-60&author=S.+Ghisaauthor=A.+Wenzauthor=C.+Thorpe&title=Suicide+Substrates+as+Irreversible+Inhibitors+of+Flavoenzymes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGhisa%26aufirst%3DS.%26aulast%3DWenz%26aufirst%3DA.%26aulast%3DThorpe%26aufirst%3DC.%26atitle%3DSuicide%2520Substrates%2520as%2520Irreversible%2520Inhibitors%2520of%2520Flavoenzymes%26jtitle%3DEnzyme%2520Inhib.%252C%2520Proc.%2520Meet.%26date%3D1980%26spage%3D43%26epage%3D60" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Fung, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thornton, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mybeck, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J. H.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hornbuckle, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muniz, E.</span><span> </span><span class="NLM_article-title">Evaluation of the Characteristics of Safety Withdrawl of Prescription Drugs from Worldwide Pharmaceutical Markets: 1960 to 1999</span> <span class="citation_source-journal">Drug. Inf. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">293</span><span class="NLM_x">–</span> <span class="NLM_lpage">317</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=16&amp;doi=10.1021%2Fjm8008597&amp;key=10.1177%2F009286150103500134" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2001&pages=293-317&author=M.+Fungauthor=A.+Thorntonauthor=K.+Mybeckauthor=J.+H.-H.+Wuauthor=K.+Hornbuckleauthor=E.+Muniz&title=Evaluation+of+the+Characteristics+of+Safety+Withdrawl+of+Prescription+Drugs+from+Worldwide+Pharmaceutical+Markets%3A+1960+to+1999"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9a&amp;dbid=16384&amp;doi=10.1177%2F009286150103500134&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F009286150103500134%26sid%3Dliteratum%253Aachs%26aulast%3DFung%26aufirst%3DM.%26aulast%3DThornton%26aufirst%3DA.%26aulast%3DMybeck%26aufirst%3DK.%26aulast%3DWu%26aufirst%3DJ.%2BH.-H.%26aulast%3DHornbuckle%26aufirst%3DK.%26aulast%3DMuniz%26aufirst%3DE.%26atitle%3DEvaluation%2520of%2520the%2520Characteristics%2520of%2520Safety%2520Withdrawl%2520of%2520Prescription%2520Drugs%2520from%2520Worldwide%2520Pharmaceutical%2520Markets%253A%25201960%2520to%25201999%26jtitle%3DDrug.%2520Inf.%2520J.%26date%3D2001%26volume%3D35%26spage%3D293%26epage%3D317" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit9b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Schuster, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laggner, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langer, T.</span><span> </span><span class="NLM_article-title">Why Drugs Fail. A Study on Side Effects in New Chemical Entities</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">3545</span><span class="NLM_x">–</span> <span class="NLM_lpage">3559</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=16&amp;doi=10.1021%2Fjm8008597&amp;key=10.2174%2F138161205774414510" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=8&amp;doi=10.1021%2Fjm8008597&amp;key=16248807" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=32&amp;doi=10.1021%2Fjm8008597&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVWrs7rE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2005&pages=3545-3559&author=D.+Schusterauthor=C.+Laggnerauthor=T.+Langer&title=Why+Drugs+Fail.+A+Study+on+Side+Effects+in+New+Chemical+Entities"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9bR"><div class="casContent"><span class="casTitleNuber">9b</span><div class="casTitle"><span class="NLM_cas:atitle">Why drugs fail - a study on side effects in new chemical entities</span></div><div class="casAuthors">Schuster, D.; Laggner, C.; Langer, T.</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">27</span>),
    <span class="NLM_cas:pages">3545-3559</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Our study focuses on the reasons for market withdrawals of drugs and drug development project terminations in clin. phases I-III from 1992 to 2002.  Over 90% of the market withdrawals were caused by drug toxicity.  Hepatotoxicity and cardiovascular toxicity proved to be the major causes for two out of three market withdrawals in the resp. time period.  In clin. phases I-III 43% of drug development project terminations were due to insufficient efficacy of the investigated compd.  The second important issue, which caused one third of the projects to be closed, was toxicity.  ADME parameters and economic and other reasons played a minor role.  The results of our study indicate that compared with previous studies on this subject, no major improvements have been achieved in the last decade.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrL6dIqIHxrybVg90H21EOLACvtfcHk0lj0GBOl31Eaiw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVWrs7rE&md5=1bef8ba43d434392969566c3e6052cf8</span></div><a href="/servlet/linkout?suffix=cit9b&amp;dbid=16384&amp;doi=10.2174%2F138161205774414510&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161205774414510%26sid%3Dliteratum%253Aachs%26aulast%3DSchuster%26aufirst%3DD.%26aulast%3DLaggner%26aufirst%3DC.%26aulast%3DLanger%26aufirst%3DT.%26atitle%3DWhy%2520Drugs%2520Fail.%2520A%2520Study%2520on%2520Side%2520Effects%2520in%2520New%2520Chemical%2520Entities%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2005%26volume%3D11%26spage%3D3545%26epage%3D3559" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Amacher, D. E.</span><span> </span><span class="NLM_article-title">Reactive Intermediates and the Pathogenesis of Adverse Drug Reactions: The Toxicology Perspective</span> <span class="citation_source-journal">Curr. Drug Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">219</span><span class="NLM_x">–</span> <span class="NLM_lpage">229</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm8008597&amp;key=10.2174%2F138920006776359284" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm8008597&amp;key=16611018" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm8008597&amp;key=1%3ACAS%3A528%3ADC%252BD28Xjs12jt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2006&pages=219-229&author=D.+E.+Amacher&title=Reactive+Intermediates+and+the+Pathogenesis+of+Adverse+Drug+Reactions%3A+The+Toxicology+Perspective"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Reactive intermediates and the pathogenesis of adverse drug reactions: the toxicology perspective</span></div><div class="casAuthors">Amacher, David E.</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Metabolism</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">219-229</span>CODEN:
                <span class="NLM_cas:coden">CDMUBU</span>;
        ISSN:<span class="NLM_cas:issn">1389-2002</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Severe adverse drug responses are infrequent but occasionally serious events that are not readily predictable at the preclin. development level using only non-human or in vitro models.  A common characteristic of the more serious toxicities is generation of short-lived and highly reactive electrophilic species in some individuals.  The objective here is to review the literature for toxicol. mechanisms that underlie known adverse drug reactions and then categorize the biol. consequences of reactive chem. intermediates and radicals in terms of human risk factors and known metabolic variables.  Xenobiotics described as being assocd. with rare but potentially serious adverse events affecting liver, skin, or causing blood dyscrasias tend to have three of four essential characteristics, (1) they are capable of forming short-lived reactive intermediates (RI) or free radicals in target tissues under ideal conditions that are distinct from primary metabolic products, (2) these RI escape/overwhelm the detoxification mechanisms assocd. with the site of origin or form toxic conjugates, (3) the unconjugated RI must either selectively damage crit. proteins or other key macromols. or (4) the RI acts as a hapten and stimulates an immunol. (hypersensitivity) response or overcomes tolerance.  Some risk factors may increase the probability of susceptibility, but this remains an active area of research.  Because of the complexity of the pathogenesis of some injuries and the role of individual factors, no highly predictive in vitro screening methods are available; however, several methods are evolving that may be used to reveal mechanisms of action when a serious adverse effect is encountered.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoze87op4UtTbVg90H21EOLACvtfcHk0lj0GBOl31Eaiw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xjs12jt7w%253D&md5=42251ea18356164392b8b95386ffd06a</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.2174%2F138920006776359284&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138920006776359284%26sid%3Dliteratum%253Aachs%26aulast%3DAmacher%26aufirst%3DD.%2BE.%26atitle%3DReactive%2520Intermediates%2520and%2520the%2520Pathogenesis%2520of%2520Adverse%2520Drug%2520Reactions%253A%2520The%2520Toxicology%2520Perspective%26jtitle%3DCurr.%2520Drug%2520Metab.%26date%3D2006%26volume%3D7%26spage%3D219%26epage%3D229" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Hadvary, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sidler, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meister, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vetter, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolfer, H.</span><span> </span><span class="NLM_article-title">The Lipase Inhibitor Tetrahydrolipstatin Binds Covalently to the Putative Active Site Serine of Pancreatic Lipase</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">266</span><span class="NLM_x">, </span> <span class="NLM_fpage">2021</span><span class="NLM_x">–</span> <span class="NLM_lpage">2027</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=266&publication_year=1991&pages=2021-2027&author=P.+Hadvaryauthor=W.+Sidlerauthor=W.+Meisterauthor=W.+Vetterauthor=H.+Wolfer&title=The+Lipase+Inhibitor+Tetrahydrolipstatin+Binds+Covalently+to+the+Putative+Active+Site+Serine+of+Pancreatic+Lipase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHadvary%26aufirst%3DP.%26aulast%3DSidler%26aufirst%3DW.%26aulast%3DMeister%26aufirst%3DW.%26aulast%3DVetter%26aufirst%3DW.%26aulast%3DWolfer%26aufirst%3DH.%26atitle%3DThe%2520Lipase%2520Inhibitor%2520Tetrahydrolipstatin%2520Binds%2520Covalently%2520to%2520the%2520Putative%2520Active%2520Site%2520Serine%2520of%2520Pancreatic%2520Lipase%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1991%26volume%3D266%26spage%3D2021%26epage%3D2027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Guerciolini, R.</span><span> </span><span class="NLM_article-title">Mode of Action of Orlistat</span> <span class="citation_source-journal">Int. J. Obes.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl. 3</span><span class="NLM_x">) </span> <span class="NLM_fpage">S12</span><span class="NLM_x">–</span> <span class="NLM_lpage">S23</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=1997&pages=S12-S23&issue=Suppl.+3&author=R.+Guerciolini&title=Mode+of+Action+of+Orlistat"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGuerciolini%26aufirst%3DR.%26atitle%3DMode%2520of%2520Action%2520of%2520Orlistat%26jtitle%3DInt.%2520J.%2520Obes.%26date%3D1997%26volume%3D21%26issue%3DSuppl.%25203%26spage%3DS12%26epage%3DS23" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Lu, W.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kincaid, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bauer, M. D.</span><span> </span><span class="NLM_article-title">Kinetics of β-Lactam Interactions with Penicillin-Susceptible and -Resistant Penicillin-Binding Protein 2× Proteins from <i>Streptococcus pneumoniae</i>: Involvement of Acylation and Deacylation in β-Lactam Resistance</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">276</span><span class="NLM_x">, </span> <span class="NLM_fpage">31494</span><span class="NLM_x">–</span> <span class="NLM_lpage">31501</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2001&pages=31494-31501&author=W.-P.+Luauthor=E.+Kincaidauthor=Y.+Sunauthor=M.+D.+Bauer&title=Kinetics+of+%CE%B2-Lactam+Interactions+with+Penicillin-Susceptible+and+-Resistant+Penicillin-Binding+Protein+2%C3%97+Proteins+from+Streptococcus+pneumoniae%3A+Involvement+of+Acylation+and+Deacylation+in+%CE%B2-Lactam+Resistance"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DW.-P.%26aulast%3DKincaid%26aufirst%3DE.%26aulast%3DSun%26aufirst%3DY.%26aulast%3DBauer%26aufirst%3DM.%2BD.%26atitle%3DKinetics%2520of%2520%25CE%25B2-Lactam%2520Interactions%2520with%2520Penicillin-Susceptible%2520and%2520-Resistant%2520Penicillin-Binding%2520Protein%25202%25C3%2597%2520Proteins%2520from%2520Streptococcus%2520pneumoniae%253A%2520Involvement%2520of%2520Acylation%2520and%2520Deacylation%2520in%2520%25CE%25B2-Lactam%2520Resistance%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2001%26volume%3D276%26spage%3D31494%26epage%3D31501" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><div class="note"><p class="first last">Data presented for penicillin allergy.</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Data+presented+for+penicillin+allergy."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit14a"><span><span class="NLM_contrib-group">Bigby, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jick, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jick, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arndt, K.</span><span> </span><span class="NLM_article-title">Drug-Induced Cutaneous Reactions: A Report from the Boston Collaborative Drug Surveillance Program on 15,438 Consecutive Inpatients, 1975 to 1982</span> <span class="citation_source-journal">JAMA, J. Am. Med. Assoc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1986</span><span class="NLM_x">, </span> <span class="NLM_volume">256</span><span class="NLM_x">, </span> <span class="NLM_fpage">3358</span><span class="NLM_x">–</span> <span class="NLM_lpage">3363</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=256&publication_year=1986&pages=3358-3363&author=M.+Bigbyauthor=S.+Jickauthor=H.+Jickauthor=K.+Arndt&title=Drug-Induced+Cutaneous+Reactions%3A+A+Report+from+the+Boston+Collaborative+Drug+Surveillance+Program+on+15%2C438+Consecutive+Inpatients%2C+1975+to+1982"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBigby%26aufirst%3DM.%26aulast%3DJick%26aufirst%3DS.%26aulast%3DJick%26aufirst%3DH.%26aulast%3DArndt%26aufirst%3DK.%26atitle%3DDrug-Induced%2520Cutaneous%2520Reactions%253A%2520A%2520Report%2520from%2520the%2520Boston%2520Collaborative%2520Drug%2520Surveillance%2520Program%2520on%252015%252C438%2520Consecutive%2520Inpatients%252C%25201975%2520to%25201982%26jtitle%3DJAMA%252C%2520J.%2520Am.%2520Med.%2520Assoc.%26date%3D1986%26volume%3D256%26spage%3D3358%26epage%3D3363" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><div class="note"><p class="first last">Although the precise factor(s) have not been identified, it has been shown that ultrafiltration of serum reduces penicillin binding. However, when the ultrafiltered serum was reconstituted with serum ultrafiltrate, the binding capacity was restored to 82% of that of intact serum.</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Although+the+precise+factor%28s%29+have+not+been+identified%2C+it+has+been+shown+that+ultrafiltration+of+serum+reduces+penicillin+binding.+However%2C+when+the+ultrafiltered+serum+was+reconstituted+with+serum+ultrafiltrate%2C+the+binding+capacity+was+restored+to+82%25+of+that+of+intact+serum."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit15a"><span><span class="NLM_contrib-group">Di Piro, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adkinson, N. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamilton, R. G.</span><span> </span><span class="NLM_article-title">Facilitation of Penicillin Haptenation to Serum Proteins</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">1463</span><span class="NLM_x">–</span> <span class="NLM_lpage">1467</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1993&pages=1463-1467&author=J.+T.+Di+Piroauthor=N.+F.+Adkinsonauthor=R.+G.+Hamilton&title=Facilitation+of+Penicillin+Haptenation+to+Serum+Proteins"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDi%2BPiro%26aufirst%3DJ.%2BT.%26aulast%3DAdkinson%26aufirst%3DN.%2BF.%26aulast%3DHamilton%26aufirst%3DR.%2BG.%26atitle%3DFacilitation%2520of%2520Penicillin%2520Haptenation%2520to%2520Serum%2520Proteins%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D1993%26volume%3D37%26spage%3D1463%26epage%3D1467" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Goffin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghuysen, J.-M.</span><span> </span><span class="NLM_article-title">Multimodular Penicillin-Binding Proteins: An Enigmatic Family of Orthologs and Paralogs</span> <span class="citation_source-journal">Microbiol. Mol. Biol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">1079</span><span class="NLM_x">–</span> <span class="NLM_lpage">1093</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm8008597&amp;key=10.1128%2FMMBR.62.4.1079-1093.1998" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm8008597&amp;key=9841666" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm8008597&amp;key=1%3ACAS%3A528%3ADyaK1MXhs1Oguw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=1998&pages=1079-1093&author=C.+Goffinauthor=J.-M.+Ghuysen&title=Multimodular+Penicillin-Binding+Proteins%3A+An+Enigmatic+Family+of+Orthologs+and+Paralogs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Multimodular penicillin-binding proteins: an enigmatic family of orthologs and paralogs</span></div><div class="casAuthors">Goffin, Colette; Ghuysen, Jean-Marie</div><div class="citationInfo"><span class="NLM_cas:title">Microbiology and Molecular Biology Reviews</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1079-1093</span>CODEN:
                <span class="NLM_cas:coden">MMBRF7</span>;
        ISSN:<span class="NLM_cas:issn">1092-2172</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">A review with 74 refs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpf0oL0mHlO07Vg90H21EOLACvtfcHk0lg61NtjzjXKGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXhs1Oguw%253D%253D&md5=5014e2f1dc604024faf25a320a7c0134</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1128%2FMMBR.62.4.1079-1093.1998&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMMBR.62.4.1079-1093.1998%26sid%3Dliteratum%253Aachs%26aulast%3DGoffin%26aufirst%3DC.%26aulast%3DGhuysen%26aufirst%3DJ.-M.%26atitle%3DMultimodular%2520Penicillin-Binding%2520Proteins%253A%2520An%2520Enigmatic%2520Family%2520of%2520Orthologs%2520and%2520Paralogs%26jtitle%3DMicrobiol.%2520Mol.%2520Biol.%2520Rev.%26date%3D1998%26volume%3D62%26spage%3D1079%26epage%3D1093" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><div class="note"><p class="first last">As indicated on the FDA drug label.</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=As+indicated+on+the+FDA+drug+label."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Bar-On, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Millard, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dvir, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Enz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sussman, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silman, I.</span><span> </span><span class="NLM_article-title">Kinetic and Structural Studies on the Interaction of Cholinesterases with the Anti-Alzheimer Drug Rivastigmine</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">3555</span><span class="NLM_x">–</span> <span class="NLM_lpage">3564</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi020016x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm8008597&amp;key=1%3ACAS%3A528%3ADC%252BD38Xht1Gktr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2002&pages=3555-3564&author=P.+Bar-Onauthor=C.+B.+Millardauthor=M.+Harelauthor=H.+Dvirauthor=A.+Enzauthor=J.+L.+Sussmanauthor=I.+Silman&title=Kinetic+and+Structural+Studies+on+the+Interaction+of+Cholinesterases+with+the+Anti-Alzheimer+Drug+Rivastigmine"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Kinetic and Structural Studies on the Interaction of Cholinesterases with the Anti-Alzheimer Drug Rivastigmine</span></div><div class="casAuthors">Bar-On, P.; Millard, C. B.; Harel, M.; Dvir, H.; Enz, A.; Sussman, J. L.; Silman, I.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3555-3564</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Rivastigmine, a carbamate inhibitor of acetylcholinesterase, is already in use for treatment of Alzheimer's disease under the trade name of Exelon.  Rivastigmine carbamylates Torpedo californica acetylcholinesterase very slowly (ki = 2.0 M-1 min-1), whereas the bimol. rate const. for inhibition of human acetylcholinesterase is >1600-fold higher (ki = 3300 M-1 min-1).  For human butyrylcholinesterase and for Drosophila melanogaster acetylcholinesterase, carbamylation is even more rapid (ki = 9×104 and 5×105 M-1 min-1, resp.).  Spontaneous reactivation of all four conjugates is very slow, with <10% reactivation being obsd. for the Torpedo enzyme after 48 h.  The crystal structure of the conjugate of rivastigmine with Torpedo acetylcholinesterase was detd. to 2.2 Å resoln.  It revealed that the carbamyl moiety is covalently linked to the active-site serine, with the leaving group, (-)-S-3-[1-(dimethylamino)ethyl]phenol, being retained in the "anionic" site.  A significant movement of the active-site histidine (H440) away from its normal hydrogen-bonded partner, E327, was obsd., resulting in disruption of the catalytic triad.  This movement may provide an explanation for the unusually slow kinetics of reactivation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGJOeQbUGo9bVg90H21EOLACvtfcHk0lg61NtjzjXKGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xht1Gktr8%253D&md5=20e7133e9a11db07979d6f6933f00255</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fbi020016x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi020016x%26sid%3Dliteratum%253Aachs%26aulast%3DBar-On%26aufirst%3DP.%26aulast%3DMillard%26aufirst%3DC.%2BB.%26aulast%3DHarel%26aufirst%3DM.%26aulast%3DDvir%26aufirst%3DH.%26aulast%3DEnz%26aufirst%3DA.%26aulast%3DSussman%26aufirst%3DJ.%2BL.%26aulast%3DSilman%26aufirst%3DI.%26atitle%3DKinetic%2520and%2520Structural%2520Studies%2520on%2520the%2520Interaction%2520of%2520Cholinesterases%2520with%2520the%2520Anti-Alzheimer%2520Drug%2520Rivastigmine%26jtitle%3DBiochemistry%26date%3D2002%26volume%3D41%26spage%3D3555%26epage%3D3564" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><div class="note"><p class="first last">COX is required for the production of thromboxane A<sub>2</sub>, a powerful promoter of platelet aggregation.</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=COX+is+required+for+the+production+of+thromboxane+A2%2C+a+powerful+promoter+of+platelet+aggregation."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit19a"><span><span class="NLM_contrib-group">Hennekens, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sechenova, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollar, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serebruany, V. L.</span><span> </span><span class="NLM_article-title">Dose of Aspirin in the Treatment and Prevention of Cardiovascular Disease: Current and Future Directions</span> <span class="citation_source-journal">J. Cardiovasc. Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">170</span><span class="NLM_x">–</span> <span class="NLM_lpage">176</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19a&amp;dbid=16&amp;doi=10.1021%2Fjm8008597&amp;key=10.1177%2F1074248406292263" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19a&amp;dbid=8&amp;doi=10.1021%2Fjm8008597&amp;key=17056829" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19a&amp;dbid=32&amp;doi=10.1021%2Fjm8008597&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtF2ls7vE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2006&pages=170-176&author=C.+H.+Hennekensauthor=O.+Sechenovaauthor=D.+Hollarauthor=V.+L.+Serebruany&title=Dose+of+Aspirin+in+the+Treatment+and+Prevention+of+Cardiovascular+Disease%3A+Current+and+Future+Directions"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19aR"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Dose of aspirin in the treatment and prevention of cardiovascular disease: current and future directions</span></div><div class="casAuthors">Hennekens, Charles H.; Sechenova, Oksana; Hollar, Danielle; Serebruany, Victor L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cardiovascular Pharmacology and Therapeutics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">170-176</span>CODEN:
                <span class="NLM_cas:coden">JCPTFE</span>;
        ISSN:<span class="NLM_cas:issn">1074-2484</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">In meta-analyses of randomized trials of aspirin among patients with prior occlusive vascular disease events (secondary prevention), doses from 75 mg to more than 1500 mg daily provide similar benefits on myocardial infarction, stroke, and cardiovascular death.  In acute myocardial infarction and during acute occlusive stroke, a loading dose of 162.5 to 325 mg is necessary to achieve a rapid clin. antithrombotic effect.  In primary prevention trials, predominantly among men, aspirin (75 mg daily to 325 mg on alternate days) reduced the risk of a first myocardial infarction.  In a large-scale trial in women, aspirin (100 mg on alternate days) reduced risk of a first stroke.  In subgroup analyses of women older than age 65, aspirin significantly reduced first myocardial infarction and ischemic stroke.  Direct comparisons of higher doses may yield addnl. cardiovascular benefits.  At present, daily doses of 75 to 325 mg aspirin are sufficient for long-term treatment and prevention of cardiovascular disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqeOGS_Sm4ZZbVg90H21EOLACvtfcHk0lg61NtjzjXKGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtF2ls7vE&md5=8766490247ede4958dee9bec82526c9d</span></div><a href="/servlet/linkout?suffix=cit19a&amp;dbid=16384&amp;doi=10.1177%2F1074248406292263&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1074248406292263%26sid%3Dliteratum%253Aachs%26aulast%3DHennekens%26aufirst%3DC.%2BH.%26aulast%3DSechenova%26aufirst%3DO.%26aulast%3DHollar%26aufirst%3DD.%26aulast%3DSerebruany%26aufirst%3DV.%2BL.%26atitle%3DDose%2520of%2520Aspirin%2520in%2520the%2520Treatment%2520and%2520Prevention%2520of%2520Cardiovascular%2520Disease%253A%2520Current%2520and%2520Future%2520Directions%26jtitle%3DJ.%2520Cardiovasc.%2520Pharmacol.%2520Ther.%26date%3D2006%26volume%3D11%26spage%3D170%26epage%3D176" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Van der Ouderaa, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buytenhek, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nugteren, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Dorp, D. A.</span><span> </span><span class="NLM_article-title">Acetylation of Prostaglandin Endoperoxide Synthetase with Acetylsalicyclic Acid</span> <span class="citation_source-journal">Eur. J. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1980</span><span class="NLM_x">, </span> <span class="NLM_volume">109</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">8</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm8008597&amp;key=10.1111%2Fj.1432-1033.1980.tb04760.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm8008597&amp;key=6773769" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm8008597&amp;key=1%3ACAS%3A528%3ADyaL3cXkvFWjsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=1980&pages=1-8&author=F.+J.+Van+der+Ouderaaauthor=M.+Buytenhekauthor=D.+H.+Nugterenauthor=D.+A.+Van+Dorp&title=Acetylation+of+Prostaglandin+Endoperoxide+Synthetase+with+Acetylsalicyclic+Acid"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Acetylation of prostaglandin endoperoxide synthetase with acetylsalicylic acid</span></div><div class="casAuthors">Van der Ouderaa, Frans J.; Buytenhek, Marinus; Nugteren, Diederik H.; Van Dorp, David A.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Biochemistry</span>
        (<span class="NLM_cas:date">1980</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-8</span>CODEN:
                <span class="NLM_cas:coden">EJBCAI</span>;
        ISSN:<span class="NLM_cas:issn">0014-2956</span>.
    </div><div class="casAbstract">Incubation of purified prostaglandin endoperoxide synthetase from sheep vesicular glands with aspirin results in a covalent binding of the acetyl group of acetylsalicylic acid to the protein.  During this acetylation, the cyclooxygenase activity is lost, but not the peroxidase activity.  The reaction is completed when almost 1 acetyl group is bound per polypeptide chain (mol. wt. 68,000).  After proteolysis of [3H]acetyl-protein with Pronase, radioactive N-acetylserine was obtained.  Originally, however, the hydroxyl group of an internal serine residue in the chain is acetylated.  The formation of N-acetylserine can be explained by a rapid O → N acetyl shift as soon as the NH2 group of serine is liberated.  A radioactive dipeptide was isolated from a thermolysin digest of the [3H]acetyl-enzyme contg. phenylalanine and serine, phenylalanine being its N-terminal amino acid.  Automatic Edman degrdn. of native and acetylated enzyme showed that only one polypeptide sequence was present: Ala-Asp-Pro-Gly-Ala-Pro-Ala-Pro-Val-Asn-Pro-X-X-Tyr-.  The N-terminal sequence has an apolar character.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0wuoDk91wVrVg90H21EOLACvtfcHk0liaL2BLcQB2bg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3cXkvFWjsbo%253D&md5=ed5c961de6abc429907582b3f75642d7</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1111%2Fj.1432-1033.1980.tb04760.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1432-1033.1980.tb04760.x%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2Bder%2BOuderaa%26aufirst%3DF.%2BJ.%26aulast%3DBuytenhek%26aufirst%3DM.%26aulast%3DNugteren%26aufirst%3DD.%2BH.%26aulast%3DVan%2BDorp%26aufirst%3DD.%2BA.%26atitle%3DAcetylation%2520of%2520Prostaglandin%2520Endoperoxide%2520Synthetase%2520with%2520Acetylsalicyclic%2520Acid%26jtitle%3DEur.%2520J.%2520Biochem.%26date%3D1980%26volume%3D109%26spage%3D1%26epage%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Sorensen, H. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mellemkjaer, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blot, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nielsen, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steffensen, F. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLaughlin, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">P Olsen, J. H.</span><span> </span><span class="NLM_article-title">Risk of Upper Gastrointestinal Bleeding Associated with Use of Low-Dose Aspirin</span> <span class="citation_source-journal">Am. J. Gastroenterol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">95</span><span class="NLM_x">, </span> <span class="NLM_fpage">2218</span><span class="NLM_x">–</span> <span class="NLM_lpage">2224</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm8008597&amp;key=11007221" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm8008597&amp;key=1%3ACAS%3A528%3ADC%252BD3cXntFCmtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=2000&pages=2218-2224&author=H.+T.+Sorensenauthor=L.+Mellemkjaerauthor=W.+J.+Blotauthor=G.+L.+Nielsenauthor=F.+H.+Steffensenauthor=J.+K.+McLaughlinauthor=J.+H.+P+Olsen&title=Risk+of+Upper+Gastrointestinal+Bleeding+Associated+with+Use+of+Low-Dose+Aspirin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Risk of upper gastrointestinal bleeding associated with use of low-dose aspirin</span></div><div class="casAuthors">Sorensen, Henrik Toft; Mellemkjaer, Lene; Blot, William J.; Nielsen, Gunnar Lauge; Steffensen, Flemming Hald; McLaughlin, Joseph K.; Olsen, Jorgen H.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Gastroenterology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2218-2224</span>CODEN:
                <span class="NLM_cas:coden">AJGAAR</span>;
        ISSN:<span class="NLM_cas:issn">0002-9270</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">Aspirin products are known to cause irritation and injury to the gastric mucosa.  We examd. the risk of hospitalization for upper gastrointestinal bleeding with use of low-dose aspirin.  This was a cohort study based on record linkage between a population-based prescription database and a hospital discharge registry in North Jutland County, Denmark, from Jan. 1, 1991, to Dec. 31, 1995.  Incidence rates of upper gastrointestinal bleeding in 27,694 users of low-dose aspirin were compared with the incidence rates in the general population in the county.  A total of 207 exclusive users of low-dose aspirin experienced a first episode of upper gastrointestinal bleeding with admission to the hospital during the study period.  The standardized incidence rate ratio was 2.6 (95% confidence interval, 2.2-2.9), 2.3 in women and 2.8 in men.  The standardized incidence rate ratio for combined use of low-dose aspirin and other nonsteroidal anti-inflammatory drugs was 5.6 (95% confidence interval, 4.4-7.0).  The risk was similar among users of noncoated low-dose aspirin (standardized incidence rate ratio, 2.6; 95% confidence interval, 1.8-3.5) and coated low-dose aspirin (standardized incidence rate ratio, 2.6; 95% confidence interval, 2.2-3.0).  Use of low-dose aspirin was assocd. with an increased risk of upper gastrointestinal bleeding, with still higher risks when combined with other nonsteroidal anti-inflammatory drugs.  Enteric coating did not seem to reduce the risk.  The findings from this observational study raise the possibility that prophylactic use of low-dose aspirin may convey an increased risk of gastrointestinal bleeding, which may offset some of its benefits.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRNcV2hS0iDbVg90H21EOLACvtfcHk0liaL2BLcQB2bg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXntFCmtr8%253D&md5=8889c58854bf2fd3471d88133bfb9045</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSorensen%26aufirst%3DH.%2BT.%26aulast%3DMellemkjaer%26aufirst%3DL.%26aulast%3DBlot%26aufirst%3DW.%2BJ.%26aulast%3DNielsen%26aufirst%3DG.%2BL.%26aulast%3DSteffensen%26aufirst%3DF.%2BH.%26aulast%3DMcLaughlin%26aufirst%3DJ.%2BK.%26aulast%3DP%2BOlsen%26aufirst%3DJ.%2BH.%26atitle%3DRisk%2520of%2520Upper%2520Gastrointestinal%2520Bleeding%2520Associated%2520with%2520Use%2520of%2520Low-Dose%2520Aspirin%26jtitle%3DAm.%2520J.%2520Gastroenterol.%26date%3D2000%26volume%3D95%26spage%3D2218%26epage%3D2224" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Fasco, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Principe, L. M.</span><span> </span><span class="NLM_article-title"><i>R</i>- and <i>S</i>-Warfarin Inhibition of Vitamin K and Vitamin K 2,3-Epoxide Reductase Activities in the Rat</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1982</span><span class="NLM_x">, </span> <span class="NLM_volume">257</span><span class="NLM_x">, </span> <span class="NLM_fpage">4894</span><span class="NLM_x">–</span> <span class="NLM_lpage">4901</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=257&publication_year=1982&pages=4894-4901&author=M.+J.+Fascoauthor=L.+M.+Principe&title=R-+and+S-Warfarin+Inhibition+of+Vitamin+K+and+Vitamin+K+2%2C3-Epoxide+Reductase+Activities+in+the+Rat"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFasco%26aufirst%3DM.%2BJ.%26aulast%3DPrincipe%26aufirst%3DL.%2BM.%26atitle%3DR-%2520and%2520S-Warfarin%2520Inhibition%2520of%2520Vitamin%2520K%2520and%2520Vitamin%2520K%25202%252C3-Epoxide%2520Reductase%2520Activities%2520in%2520the%2520Rat%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1982%26volume%3D257%26spage%3D4894%26epage%3D4901" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Silverman, R. B.</span><span> </span><span class="NLM_article-title">Model Studies for a Molecular Mechanism of Action of Oral Anticoagulants</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1981</span><span class="NLM_x">, </span> <span class="NLM_volume">103</span><span class="NLM_x">, </span> <span class="NLM_fpage">3910</span><span class="NLM_x">–</span> <span class="NLM_lpage">3915</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja00403a050" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=1981&pages=3910-3915&author=R.+B.+Silverman&title=Model+Studies+for+a+Molecular+Mechanism+of+Action+of+Oral+Anticoagulants"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fja00403a050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00403a050%26sid%3Dliteratum%253Aachs%26aulast%3DSilverman%26aufirst%3DR.%2BB.%26atitle%3DModel%2520Studies%2520for%2520a%2520Molecular%2520Mechanism%2520of%2520Action%2520of%2520Oral%2520Anticoagulants%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1981%26volume%3D103%26spage%3D3910%26epage%3D3915" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Rozwarski, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grant, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barton, D. H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobs, W. R.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sacchettini, J. C.</span><span> </span><span class="NLM_article-title">Modification of the NADH of the Isoniazid Targets (InhA) from <i>Mycobacterium tuberculosis</i></span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">279</span><span class="NLM_x">, </span> <span class="NLM_fpage">98</span><span class="NLM_x">–</span> <span class="NLM_lpage">102</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=1998&pages=98-102&author=D.+A.+Rozwarskiauthor=G.+A.+Grantauthor=D.+H.+R.+Bartonauthor=W.+R.+Jacobsauthor=J.+C.+Sacchettini&title=Modification+of+the+NADH+of+the+Isoniazid+Targets+%28InhA%29+from+Mycobacterium+tuberculosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRozwarski%26aufirst%3DD.%2BA.%26aulast%3DGrant%26aufirst%3DG.%2BA.%26aulast%3DBarton%26aufirst%3DD.%2BH.%2BR.%26aulast%3DJacobs%26aufirst%3DW.%2BR.%26aulast%3DSacchettini%26aufirst%3DJ.%2BC.%26atitle%3DModification%2520of%2520the%2520NADH%2520of%2520the%2520Isoniazid%2520Targets%2520%2528InhA%2529%2520from%2520Mycobacterium%2520tuberculosis%26jtitle%3DScience%26date%3D1998%26volume%3D279%26spage%3D98%26epage%3D102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Zhou, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goh, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duan, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLeod, H. L.</span><span> </span><span class="NLM_article-title">Mechanism-Based Inhibition of Cytochrome P450 3A4 by Therapeutic Drugs</span> <span class="citation_source-journal">Clin. Pharmacokinet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">279</span><span class="NLM_x">–</span> <span class="NLM_lpage">304</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm8008597&amp;key=10.2165%2F00003088-200544030-00005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm8008597&amp;key=15762770" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm8008597&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjs1Kru7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2005&pages=279-304&author=S.+Zhouauthor=S.+Y.+Chanauthor=B.+C.+Gohauthor=E.+Chanauthor=W.+Duanauthor=M.+Huangauthor=H.+L.+McLeod&title=Mechanism-Based+Inhibition+of+Cytochrome+P450+3A4+by+Therapeutic+Drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanism-based inhibition of cytochrome P450 3A4 by therapeutic drugs</span></div><div class="casAuthors">Zhou, Shufeng; Chan, Sui Yung; Goh, Boon Cher; Chan, Eli; Duan, Wei; Huang, Min; McLeod, Howard L.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Pharmacokinetics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">279-304</span>CODEN:
                <span class="NLM_cas:coden">CPKNDH</span>;
        ISSN:<span class="NLM_cas:issn">0312-5963</span>.
    
            (<span class="NLM_cas:orgname">Adis International Ltd.</span>)
        </div><div class="casAbstract">A review.  Consistent with its highest abundance in humans, cytochrome P 450 (CYP) 3A is responsible for the metab. of about 60% of currently known drugs.  However, this unusual low substrate specificity also makes CYP3A4 susceptible to reversible or irreversible inhibition by a variety of drugs.  Mechanism-based inhibition of CYP3A4 is characterized by NADP hydrogen (NADPH)-, time- and concn.-dependent enzyme inactivation, occurring when some drugs are converted by CYP isoenzymes to reactive metabolites capable of irreversibly binding covalently to CYP3A4.  Approaches using in vitro, in silico and in vivo models can be used to study CYP3A4 inactivation by drugs.  Human liver microsomes are always used to est. inactivation kinetic parameters including the concn. required for half-maximal inactivation (KI) and the maximal rate of inactivation at satn. (kinact).  Clin. important mechanism-based CYP3A4 inhibitors include antibacterials (e.g. clarithromycin, erythromycin and isoniazid), anticancer agents (e.g. tamoxifen and irinotecan), anti-HIV agents (e.g. ritonavir and delavirdine), antihypertensives (e.g. dihydralazine, verapamil and diltiazem), sex steroids and their receptor modulators (e.g. gestodene and raloxifene), and several herbal constituents (e.g. bergamottin and glabridin).  Drugs inactivating CYP3A4 often possess several common moieties such as a tertiary amine function, furan ring, and acetylene function.  It appears that the chem. properties of a drug crit. to CYP3A4 inactivation include formation of reactive metabolites by CYP isoenzymes, preponderance of CYP inducers and P-glycoprotein (P-gp) substrate, and occurrence of clin. significant pharmacokinetic interactions with coadministered drugs.  Compared with reversible inhibition of CYP3A4, mechanism-based inhibition of CYP3A4 more frequently cause pharmacokinetic-pharmacodynamic drug-drug interactions, as the inactivated CYP3A4 has to be replaced by newly synthesized CYP3A4 protein.  The resultant drug interactions may lead to adverse drug effects, including some fatal events.  For example, when aforementioned CYP3A4 inhibitors are coadministered with terfenadine, cisapride or astemizole (all CYP3A4 substrates), torsades de pointes (a life-threatening ventricular arrhythmia assocd. with QT prolongation) may occur.  However, predicting drug-drug interactions involving CYP3A4 inactivation is difficult, since the clin. outcomes depend on a no. of factors that are assocd. with drugs and patients.  The apparent pharmacokinetic effect of a mechanism-based inhibitor of CYP3A4 would be a function of its KI, kinact and partition ratio and the zero-order synthesis rate of new or replacement enzyme.  The inactivators for CYP3A4 can be inducers and P-gp substrates/inhibitors, confounding in vitro-in vivo extrapolation.  The clin. significance of CYP3A inhibition for drug safety and efficacy warrants closer understanding of the mechanisms for each inhibitor.  Furthermore, such inactivation may be exploited for therapeutic gain in certain circumstances.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqyCrj3HT5CYLVg90H21EOLACvtfcHk0lgYrdbCHuyvLg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjs1Kru7o%253D&md5=1fcb85c8111a1959c54f79181a40082b</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.2165%2F00003088-200544030-00005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2165%252F00003088-200544030-00005%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DS.%26aulast%3DChan%26aufirst%3DS.%2BY.%26aulast%3DGoh%26aufirst%3DB.%2BC.%26aulast%3DChan%26aufirst%3DE.%26aulast%3DDuan%26aufirst%3DW.%26aulast%3DHuang%26aufirst%3DM.%26aulast%3DMcLeod%26aufirst%3DH.%2BL.%26atitle%3DMechanism-Based%2520Inhibition%2520of%2520Cytochrome%2520P450%25203A4%2520by%2520Therapeutic%2520Drugs%26jtitle%3DClin.%2520Pharmacokinet.%26date%3D2005%26volume%3D44%26spage%3D279%26epage%3D304" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Hussain, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kar, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Husain, S. A.</span><span> </span><span class="NLM_article-title">Antituberculosis Drug-Induced Hepatitis: Risk Factors, Prevention and Management</span> <span class="citation_source-journal">Indian J. Exp. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">1226</span><span class="NLM_x">–</span> <span class="NLM_lpage">1232</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2003&pages=1226-1232&author=Z.+Hussainauthor=P.+Karauthor=S.+A.+Husain&title=Antituberculosis+Drug-Induced+Hepatitis%3A+Risk+Factors%2C+Prevention+and+Management"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHussain%26aufirst%3DZ.%26aulast%3DKar%26aufirst%3DP.%26aulast%3DHusain%26aufirst%3DS.%2BA.%26atitle%3DAntituberculosis%2520Drug-Induced%2520Hepatitis%253A%2520Risk%2520Factors%252C%2520Prevention%2520and%2520Management%26jtitle%3DIndian%2520J.%2520Exp.%2520Biol.%26date%3D2003%26volume%3D41%26spage%3D1226%26epage%3D1232" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Nagasawa, H. T.; Shirota, F. N.; Demaster, E. G.</span><span> </span><span class="NLM_article-title">Alcoholism: Aldehyde Dehydrogenase Inhibitors as Alcohol Deterrent Agents in Biomedical Chemistry</span>. In  <span class="citation_source-book">Applying Chemical Principles to the Understanding and Treatment of Disease</span>; <span class="NLM_publisher-name">John Wiley & Sons</span>: <span class="NLM_publisher-loc">Hoboken, NJ</span>,<span class="NLM_x"> </span><span class="NLM_year">2000</span><span class="NLM_x">; </span>Chapter 3, pp  <span class="NLM_fpage">73</span>− <span class="NLM_lpage">97</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2000&pages=73-97&author=H.+T.+Nagasawa&author=F.+N.+Shirota&author=E.+G.+Demaster&title=Applying+Chemical+Principles+to+the+Understanding+and+Treatment+of+Disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DNagasawa%26aufirst%3DH.%2BT.%26atitle%3DAlcoholism%253A%2520Aldehyde%2520Dehydrogenase%2520Inhibitors%2520as%2520Alcohol%2520Deterrent%2520Agents%2520in%2520Biomedical%2520Chemistry%26btitle%3DApplying%2520Chemical%2520Principles%2520to%2520the%2520Understanding%2520and%2520Treatment%2520of%2520Disease%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%26date%3D2000%26spage%3D73%26epage%3D97" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Shen, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mays, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lipsky, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naylor, S.</span><span> </span><span class="NLM_article-title">Determination of In-Vivo Adducts of Disulfiram with Mitochondrial Aldehyde Dehydrogenase</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">537</span><span class="NLM_x">–</span> <span class="NLM_lpage">545</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2001&pages=537-545&author=M.+L.+Shenauthor=K.+L.+Johnsonauthor=D.+C.+Maysauthor=J.+J.+Lipskyauthor=S.+Naylor&title=Determination+of+In-Vivo+Adducts+of+Disulfiram+with+Mitochondrial+Aldehyde+Dehydrogenase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShen%26aufirst%3DM.%2BL.%26aulast%3DJohnson%26aufirst%3DK.%2BL.%26aulast%3DMays%26aufirst%3DD.%2BC.%26aulast%3DLipsky%26aufirst%3DJ.%2BJ.%26aulast%3DNaylor%26aufirst%3DS.%26atitle%3DDetermination%2520of%2520In-Vivo%2520Adducts%2520of%2520Disulfiram%2520with%2520Mitochondrial%2520Aldehyde%2520Dehydrogenase%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2001%26volume%3D61%26spage%3D537%26epage%3D545" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Skarzynski, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mistry, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wonacott, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutchinson, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelly, V. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duncan, K.</span><span> </span><span class="NLM_article-title">Structure of UDP <i>N</i>-Actylglucosamine Enolpyruvyl Transferase, an Enzyme Essential for the Synthesis of Bacterial Peptidoglycan, Complexed with Substrate UDP-<i>N</i>-acetylglucosamine and the Drug Fosfomycin</span> <span class="citation_source-journal">Structure</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">1465</span><span class="NLM_x">–</span> <span class="NLM_lpage">1474</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1996&pages=1465-1474&author=T.+Skarzynskiauthor=A.+Mistryauthor=A.+Wonacottauthor=S.+E.+Hutchinsonauthor=V.+A.+Kellyauthor=K.+Duncan&title=Structure+of+UDP+N-Actylglucosamine+Enolpyruvyl+Transferase%2C+an+Enzyme+Essential+for+the+Synthesis+of+Bacterial+Peptidoglycan%2C+Complexed+with+Substrate+UDP-N-acetylglucosamine+and+the+Drug+Fosfomycin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSkarzynski%26aufirst%3DT.%26aulast%3DMistry%26aufirst%3DA.%26aulast%3DWonacott%26aufirst%3DA.%26aulast%3DHutchinson%26aufirst%3DS.%2BE.%26aulast%3DKelly%26aufirst%3DV.%2BA.%26aulast%3DDuncan%26aufirst%3DK.%26atitle%3DStructure%2520of%2520UDP%2520N-Actylglucosamine%2520Enolpyruvyl%2520Transferase%252C%2520an%2520Enzyme%2520Essential%2520for%2520the%2520Synthesis%2520of%2520Bacterial%2520Peptidoglycan%252C%2520Complexed%2520with%2520Substrate%2520UDP-N-acetylglucosamine%2520and%2520the%2520Drug%2520Fosfomycin%26jtitle%3DStructure%26date%3D1996%26volume%3D4%26spage%3D1465%26epage%3D1474" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit29b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Thomas, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ginj, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jelesarov, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amrhein, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macheroux, P.</span><span> </span><span class="NLM_article-title">Role of K22 and R120 in the Covalent Binding of the Antibiotic Fosfomycin and the Substrate-Induced Conformational Change in USP-<i>N</i>-acetylglucosamine Enolpyruvyl Transferase</span> <span class="citation_source-journal">Eur. J. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">271</span><span class="NLM_x">, </span> <span class="NLM_fpage">2682</span><span class="NLM_x">–</span> <span class="NLM_lpage">2690</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29b&amp;dbid=16&amp;doi=10.1021%2Fjm8008597&amp;key=10.1111%2Fj.1432-1033.2004.04196.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29b&amp;dbid=8&amp;doi=10.1021%2Fjm8008597&amp;key=15206933" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29b&amp;dbid=32&amp;doi=10.1021%2Fjm8008597&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlvFOitrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=271&publication_year=2004&pages=2682-2690&author=A.+M.+Thomasauthor=C.+Ginjauthor=I.+Jelesarovauthor=N.+Amrheinauthor=P.+Macheroux&title=Role+of+K22+and+R120+in+the+Covalent+Binding+of+the+Antibiotic+Fosfomycin+and+the+Substrate-Induced+Conformational+Change+in+USP-N-acetylglucosamine+Enolpyruvyl+Transferase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29bR"><div class="casContent"><span class="casTitleNuber">29b</span><div class="casTitle"><span class="NLM_cas:atitle">Role of K22 and R120 in the covalent binding of the antibiotic fosfomycin and the substrate-induced conformational change in UDP-N-acetylglucosamine enolpyruvyl transferase</span></div><div class="casAuthors">Thomas, Alison M.; Ginj, Cristian; Jelesarov, Ilian; Amrhein, Nikolaus; Macheroux, Peter</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Biochemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">271</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">2682-2690</span>CODEN:
                <span class="NLM_cas:coden">EJBCAI</span>;
        ISSN:<span class="NLM_cas:issn">0014-2956</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">UDP-N-acetylglucosamine enolpyruvyl transferase (MurA), catalyzes the first step in the biosynthesis of peptidoglycan, involving the transfer of the intact enolpyruvyl moiety from phosphoenolpyruvate to the 3'-hydroxyl group of UDP-N-acetylglucosamine (UDPNAG).  The enzyme is irreversibly inhibited by the antibiotic fosfomycin.  The inactivation is caused by alkylation of a highly conserved cysteine residue (C115) that participates in the binding of phosphoenolpyruvate.  The three-dimensional structure of the enzyme suggests that two residues may play a decisive role in fosfomycin binding: K22 and R120.  To investigate the role of these residues, we have generated the K22V, K22E, K22R and R120K single mutant proteins as well as the K22V/R120K and K22V/R120V double mutant proteins.  We demonstrated that the K22R mutant protein behaves similarly to wild-type enzyme, whereas the K22E mutant protein failed to form the covalent adduct.  On the other hand, the K22V mutant protein requires the presence of UDPNAG for the formation of the adduct indicating that UDPNAG plays a crucial role in the organization of productive interactions in the active site.  This model receives strong support from heat capacity changes obsd. for the K22V/R120K and R120K mutant proteins; in both mutant proteins, the heat capacity changes are markedly reduced, indicating that their ability to form a closed protein conformation is impeded due to the R120K exchange.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPsQu-rgoH-7Vg90H21EOLACvtfcHk0liJVS3w4TlE2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlvFOitrs%253D&md5=5921149bf4314955d135fe570397ceef</span></div><a href="/servlet/linkout?suffix=cit29b&amp;dbid=16384&amp;doi=10.1111%2Fj.1432-1033.2004.04196.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1432-1033.2004.04196.x%26sid%3Dliteratum%253Aachs%26aulast%3DThomas%26aufirst%3DA.%2BM.%26aulast%3DGinj%26aufirst%3DC.%26aulast%3DJelesarov%26aufirst%3DI.%26aulast%3DAmrhein%26aufirst%3DN.%26aulast%3DMacheroux%26aufirst%3DP.%26atitle%3DRole%2520of%2520K22%2520and%2520R120%2520in%2520the%2520Covalent%2520Binding%2520of%2520the%2520Antibiotic%2520Fosfomycin%2520and%2520the%2520Substrate-Induced%2520Conformational%2520Change%2520in%2520USP-N-acetylglucosamine%2520Enolpyruvyl%2520Transferase%26jtitle%3DEur.%2520J.%2520Biochem.%26date%3D2004%26volume%3D271%26spage%3D2682%26epage%3D2690" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Fenn, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stamper, G. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morollo, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ringe, D.</span><span> </span><span class="NLM_article-title">A Side Reaction of Alanine Racemase: Transamination of Cycloserine</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">5775</span><span class="NLM_x">–</span> <span class="NLM_lpage">5783</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi027022d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2003&pages=5775-5783&author=T.+Fennauthor=G.+F.+Stamperauthor=A.+A.+Morolloauthor=D.+Ringe&title=A+Side+Reaction+of+Alanine+Racemase%3A+Transamination+of+Cycloserine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fbi027022d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi027022d%26sid%3Dliteratum%253Aachs%26aulast%3DFenn%26aufirst%3DT.%26aulast%3DStamper%26aufirst%3DG.%2BF.%26aulast%3DMorollo%26aufirst%3DA.%2BA.%26aulast%3DRinge%26aufirst%3DD.%26atitle%3DA%2520Side%2520Reaction%2520of%2520Alanine%2520Racemase%253A%2520Transamination%2520of%2520Cycloserine%26jtitle%3DBiochemistry%26date%3D2003%26volume%3D42%26spage%3D5775%26epage%3D5783" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Constable, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pirmohamed, M.</span><span> </span><span class="NLM_article-title">Drugs and the Retina</span> <span class="citation_source-journal">Expert Opin. Drug Saf.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">249</span><span class="NLM_x">–</span> <span class="NLM_lpage">259</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Fjm8008597&amp;key=10.1517%2F14740338.3.3.249" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Fjm8008597&amp;key=15155152" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm8008597&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjsVektLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=249-259&author=S.+Constableauthor=M.+Pirmohamed&title=Drugs+and+the+Retina"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Drugs and the retina</span></div><div class="casAuthors">Constable, Simon; Pirmohamed, Munir</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Safety</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">249-259</span>CODEN:
                <span class="NLM_cas:coden">EODSA9</span>;
        ISSN:<span class="NLM_cas:issn">1474-0338</span>.
    
            (<span class="NLM_cas:orgname">Ashley Publications Ltd.</span>)
        </div><div class="casAbstract">A review.  The retina is relatively protected from systemic drug administration because of the blood-retinal barrier, a highly selective mechanism adapted to providing a regulated homeostatic environment for this highly specialised tissue.  However, a no. of drugs have been assocd. with retinal toxicity.  Vigabatrin, as an adjunctive therapy for the management of partial epilepsy, is assocd. with visual field defects in ∼ 40% of patients.  Hydroxychloroquine, used in the treatment of rheumatoid arthritis and systemic lupus erythematosus, is also assocd. with a retinopathy.  In view of this, ophthalmol. screening and monitoring is recommended during prescription of both of these drugs.  In these cases, the retina is the site for an adverse drug reaction and the dose of therapy may be important in detg. the likelihood of retinal toxicity.  However, in the case of cytomegalovirus retinitis, the retina is the intended site for pharmacol. action.  The treatment of this condition with the antiviral agents ganciclovir, valganciclovir, foscarnet and cidofovir, can also be assocd. with significant systemic toxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5gLxXgO3CiLVg90H21EOLACvtfcHk0liJVS3w4TlE2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjsVektLc%253D&md5=0f3d29e8726dc1a2894984c667c61c73</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1517%2F14740338.3.3.249&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14740338.3.3.249%26sid%3Dliteratum%253Aachs%26aulast%3DConstable%26aufirst%3DS.%26aulast%3DPirmohamed%26aufirst%3DM.%26atitle%3DDrugs%2520and%2520the%2520Retina%26jtitle%3DExpert%2520Opin.%2520Drug%2520Saf.%26date%3D2004%26volume%3D3%26spage%3D249%26epage%3D259" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Brodie, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Figueroa, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laska, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dewey, S. L.</span><span> </span><span class="NLM_article-title">Safety and Efficacy of γ-Vinyl GABA (GVG) for the Treatment of Methamphetamine and/or Cocaine Addiction</span> <span class="citation_source-journal">Synapse</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">122</span><span class="NLM_x">–</span> <span class="NLM_lpage">125</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2005&pages=122-125&author=J.+D.+Brodieauthor=E.+Figueroaauthor=E.+M.+Laskaauthor=S.+L.+Dewey&title=Safety+and+Efficacy+of+%CE%B3-Vinyl+GABA+%28GVG%29+for+the+Treatment+of+Methamphetamine+and%2For+Cocaine+Addiction"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrodie%26aufirst%3DJ.%2BD.%26aulast%3DFigueroa%26aufirst%3DE.%26aulast%3DLaska%26aufirst%3DE.%2BM.%26aulast%3DDewey%26aufirst%3DS.%2BL.%26atitle%3DSafety%2520and%2520Efficacy%2520of%2520%25CE%25B3-Vinyl%2520GABA%2520%2528GVG%2529%2520for%2520the%2520Treatment%2520of%2520Methamphetamine%2520and%252For%2520Cocaine%2520Addiction%26jtitle%3DSynapse%26date%3D2005%26volume%3D55%26spage%3D122%26epage%3D125" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit32b"><span><span class="NLM_label">(b) </span> Investigational Drugs Database. <a href="http://www.iddb.com" class="extLink">www.iddb.com</a>. Press release entitled “Catalyst Pharmaceutical Partners Reports Third Quarter 2007 Financial Results” detailing plans to initiate vigabatrin (CPP-109) in phase II trials Q1 2008, Catalyst Pharmaceutical Partners, posted on November 14, 2007.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Investigational+Drugs+Database.+www.iddb.com.+Press+release+entitled+%E2%80%9CCatalyst+Pharmaceutical+Partners+Reports+Third+Quarter+2007+Financial+Results%E2%80%9D+detailing+plans+to+initiate+vigabatrin+%28CPP-109%29+in+phase+II+trials+Q1+2008%2C+Catalyst+Pharmaceutical+Partners%2C+posted+on+November+14%2C+2007."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Sheean, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schramm, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eadie, M. J.</span><span> </span><span class="NLM_article-title">Vigabatrin-Plasma Enantiomer Concentrations and Clinical Effects</span> <span class="citation_source-journal">Clin. Exp. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">107</span><span class="NLM_x">–</span> <span class="NLM_lpage">116</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Fjm8008597&amp;key=1343855" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm8008597&amp;key=1%3ACAS%3A280%3ADyaK2c7lsFCgtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=1992&pages=107-116&author=G.+Sheeanauthor=R.+Schrammauthor=D.+S.+Andersonauthor=M.+J.+Eadie&title=Vigabatrin-Plasma+Enantiomer+Concentrations+and+Clinical+Effects"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Vigabatrin--plasma enantiomer concentrations and clinical effects</span></div><div class="casAuthors">Sheean G; Schramm T; Anderson D S; Eadie M J</div><div class="citationInfo"><span class="NLM_cas:title">Clinical and experimental neurology</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">107-16</span>
        ISSN:<span class="NLM_cas:issn">0196-6383</span>.
    </div><div class="casAbstract">Plasma concentrations of the [R]- and [S]- enantiomers of the new anticonvulsant vigabatrin were measured by an enantiospecific gas-liquid chromatographic assay in a group of therapy-resistant epileptic patients in whom racemic vigabatrin was added to their existing antiepileptic drug regimens.  The peak plasma concentrations of the biologically active [S]-enantiomer of vigabatrin were correlated with those of the [R]-enantiomer, with drug dose, seizure frequency and change in score on various tests of psychological function administered prior to and when the subjects were under steady-state conditions following vigabatrin therapy.  Plasma [S]-vigabatrin concentrations correlated with drug dose, [R]-vigabatrin concentration and change in score of certain psychological tests reflecting verbal memory, recall and speed of information processing.  No definite pharmacokinetic interactions were detected, though plasma phenobarbitone concentrations tended to fall during vigabatrin administration.  There were too few data to assess the relation between [S]-vigabatrin concentrations and seizure frequency.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSOWtkpb3eKRyCEBeYuoi7AfW6udTcc2eYeHAXpUQ7ANbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2c7lsFCgtQ%253D%253D&md5=a753e43942d7683555e1d1c87b05ea73</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSheean%26aufirst%3DG.%26aulast%3DSchramm%26aufirst%3DR.%26aulast%3DAnderson%26aufirst%3DD.%2BS.%26aulast%3DEadie%26aufirst%3DM.%2BJ.%26atitle%3DVigabatrin-Plasma%2520Enantiomer%2520Concentrations%2520and%2520Clinical%2520Effects%26jtitle%3DClin.%2520Exp.%2520Neurol.%26date%3D1992%26volume%3D29%26spage%3D107%26epage%3D116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">De Biase, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barra, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bossa, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pucci, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">John, R. A.</span><span> </span><span class="NLM_article-title">Chemistry of the Inactivation of 4-Aminobutyrate Aminotransferase by the Antiepileptic Drug Vigabatrin</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">266</span><span class="NLM_x">, </span> <span class="NLM_fpage">20056</span><span class="NLM_x">–</span> <span class="NLM_lpage">20061</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=266&publication_year=1991&pages=20056-20061&author=D.+De+Biaseauthor=D.+Barraauthor=F.+Bossaauthor=P.+Pucciauthor=R.+A.+John&title=Chemistry+of+the+Inactivation+of+4-Aminobutyrate+Aminotransferase+by+the+Antiepileptic+Drug+Vigabatrin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BBiase%26aufirst%3DD.%26aulast%3DBarra%26aufirst%3DD.%26aulast%3DBossa%26aufirst%3DF.%26aulast%3DPucci%26aufirst%3DP.%26aulast%3DJohn%26aufirst%3DR.%2BA.%26atitle%3DChemistry%2520of%2520the%2520Inactivation%2520of%25204-Aminobutyrate%2520Aminotransferase%2520by%2520the%2520Antiepileptic%2520Drug%2520Vigabatrin%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1991%26volume%3D266%26spage%3D20056%26epage%3D20061" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><div class="note"><p class="first last">Interestingly eflornithine (see ref <a onclick="showRef(event, 'cit66a'); return false;" href="javascript:void(0);" class="ref cit66a">66a</a>, Poulin et. al.) utilizes PLP by a similar mechanism but generates the reactive imminium intermediate via decarboxylation and elimination of a fluorine. The nucleophile in this case is a cysteine.</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Interestingly+eflornithine+%28see+ref+66a%2C+Poulin+et.+al.%29+utilizes+PLP+by+a+similar+mechanism+but+generates+the+reactive+imminium+intermediate+via+decarboxylation+and+elimination+of+a+fluorine.+The+nucleophile+in+this+case+is+a+cysteine."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Giudici, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ornati, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Briatico, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buzzetti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lombardi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Salle, E.</span><span> </span><span class="NLM_article-title">6-Methyleneandrost-1,4-diene-3,17-dione (FDE 24304): A New Irreversible Aromatase Inhibtor</span> <span class="citation_source-journal">J. Steroid Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">391</span><span class="NLM_x">–</span> <span class="NLM_lpage">394</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Fjm8008597&amp;key=10.1016%2F0022-4731%2888%2990129-X" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=1998&pages=391-394&author=D.+Giudiciauthor=G.+Ornatiauthor=G.+Briaticoauthor=F.+Buzzettiauthor=P.+Lombardiauthor=E.+Di+Salle&title=6-Methyleneandrost-1%2C4-diene-3%2C17-dione+%28FDE+24304%29%3A+A+New+Irreversible+Aromatase+Inhibtor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2F0022-4731%2888%2990129-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0022-4731%252888%252990129-X%26sid%3Dliteratum%253Aachs%26aulast%3DGiudici%26aufirst%3DD.%26aulast%3DOrnati%26aufirst%3DG.%26aulast%3DBriatico%26aufirst%3DG.%26aulast%3DBuzzetti%26aufirst%3DF.%26aulast%3DLombardi%26aufirst%3DP.%26aulast%3DDi%2BSalle%26aufirst%3DE.%26atitle%3D6-Methyleneandrost-1%252C4-diene-3%252C17-dione%2520%2528FDE%252024304%2529%253A%2520A%2520New%2520Irreversible%2520Aromatase%2520Inhibtor%26jtitle%3DJ.%2520Steroid%2520Biochem.%26date%3D1998%26volume%3D30%26spage%3D391%26epage%3D394" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Brueggemeier, R. W.</span><span> </span><span class="NLM_article-title">Aromatase, Aromatase Inhibitors and Breast Cancer</span> <span class="citation_source-journal">Am. J. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">333</span><span class="NLM_x">–</span> <span class="NLM_lpage">344</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Fjm8008597&amp;key=10.1097%2F00045391-200109000-00007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Fjm8008597&amp;key=11550075" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm8008597&amp;key=1%3ACAS%3A280%3ADC%252BD3MvpvF2luw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2001&pages=333-344&author=R.+W.+Brueggemeier&title=Aromatase%2C+Aromatase+Inhibitors+and+Breast+Cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Aromatase, aromatase inhibitors, and breast cancer</span></div><div class="casAuthors">Brueggemeier R W</div><div class="citationInfo"><span class="NLM_cas:title">American journal of therapeutics</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">333-44</span>
        ISSN:<span class="NLM_cas:issn">1075-2765</span>.
    </div><div class="casAbstract">Estrogens are involved in numerous physiologic processes and have crucial roles in particular disease states, such as mammary carcinomas.  Estradiol, the most potent endogenous estrogen, is biosynthesized from androgens by the cytochrome P-450 enzyme complex called aromatase.  Aromatase is found in breast tissue, and the importance of intratumoral aromatase and local estrogen production is being unraveled.  Inhibition of aromatase is an important approach for reducing growth stimulatory effects of estrogens in hormone-dependent breast cancer.  Effective aromatase inhibitors have been developed as therapeutic agents for controlling estrogen-dependent breast cancer.  Investigations into the development of aromatase inhibitors began in the 1970s and have expanded greatly in the past three decades.  Competitive aromatase inhibitors are molecules that compete with the substrate androstenedione for noncovalent binding to the active site of the enzyme to decrease the amount of product formed.  Steroidal inhibitors that have been developed to date build on the basic androstenedione nucleus and incorporate chemical substituents at varying positions on the steroid.  The structure-activity relationships for steroidal inhibitors have become more refined in the past decade, and only some modifications can be made to the steroid and still keep its affinity for aromatase.  Nonsteroidal aromatase inhibitors can be divided into three classes: aminoglutethimide-like molecules, imidazole/triazole derivatives, and flavonoid analogs.  Mechanism-based aromatase inhibitors are inhibitors that mimic the substrate, are converted by the enzyme to a reactive intermediate, and result in the inactivation of aromatase.  Aromatase inhibitors, both steroidal and nonsteroidal, have shown clinical efficacy for the treatment of breast cancer.  The initial nonselective nature of nonsteroidal inhibitors such as aminoglutethimide has been greatly reduced in the later generations of inhibitors, anastrozole and letrozole.  Mechanism-based steroidal inhibitors such as 4-hydroxyandrostenedione and exemestane produce prolonged aromatase inhibition in patients.  The potent and selective third-generation aromatase inhibitors anastrozole, letrozole, and exemestane are approved for clinical use as second-line endocrine therapy in postmenopausal patients failing antiestrogen therapy alone or multiple hormonal therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTz7HOHQhUMrrmQt-ICR3qNfW6udTcc2eYvtyaq4G4w47ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3MvpvF2luw%253D%253D&md5=3051a7c0d089349231f104168bf6a1dc</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1097%2F00045391-200109000-00007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00045391-200109000-00007%26sid%3Dliteratum%253Aachs%26aulast%3DBrueggemeier%26aufirst%3DR.%2BW.%26atitle%3DAromatase%252C%2520Aromatase%2520Inhibitors%2520and%2520Breast%2520Cancer%26jtitle%3DAm.%2520J.%2520Ther.%26date%3D2001%26volume%3D8%26spage%3D333%26epage%3D344" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Groll, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berkers, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ploegh, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ovaa, H.</span><span> </span><span class="NLM_article-title">Crystal Structure of the Boronic Acid-Based Proteasome Inhibitor Bortezomib in Complex with the Yeast 20S Proteasome</span> <span class="citation_source-journal">Structure</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">451</span><span class="NLM_x">–</span> <span class="NLM_lpage">456</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Fjm8008597&amp;key=10.1016%2Fj.str.2005.11.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Fjm8008597&amp;key=16531229" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Fjm8008597&amp;key=1%3ACAS%3A528%3ADC%252BD28Xit1ylsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2006&pages=451-456&author=M.+Grollauthor=C.+R.+Berkersauthor=H.+L.+Ploeghauthor=H.+Ovaa&title=Crystal+Structure+of+the+Boronic+Acid-Based+Proteasome+Inhibitor+Bortezomib+in+Complex+with+the+Yeast+20S+Proteasome"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal Structure of the Boronic Acid-Based Proteasome Inhibitor Bortezomib in Complex with the Yeast 20S Proteasome</span></div><div class="casAuthors">Groll, Michael; Berkers, Celia R.; Ploegh, Hidde L.; Ovaa, Huib</div><div class="citationInfo"><span class="NLM_cas:title">Structure (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">451-456</span>CODEN:
                <span class="NLM_cas:coden">STRUE6</span>;
        ISSN:<span class="NLM_cas:issn">0969-2126</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Summary: The dipeptide boronic acid bortezomib, also termed VELCADE is a proteasome inhibitor now in use for the treatment of multiple myeloma, and its use for the treatment of other malignancies is being explored.  We detd. the crystal structure of the yeast 20S proteasome in complex with bortezomib to establish the specificity and binding mode of bortezomib to the proteasome's different catalytically active sites.  This structure should enable the rational design of new boronic acid derivs. with improved affinities and specificities for individual active subunits.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpusGzFSuveALVg90H21EOLACvtfcHk0lj8WW1eY-78tA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xit1ylsL8%253D&md5=d5b4e46e5a9f5259cce758770302b4fe</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.str.2005.11.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.str.2005.11.019%26sid%3Dliteratum%253Aachs%26aulast%3DGroll%26aufirst%3DM.%26aulast%3DBerkers%26aufirst%3DC.%2BR.%26aulast%3DPloegh%26aufirst%3DH.%2BL.%26aulast%3DOvaa%26aufirst%3DH.%26atitle%3DCrystal%2520Structure%2520of%2520the%2520Boronic%2520Acid-Based%2520Proteasome%2520Inhibitor%2520Bortezomib%2520in%2520Complex%2520with%2520the%2520Yeast%252020S%2520Proteasome%26jtitle%3DStructure%26date%3D2006%26volume%3D14%26spage%3D451%26epage%3D456" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Besancon, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sachs, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shin, J. M.</span><span> </span><span class="NLM_article-title">Sites of Reaction of the Gastric H,K-ATPase with Extracytoplasmic Thiol Reagents</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">272</span><span class="NLM_x">, </span> <span class="NLM_fpage">22438</span><span class="NLM_x">–</span> <span class="NLM_lpage">22446</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=272&publication_year=1997&pages=22438-22446&author=M.+Besanconauthor=A.+Simonauthor=G.+Sachsauthor=J.+M.+Shin&title=Sites+of+Reaction+of+the+Gastric+H%2CK-ATPase+with+Extracytoplasmic+Thiol+Reagents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBesancon%26aufirst%3DM.%26aulast%3DSimon%26aufirst%3DA.%26aulast%3DSachs%26aufirst%3DG.%26aulast%3DShin%26aufirst%3DJ.%2BM.%26atitle%3DSites%2520of%2520Reaction%2520of%2520the%2520Gastric%2520H%252CK-ATPase%2520with%2520Extracytoplasmic%2520Thiol%2520Reagents%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1997%26volume%3D272%26spage%3D22438%26epage%3D22446" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40a"><span><span class="NLM_contrib-group">Shin, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, Y. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sachs, G.</span><span> </span><span class="NLM_article-title">Chemistry of Covalent Inhibition of the Gastric (H<sup>+</sup>, K<sup>+</sup>)-ATPase by Proton Pump Inhibitors</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">126</span><span class="NLM_x">, </span> <span class="NLM_fpage">7800</span><span class="NLM_x">–</span> <span class="NLM_lpage">7811</span><div class="note"><p class="first last">and references therein</p></div></span><div class="citationLinks">[<a href="/doi/10.1021/ja049607w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=126&publication_year=2004&pages=7800-7811&author=J.+M.+Shinauthor=Y.+M.+Choauthor=G.+Sachs&title=Chemistry+of+Covalent+Inhibition+of+the+Gastric+%28H%2B%2C+K%2B%29-ATPase+by+Proton+Pump+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40a&amp;dbid=16384&amp;doi=10.1021%2Fja049607w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja049607w%26sid%3Dliteratum%253Aachs%26aulast%3DShin%26aufirst%3DJ.%2BM.%26aulast%3DCho%26aufirst%3DY.%2BM.%26aulast%3DSachs%26aufirst%3DG.%26atitle%3DChemistry%2520of%2520Covalent%2520Inhibition%2520of%2520the%2520Gastric%2520%2528H%252B%252C%2520K%252B%2529-ATPase%2520by%2520Proton%2520Pump%2520Inhibitors%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2004%26volume%3D126%26spage%3D7800%26epage%3D7811" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Savi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pereillo, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uzabiaga, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Combalbert, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Picard, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maffrand, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pascal, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herbert, J. M.</span><span> </span><span class="NLM_article-title">Identification and Biological Activity of the Active Metabolite of Clopidogrel</span> <span class="citation_source-journal">Thromb. Haemostasis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">84</span><span class="NLM_x">, </span> <span class="NLM_fpage">891</span><span class="NLM_x">–</span> <span class="NLM_lpage">896</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Fjm8008597&amp;key=10.1055%2Fs-0037-1614133" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Fjm8008597&amp;key=11127873" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Fjm8008597&amp;key=1%3ACAS%3A528%3ADC%252BD3cXovFCjsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2000&pages=891-896&author=P.+Saviauthor=J.+M.+Pereilloauthor=M.+F.+Uzabiagaauthor=J.+Combalbertauthor=C.+Picardauthor=J.+P.+Maffrandauthor=M.+Pascalauthor=J.+M.+Herbert&title=Identification+and+Biological+Activity+of+the+Active+Metabolite+of+Clopidogrel"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Identification and biological activity of the active metabolite of clopidogrel</span></div><div class="casAuthors">Savi, P.; Pereillo, J. M.; Uzabiaga, M. F.; Combalbert, J.; Picard, C.; Maffrand, J. P.; Pascal, M.; Herbert, J. M.</div><div class="citationInfo"><span class="NLM_cas:title">Thrombosis and Haemostasis</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">891-896</span>CODEN:
                <span class="NLM_cas:coden">THHADQ</span>;
        ISSN:<span class="NLM_cas:issn">0340-6245</span>.
    
            (<span class="NLM_cas:orgname">F. K. Schattauer Verlagsgesellschaft mbH</span>)
        </div><div class="casAbstract">Like ticlopidine, the ADP receptor antagonist clopidogrel is inactive in vitro and must be administered i.v. or orally to exhibit antiaggregatory and antithrombotic activities.  We have previously shown that hepatic metab. is necessary for activity.  This study demonstrates that an active metabolite can be generated from human liver microsomes incubated with clopidogrel.  Using several anal. methodologies (LC/MS, NMR, chiral supercrit. fluid chromatog.), we have identified its structure.  In vitro, this highly unstable compd., different from that formed from ticlopidine, exhibited all the biol. activities of clopidogrel obsd. ex vivo: Irreversible inhibition of the binding of 33P-2MeS-ADP to washed human platelets (IC50 = 0.53 μM), selective inhibition of ADP-induced platelet aggregation (IC50 = 1.8 μM) and ADP-induced adenylyl cyclase down-regulation.  The irreversible modification of the ADP-receptor site which is responsible for the biol. activity could be explained by the formation of a disulfide bridge between the reactive thiol group of the active metabolite and a cysteine residue of the platelet ADP receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqp6q3TXPondbVg90H21EOLACvtfcHk0li6h4NRRDv3DA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXovFCjsbs%253D&md5=822a367258ccea5111da1ad6e94847ca</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1055%2Fs-0037-1614133&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-0037-1614133%26sid%3Dliteratum%253Aachs%26aulast%3DSavi%26aufirst%3DP.%26aulast%3DPereillo%26aufirst%3DJ.%2BM.%26aulast%3DUzabiaga%26aufirst%3DM.%2BF.%26aulast%3DCombalbert%26aufirst%3DJ.%26aulast%3DPicard%26aufirst%3DC.%26aulast%3DMaffrand%26aufirst%3DJ.%2BP.%26aulast%3DPascal%26aufirst%3DM.%26aulast%3DHerbert%26aufirst%3DJ.%2BM.%26atitle%3DIdentification%2520and%2520Biological%2520Activity%2520of%2520the%2520Active%2520Metabolite%2520of%2520Clopidogrel%26jtitle%3DThromb.%2520Haemostasis%26date%3D2000%26volume%3D84%26spage%3D891%26epage%3D896" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Cattaneo, M.</span><span> </span><span class="NLM_article-title">ADP Receptors: Inhibitory Strategies for Antiplatelet Therapy</span> <span class="citation_source-journal">Drug News Perspect.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">253</span><span class="NLM_x">–</span> <span class="NLM_lpage">259</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Fjm8008597&amp;key=10.1358%2Fdnp.2006.19.5.985936" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Fjm8008597&amp;key=16941047" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Fjm8008597&amp;key=1%3ACAS%3A528%3ADC%252BD28XpvFejur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2006&pages=253-259&author=M.+Cattaneo&title=ADP+Receptors%3A+Inhibitory+Strategies+for+Antiplatelet+Therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">ADP receptors: inhibitory strategies for antiplatelet therapy</span></div><div class="casAuthors">Cattaneo, Marco</div><div class="citationInfo"><span class="NLM_cas:title">Drug News & Perspectives</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">253-259</span>CODEN:
                <span class="NLM_cas:coden">DNPEED</span>;
        ISSN:<span class="NLM_cas:issn">0214-0934</span>.
    
            (<span class="NLM_cas:orgname">Prous Science</span>)
        </div><div class="casAbstract">A review.  The interaction of adenosine-5'-diphosphate (ADP) with its platelet receptors (P2Y1 and P2Y12) plays a very important role in thrombogenesis.  The thienopyridine ticlopidine was the first specific antagonist of the platelet P2Y12 ADP receptor to be tested in randomized clin. trials for the prevention of arterial thrombotic events.  Although ticlopidine reduces the incidence of vascular events in patients at risk, it also unfortunately has some significant drawbacks: a relatively high incidence of toxic effects, which may be fatal in some cases; delayed onset of action; and a high interindividual variability in response.  A second thienopyridine, clopidogrel, has superseded ticlopidine, because it is also an efficacious antithrombotic drug and is less toxic than ticlopidine.  However, clopidogrel is not completely free from faults: severe toxic effects, albeit occurring much less frequently than with ticlopidine, may still complicate its administration to patients; the onset of pharmacol. action can be accelerated by the use of large loading doses, but may still not be optimal; the high interpatient variability in response remains an important issue.  These concerns justify the continued search for agents that can further improve the clin. outcome of patients with atherosclerosis through greater efficacy and/or safety.  A new thienopyridyl compd., prasugrel, which is characterized by higher potency and faster onset of action compared with clopidogrel, is currently under clin. evaluation.  Two direct and reversible P2Y12 antagonists, cangrelor and AZD6140, feature very rapid onset and reversal of platelet inhibition, which make them attractive alternatives to thienopyridines, esp. when rapid inhibition of platelet aggregation or its quick reversal are required.  Along with new the P2Y12 antagonists, inhibitors of the other platelet receptor for ADP, the antagonists P2Y1, are under development and may prove to be effective antithrombotic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmHmKVThnP17Vg90H21EOLACvtfcHk0li6h4NRRDv3DA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XpvFejur0%253D&md5=0302a0902658503a11691a421fad9c08</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1358%2Fdnp.2006.19.5.985936&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1358%252Fdnp.2006.19.5.985936%26sid%3Dliteratum%253Aachs%26aulast%3DCattaneo%26aufirst%3DM.%26atitle%3DADP%2520Receptors%253A%2520Inhibitory%2520Strategies%2520for%2520Antiplatelet%2520Therapy%26jtitle%3DDrug%2520News%2520Perspect.%26date%3D2006%26volume%3D19%26spage%3D253%26epage%3D259" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><div class="note"><p class="first last"><b>1p</b> also irreversibly inhibits iodine peroxidase, a heme containing enzyme involved in the same biological pathway. This additional inhibitory effect is beneficial in the treatment of hyperthyroidism.</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=1p+also+irreversibly+inhibits+iodine+peroxidase%2C+a+heme+containing+enzyme+involved+in+the+same+biological+pathway.+This+additional+inhibitory+effect+is+beneficial+in+the+treatment+of+hyperthyroidism."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Mugesh, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klotz, L.-O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">du Mont, W.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Becker, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sies, H.</span><span> </span><span class="NLM_article-title">Selenyl Iodide: A New Substrate for Mamallian Thioredoxin Reductase</span> <span class="citation_source-journal">Org. Biomol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">2848</span><span class="NLM_x">–</span> <span class="NLM_lpage">2852</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2003&pages=2848-2852&author=G.+Mugeshauthor=L.-O.+Klotzauthor=W.-W.+du+Montauthor=K.+Beckerauthor=H.+Sies&title=Selenyl+Iodide%3A+A+New+Substrate+for+Mamallian+Thioredoxin+Reductase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMugesh%26aufirst%3DG.%26aulast%3DKlotz%26aufirst%3DL.-O.%26aulast%3Ddu%2BMont%26aufirst%3DW.-W.%26aulast%3DBecker%26aufirst%3DK.%26aulast%3DSies%26aufirst%3DH.%26atitle%3DSelenyl%2520Iodide%253A%2520A%2520New%2520Substrate%2520for%2520Mamallian%2520Thioredoxin%2520Reductase%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2003%26volume%3D1%26spage%3D2848%26epage%3D2852" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Chander, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sulkowski, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenkes, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torbenson, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herlog, H. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bass, E. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gebo, K. A.</span><span> </span><span class="NLM_article-title">Treatment of Chronic Hepatitis C: A Systematic Review</span> <span class="citation_source-journal">Hepatology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl. 5</span><span class="NLM_x">) </span> <span class="NLM_fpage">A135</span><span class="NLM_x">–</span> <span class="NLM_lpage">A144</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2002&pages=A135-A144&issue=Suppl.+5&author=G.+Chanderauthor=M.+S.+Sulkowskiauthor=M.+W.+Jenkesauthor=M.+S.+Torbensonauthor=H.+F.+Herlogauthor=E.+B.+Bassauthor=K.+A.+Gebo&title=Treatment+of+Chronic+Hepatitis+C%3A+A+Systematic+Review"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChander%26aufirst%3DG.%26aulast%3DSulkowski%26aufirst%3DM.%2BS.%26aulast%3DJenkes%26aufirst%3DM.%2BW.%26aulast%3DTorbenson%26aufirst%3DM.%2BS.%26aulast%3DHerlog%26aufirst%3DH.%2BF.%26aulast%3DBass%26aufirst%3DE.%2BB.%26aulast%3DGebo%26aufirst%3DK.%2BA.%26atitle%3DTreatment%2520of%2520Chronic%2520Hepatitis%2520C%253A%2520A%2520Systematic%2520Review%26jtitle%3DHepatology%26date%3D2002%26volume%3D36%26issue%3DSuppl.%25205%26spage%3DA135%26epage%3DA144" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><div class="note"><p class="first last">(HCV) NS3·4A been shown to be essential for the HCV replication in chimpanzees.</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=%28HCV%29+NS3%C2%B74A+been+shown+to+be+essential+for+the+HCV+replication+in+chimpanzees."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit46a"><span><span class="NLM_contrib-group">Kolykhalov, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mihalik, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feinstone, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rice, C. M.</span><span> </span><span class="NLM_article-title">Hepatitis C Virus-Encoded Enzymatic Activities and Conserved RNA Elements in the 3′ Nontranslated Region Are Essential for Virus Replication in Vivo</span> <span class="citation_source-journal">J. Virol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x">, </span> <span class="NLM_fpage">2046</span><span class="NLM_x">–</span> <span class="NLM_lpage">2051</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46a&amp;dbid=16&amp;doi=10.1021%2Fjm8008597&amp;key=10.1128%2FJVI.74.4.2046-2051.2000" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46a&amp;dbid=8&amp;doi=10.1021%2Fjm8008597&amp;key=10644379" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46a&amp;dbid=32&amp;doi=10.1021%2Fjm8008597&amp;key=1%3ACAS%3A528%3ADC%252BD3cXptlGitA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2000&pages=2046-2051&author=A.+A.+Kolykhalovauthor=K.+Mihalikauthor=S.+M.+Feinstoneauthor=C.+M.+Rice&title=Hepatitis+C+Virus-Encoded+Enzymatic+Activities+and+Conserved+RNA+Elements+in+the+3%E2%80%B2+Nontranslated+Region+Are+Essential+for+Virus+Replication+in+Vivo"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46aR"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Hepatitis C virus-encoded enzymatic activities and conserved RNA elements in the 3' nontranslated region are essential for virus replication in vivo</span></div><div class="casAuthors">Kolykhalov, Alexander A.; Mihalik, Kathy; Feinstone, Stephen M.; Rice, Charles M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">2046-2051</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">0022-538X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Hepatitis C virus (HCV) infection is a widespread major human health concern.  Significant obstacles in the study of this virus include the absence of a reliable tissue culture system and a small-animal model.  Recently, full-length HCV cDNA clones were constructed and HCV infection was successfully initiated in 2 chimpanzees by intrahepatic injection of in vitro-transcribed RNA.  In order to validate potential targets for development of anti-HCV therapeutics, 6 mutant derivs. of this prototype infectious clone were constructed.  Four clones contained point mutations ablating the activity of the NS2-3 protease, the NS3-4A serine protease, the NS3 NTPase/helicase, and the NS5B polymerase.  Two addnl. clones contained deletions encompassing all or part of the highly conserved 98-base sequence at the 3' terminus of the HCV genome RNA.  The RNA transcript from each of the 6 clones was injected intrahepatically into a chimpanzee.  No signs of HCV infection were detected in the 8 mo following the injection.  Inoculation of the same animal with nonmutant RNA transcripts resulted in productive HCV infection, as evidenced by viremia, elevated serum alanine aminotransferase, and HCV-specific seroconversion.  These data suggest that these 4 HCV-encoded enzymic activities and the conserved 3' terminal RNA element are essential for productive replication in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcxsUWOuM9sLVg90H21EOLACvtfcHk0lgQP5HsUzFnag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXptlGitA%253D%253D&md5=69facc6778408ae96f31373f78c06600</span></div><a href="/servlet/linkout?suffix=cit46a&amp;dbid=16384&amp;doi=10.1128%2FJVI.74.4.2046-2051.2000&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.74.4.2046-2051.2000%26sid%3Dliteratum%253Aachs%26aulast%3DKolykhalov%26aufirst%3DA.%2BA.%26aulast%3DMihalik%26aufirst%3DK.%26aulast%3DFeinstone%26aufirst%3DS.%2BM.%26aulast%3DRice%26aufirst%3DC.%2BM.%26atitle%3DHepatitis%2520C%2520Virus-Encoded%2520Enzymatic%2520Activities%2520and%2520Conserved%2520RNA%2520Elements%2520in%2520the%25203%25E2%2580%25B2%2520Nontranslated%2520Region%2520Are%2520Essential%2520for%2520Virus%2520Replication%2520in%2520Vivo%26jtitle%3DJ.%2520Virol.%26date%3D2000%26volume%3D74%26spage%3D2046%26epage%3D2051" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Lin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luong, Y.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, Y.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brennan, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fulghum, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsaio, H.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maxwell, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cottrell, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perni, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gates, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwong, A. D.</span><span> </span><span class="NLM_article-title">In Vitro Resistance Studies of Hepatitis C Virus Serine Protease Inhibitors, VX-950 and BILN 2061</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">279</span><span class="NLM_x">, </span> <span class="NLM_fpage">17508</span><span class="NLM_x">–</span> <span class="NLM_lpage">17514</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=17508-17514&author=C.+Linauthor=K.+Linauthor=Y.-P.+Luongauthor=B.+G.+Raoauthor=Y.-Y.+Weiauthor=D.+L.+Brennanauthor=J.+R.+Fulghumauthor=H.-M.+Hsaioauthor=S.+Maauthor=J.+P.+Maxwellauthor=K.+M.+Cottrellauthor=R.+B.+Perniauthor=C.+A.+Gatesauthor=A.+D.+Kwong&title=In+Vitro+Resistance+Studies+of+Hepatitis+C+Virus+Serine+Protease+Inhibitors%2C+VX-950+and+BILN+2061"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DC.%26aulast%3DLin%26aufirst%3DK.%26aulast%3DLuong%26aufirst%3DY.-P.%26aulast%3DRao%26aufirst%3DB.%2BG.%26aulast%3DWei%26aufirst%3DY.-Y.%26aulast%3DBrennan%26aufirst%3DD.%2BL.%26aulast%3DFulghum%26aufirst%3DJ.%2BR.%26aulast%3DHsaio%26aufirst%3DH.-M.%26aulast%3DMa%26aufirst%3DS.%26aulast%3DMaxwell%26aufirst%3DJ.%2BP.%26aulast%3DCottrell%26aufirst%3DK.%2BM.%26aulast%3DPerni%26aufirst%3DR.%2BB.%26aulast%3DGates%26aufirst%3DC.%2BA.%26aulast%3DKwong%26aufirst%3DA.%2BD.%26atitle%3DIn%2520Vitro%2520Resistance%2520Studies%2520of%2520Hepatitis%2520C%2520Virus%2520Serine%2520Protease%2520Inhibitors%252C%2520VX-950%2520and%2520BILN%25202061%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26spage%3D17508%26epage%3D17514" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Heinemann, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Y.-Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chubb, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hertel, L. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grindey, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plunkett, W.</span><span> </span><span class="NLM_article-title">Inhibition of Ribonucleotide Reduction in CCRF-CEM Cells by 2′,2′-Difluorodeoxycytidine</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">567</span><span class="NLM_x">–</span> <span class="NLM_lpage">572</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1990&pages=567-572&author=V.+Heinemannauthor=Y.-Z.+Xuauthor=S.+Chubbauthor=A.+Senauthor=L.+W.+Hertelauthor=G.+B.+Grindeyauthor=W.+Plunkett&title=Inhibition+of+Ribonucleotide+Reduction+in+CCRF-CEM+Cells+by+2%E2%80%B2%2C2%E2%80%B2-Difluorodeoxycytidine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHeinemann%26aufirst%3DV.%26aulast%3DXu%26aufirst%3DY.-Z.%26aulast%3DChubb%26aufirst%3DS.%26aulast%3DSen%26aufirst%3DA.%26aulast%3DHertel%26aufirst%3DL.%2BW.%26aulast%3DGrindey%26aufirst%3DG.%2BB.%26aulast%3DPlunkett%26aufirst%3DW.%26atitle%3DInhibition%2520of%2520Ribonucleotide%2520Reduction%2520in%2520CCRF-CEM%2520Cells%2520by%25202%25E2%2580%25B2%252C2%25E2%2580%25B2-Difluorodeoxycytidine%26jtitle%3DMol.%2520Pharmacol.%26date%3D1990%26volume%3D38%26spage%3D567%26epage%3D572" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Baker, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banzon, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bollinger, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stubbe, J.</span><span> </span><span class="NLM_article-title">2′-Deoxy-2′-methylenecytidine and 2′-Deoxy-2′,2′-difluorocytidine 5′-Diphosphates: Potent Mechanism-Based Inhibitors of Ribonucleotide Reductase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">1879</span><span class="NLM_x">–</span> <span class="NLM_lpage">1884</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00110a019" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1991&pages=1879-1884&author=C.+H.+Bakerauthor=J.+Banzonauthor=J.+M.+Bollingerauthor=J.+Stubbe&title=2%E2%80%B2-Deoxy-2%E2%80%B2-methylenecytidine+and+2%E2%80%B2-Deoxy-2%E2%80%B2%2C2%E2%80%B2-difluorocytidine+5%E2%80%B2-Diphosphates%3A+Potent+Mechanism-Based+Inhibitors+of+Ribonucleotide+Reductase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1021%2Fjm00110a019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00110a019%26sid%3Dliteratum%253Aachs%26aulast%3DBaker%26aufirst%3DC.%2BH.%26aulast%3DBanzon%26aufirst%3DJ.%26aulast%3DBollinger%26aufirst%3DJ.%2BM.%26aulast%3DStubbe%26aufirst%3DJ.%26atitle%3D2%25E2%2580%25B2-Deoxy-2%25E2%2580%25B2-methylenecytidine%2520and%25202%25E2%2580%25B2-Deoxy-2%25E2%2580%25B2%252C2%25E2%2580%25B2-difluorocytidine%25205%25E2%2580%25B2-Diphosphates%253A%2520Potent%2520Mechanism-Based%2520Inhibitors%2520of%2520Ribonucleotide%2520Reductase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1991%26volume%3D34%26spage%3D1879%26epage%3D1884" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Santi, D. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McHenry, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sommer, H.</span><span> </span><span class="NLM_article-title">Mechanism of Interaction of Thymidylate Synthetase with 5-Fluorodeoxyuridylate</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1974</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">471</span><span class="NLM_x">–</span> <span class="NLM_lpage">481</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi00700a012" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=1974&pages=471-481&author=D.+V.+Santiauthor=C.+S.+McHenryauthor=H.+Sommer&title=Mechanism+of+Interaction+of+Thymidylate+Synthetase+with+5-Fluorodeoxyuridylate"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1021%2Fbi00700a012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi00700a012%26sid%3Dliteratum%253Aachs%26aulast%3DSanti%26aufirst%3DD.%2BV.%26aulast%3DMcHenry%26aufirst%3DC.%2BS.%26aulast%3DSommer%26aufirst%3DH.%26atitle%3DMechanism%2520of%2520Interaction%2520of%2520Thymidylate%2520Synthetase%2520with%25205-Fluorodeoxyuridylate%26jtitle%3DBiochemistry%26date%3D1974%26volume%3D13%26spage%3D471%26epage%3D481" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Wong, K.-K.</span><span> </span><span class="NLM_article-title">HKI-272 in Non-Small Cell Lung Cancer</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl. 15</span><span class="NLM_x">) </span> <span class="NLM_fpage">4953s</span><span class="NLM_x">–</span> <span class="NLM_lpage">4596s</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2007&pages=4953s-4596s&issue=Suppl.+15&author=K.-K.+Wong&title=HKI-272+in+Non-Small+Cell+Lung+Cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWong%26aufirst%3DK.-K.%26atitle%3DHKI-272%2520in%2520Non-Small%2520Cell%2520Lung%2520Cancer%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2007%26volume%3D13%26issue%3DSuppl.%252015%26spage%3D4953s%26epage%3D4596s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Wissner, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Overbeek, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reich, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Floyd, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mamuya, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosfjord, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Discafani, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rabindran, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gruber, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hallett, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nilakantan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.-F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenberger, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsou, H.-R.</span><span> </span><span class="NLM_article-title">Synthesis and Structure−Activity Relationship of 6,7-Disubstituted 4-Anilinoquinoline-3-carbonitriles. The Design of an Orally Active, Irreversible Inhibitor of the Tyrosine Kinase Activity of the Epidermal Growth Factor Receptor (EGFR) and the Human Epidermal Growth Factor Receptor-2 (HER-2)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">49</span><span class="NLM_x">–</span> <span class="NLM_lpage">63</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm020241c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=49-63&author=A.+Wissnerauthor=E.+Overbeekauthor=M.+Reichauthor=M.+B.+Floydauthor=B.+D.+Johnsonauthor=N.+Mamuyaauthor=E.+C.+Rosfjordauthor=C.+Discafaniauthor=R.+Davisauthor=X.+Shiauthor=S.+K.+Rabindranauthor=B.+C.+Gruberauthor=F.+Yeauthor=W.+A.+Hallettauthor=R.+Nilakantanauthor=R.+Shenauthor=Y.-F.+Wangauthor=L.+M.+Greenbergerauthor=H.-R.+Tsou&title=Synthesis+and+Structure%E2%88%92Activity+Relationship+of+6%2C7-Disubstituted+4-Anilinoquinoline-3-carbonitriles.+The+Design+of+an+Orally+Active%2C+Irreversible+Inhibitor+of+the+Tyrosine+Kinase+Activity+of+the+Epidermal+Growth+Factor+Receptor+%28EGFR%29+and+the+Human+Epidermal+Growth+Factor+Receptor-2+%28HER-2%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1021%2Fjm020241c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm020241c%26sid%3Dliteratum%253Aachs%26aulast%3DWissner%26aufirst%3DA.%26aulast%3DOverbeek%26aufirst%3DE.%26aulast%3DReich%26aufirst%3DM.%26aulast%3DFloyd%26aufirst%3DM.%2BB.%26aulast%3DJohnson%26aufirst%3DB.%2BD.%26aulast%3DMamuya%26aufirst%3DN.%26aulast%3DRosfjord%26aufirst%3DE.%2BC.%26aulast%3DDiscafani%26aufirst%3DC.%26aulast%3DDavis%26aufirst%3DR.%26aulast%3DShi%26aufirst%3DX.%26aulast%3DRabindran%26aufirst%3DS.%2BK.%26aulast%3DGruber%26aufirst%3DB.%2BC.%26aulast%3DYe%26aufirst%3DF.%26aulast%3DHallett%26aufirst%3DW.%2BA.%26aulast%3DNilakantan%26aufirst%3DR.%26aulast%3DShen%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DY.-F.%26aulast%3DGreenberger%26aufirst%3DL.%2BM.%26aulast%3DTsou%26aufirst%3DH.-R.%26atitle%3DSynthesis%2520and%2520Structure%25E2%2588%2592Activity%2520Relationship%2520of%25206%252C7-Disubstituted%25204-Anilinoquinoline-3-carbonitriles.%2520The%2520Design%2520of%2520an%2520Orally%2520Active%252C%2520Irreversible%2520Inhibitor%2520of%2520the%2520Tyrosine%2520Kinase%2520Activity%2520of%2520the%2520Epidermal%2520Growth%2520Factor%2520Receptor%2520%2528EGFR%2529%2520and%2520the%2520Human%2520Epidermal%2520Growth%2520Factor%2520Receptor-2%2520%2528HER-2%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D49%26epage%3D63" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><div class="note"><p class="first last">Upon removal of the dimethylamino group, no glutathione addition is detected (ref <a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">52</a>, Wissner et al.)</p></div>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Upon+removal+of+the+dimethylamino+group%2C+no+glutathione+addition+is+detected+%28ref+52%2C+Wissner+et+al.%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group">Tsou, H.-R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Overbeek-Klumpers, E. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hallett, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reich, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Floyd, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michalak, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nilakantan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Discafani, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rabindran, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.-F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Upeslacis, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wissner, A.</span><span> </span><span class="NLM_article-title">Optimization of 6,7-Disubstituted-4-(arylamino)quinoline-3-carbonitriles as Orally Active Irreversible Inhibitors of Human Epidermal Growth Factor Receptor-2 Kinase Activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">1107</span><span class="NLM_x">–</span> <span class="NLM_lpage">1131</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm040159c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=1107-1131&author=H.-R.+Tsouauthor=E.+G.+Overbeek-Klumpersauthor=W.+A.+Hallettauthor=M.+F.+Reichauthor=M.+B.+Floydauthor=B.+D.+Johnsonauthor=R.+S.+Michalakauthor=R.+Nilakantanauthor=C.+Discafaniauthor=J.+Golasauthor=S.+K.+Rabindranauthor=R.+Shenauthor=X.+Shiauthor=Y.-F.+Wangauthor=J.+Upeslacisauthor=A.+Wissner&title=Optimization+of+6%2C7-Disubstituted-4-%28arylamino%29quinoline-3-carbonitriles+as+Orally+Active+Irreversible+Inhibitors+of+Human+Epidermal+Growth+Factor+Receptor-2+Kinase+Activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1021%2Fjm040159c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm040159c%26sid%3Dliteratum%253Aachs%26aulast%3DTsou%26aufirst%3DH.-R.%26aulast%3DOverbeek-Klumpers%26aufirst%3DE.%2BG.%26aulast%3DHallett%26aufirst%3DW.%2BA.%26aulast%3DReich%26aufirst%3DM.%2BF.%26aulast%3DFloyd%26aufirst%3DM.%2BB.%26aulast%3DJohnson%26aufirst%3DB.%2BD.%26aulast%3DMichalak%26aufirst%3DR.%2BS.%26aulast%3DNilakantan%26aufirst%3DR.%26aulast%3DDiscafani%26aufirst%3DC.%26aulast%3DGolas%26aufirst%3DJ.%26aulast%3DRabindran%26aufirst%3DS.%2BK.%26aulast%3DShen%26aufirst%3DR.%26aulast%3DShi%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DY.-F.%26aulast%3DUpeslacis%26aufirst%3DJ.%26aulast%3DWissner%26aufirst%3DA.%26atitle%3DOptimization%2520of%25206%252C7-Disubstituted-4-%2528arylamino%2529quinoline-3-carbonitriles%2520as%2520Orally%2520Active%2520Irreversible%2520Inhibitors%2520of%2520Human%2520Epidermal%2520Growth%2520Factor%2520Receptor-2%2520Kinase%2520Activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D1107%26epage%3D1131" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group">Yun, C.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mengwasser, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toms, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woo, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greulich, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, K.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyerson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eck, M. J.</span><span> </span><span class="NLM_article-title">The T790M Mutation in EGFR Kinase Causes Drug Resistance by Increasing the Affinity for ATP</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x">, </span> <span class="NLM_fpage">2070</span><span class="NLM_x">–</span> <span class="NLM_lpage">2075</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Fjm8008597&amp;key=10.1073%2Fpnas.0709662105" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Fjm8008597&amp;key=18227510" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Fjm8008597&amp;key=1%3ACAS%3A528%3ADC%252BD1cXitl2mu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2008&pages=2070-2075&author=C.-H.+Yunauthor=K.+E.+Mengwasserauthor=A.+V.+Tomsauthor=M.+S.+Wooauthor=H.+Greulichauthor=K.-K.+Wongauthor=M.+Meyersonauthor=M.+J.+Eck&title=The+T790M+Mutation+in+EGFR+Kinase+Causes+Drug+Resistance+by+Increasing+the+Affinity+for+ATP"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">The T790M mutation in EGFR kinase causes drug resistance by increasing the affinity for ATP</span></div><div class="casAuthors">Yun, Cai-Hong; Mengwasser, Kristen E.; Toms, Angela V.; Woo, Michele S.; Greulich, Heidi; Wong, Kwok-Kin; Meyerson, Matthew; Eck, Michael J.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2070-2075</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Lung cancers caused by activating mutations in the epidermal growth factor receptor (EGFR) are initially responsive to small mol. tyrosine kinase inhibitors (TKIs), but the efficacy of these agents is often limited because of the emergence of drug resistance conferred by a second mutation, T790M.  Threonine 790 is the "gatekeeper" residue, an important determinant of inhibitor specificity in the ATP binding pocket.  The T790M mutation has been thought to cause resistance by sterically blocking binding of TKIs such as gefitinib and erlotinib, but this explanation is difficult to reconcile with the fact that it remains sensitive to structurally similar irreversible inhibitors.  Here, we show by using a direct binding assay that T790M mutants retain low-nanomolar affinity for gefitinib.  Furthermore, we show that the T790M mutation activates WT EGFR and that introduction of the T790M mutation increases the ATP affinity of the oncogenic L858R mutant by more than an order of magnitude.  The increased ATP affinity is the primary mechanism by which the T790M mutation confers drug resistance.  Crystallog. anal. of the T790M mutant shows how it can adapt to accommodate tight binding of diverse inhibitors, including the irreversible inhibitor HKI-272, and also suggests a structural mechanism for catalytic activation.  We conclude that the T790M mutation is a "generic" resistance mutation that will reduce the potency of any ATP-competitive kinase inhibitor and that irreversible inhibitors overcome this resistance simply through covalent binding, not as a result of an alternative binding mode.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXXP7TBlyrdrVg90H21EOLACvtfcHk0ljTLs4M5eXpZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXitl2mu7k%253D&md5=f5f5d791a65f73ca628d95e9922b8ea8</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0709662105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0709662105%26sid%3Dliteratum%253Aachs%26aulast%3DYun%26aufirst%3DC.-H.%26aulast%3DMengwasser%26aufirst%3DK.%2BE.%26aulast%3DToms%26aufirst%3DA.%2BV.%26aulast%3DWoo%26aufirst%3DM.%2BS.%26aulast%3DGreulich%26aufirst%3DH.%26aulast%3DWong%26aufirst%3DK.-K.%26aulast%3DMeyerson%26aufirst%3DM.%26aulast%3DEck%26aufirst%3DM.%2BJ.%26atitle%3DThe%2520T790M%2520Mutation%2520in%2520EGFR%2520Kinase%2520Causes%2520Drug%2520Resistance%2520by%2520Increasing%2520the%2520Affinity%2520for%2520ATP%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2008%26volume%3D105%26spage%3D2070%26epage%3D2075" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group">Erlichman, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hidalgo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boni, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martins, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quinn, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zacharchuk, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amorusi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adjei, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowinksy, E. K.</span><span> </span><span class="NLM_article-title">Phase I Study of EKB-569, an Irreversible Inhibitor of the Epidermal Growth Factor Receptor, in Patients with Advanced Solid Tumors</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">2252</span><span class="NLM_x">–</span> <span class="NLM_lpage">2260</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Fjm8008597&amp;key=10.1200%2FJCO.2005.01.8960" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Fjm8008597&amp;key=16710023" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Fjm8008597&amp;key=1%3ACAS%3A528%3ADC%252BD28XlvV2ksLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2006&pages=2252-2260&author=C.+Erlichmanauthor=M.+Hidalgoauthor=J.+P.+Boniauthor=P.+Martinsauthor=S.+E.+Quinnauthor=C.+Zacharchukauthor=P.+Amorusiauthor=A.+A.+Adjeiauthor=E.+K.+Rowinksy&title=Phase+I+Study+of+EKB-569%2C+an+Irreversible+Inhibitor+of+the+Epidermal+Growth+Factor+Receptor%2C+in+Patients+with+Advanced+Solid+Tumors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Phase I study of EKB-569, an irreversible inhibitor of the epidermal growth factor receptor, in patients with advanced solid tumors</span></div><div class="casAuthors">Erlichman, Charles; Hidalgo, Manuel; Boni, Joseph P.; Martins, Patricia; Quinn, Susan E.; Zacharchuk, Charles; Amorusi, Peter; Adjei, Alex A.; Rowinsky, Eric K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">2252-2260</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">American Society of Clinical Oncology</span>)
        </div><div class="casAbstract">The max. tolerated dose (MTD) and the dose-limiting toxicities of EKB-569, a selective, irreversible inhibitor of the epidermal growth factor receptor (EGFR), when administered orally once daily on an intermittent-dose schedule (14 days of a 28-day cycle) or on a continuous-dose schedule (each day of a 28-day cycle), were detd. in patients with advanced solid tumors.  Planned dose escalation was 25, 50, 75, 125, 175, and 225 mg.  Pharmacokinetic sampling was performed on days 1 and 14 for the intermittent-dose cohort and on days 1 and 15 for the continuous-dose cohort.  Thirty patients received a median of two cycles (range, one to 10 cycles) in the intermittent-dose cohort; 29 patients received a median of three cycles (range, one to eight cycles) in the continuous-dose cohort.  Dose-limiting toxicity was grade 3 diarrhea, and the MTD was 75 mg EKB-569 per day for both cohorts.  Other common toxicities included rash, nausea, and asthenia.  Exposure to EKB-569 was dose proportional.  At the MTD, the mean ± std. deviation terminal half-life was 21.7 ± 4.2 h and peak concn. increased 1.2-fold from day 1 to day 14/15.  No major antitumor responses were obsd.  However, one patient with non-small-cell lung cancer and one with cutaneous squamous cell carcinoma had stable disease for 33 and 24 wk, resp.  The MTD of once-daily oral EKB-569 is 75 mg.  The tolerable toxicity profile and long half-life of this irreversible EGFR inhibitor warrant its further evaluation as a single agent and in combination with other drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpoWU_wd20ORbVg90H21EOLACvtfcHk0lgxrV1YI2CDgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XlvV2ksLk%253D&md5=3a7766538e63808314fe4ea73b5f766d</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1200%2FJCO.2005.01.8960&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2005.01.8960%26sid%3Dliteratum%253Aachs%26aulast%3DErlichman%26aufirst%3DC.%26aulast%3DHidalgo%26aufirst%3DM.%26aulast%3DBoni%26aufirst%3DJ.%2BP.%26aulast%3DMartins%26aufirst%3DP.%26aulast%3DQuinn%26aufirst%3DS.%2BE.%26aulast%3DZacharchuk%26aufirst%3DC.%26aulast%3DAmorusi%26aufirst%3DP.%26aulast%3DAdjei%26aufirst%3DA.%2BA.%26aulast%3DRowinksy%26aufirst%3DE.%2BK.%26atitle%3DPhase%2520I%2520Study%2520of%2520EKB-569%252C%2520an%2520Irreversible%2520Inhibitor%2520of%2520the%2520Epidermal%2520Growth%2520Factor%2520Receptor%252C%2520in%2520Patients%2520with%2520Advanced%2520Solid%2520Tumors%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2006%26volume%3D24%26spage%3D2252%26epage%3D2260" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group">Bull, H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia-Calvo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andersson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baginsky, W. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellsworth, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stearns, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bakshi, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rasmusson, G. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tolman, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Myers, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kozarich, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, G. S.</span><span> </span><span class="NLM_article-title">Mechanism-Based Inhibition of Human Steroid 5α-Reductase by Finasteride: Enyzme-Catalyzed Formation of NADP-Dihydrofinasteride, a Potent Bisubstrate Analog Inhibitor</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">118</span><span class="NLM_x">, </span> <span class="NLM_fpage">2359</span><span class="NLM_x">–</span> <span class="NLM_lpage">2365</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja953069t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=1996&pages=2359-2365&author=H.+G.+Bullauthor=M.+Garcia-Calvoauthor=S.+Anderssonauthor=W.+F.+Baginskyauthor=H.+K.+Chanauthor=D.+E.+Ellsworthauthor=R.+R.+Millerauthor=R.+A.+Stearnsauthor=R.+K.+Bakshiauthor=G.+H.+Rasmussonauthor=R.+L.+Tolmanauthor=R.+W.+Myersauthor=J.+W.+Kozarichauthor=G.+S.+Harris&title=Mechanism-Based+Inhibition+of+Human+Steroid+5%CE%B1-Reductase+by+Finasteride%3A+Enyzme-Catalyzed+Formation+of+NADP-Dihydrofinasteride%2C+a+Potent+Bisubstrate+Analog+Inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1021%2Fja953069t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja953069t%26sid%3Dliteratum%253Aachs%26aulast%3DBull%26aufirst%3DH.%2BG.%26aulast%3DGarcia-Calvo%26aufirst%3DM.%26aulast%3DAndersson%26aufirst%3DS.%26aulast%3DBaginsky%26aufirst%3DW.%2BF.%26aulast%3DChan%26aufirst%3DH.%2BK.%26aulast%3DEllsworth%26aufirst%3DD.%2BE.%26aulast%3DMiller%26aufirst%3DR.%2BR.%26aulast%3DStearns%26aufirst%3DR.%2BA.%26aulast%3DBakshi%26aufirst%3DR.%2BK.%26aulast%3DRasmusson%26aufirst%3DG.%2BH.%26aulast%3DTolman%26aufirst%3DR.%2BL.%26aulast%3DMyers%26aufirst%3DR.%2BW.%26aulast%3DKozarich%26aufirst%3DJ.%2BW.%26aulast%3DHarris%26aufirst%3DG.%2BS.%26atitle%3DMechanism-Based%2520Inhibition%2520of%2520Human%2520Steroid%25205%25CE%25B1-Reductase%2520by%2520Finasteride%253A%2520Enyzme-Catalyzed%2520Formation%2520of%2520NADP-Dihydrofinasteride%252C%2520a%2520Potent%2520Bisubstrate%2520Analog%2520Inhibitor%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1996%26volume%3D118%26spage%3D2359%26epage%3D2365" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><div class="note"><p class="first last">Other covalent MAO inhibitors are used to treat depression, albeit using a different chemotype and mechanism. These include the hydrazide isocarboxazid and the hydrazine phenelzine.</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Other+covalent+MAO+inhibitors+are+used+to+treat+depression%2C+albeit+using+a+different+chemotype+and+mechanism.+These+include+the+hydrazide+isocarboxazid+and+the+hydrazine+phenelzine."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group">Salach, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demeterm, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Youdim, M. B. H.</span><span> </span><span class="NLM_article-title">The Reaction of Bovine and Rat Liver Monoamine Oxidase with [<sup>14</sup>C]-Clorgyline and [<sup>14</sup>C]-Deprenyl</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1979</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">234</span><span class="NLM_x">–</span> <span class="NLM_lpage">241</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1979&pages=234-241&author=J.+I.+Salachauthor=K.+Demetermauthor=M.+B.+H.+Youdim&title=The+Reaction+of+Bovine+and+Rat+Liver+Monoamine+Oxidase+with+%5B14C%5D-Clorgyline+and+%5B14C%5D-Deprenyl"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSalach%26aufirst%3DJ.%2BI.%26aulast%3DDemeterm%26aufirst%3DK.%26aulast%3DYoudim%26aufirst%3DM.%2BB.%2BH.%26atitle%3DThe%2520Reaction%2520of%2520Bovine%2520and%2520Rat%2520Liver%2520Monoamine%2520Oxidase%2520with%2520%255B14C%255D-Clorgyline%2520and%2520%255B14C%255D-Deprenyl%26jtitle%3DMol.%2520Pharmacol.%26date%3D1979%26volume%3D16%26spage%3D234%26epage%3D241" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group">Van Houten, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bogdan, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferri, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mariano, P. S.</span><span> </span><span class="NLM_article-title">A New Strategy for the Design of Monoamine Oxidase Inactivators. Exploratory Studies with Tertiary Allylic and Propargylic Amino Alcohols</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">120</span><span class="NLM_x">, </span> <span class="NLM_fpage">5864</span><span class="NLM_x">–</span> <span class="NLM_lpage">5872</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja973978d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=120&publication_year=1998&pages=5864-5872&author=K.+A.+Van+Houtenauthor=J.-M.+Kimauthor=M.+A.+Bogdanauthor=D.+C.+Ferriauthor=P.+S.+Mariano&title=A+New+Strategy+for+the+Design+of+Monoamine+Oxidase+Inactivators.+Exploratory+Studies+with+Tertiary+Allylic+and+Propargylic+Amino+Alcohols"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1021%2Fja973978d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja973978d%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2BHouten%26aufirst%3DK.%2BA.%26aulast%3DKim%26aufirst%3DJ.-M.%26aulast%3DBogdan%26aufirst%3DM.%2BA.%26aulast%3DFerri%26aufirst%3DD.%2BC.%26aulast%3DMariano%26aufirst%3DP.%2BS.%26atitle%3DA%2520New%2520Strategy%2520for%2520the%2520Design%2520of%2520Monoamine%2520Oxidase%2520Inactivators.%2520Exploratory%2520Studies%2520with%2520Tertiary%2520Allylic%2520and%2520Propargylic%2520Amino%2520Alcohols%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1998%26volume%3D120%26spage%3D5864%26epage%3D5872" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group">Peters, J.-U.</span><span> </span><span class="NLM_article-title">11 Years of Cyanopyrrolidines as DPP-IV Inhibitors</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">579</span><span class="NLM_x">–</span> <span class="NLM_lpage">595</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Fjm8008597&amp;key=10.2174%2F156802607780091000" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Fjm8008597&amp;key=17352679" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Fjm8008597&amp;key=1%3ACAS%3A528%3ADC%252BD2sXlsFers78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2007&pages=579-595&author=J.-U.+Peters&title=11+Years+of+Cyanopyrrolidines+as+DPP-IV+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">11 years of cyanopyrrolidines as DPP-IV inhibitors</span></div><div class="casAuthors">Peters, Jens-Uwe</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">579-595</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Cyanopyrrolidines (cyanopyrrolidides, pyrrolidine-2-nitriles, prolinenitriles) as inhibitors of the serine protease dipeptidyl peptidase IV (DPP-IV, DP IV, CD26, EC 3.4.14.5) were first reported in 1995.  The interest in this compd. class grew immensely when DPP-IV was discovered as a target for the treatment of type 2 diabetes.  The research on cyanopyrrolidines cumulated in the discoveries of vildagliptin (LAF237, NVP-LAF237) and saxagliptin (BMS-477118).  These compds. entered Phase III clin. trials in 2004 and 2005, resp., and an application for market approval has been filed for vildagliptin in 2006.  Today cyanopyrrolidines are, as judged by the nos. of patent applications, the most prominent of several series of DPP-IV inhibitors, and have the potential to become valuable medicines for type 2 diabetes in the near future.  This review summarizes some historical aspects of the discovery of cyanopyrrolidine DPP-IV inhibitors, and then focuses mainly on structure-activity-relationships, the evolution of different subseries, the possibilities to improve on the chem. instability that is assocd. with this compd. class, and on the discoveries of vildagliptin and saxagliptin.  Within this context, the properties of individual compds. and results from biol. studies are discussed.  The rationale of DPP-IV inhibition, clin. data, and the relevance of selectivity over related proteases are extensively reviewed in other contributions to this issue of Curr.  Top. Med. Chem., and are therefore only very briefly touched.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMheLlajHi0LVg90H21EOLACvtfcHk0ljDVC8U09HQBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXlsFers78%253D&md5=1aed687f83d3d35a2a581956ce4b82e0</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.2174%2F156802607780091000&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802607780091000%26sid%3Dliteratum%253Aachs%26aulast%3DPeters%26aufirst%3DJ.-U.%26atitle%3D11%2520Years%2520of%2520Cyanopyrrolidines%2520as%2520DPP-IV%2520Inhibitors%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2007%26volume%3D7%26spage%3D579%26epage%3D595" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group">Kim, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beconi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eiermann, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickey, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kowalchick, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leiting, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyons, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsilio, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCann, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scapin, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roy, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wyvratt, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thornberry, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, A. E.</span><span> </span><span class="NLM_article-title">(2<i>R</i>)-4-Oxo-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-<i>a</i>]pyrazin-7(8<i>H</i>)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine: A Potent, Orally Active Dipeptidyl Peptidase IV Inhibitor for the Treatment of Type 2 Diabetes</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">141</span><span class="NLM_x">–</span> <span class="NLM_lpage">151</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0493156" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=141-151&author=D.+Kimauthor=L.+Wangauthor=M.+Beconiauthor=G.+J.+Eiermannauthor=M.+H.+Fisherauthor=H.+Heauthor=G.+J.+Hickeyauthor=J.+E.+Kowalchickauthor=B.+Leitingauthor=K.+Lyonsauthor=F.+Marsilioauthor=M.+E.+McCannauthor=R.+A.+Patelauthor=A.+Petrovauthor=G.+Scapinauthor=S.+B.+Patelauthor=R.+S.+Royauthor=J.+K.+Wuauthor=M.+J.+Wyvrattauthor=B.+B.+Zhangauthor=L.+Zhuauthor=N.+A.+Thornberryauthor=A.+E.+Weber&title=%282R%29-4-Oxo-4-%5B3-%28trifluoromethyl%29-5%2C6-dihydro%5B1%2C2%2C4%5Dtriazolo%5B4%2C3-a%5Dpyrazin-7%288H%29-yl%5D-1-%282%2C4%2C5-trifluorophenyl%29butan-2-amine%3A+A+Potent%2C+Orally+Active+Dipeptidyl+Peptidase+IV+Inhibitor+for+the+Treatment+of+Type+2+Diabetes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1021%2Fjm0493156&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0493156%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DBeconi%26aufirst%3DM.%26aulast%3DEiermann%26aufirst%3DG.%2BJ.%26aulast%3DFisher%26aufirst%3DM.%2BH.%26aulast%3DHe%26aufirst%3DH.%26aulast%3DHickey%26aufirst%3DG.%2BJ.%26aulast%3DKowalchick%26aufirst%3DJ.%2BE.%26aulast%3DLeiting%26aufirst%3DB.%26aulast%3DLyons%26aufirst%3DK.%26aulast%3DMarsilio%26aufirst%3DF.%26aulast%3DMcCann%26aufirst%3DM.%2BE.%26aulast%3DPatel%26aufirst%3DR.%2BA.%26aulast%3DPetrov%26aufirst%3DA.%26aulast%3DScapin%26aufirst%3DG.%26aulast%3DPatel%26aufirst%3DS.%2BB.%26aulast%3DRoy%26aufirst%3DR.%2BS.%26aulast%3DWu%26aufirst%3DJ.%2BK.%26aulast%3DWyvratt%26aufirst%3DM.%2BJ.%26aulast%3DZhang%26aufirst%3DB.%2BB.%26aulast%3DZhu%26aufirst%3DL.%26aulast%3DThornberry%26aufirst%3DN.%2BA.%26aulast%3DWeber%26aufirst%3DA.%2BE.%26atitle%3D%25282R%2529-4-Oxo-4-%255B3-%2528trifluoromethyl%2529-5%252C6-dihydro%255B1%252C2%252C4%255Dtriazolo%255B4%252C3-a%255Dpyrazin-7%25288H%2529-yl%255D-1-%25282%252C4%252C5-trifluorophenyl%2529butan-2-amine%253A%2520A%2520Potent%252C%2520Orally%2520Active%2520Dipeptidyl%2520Peptidase%2520IV%2520Inhibitor%2520for%2520the%2520Treatment%2520of%2520Type%25202%2520Diabetes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D141%26epage%3D151" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group">Gauthier, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chauret, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cromlish, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desmarais, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duong, L. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Falgueyret, J.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimmel, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamontagne, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leger, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LeRiche, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masse, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKay, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicoll-Griffith, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oballa, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palmer, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Percival, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riendeau, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robichaud, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodan, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodan, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seto, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Therien, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Truong, V.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venuti, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wesolowski, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, R. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zamboni, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Black, W. C.</span><span> </span><span class="NLM_article-title">The Discovery of Odanacatib (MK-0822), a Selective Inhibitor of Cathepsin K</span> <span class="citation_source-journal">Biol. Org. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">923</span><span class="NLM_x">–</span> <span class="NLM_lpage">928</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Fjm8008597&amp;key=10.1016%2Fj.bmcl.2007.12.047" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Fjm8008597&amp;key=18226527" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Fjm8008597&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsFWktro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=923-928&author=J.+Y.+Gauthierauthor=N.+Chauretauthor=W.+Cromlishauthor=S.+Desmaraisauthor=L.+T.+Duongauthor=J.-P.+Falgueyretauthor=D.+B.+Kimmelauthor=S.+Lamontagneauthor=S.+Legerauthor=T.+LeRicheauthor=C.+S.+Liauthor=F.+Masseauthor=D.+J.+McKayauthor=D.+A.+Nicoll-Griffithauthor=R.+M.+Oballaauthor=J.+T.+Palmerauthor=M.+D.+Percivalauthor=D.+Riendeauauthor=J.+Robichaudauthor=G.+A.+Rodanauthor=S.+B.+Rodanauthor=C.+Setoauthor=M.+Therienauthor=V.-L.+Truongauthor=M.+C.+Venutiauthor=G.+Wesolowskiauthor=R.+N.+Youngauthor=R.+Zamboniauthor=W.+C.+Black&title=The+Discovery+of+Odanacatib+%28MK-0822%29%2C+a+Selective+Inhibitor+of+Cathepsin+K"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">The discovery of odanacatib (MK-0822), a selective inhibitor of cathepsin K</span></div><div class="casAuthors">Gauthier, Jacques Yves; Chauret, Nathalie; Cromlish, Wanda; Desmarais, Sylvie; Duong, Le T.; Falgueyret, Jean-Pierre; Kimmel, Donald B.; Lamontagne, Sonia; Leger, Serge; LeRiche, Tammy; Li, Chun Sing; Masse, Frederic; McKay, Daniel J.; Nicoll-Griffith, Deborah A.; Oballa, Renata M.; Palmer, James T.; Percival, M. David; Riendeau, Denis; Robichaud, Joel; Rodan, Gideon A.; Rodan, Sevgi B.; Seto, Carmai; Therien, Michel; Truong, Vouy-Linh; Venuti, Michael C.; Wesolowski, Gregg; Young, Robert N.; Zamboni, Robert; Black, W. Cameron</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">923-928</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Odanacatib is a potent, selective, and neutral cathepsin K inhibitor which was developed to address the metabolic liabilities of the Cat K inhibitor L-873724.  Substituting P1 and modifying the P2 side chain led to a metabolically robust inhibitor with a long half-life in preclin. species.  Odanacatib was more selective in whole cell assays than the published Cat K inhibitors balicatib and relacatib.  Evaluation in dermal fibroblast culture showed minimal intracellular collagen accumulation relative to less selective Cat K inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7ytNI-SBgarVg90H21EOLACvtfcHk0liYXRRERPBd6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsFWktro%253D&md5=e432a420a3ec99c784117750b9bbeda8</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2007.12.047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2007.12.047%26sid%3Dliteratum%253Aachs%26aulast%3DGauthier%26aufirst%3DJ.%2BY.%26aulast%3DChauret%26aufirst%3DN.%26aulast%3DCromlish%26aufirst%3DW.%26aulast%3DDesmarais%26aufirst%3DS.%26aulast%3DDuong%26aufirst%3DL.%2BT.%26aulast%3DFalgueyret%26aufirst%3DJ.-P.%26aulast%3DKimmel%26aufirst%3DD.%2BB.%26aulast%3DLamontagne%26aufirst%3DS.%26aulast%3DLeger%26aufirst%3DS.%26aulast%3DLeRiche%26aufirst%3DT.%26aulast%3DLi%26aufirst%3DC.%2BS.%26aulast%3DMasse%26aufirst%3DF.%26aulast%3DMcKay%26aufirst%3DD.%2BJ.%26aulast%3DNicoll-Griffith%26aufirst%3DD.%2BA.%26aulast%3DOballa%26aufirst%3DR.%2BM.%26aulast%3DPalmer%26aufirst%3DJ.%2BT.%26aulast%3DPercival%26aufirst%3DM.%2BD.%26aulast%3DRiendeau%26aufirst%3DD.%26aulast%3DRobichaud%26aufirst%3DJ.%26aulast%3DRodan%26aufirst%3DG.%2BA.%26aulast%3DRodan%26aufirst%3DS.%2BB.%26aulast%3DSeto%26aufirst%3DC.%26aulast%3DTherien%26aufirst%3DM.%26aulast%3DTruong%26aufirst%3DV.-L.%26aulast%3DVenuti%26aufirst%3DM.%2BC.%26aulast%3DWesolowski%26aufirst%3DG.%26aulast%3DYoung%26aufirst%3DR.%2BN.%26aulast%3DZamboni%26aufirst%3DR.%26aulast%3DBlack%26aufirst%3DW.%2BC.%26atitle%3DThe%2520Discovery%2520of%2520Odanacatib%2520%2528MK-0822%2529%252C%2520a%2520Selective%2520Inhibitor%2520of%2520Cathepsin%2520K%26jtitle%3DBiol.%2520Org.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D923%26epage%3D928" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group">Palmer, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bryant, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, D.-X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Setti, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rydzewski, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venkatraman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, Z.-Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burrill, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendonca, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Springman, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCarter, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheung, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janc, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGrath, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Somoza, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Enriquez, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, Z. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strickley, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venuti, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Percival, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Falgueyret, J.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prasit, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oballa, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riendeau, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, R. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wesolowski, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodan, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimmel, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodan, G.</span><span> </span><span class="NLM_article-title">Design and Synthesis of Tri-Ring P<sub>3</sub> Benzamide-Containing Aminonitriles as Potent, Selective, Orally Effective Inhibitors of Cathepsin K</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">7520</span><span class="NLM_x">–</span> <span class="NLM_lpage">7534</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm058198r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=7520-7534&author=J.+T.+Palmerauthor=C.+Bryantauthor=D.-X.+Wangauthor=D.+E.+Davisauthor=E.+L.+Settiauthor=R.+M.+Rydzewskiauthor=S.+Venkatramanauthor=Z.-Q.+Tianauthor=L.+C.+Burrillauthor=R.+H.+Mendoncaauthor=E.+Springmanauthor=J.+McCarterauthor=T.+Chungauthor=H.+Cheungauthor=J.+W.+Jancauthor=M.+McGrathauthor=J.+R.+Somozaauthor=P.+Enriquezauthor=Z.+W.+Yuauthor=R.+M.+Strickleyauthor=L.+Liuauthor=M.+C.+Venutiauthor=M.+D.+Percivalauthor=J.-P.+Falgueyretauthor=P.+Prasitauthor=R.+Oballaauthor=D.+Riendeauauthor=R.+N.+Youngauthor=G.+Wesolowskiauthor=S.+B.+Rodanauthor=C.+Johnsonauthor=D.+B.+Kimmelauthor=G.+Rodan&title=Design+and+Synthesis+of+Tri-Ring+P3+Benzamide-Containing+Aminonitriles+as+Potent%2C+Selective%2C+Orally+Effective+Inhibitors+of+Cathepsin+K"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1021%2Fjm058198r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm058198r%26sid%3Dliteratum%253Aachs%26aulast%3DPalmer%26aufirst%3DJ.%2BT.%26aulast%3DBryant%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DD.-X.%26aulast%3DDavis%26aufirst%3DD.%2BE.%26aulast%3DSetti%26aufirst%3DE.%2BL.%26aulast%3DRydzewski%26aufirst%3DR.%2BM.%26aulast%3DVenkatraman%26aufirst%3DS.%26aulast%3DTian%26aufirst%3DZ.-Q.%26aulast%3DBurrill%26aufirst%3DL.%2BC.%26aulast%3DMendonca%26aufirst%3DR.%2BH.%26aulast%3DSpringman%26aufirst%3DE.%26aulast%3DMcCarter%26aufirst%3DJ.%26aulast%3DChung%26aufirst%3DT.%26aulast%3DCheung%26aufirst%3DH.%26aulast%3DJanc%26aufirst%3DJ.%2BW.%26aulast%3DMcGrath%26aufirst%3DM.%26aulast%3DSomoza%26aufirst%3DJ.%2BR.%26aulast%3DEnriquez%26aufirst%3DP.%26aulast%3DYu%26aufirst%3DZ.%2BW.%26aulast%3DStrickley%26aufirst%3DR.%2BM.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DVenuti%26aufirst%3DM.%2BC.%26aulast%3DPercival%26aufirst%3DM.%2BD.%26aulast%3DFalgueyret%26aufirst%3DJ.-P.%26aulast%3DPrasit%26aufirst%3DP.%26aulast%3DOballa%26aufirst%3DR.%26aulast%3DRiendeau%26aufirst%3DD.%26aulast%3DYoung%26aufirst%3DR.%2BN.%26aulast%3DWesolowski%26aufirst%3DG.%26aulast%3DRodan%26aufirst%3DS.%2BB.%26aulast%3DJohnson%26aufirst%3DC.%26aulast%3DKimmel%26aufirst%3DD.%2BB.%26aulast%3DRodan%26aufirst%3DG.%26atitle%3DDesign%2520and%2520Synthesis%2520of%2520Tri-Ring%2520P3%2520Benzamide-Containing%2520Aminonitriles%2520as%2520Potent%252C%2520Selective%252C%2520Orally%2520Effective%2520Inhibitors%2520of%2520Cathepsin%2520K%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2005%26volume%3D48%26spage%3D7520%26epage%3D7534" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><div class="note"><p class="first last">There were no literature reports found indicating adduct formation with a cysteine residue or glutathione, which would be indicative of nonspecific reactivity.</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=There+were+no+literature+reports+found+indicating+adduct+formation+with+a+cysteine+residue+or+glutathione%2C+which+would+be+indicative+of+nonspecific+reactivity."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><div class="note"><p class="first last">Another class of drug that reaches less systematic exposure include topical agents. For examples of topical agents that covalently modulate their target, see the following.</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Another+class+of+drug+that+reaches+less+systematic+exposure+include+topical+agents.+For+examples+of+topical+agents+that+covalently+modulate+their+target%2C+see+the+following."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit66a"><span><span class="NLM_label">(a) </span><div class="note"><p class="first last">Eflornithine (an inhibitor of ornithine decarboxylase) used for facial hair removal:</p></div><span class="NLM_contrib-group">Poulin, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ackermann, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bey, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pegg, A. E.</span><span> </span><span class="NLM_article-title">Mechanism of the Irreversible Inactivation of Mouse Ornithine Decarboxylase by α-Difluoromethylornithine. Characterization of Sequences at the Inhibitor and Coenzyme Binding Sites</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">267</span><span class="NLM_x">, </span> <span class="NLM_fpage">150</span><span class="NLM_x">–</span> <span class="NLM_lpage">158</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=267&publication_year=1992&pages=150-158&author=R.+Poulinauthor=L.+Luauthor=B.+Ackermannauthor=P.+Beyauthor=A.+E.+Pegg&title=Mechanism+of+the+Irreversible+Inactivation+of+Mouse+Ornithine+Decarboxylase+by+%CE%B1-Difluoromethylornithine.+Characterization+of+Sequences+at+the+Inhibitor+and+Coenzyme+Binding+Sites"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPoulin%26aufirst%3DR.%26aulast%3DLu%26aufirst%3DL.%26aulast%3DAckermann%26aufirst%3DB.%26aulast%3DBey%26aufirst%3DP.%26aulast%3DPegg%26aufirst%3DA.%2BE.%26atitle%3DMechanism%2520of%2520the%2520Irreversible%2520Inactivation%2520of%2520Mouse%2520Ornithine%2520Decarboxylase%2520by%2520%25CE%25B1-Difluoromethylornithine.%2520Characterization%2520of%2520Sequences%2520at%2520the%2520Inhibitor%2520and%2520Coenzyme%2520Binding%2520Sites%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1992%26volume%3D267%26spage%3D150%26epage%3D158" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit66c"><span><span class="NLM_label">(b) </span><div class="note"><p class="first last">AN 2690 is an antifungal agent targeting aminoacyl-tRNA synthetase under clinical investigation.</p></div><span class="NLM_contrib-group">Rock, F. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yaremchuck, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tukalo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crepin, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hernandez, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plattner, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shapiro, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinis, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benkovic, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cusack, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alley, M. R. K.</span><span> </span><span class="NLM_article-title">An Antifungal Agent Inhibits an Aminoacyl-tRNA Synthetase by Trapping tRNA in the Editing Site</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">316</span><span class="NLM_x">, </span> <span class="NLM_fpage">1759</span><span class="NLM_x">–</span> <span class="NLM_lpage">1761</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66c&amp;dbid=16&amp;doi=10.1021%2Fjm8008597&amp;key=10.1126%2Fscience.1142189" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66c&amp;dbid=8&amp;doi=10.1021%2Fjm8008597&amp;key=17588934" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66c&amp;dbid=32&amp;doi=10.1021%2Fjm8008597&amp;key=1%3ACAS%3A528%3ADC%252BD2sXms1Wgsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=316&publication_year=2007&pages=1759-1761&author=F.+L.+Rockauthor=W.+Maoauthor=A.+Yaremchuckauthor=M.+Tukaloauthor=T.+Crepinauthor=H.+Zhouauthor=Y.-K.+Zhangauthor=V.+Hernandezauthor=T.+Akamaauthor=S.+J.+Bakerauthor=J.+J.+Plattnerauthor=L.+Shapiroauthor=S.+A.+Martinisauthor=S.+J.+Benkovicauthor=S.+Cusackauthor=M.+R.+K.+Alley&title=An+Antifungal+Agent+Inhibits+an+Aminoacyl-tRNA+Synthetase+by+Trapping+tRNA+in+the+Editing+Site"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit66cR"><div class="casContent"><span class="casTitleNuber">66b</span><div class="casTitle"><span class="NLM_cas:atitle">An Antifungal Agent Inhibits an Aminoacyl-tRNA Synthetase by Trapping tRNA in the Editing Site</span></div><div class="casAuthors">Rock, Fernando L.; Mao, Weimin; Yaremchuk, Anya; Tukalo, Mikhail; Crepin, Thibaut; Zhou, Huchen; Zhang, Yong-Kang; Hernandez, Vincent; Akama, Tsutomu; Baker, Stephen J.; Plattner, Jacob J.; Shapiro, Lucy; Martinis, Susan A.; Benkovic, Stephen J.; Cusack, Stephen; Alley, M. R. K.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">316</span>
        (<span class="NLM_cas:issue">5832</span>),
    <span class="NLM_cas:pages">1759-1761</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Aminoacyl-tRNA synthetases, which catalyze the attachment of the correct amino acid to its corresponding tRNA during translation of the genetic code, are proven antimicrobial drug targets.  We show that the broad-spectrum antifungal 5-fluoro-1,3-dihydro-1-hydroxy-2,1-benzoxaborole (AN2690), in development for the treatment of onychomycosis, inhibits yeast cytoplasmic leucyl-tRNA synthetase by formation of a stable tRNALeu-AN2690 adduct in the editing site of the enzyme.  Adduct formation is mediated through the boron atom of AN2690 and the 2'- and 3'-oxygen atoms of tRNA's 3'-terminal adenosine.  The trapping of enzyme-bound tRNALeu in the editing site prevents catalytic turnover, thus inhibiting synthesis of leucyl-tRNALeu and consequentially blocking protein synthesis.  This result establishes the editing site as a bona fide target for aminoacyl-tRNA synthetase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohcTqC8iispbVg90H21EOLACvtfcHk0ljBfXx2XKMUMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXms1Wgsbo%253D&md5=0da444baf3c2f6e0768fe19febcaee6a</span></div><a href="/servlet/linkout?suffix=cit66c&amp;dbid=16384&amp;doi=10.1126%2Fscience.1142189&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1142189%26sid%3Dliteratum%253Aachs%26aulast%3DRock%26aufirst%3DF.%2BL.%26aulast%3DMao%26aufirst%3DW.%26aulast%3DYaremchuck%26aufirst%3DA.%26aulast%3DTukalo%26aufirst%3DM.%26aulast%3DCrepin%26aufirst%3DT.%26aulast%3DZhou%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DY.-K.%26aulast%3DHernandez%26aufirst%3DV.%26aulast%3DAkama%26aufirst%3DT.%26aulast%3DBaker%26aufirst%3DS.%2BJ.%26aulast%3DPlattner%26aufirst%3DJ.%2BJ.%26aulast%3DShapiro%26aufirst%3DL.%26aulast%3DMartinis%26aufirst%3DS.%2BA.%26aulast%3DBenkovic%26aufirst%3DS.%2BJ.%26aulast%3DCusack%26aufirst%3DS.%26aulast%3DAlley%26aufirst%3DM.%2BR.%2BK.%26atitle%3DAn%2520Antifungal%2520Agent%2520Inhibits%2520an%2520Aminoacyl-tRNA%2520Synthetase%2520by%2520Trapping%2520tRNA%2520in%2520the%2520Editing%2520Site%26jtitle%3DScience%26date%3D2007%26volume%3D316%26spage%3D1759%26epage%3D1761" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit66e"><span><span class="NLM_label">(c) </span><div class="note"><p class="first last">Malathion is an organophosphate used to treat head lice by binding irreversible to acetycholinesterase.</p></div><span class="NLM_contrib-group">Guo, J.-X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J. J.-Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lushington, G. H.</span><span> </span><span class="NLM_article-title">Mechanistic Insight into Acetylcholinesterase Inhibition and Acute Toxicity of Organophosphorus Compounds: A Molecular Modeling Study</span> <span class="citation_source-journal">Chem. Res. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">209</span><span class="NLM_x">–</span> <span class="NLM_lpage">−216</span></span><div class="citationLinks">[<a href="/doi/10.1021/tx050090r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2006&pages=209-%E2%88%92216&author=J.-X.+Guoauthor=J.+J.-Q.+Wuauthor=J.+B.+Wrightauthor=G.+H.+Lushington&title=Mechanistic+Insight+into+Acetylcholinesterase+Inhibition+and+Acute+Toxicity+of+Organophosphorus+Compounds%3A+A+Molecular+Modeling+Study"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66e&amp;dbid=16384&amp;doi=10.1021%2Ftx050090r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx050090r%26sid%3Dliteratum%253Aachs%26aulast%3DGuo%26aufirst%3DJ.-X.%26aulast%3DWu%26aufirst%3DJ.%2BJ.-Q.%26aulast%3DWright%26aufirst%3DJ.%2BB.%26aulast%3DLushington%26aufirst%3DG.%2BH.%26atitle%3DMechanistic%2520Insight%2520into%2520Acetylcholinesterase%2520Inhibition%2520and%2520Acute%2520Toxicity%2520of%2520Organophosphorus%2520Compounds%253A%2520A%2520Molecular%2520Modeling%2520Study%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2006%26volume%3D19%26spage%3D209%26epage%3D%25E2%2588%2592216" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group">Copeland, R. A.</span> Irreversible Enzyme Inactivators in Evaluation of Enzyme Inhibitors. In  <span class="citation_source-book">Drug Discovery. A Guide for Medicinal Chemists and Pharmacologists</span>; <span class="NLM_publisher-name">John Wiley & Sons</span>: <span class="NLM_publisher-loc">New York</span>; Chapter 8, pp  <span class="NLM_fpage">214</span>− <span class="NLM_lpage">248</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Copeland%2C+R.+A.+Irreversible+Enzyme+Inactivators+in+Evaluation+of+Enzyme+Inhibitors.+In+Drug+Discovery.+A+Guide+for+Medicinal+Chemists+and+Pharmacologists%3B+John+Wiley+%26+Sons%3A+New+York%3B+Chapter+8%2C+pp+214%E2%88%92248."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DCopeland%26aufirst%3DR.%2BA.%26btitle%3DDrug%2520Discovery.%2520A%2520Guide%2520for%2520Medicinal%2520Chemists%2520and%2520Pharmacologists%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%26spage%3D214%26epage%3D248" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group">Rybak, M. J.</span><span> </span><span class="NLM_article-title">Pharmacodynamics: Relationship to Antimicrobial Resistance</span> <span class="citation_source-journal">Am. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">119</span><span class="NLM_elocation-id">S37−S44</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=2006&author=M.+J.+Rybak&title=Pharmacodynamics%3A+Relationship+to+Antimicrobial+Resistance"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRybak%26aufirst%3DM.%2BJ.%26atitle%3DPharmacodynamics%253A%2520Relationship%2520to%2520Antimicrobial%2520Resistance%26jtitle%3DAm.%2520J.%2520Med.%26date%3D2006%26volume%3D119" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><div class="note"><p class="first last">For example, see the following:</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=For+example%2C+see+the+following%3A"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit69a"><span><span class="NLM_contrib-group">Chu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rothfuss, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">d’Avignon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeng, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hotchkiss, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mach, R. H.</span><span> </span><span class="NLM_article-title">Isatin Sulfonamide Analogs Containing a Michael Addition Acceptor: A New Class of Caspase 3/7 Inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">3751</span><span class="NLM_x">–</span> <span class="NLM_lpage">3755</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm070506t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=3751-3755&author=W.+Chuauthor=J.+Rothfussauthor=A.+d%E2%80%99Avignonauthor=C.+Zengauthor=D.+Zhouauthor=R.+S.+Hotchkissauthor=R.+H.+Mach&title=Isatin+Sulfonamide+Analogs+Containing+a+Michael+Addition+Acceptor%3A+A+New+Class+of+Caspase+3%2F7+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit69a&amp;dbid=16384&amp;doi=10.1021%2Fjm070506t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070506t%26sid%3Dliteratum%253Aachs%26aulast%3DChu%26aufirst%3DW.%26aulast%3DRothfuss%26aufirst%3DJ.%26aulast%3Dd%25E2%2580%2599Avignon%26aufirst%3DA.%26aulast%3DZeng%26aufirst%3DC.%26aulast%3DZhou%26aufirst%3DD.%26aulast%3DHotchkiss%26aufirst%3DR.%2BS.%26aulast%3DMach%26aufirst%3DR.%2BH.%26atitle%3DIsatin%2520Sulfonamide%2520Analogs%2520Containing%2520a%2520Michael%2520Addition%2520Acceptor%253A%2520A%2520New%2520Class%2520of%2520Caspase%25203%252F7%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D3751%26epage%3D3755" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group">Overall, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kleifeld, O.</span><span> </span><span class="NLM_article-title">Towards Third Generation Matrix Metalloproteinase Inhibitors for Cancer Therapy</span> <span class="citation_source-journal">Br. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">94</span><span class="NLM_x">, </span> <span class="NLM_fpage">941</span><span class="NLM_x">–</span> <span class="NLM_lpage">946</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Fjm8008597&amp;key=10.1038%2Fsj.bjc.6603043" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Fjm8008597&amp;key=16538215" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Fjm8008597&amp;key=1%3ACAS%3A528%3ADC%252BD28XjtFGqt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=2006&pages=941-946&author=C.+M.+Overallauthor=O.+Kleifeld&title=Towards+Third+Generation+Matrix+Metalloproteinase+Inhibitors+for+Cancer+Therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Towards third generation matrix metalloproteinase inhibitors for cancer therapy</span></div><div class="casAuthors">Overall, C. M.; Kleifeld, O.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">941-946</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The failure of matrix metalloproteinase (MMP) inhibitor drug clin. trials in cancer was partly due to the inadvertent inhibition of MMP antitargets that counterbalanced the benefits of MMP target inhibition.  We explore how MMP inhibitor drugs might be developed to achieve potent selectivity for validated MMP targets yet therapeutically spare MMP antitargets that are crit. in host protection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWaFApPMIKRLVg90H21EOLACvtfcHk0ljBfXx2XKMUMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjtFGqt7g%253D&md5=5e672a6e9495ec2e283856edc6e61a60</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjc.6603043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjc.6603043%26sid%3Dliteratum%253Aachs%26aulast%3DOverall%26aufirst%3DC.%2BM.%26aulast%3DKleifeld%26aufirst%3DO.%26atitle%3DTowards%2520Third%2520Generation%2520Matrix%2520Metalloproteinase%2520Inhibitors%2520for%2520Cancer%2520Therapy%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2006%26volume%3D94%26spage%3D941%26epage%3D946" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group">Arnold, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kosinski, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Estebanez-Perpina, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fletterick, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guy, R. K.</span><span> </span><span class="NLM_article-title">Inhibitors of the Interaction of a Thyroid Hormone Receptor and Coactivators: Preliminary Structure−Activity Relationships</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">5269</span><span class="NLM_x">–</span> <span class="NLM_lpage">5280</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm070556y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=5269-5280&author=L.+A.+Arnoldauthor=A.+Kosinskiauthor=E.+Estebanez-Perpinaauthor=R.+J.+Fletterickauthor=R.+K.+Guy&title=Inhibitors+of+the+Interaction+of+a+Thyroid+Hormone+Receptor+and+Coactivators%3A+Preliminary+Structure%E2%88%92Activity+Relationships"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1021%2Fjm070556y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070556y%26sid%3Dliteratum%253Aachs%26aulast%3DArnold%26aufirst%3DL.%2BA.%26aulast%3DKosinski%26aufirst%3DA.%26aulast%3DEstebanez-Perpina%26aufirst%3DE.%26aulast%3DFletterick%26aufirst%3DR.%2BJ.%26aulast%3DGuy%26aufirst%3DR.%2BK.%26atitle%3DInhibitors%2520of%2520the%2520Interaction%2520of%2520a%2520Thyroid%2520Hormone%2520Receptor%2520and%2520Coactivators%253A%2520Preliminary%2520Structure%25E2%2588%2592Activity%2520Relationships%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D5269%26epage%3D5280" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group">Mor, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lodola, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rivara, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacondio, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duranti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tontini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanchini, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piersanti, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clapper, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarzia, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piomello, D.</span><span> </span><span class="NLM_article-title">Synthesis and Quantitative Structure−Activity Relationship of Fatty Acid Amide Hydrolase Inhibitors: Modulation at the N-Portion of Biphenyl-3-yl Alkylcarbamates</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">3484</span><span class="NLM_x">–</span> <span class="NLM_lpage">3498</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=3484-3498&author=M.+Morauthor=A.+Lodolaauthor=S.+Rivaraauthor=F.+Vacondioauthor=A.+Durantiauthor=A.+Tontiniauthor=S.+Sanchiniauthor=G.+Piersantiauthor=J.+R.+Clapperauthor=A.+R.+Kingauthor=G.+Tarziaauthor=D.+Piomello&title=Synthesis+and+Quantitative+Structure%E2%88%92Activity+Relationship+of+Fatty+Acid+Amide+Hydrolase+Inhibitors%3A+Modulation+at+the+N-Portion+of+Biphenyl-3-yl+Alkylcarbamates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMor%26aufirst%3DM.%26aulast%3DLodola%26aufirst%3DA.%26aulast%3DRivara%26aufirst%3DS.%26aulast%3DVacondio%26aufirst%3DF.%26aulast%3DDuranti%26aufirst%3DA.%26aulast%3DTontini%26aufirst%3DA.%26aulast%3DSanchini%26aufirst%3DS.%26aulast%3DPiersanti%26aufirst%3DG.%26aulast%3DClapper%26aufirst%3DJ.%2BR.%26aulast%3DKing%26aufirst%3DA.%2BR.%26aulast%3DTarzia%26aufirst%3DG.%26aulast%3DPiomello%26aufirst%3DD.%26atitle%3DSynthesis%2520and%2520Quantitative%2520Structure%25E2%2588%2592Activity%2520Relationship%2520of%2520Fatty%2520Acid%2520Amide%2520Hydrolase%2520Inhibitors%253A%2520Modulation%2520at%2520the%2520N-Portion%2520of%2520Biphenyl-3-yl%2520Alkylcarbamates%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D3484%26epage%3D3498" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1a','cit1b','cit1c','cit1d','cit1e'],'ref2':['cit2a','cit2b'],'ref3':['cit3a','cit3b'],'ref4':['cit4'],'ref5':['cit5','cit5a','cit5c','cit5d'],'ref6':['cit6','cit6a'],'ref7':['cit7','cit7a'],'ref8':['cit8a','cit8b','cit8c','cit8d','cit8e'],'ref9':['cit9a','cit9b'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14','cit14a'],'ref15':['cit15','cit15a'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19','cit19a'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29a','cit29b'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32','cit32b'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40a'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46','cit46a'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66','cit66a','cit66c','cit66e'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69','cit69a'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 250 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Yong Ai, Lucia Hwang, Alexander D. MacKerell Jr., Ari Melnick, <span class="NLM_string-name hlFld-ContribAuthor">Fengtian Xue</span>. </span><span class="cited-content_cbyCitation_article-title">Progress toward B-Cell Lymphoma 6 BTB Domain Inhibitors for the Treatment of Diffuse Large B-Cell Lymphoma and Beyond. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (8)
                                     , 4333-4358. <a href="https://doi.org/10.1021/acs.jmedchem.0c01686" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01686</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01686&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01686%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DProgress%252Btoward%252BB-Cell%252BLymphoma%252B6%252BBTB%252BDomain%252BInhibitors%252Bfor%252Bthe%252BTreatment%252Bof%252BDiffuse%252BLarge%252BB-Cell%252BLymphoma%252Band%252BBeyond%26aulast%3DAi%26aufirst%3DYong%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D25092020%26date%3D12042021%26volume%3D64%26issue%3D8%26spage%3D4333%26epage%3D4358" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Hao Chen, Jeff B. Smaill, Tongzheng Liu, Ke Ding, <span class="NLM_string-name hlFld-ContribAuthor">Xiaoyun Lu</span>. </span><span class="cited-content_cbyCitation_article-title">Small-Molecule Inhibitors Directly Targeting KRAS as Anticancer Therapeutics. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (23)
                                     , 14404-14424. <a href="https://doi.org/10.1021/acs.jmedchem.0c01312" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01312</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01312&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01312%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSmall-Molecule%252BInhibitors%252BDirectly%252BTargeting%252BKRAS%252Bas%252BAnticancer%252BTherapeutics%26aulast%3DChen%26aufirst%3DHao%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D28072020%26date%3D23112020%26volume%3D63%26issue%3D23%26spage%3D14404%26epage%3D14424" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Keisuke Tokunaga, Mami Sato, Keiko Kuwata, Chizuru Miura, Hirokazu Fuchida, Naoya Matsunaga, Satoru Koyanagi, Shigehiro Ohdo, Naoya Shindo, <span class="NLM_string-name hlFld-ContribAuthor">Akio Ojida</span>. </span><span class="cited-content_cbyCitation_article-title">Bicyclobutane Carboxylic Amide as a Cysteine-Directed Strained Electrophile for Selective Targeting of Proteins. </span><span class="cited-content_cbyCitation_journal-name">Journal of the American Chemical Society</span><span> <strong>2020,</strong> <em>142 </em>
                                    (43)
                                     , 18522-18531. <a href="https://doi.org/10.1021/jacs.0c07490" title="DOI URL">https://doi.org/10.1021/jacs.0c07490</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jacs.0c07490&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjacs.0c07490%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520American%2520Chemical%2520Society%26atitle%3DBicyclobutane%252BCarboxylic%252BAmide%252Bas%252Ba%252BCysteine-Directed%252BStrained%252BElectrophile%252Bfor%252BSelective%252BTargeting%252Bof%252BProteins%26aulast%3DTokunaga%26aufirst%3DKeisuke%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D12072020%26date%3D13102020%26volume%3D142%26issue%3D43%26spage%3D18522%26epage%3D18531" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="NLM_string-name hlFld-ContribAuthor">Tanaji T. Talele</span>. </span><span class="cited-content_cbyCitation_article-title">Acetylene Group, Friend or Foe in Medicinal Chemistry. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (11)
                                     , 5625-5663. <a href="https://doi.org/10.1021/acs.jmedchem.9b01617" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01617</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01617&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01617%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DAcetylene%252BGroup%25252C%252BFriend%252Bor%252BFoe%252Bin%252BMedicinal%252BChemistry%26aulast%3DTalele%26aufirst%3DTanaji%2BT.%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D29092019%26date%3D19022020%26date%3D07022020%26volume%3D63%26issue%3D11%26spage%3D5625%26epage%3D5663" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Mami Sato, Hirokazu Fuchida, Naoya Shindo, Keiko Kuwata, Keisuke Tokunaga, Guo Xiao-Lin, Ryo Inamori, Keitaro Hosokawa, Kosuke Watari, Tomohiro Shibata, Naoya Matsunaga, Satoru Koyanagi, Shigehiro Ohdo, Mayumi Ono, <span class="NLM_string-name hlFld-ContribAuthor">Akio Ojida</span>. </span><span class="cited-content_cbyCitation_article-title">Selective Covalent Targeting of Mutated EGFR(T790M) with Chlorofluoroacetamide-Pyrimidines. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>11 </em>
                                    (6)
                                     , 1137-1144. <a href="https://doi.org/10.1021/acsmedchemlett.9b00574" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.9b00574</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.9b00574&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.9b00574%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSelective%252BCovalent%252BTargeting%252Bof%252BMutated%252BEGFR%252528T790M%252529%252Bwith%252BChlorofluoroacetamide-Pyrimidines%26aulast%3DSato%26aufirst%3DMami%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D04122019%26date%3D08042020%26date%3D10042020%26date%3D08042020%26volume%3D11%26issue%3D6%26spage%3D1137%26epage%3D1144" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Damien Bosc, Virgyl Camberlein, Ronan Gealageas, Omar Castillo-Aguilera, Benoit Deprez, <span class="NLM_string-name hlFld-ContribAuthor">Rebecca Deprez-Poulain</span>. </span><span class="cited-content_cbyCitation_article-title">Kinetic Target-Guided Synthesis: Reaching the Age of Maturity. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (8)
                                     , 3817-3833. <a href="https://doi.org/10.1021/acs.jmedchem.9b01183" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01183</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01183&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01183%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DKinetic%252BTarget-Guided%252BSynthesis%25253A%252BReaching%252Bthe%252BAge%252Bof%252BMaturity%26aulast%3DBosc%26aufirst%3DDamien%26date%3D2020%26date%3D2019%26date%3D2019%26date%3D22072019%26date%3D24122019%26date%3D10122019%26volume%3D63%26issue%3D8%26spage%3D3817%26epage%3D3833" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Sneha Ray, <span class="NLM_string-name hlFld-ContribAuthor">Andrew S. Murkin</span>. </span><span class="cited-content_cbyCitation_article-title">New Electrophiles and Strategies for Mechanism-Based and Targeted Covalent Inhibitor Design. </span><span class="cited-content_cbyCitation_journal-name">Biochemistry</span><span> <strong>2019,</strong> <em>58 </em>
                                    (52)
                                     , 5234-5244. <a href="https://doi.org/10.1021/acs.biochem.9b00293" title="DOI URL">https://doi.org/10.1021/acs.biochem.9b00293</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.biochem.9b00293&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.biochem.9b00293%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemistry%26atitle%3DNew%252BElectrophiles%252Band%252BStrategies%252Bfor%252BMechanism-Based%252Band%252BTargeted%252BCovalent%252BInhibitor%252BDesign%26aulast%3DRay%26aufirst%3DSneha%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D02042019%26date%3D15042019%26date%3D24042019%26date%3D16042019%26volume%3D58%26issue%3D52%26spage%3D5234%26epage%3D5244" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Jessica Plescia, Stéphane De Cesco, Mihai Burai Patrascu, Jerry Kurian, Justin Di Trani, Caroline Dufresne, Alexander S. Wahba, Naëla Janmamode, Anthony K. Mittermaier, <span class="NLM_string-name hlFld-ContribAuthor">Nicolas Moitessier</span>. </span><span class="cited-content_cbyCitation_article-title">Integrated Synthetic, Biophysical, and Computational Investigations of Covalent Inhibitors of Prolyl Oligopeptidase and Fibroblast Activation Protein α. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (17)
                                     , 7874-7884. <a href="https://doi.org/10.1021/acs.jmedchem.9b00642" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00642</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00642&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b00642%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DIntegrated%252BSynthetic%25252C%252BBiophysical%25252C%252Band%252BComputational%252BInvestigations%252Bof%252BCovalent%252BInhibitors%252Bof%252BProlyl%252BOligopeptidase%252Band%252BFibroblast%252BActivation%252BProtein%252B%2525CE%2525B1%26aulast%3DPlescia%26aufirst%3DJessica%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D15042019%26date%3D22082019%26date%3D08082019%26volume%3D62%26issue%3D17%26spage%3D7874%26epage%3D7884" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Feng Ni, Arunika Ekanayake, Bianca Espinosa, Caiqun Yu, Jacob N. Sanders, John Perino, K. N. Houk, <span class="NLM_string-name hlFld-ContribAuthor">Chao Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Target Identification of a Novel Electrophilic Warhead, 2-Chloromethylquinoline. </span><span class="cited-content_cbyCitation_journal-name">Biochemistry</span><span> <strong>2019,</strong> <em>58 </em>
                                    (24)
                                     , 2715-2719. <a href="https://doi.org/10.1021/acs.biochem.9b00359" title="DOI URL">https://doi.org/10.1021/acs.biochem.9b00359</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.biochem.9b00359&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.biochem.9b00359%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemistry%26atitle%3DSynthesis%252Band%252BTarget%252BIdentification%252Bof%252Ba%252BNovel%252BElectrophilic%252BWarhead%25252C%252B2-Chloromethylquinoline%26aulast%3DNi%26aufirst%3DFeng%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D21042019%26date%3D29052019%26date%3D07062019%26date%3D04062019%26volume%3D58%26issue%3D24%26spage%3D2715%26epage%3D2719" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Kuen-Da Wu, Grace Shiahuy Chen, Jia-Rong Liu, Chen-En Hsieh, <span class="NLM_string-name hlFld-ContribAuthor">Ji-Wang Chern</span>. </span><span class="cited-content_cbyCitation_article-title">Acrylamide Functional Group Incorporation Improves Drug-like Properties: An Example with EGFR Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>10 </em>
                                    (1)
                                     , 22-26. <a href="https://doi.org/10.1021/acsmedchemlett.8b00270" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.8b00270</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.8b00270&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.8b00270%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DAcrylamide%252BFunctional%252BGroup%252BIncorporation%252BImproves%252BDrug-like%252BProperties%25253A%252BAn%252BExample%252Bwith%252BEGFR%252BInhibitors%26aulast%3DWu%26aufirst%3DKuen-Da%26date%3D2019%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D15062018%26date%3D06122018%26date%3D10122018%26date%3D06122018%26volume%3D10%26issue%3D1%26spage%3D22%26epage%3D26" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Raúl Pérez-Ruiz, Oscar Molins-Molina, Emilio Lence, Concepción González-Bello, Miguel A. Miranda, <span class="NLM_string-name hlFld-ContribAuthor">M. Consuelo Jiménez</span>. </span><span class="cited-content_cbyCitation_article-title">Photogeneration of Quinone Methides as Latent Electrophiles for Lysine Targeting. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2018,</strong> <em>83 </em>
                                    (21)
                                     , 13019-13029. <a href="https://doi.org/10.1021/acs.joc.8b01559" title="DOI URL">https://doi.org/10.1021/acs.joc.8b01559</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.8b01559&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.8b01559%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DPhotogeneration%252Bof%252BQuinone%252BMethides%252Bas%252BLatent%252BElectrophiles%252Bfor%252BLysine%252BTargeting%26aulast%3DP%25C3%25A9rez-Ruiz%26aufirst%3DRa%25C3%25BAl%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D21062018%26date%3D16102018%26date%3D02102018%26volume%3D83%26issue%3D21%26spage%3D13019%26epage%3D13029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Ernest Awoonor-Williams, <span class="NLM_string-name hlFld-ContribAuthor">Christopher N. Rowley</span>. </span><span class="cited-content_cbyCitation_article-title">How Reactive are Druggable Cysteines in Protein Kinases?. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2018,</strong> <em>58 </em>
                                    (9)
                                     , 1935-1946. <a href="https://doi.org/10.1021/acs.jcim.8b00454" title="DOI URL">https://doi.org/10.1021/acs.jcim.8b00454</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jcim.8b00454&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jcim.8b00454%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DHow%252BReactive%252Bare%252BDruggable%252BCysteines%252Bin%252BProtein%252BKinases%25253F%26aulast%3DAwoonor-Williams%26aufirst%3DErnest%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D09072018%26date%3D29082018%26date%3D17082018%26volume%3D58%26issue%3D9%26spage%3D1935%26epage%3D1946" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Mami Yoshizawa, Toshimasa Itoh, Tatsuya Hori, Akira Kato, Yasuaki Anami, Nobuko Yoshimoto, <span class="NLM_string-name hlFld-ContribAuthor">Keiko Yamamoto</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of the Histidine Residue in Vitamin D Receptor That Covalently Binds to Electrophilic Ligands. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (14)
                                     , 6339-6349. <a href="https://doi.org/10.1021/acs.jmedchem.8b00774" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00774</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00774&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00774%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DIdentification%252Bof%252Bthe%252BHistidine%252BResidue%252Bin%252BVitamin%252BD%252BReceptor%252BThat%252BCovalently%252BBinds%252Bto%252BElectrophilic%252BLigands%26aulast%3DYoshizawa%26aufirst%3DMami%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D15052018%26date%3D11072018%26date%3D23062018%26volume%3D61%26issue%3D14%26spage%3D6339%26epage%3D6349" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Alfred Tuley, <span class="NLM_string-name hlFld-ContribAuthor">Walter Fast</span>. </span><span class="cited-content_cbyCitation_article-title">The Taxonomy of Covalent Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Biochemistry</span><span> <strong>2018,</strong> <em>57 </em>
                                    (24)
                                     , 3326-3337. <a href="https://doi.org/10.1021/acs.biochem.8b00315" title="DOI URL">https://doi.org/10.1021/acs.biochem.8b00315</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.biochem.8b00315&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.biochem.8b00315%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemistry%26atitle%3DThe%252BTaxonomy%252Bof%252BCovalent%252BInhibitors%26aulast%3DTuley%26aufirst%3DAlfred%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D15032018%26date%3D24042018%26date%3D30042018%26date%3D24042018%26volume%3D57%26issue%3D24%26spage%3D3326%26epage%3D3337" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Shuhei Kawamura, Yoshihiko Ito, Takatsugu Hirokawa, Eriko Hikiyama, Shizuo Yamada, <span class="NLM_string-name hlFld-ContribAuthor">Satoshi Shuto</span>. </span><span class="cited-content_cbyCitation_article-title">Ligand–Phospholipid Conjugation: A Versatile Strategy for Developing Long-Acting Ligands That Bind to Membrane Proteins by Restricting the Subcellular Localization of the Ligand. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (9)
                                     , 4020-4029. <a href="https://doi.org/10.1021/acs.jmedchem.8b00041" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00041</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00041%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DLigand%2525E2%252580%252593Phospholipid%252BConjugation%25253A%252BA%252BVersatile%252BStrategy%252Bfor%252BDeveloping%252BLong-Acting%252BLigands%252BThat%252BBind%252Bto%252BMembrane%252BProteins%252Bby%252BRestricting%252Bthe%252BSubcellular%252BLocalization%252Bof%252Bthe%252BLigand%26aulast%3DKawamura%26aufirst%3DShuhei%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D10012018%26date%3D20042018%26date%3D13042018%26volume%3D61%26issue%3D9%26spage%3D4020%26epage%3D4029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tomoya  Sameshima</span>, <span class="hlFld-ContribAuthor ">Takeshi  Yamamoto</span>, <span class="hlFld-ContribAuthor ">Osamu  Sano</span>, <span class="hlFld-ContribAuthor ">Satoshi  Sogabe</span>, <span class="hlFld-ContribAuthor ">Shigeru  Igaki</span>, <span class="hlFld-ContribAuthor ">Kotaro  Sakamoto</span>, <span class="hlFld-ContribAuthor ">Koh  Ida</span>, <span class="hlFld-ContribAuthor ">Mika  Gotou</span>, <span class="hlFld-ContribAuthor ">Yasuhiro  Imaeda</span>, <span class="hlFld-ContribAuthor ">Junichi  Sakamoto</span>, and <span class="hlFld-ContribAuthor ">Ikuo  Miyahisa</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of an Irreversible and Cell-Active BCL6 Inhibitor Selectively Targeting Cys53 Located at the Protein–Protein Interaction Interface. </span><span class="cited-content_cbyCitation_journal-name">Biochemistry</span><span> <strong>2018,</strong> <em>57 </em>
                                    (8)
                                     , 1369-1379. <a href="https://doi.org/10.1021/acs.biochem.7b00732" title="DOI URL">https://doi.org/10.1021/acs.biochem.7b00732</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.biochem.7b00732&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.biochem.7b00732%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemistry%26atitle%3DDiscovery%252Bof%252Ban%252BIrreversible%252Band%252BCell-Active%252BBCL6%252BInhibitor%252BSelectively%252BTargeting%252BCys53%252BLocated%252Bat%252Bthe%252BProtein%2525E2%252580%252593Protein%252BInteraction%252BInterface%26aulast%3DSameshima%26aufirst%3DTomoya%26date%3D2018%26date%3D2018%26date%3D2017%26date%3D2017%26date%3D31072017%26date%3D20122017%26date%3D07022018%26date%3D27022018%26date%3D02012018%26volume%3D57%26issue%3D8%26spage%3D1369%26epage%3D1379" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kevin  Pels</span>, <span class="hlFld-ContribAuthor ">Paige  Dickson</span>, <span class="hlFld-ContribAuthor ">Hongchan  An</span>, and <span class="hlFld-ContribAuthor ">Thomas  Kodadek</span>  . </span><span class="cited-content_cbyCitation_article-title">DNA-Compatible Solid-Phase Combinatorial Synthesis of β-Cyanoacrylamides and Related Electrophiles. </span><span class="cited-content_cbyCitation_journal-name">ACS Combinatorial Science</span><span> <strong>2018,</strong> <em>20 </em>
                                    (2)
                                     , 61-69. <a href="https://doi.org/10.1021/acscombsci.7b00169" title="DOI URL">https://doi.org/10.1021/acscombsci.7b00169</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acscombsci.7b00169&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facscombsci.7b00169%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Combinatorial%2520Science%26atitle%3DDNA-Compatible%252BSolid-Phase%252BCombinatorial%252BSynthesis%252Bof%252B%2525CE%2525B2-Cyanoacrylamides%252Band%252BRelated%252BElectrophiles%26aulast%3DPels%26aufirst%3DKevin%26date%3D2018%26date%3D2018%26date%3D2017%26date%3D2017%26date%3D07112017%26date%3D30122017%26date%3D17012018%26date%3D12022018%26date%3D03012018%26volume%3D20%26issue%3D2%26spage%3D61%26epage%3D69" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Danilo  Del Prete</span>, <span class="hlFld-ContribAuthor ">Orazio  Taglialatela-Scafati</span>, <span class="hlFld-ContribAuthor ">Alberto  Minassi</span>, <span class="hlFld-ContribAuthor ">Carmina  Sirignano</span>, <span class="hlFld-ContribAuthor ">Cristina  Cruz</span>, <span class="hlFld-ContribAuthor ">Maria L.  Bellido</span>, <span class="hlFld-ContribAuthor ">Eduardo  Muñoz</span>, and <span class="hlFld-ContribAuthor ">Giovanni  Appendino</span>  . </span><span class="cited-content_cbyCitation_article-title">Electrophilic Triterpenoid Enones: A Comparative Thiol-Trapping and Bioactivity Study. </span><span class="cited-content_cbyCitation_journal-name">Journal of Natural Products</span><span> <strong>2017,</strong> <em>80 </em>
                                    (8)
                                     , 2276-2283. <a href="https://doi.org/10.1021/acs.jnatprod.7b00271" title="DOI URL">https://doi.org/10.1021/acs.jnatprod.7b00271</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jnatprod.7b00271&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jnatprod.7b00271%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Natural%2520Products%26atitle%3DElectrophilic%252BTriterpenoid%252BEnones%25253A%252BA%252BComparative%252BThiol-Trapping%252Band%252BBioactivity%252BStudy%26aulast%3DDel%2BPrete%26aufirst%3DDanilo%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D28032017%26date%3D28072017%26date%3D25082017%26volume%3D80%26issue%3D8%26spage%3D2276%26epage%3D2283" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dharmaraja  Allimuthu</span> and <span class="hlFld-ContribAuthor ">Drew J.  Adams</span>  . </span><span class="cited-content_cbyCitation_article-title">2-Chloropropionamide As a Low-Reactivity Electrophile for Irreversible Small-Molecule Probe Identification. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Biology</span><span> <strong>2017,</strong> <em>12 </em>
                                    (8)
                                     , 2124-2131. <a href="https://doi.org/10.1021/acschembio.7b00424" title="DOI URL">https://doi.org/10.1021/acschembio.7b00424</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschembio.7b00424&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschembio.7b00424%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Biology%26atitle%3D2-Chloropropionamide%252BAs%252Ba%252BLow-Reactivity%252BElectrophile%252Bfor%252BIrreversible%252BSmall-Molecule%252BProbe%252BIdentification%26aulast%3DAllimuthu%26aufirst%3DDharmaraja%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D22052017%26date%3D14062017%26date%3D06072017%26date%3D18082017%26date%3D14062017%26volume%3D12%26issue%3D8%26spage%3D2124%26epage%3D2131" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Weilin  Zhang</span>, <span class="hlFld-ContribAuthor ">Jianfeng  Pei</span>, and <span class="hlFld-ContribAuthor ">Luhua  Lai</span>  . </span><span class="cited-content_cbyCitation_article-title">Statistical Analysis and Prediction of Covalent Ligand Targeted Cysteine Residues. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2017,</strong> <em>57 </em>
                                    (6)
                                     , 1453-1460. <a href="https://doi.org/10.1021/acs.jcim.7b00163" title="DOI URL">https://doi.org/10.1021/acs.jcim.7b00163</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jcim.7b00163&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jcim.7b00163%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DStatistical%252BAnalysis%252Band%252BPrediction%252Bof%252BCovalent%252BLigand%252BTargeted%252BCysteine%252BResidues%26aulast%3DZhang%26aufirst%3DWeilin%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D20032017%26date%3D30052017%26date%3D26062017%26date%3D16052017%26volume%3D57%26issue%3D6%26spage%3D1453%26epage%3D1460" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yongsheng  Yu</span>, <span class="hlFld-ContribAuthor ">Yunyu  Nie</span>, <span class="hlFld-ContribAuthor ">Qian  Feng</span>, <span class="hlFld-ContribAuthor ">Jiale  Qu</span>, <span class="hlFld-ContribAuthor ">Rui  Wang</span>, <span class="hlFld-ContribAuthor ">Liming  Bian</span>, and <span class="hlFld-ContribAuthor ">Jiang  Xia</span>  . </span><span class="cited-content_cbyCitation_article-title">Targeted Covalent Inhibition of Grb2–Sos1 Interaction through Proximity-Induced Conjugation in Breast Cancer Cells. </span><span class="cited-content_cbyCitation_journal-name">Molecular Pharmaceutics</span><span> <strong>2017,</strong> <em>14 </em>
                                    (5)
                                     , 1548-1557. <a href="https://doi.org/10.1021/acs.molpharmaceut.6b00952" title="DOI URL">https://doi.org/10.1021/acs.molpharmaceut.6b00952</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.molpharmaceut.6b00952&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.molpharmaceut.6b00952%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Pharmaceutics%26atitle%3DTargeted%252BCovalent%252BInhibition%252Bof%252BGrb2%2525E2%252580%252593Sos1%252BInteraction%252Bthrough%252BProximity-Induced%252BConjugation%252Bin%252BBreast%252BCancer%252BCells%26aulast%3DYu%26aufirst%3DYongsheng%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D2016%26date%3D2016%26date%3D23102016%26date%3D06012017%26date%3D09122016%26date%3D17012017%26date%3D01052017%26date%3D06012017%26volume%3D14%26issue%3D5%26spage%3D1548%26epage%3D1557" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Paul A.  Jackson</span>, <span class="hlFld-ContribAuthor ">John C.  Widen</span>, <span class="hlFld-ContribAuthor ">Daniel A.  Harki</span>, and <span class="hlFld-ContribAuthor ">Kay M.  Brummond</span>  . </span><span class="cited-content_cbyCitation_article-title">Covalent Modifiers: A Chemical Perspective on the Reactivity of α,β-Unsaturated Carbonyls with Thiols via Hetero-Michael Addition Reactions. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (3)
                                     , 839-885. <a href="https://doi.org/10.1021/acs.jmedchem.6b00788" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00788</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00788&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b00788%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DCovalent%252BModifiers%25253A%252BA%252BChemical%252BPerspective%252Bon%252Bthe%252BReactivity%252Bof%252B%2525CE%2525B1%25252C%2525CE%2525B2-Unsaturated%252BCarbonyls%252Bwith%252BThiols%252Bvia%252BHetero-Michael%252BAddition%252BReactions%26aulast%3DJackson%26aufirst%3DPaul%2BA.%26date%3D2017%26date%3D2016%26date%3D2016%26date%3D25052016%26date%3D20122016%26date%3D09022017%26volume%3D60%26issue%3D3%26spage%3D839%26epage%3D885" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Arun  Tailor</span>, <span class="hlFld-ContribAuthor ">James C.  Waddington</span>, <span class="hlFld-ContribAuthor ">Xiaoli  Meng</span>, and <span class="hlFld-ContribAuthor ">B. Kevin  Park</span>  . </span><span class="cited-content_cbyCitation_article-title">Mass Spectrometric and Functional Aspects of Drug–Protein Conjugation. </span><span class="cited-content_cbyCitation_journal-name">Chemical Research in Toxicology</span><span> <strong>2016,</strong> <em>29 </em>
                                    (12)
                                     , 1912-1935. <a href="https://doi.org/10.1021/acs.chemrestox.6b00147" title="DOI URL">https://doi.org/10.1021/acs.chemrestox.6b00147</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.chemrestox.6b00147&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.chemrestox.6b00147%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Research%2520in%2520Toxicology%26atitle%3DMass%252BSpectrometric%252Band%252BFunctional%252BAspects%252Bof%252BDrug%2525E2%252580%252593Protein%252BConjugation%26aulast%3DTailor%26aufirst%3DArun%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D01052016%26date%3D30092016%26date%3D19122016%26volume%3D29%26issue%3D12%26spage%3D1912%26epage%3D1935" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jinping  Gan</span>, <span class="hlFld-ContribAuthor ">Haiying  Zhang</span>, and <span class="hlFld-ContribAuthor ">W. Griffith  Humphreys</span>  . </span><span class="cited-content_cbyCitation_article-title">Drug–Protein Adducts: Chemistry, Mechanisms of Toxicity, and Methods of Characterization. </span><span class="cited-content_cbyCitation_journal-name">Chemical Research in Toxicology</span><span> <strong>2016,</strong> <em>29 </em>
                                    (12)
                                     , 2040-2057. <a href="https://doi.org/10.1021/acs.chemrestox.6b00274" title="DOI URL">https://doi.org/10.1021/acs.chemrestox.6b00274</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.chemrestox.6b00274&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.chemrestox.6b00274%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Research%2520in%2520Toxicology%26atitle%3DDrug%2525E2%252580%252593Protein%252BAdducts%25253A%252BChemistry%25252C%252BMechanisms%252Bof%252BToxicity%25252C%252Band%252BMethods%252Bof%252BCharacterization%26aulast%3DGan%26aufirst%3DJinping%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D15082016%26date%3D05122016%26date%3D19122016%26date%3D29112016%26volume%3D29%26issue%3D12%26spage%3D2040%26epage%3D2057" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ian M.  Robertson</span>, <span class="hlFld-ContribAuthor ">Sandra E.  Pineda-Sanabria</span>, <span class="hlFld-ContribAuthor ">Ziqian  Yan</span>, <span class="hlFld-ContribAuthor ">Thomas  Kampourakis</span>, <span class="hlFld-ContribAuthor ">Yin-Biao  Sun</span>, <span class="hlFld-ContribAuthor ">Brian D.  Sykes</span>, and <span class="hlFld-ContribAuthor ">Malcolm  Irving</span>  . </span><span class="cited-content_cbyCitation_article-title">Reversible Covalent Binding to Cardiac Troponin C by the Ca2+-Sensitizer Levosimendan. </span><span class="cited-content_cbyCitation_journal-name">Biochemistry</span><span> <strong>2016,</strong> <em>55 </em>
                                    (43)
                                     , 6032-6045. <a href="https://doi.org/10.1021/acs.biochem.6b00758" title="DOI URL">https://doi.org/10.1021/acs.biochem.6b00758</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.biochem.6b00758&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.biochem.6b00758%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemistry%26atitle%3DReversible%252BCovalent%252BBinding%252Bto%252BCardiac%252BTroponin%252BC%252Bby%252Bthe%252BCa2%25252B-Sensitizer%252BLevosimendan%26aulast%3DRobertson%26aufirst%3DIan%2BM.%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D27072016%26date%3D22092016%26date%3D17102016%26date%3D01112016%26date%3D27092016%26volume%3D55%26issue%3D43%26spage%3D6032%26epage%3D6045" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yanmin  Zhang</span>, <span class="hlFld-ContribAuthor ">Danfeng  Zhang</span>, <span class="hlFld-ContribAuthor ">Haozhong  Tian</span>, <span class="hlFld-ContribAuthor ">Yu  Jiao</span>, <span class="hlFld-ContribAuthor ">Zhihao  Shi</span>, <span class="hlFld-ContribAuthor ">Ting  Ran</span>, <span class="hlFld-ContribAuthor ">Haichun  Liu</span>, <span class="hlFld-ContribAuthor ">Shuai  Lu</span>, <span class="hlFld-ContribAuthor ">Anyang  Xu</span>, <span class="hlFld-ContribAuthor ">Xin  Qiao</span>, <span class="hlFld-ContribAuthor ">Jing  Pan</span>, <span class="hlFld-ContribAuthor ">Lingfeng  Yin</span>, <span class="hlFld-ContribAuthor ">Weineng  Zhou</span>, <span class="hlFld-ContribAuthor ">Tao  Lu</span>, and <span class="hlFld-ContribAuthor ">Yadong  Chen</span>  . </span><span class="cited-content_cbyCitation_article-title">Identification of Covalent Binding Sites Targeting Cysteines Based on Computational Approaches. </span><span class="cited-content_cbyCitation_journal-name">Molecular Pharmaceutics</span><span> <strong>2016,</strong> <em>13 </em>
                                    (9)
                                     , 3106-3118. <a href="https://doi.org/10.1021/acs.molpharmaceut.6b00302" title="DOI URL">https://doi.org/10.1021/acs.molpharmaceut.6b00302</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.molpharmaceut.6b00302&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.molpharmaceut.6b00302%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Pharmaceutics%26atitle%3DIdentification%252Bof%252BCovalent%252BBinding%252BSites%252BTargeting%252BCysteines%252BBased%252Bon%252BComputational%252BApproaches%26aulast%3DZhang%26aufirst%3DYanmin%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D05042016%26date%3D02082016%26date%3D07072016%26date%3D10082016%26date%3D06092016%26date%3D02082016%26volume%3D13%26issue%3D9%26spage%3D3106%26epage%3D3118" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yuanbao  Ai</span>, <span class="hlFld-ContribAuthor ">Lingling  Yu</span>, <span class="hlFld-ContribAuthor ">Xiao  Tan</span>, <span class="hlFld-ContribAuthor ">Xiaoying  Chai</span>, and <span class="hlFld-ContribAuthor ">Sen  Liu</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of Covalent Ligands via Noncovalent Docking by Dissecting Covalent Docking Based on a “Steric-Clashes Alleviating Receptor (SCAR)” Strategy. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2016,</strong> <em>56 </em>
                                    (8)
                                     , 1563-1575. <a href="https://doi.org/10.1021/acs.jcim.6b00334" title="DOI URL">https://doi.org/10.1021/acs.jcim.6b00334</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jcim.6b00334&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jcim.6b00334%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DDiscovery%252Bof%252BCovalent%252BLigands%252Bvia%252BNoncovalent%252BDocking%252Bby%252BDissecting%252BCovalent%252BDocking%252BBased%252Bon%252Ba%252B%2525E2%252580%25259CSteric-Clashes%252BAlleviating%252BReceptor%252B%252528SCAR%252529%2525E2%252580%25259D%252BStrategy%26aulast%3DAi%26aufirst%3DYuanbao%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D09062016%26date%3D21072016%26date%3D22082016%26date%3D13072016%26volume%3D56%26issue%3D8%26spage%3D1563%26epage%3D1575" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wentao  Chen</span>, <span class="hlFld-ContribAuthor ">Jiajia  Dong</span>, <span class="hlFld-ContribAuthor ">Lars  Plate</span>, <span class="hlFld-ContribAuthor ">David E.  Mortenson</span>, <span class="hlFld-ContribAuthor ">Gabriel J.  Brighty</span>, <span class="hlFld-ContribAuthor ">Suhua  Li</span>, <span class="hlFld-ContribAuthor ">Yu  Liu</span>, <span class="hlFld-ContribAuthor ">Andrea  Galmozzi</span>, <span class="hlFld-ContribAuthor ">Peter S.  Lee</span>, <span class="hlFld-ContribAuthor ">Jonathan J.  Hulce</span>, <span class="hlFld-ContribAuthor ">Benjamin F.  Cravatt</span>, <span class="hlFld-ContribAuthor ">Enrique  Saez</span>, <span class="hlFld-ContribAuthor ">Evan T.  Powers</span>, <span class="hlFld-ContribAuthor ">Ian A.  Wilson</span>, <span class="hlFld-ContribAuthor ">K. Barry  Sharpless</span>, and <span class="hlFld-ContribAuthor ">Jeffery W.  Kelly</span>  . </span><span class="cited-content_cbyCitation_article-title">Arylfluorosulfates Inactivate Intracellular Lipid Binding Protein(s) through Chemoselective SuFEx Reaction with a Binding Site Tyr Residue. </span><span class="cited-content_cbyCitation_journal-name">Journal of the American Chemical Society</span><span> <strong>2016,</strong> <em>138 </em>
                                    (23)
                                     , 7353-7364. <a href="https://doi.org/10.1021/jacs.6b02960" title="DOI URL">https://doi.org/10.1021/jacs.6b02960</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jacs.6b02960&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjacs.6b02960%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520American%2520Chemical%2520Society%26atitle%3DArylfluorosulfates%252BInactivate%252BIntracellular%252BLipid%252BBinding%252BProtein%252528s%252529%252Bthrough%252BChemoselective%252BSuFEx%252BReaction%252Bwith%252Ba%252BBinding%252BSite%252BTyr%252BResidue%26aulast%3DChen%26aufirst%3DWentao%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D21032016%26date%3D02062016%26date%3D15062016%26date%3D18052016%26volume%3D138%26issue%3D23%26spage%3D7353%26epage%3D7364" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gaëlle  Mariaule</span>, <span class="hlFld-ContribAuthor ">Stéphane  De Cesco</span>, <span class="hlFld-ContribAuthor ">Francesco  Airaghi</span>, <span class="hlFld-ContribAuthor ">Jerry  Kurian</span>, <span class="hlFld-ContribAuthor ">Paolo  Schiavini</span>, <span class="hlFld-ContribAuthor ">Sylvain  Rocheleau</span>, <span class="hlFld-ContribAuthor ">Igor  Huskić</span>, <span class="hlFld-ContribAuthor ">Karine  Auclair</span>, <span class="hlFld-ContribAuthor ">Anthony  Mittermaier</span>, and <span class="hlFld-ContribAuthor ">Nicolas  Moitessier</span>  . </span><span class="cited-content_cbyCitation_article-title">3-Oxo-hexahydro-1H-isoindole-4-carboxylic Acid as a Drug Chiral Bicyclic Scaffold: Structure-Based Design and Preparation of Conformationally Constrained Covalent and Noncovalent Prolyl Oligopeptidase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (9)
                                     , 4221-4234. <a href="https://doi.org/10.1021/acs.jmedchem.5b01296" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b01296</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b01296&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b01296%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3D3-Oxo-hexahydro-1H-isoindole-4-carboxylic%252BAcid%252Bas%252Ba%252BDrug%252BChiral%252BBicyclic%252BScaffold%25253A%252BStructure-Based%252BDesign%252Band%252BPreparation%252Bof%252BConformationally%252BConstrained%252BCovalent%252Band%252BNoncovalent%252BProlyl%252BOligopeptidase%252BInhibitors%26aulast%3DMariaule%26aufirst%3DGa%25C3%25ABlle%26date%3D2016%26date%3D2015%26date%3D2015%26date%3D21082015%26date%3D14122015%26date%3D12052016%26date%3D30112015%26volume%3D59%26issue%3D9%26spage%3D4221%26epage%3D4234" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yan  Li</span>, <span class="hlFld-ContribAuthor ">Zhixiong  Zhao</span>, <span class="hlFld-ContribAuthor ">Zhihai  Liu</span>, <span class="hlFld-ContribAuthor ">Minyi  Su</span>, and <span class="hlFld-ContribAuthor ">Renxiao  Wang</span>  . </span><span class="cited-content_cbyCitation_article-title">AutoT&T v.2: An Efficient and Versatile Tool for Lead Structure Generation and Optimization. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2016,</strong> <em>56 </em>
                                    (2)
                                     , 435-453. <a href="https://doi.org/10.1021/acs.jcim.5b00691" title="DOI URL">https://doi.org/10.1021/acs.jcim.5b00691</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jcim.5b00691&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jcim.5b00691%26sid%3Dliteratum%253Aachs%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2011%26volume%3D51%26spage%3D1474%26epage%3D1491%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DAutoT%252526T%252Bv.2%25253A%252BAn%252BEfficient%252Band%252BVersatile%252BTool%252Bfor%252BLead%252BStructure%252BGeneration%252Band%252BOptimization%26aulast%3DLi%26aufirst%3DYan%26date%3D2016%26date%3D2016%26date%3D2015%26date%3D17112015%26date%3D03022016%26date%3D22022016%26date%3D22012016%26volume%3D56%26issue%3D2%26spage%3D435%26epage%3D453" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chaitanya K.  Jaladanki</span>, <span class="hlFld-ContribAuthor ">Nikhil  Taxak</span>, <span class="hlFld-ContribAuthor ">Rohith A.  Varikoti</span>, and <span class="hlFld-ContribAuthor ">Prasad V.  Bharatam</span>  . </span><span class="cited-content_cbyCitation_article-title">Toxicity Originating from Thiophene Containing Drugs: Exploring the Mechanism using Quantum Chemical Methods. </span><span class="cited-content_cbyCitation_journal-name">Chemical Research in Toxicology</span><span> <strong>2015,</strong> <em>28 </em>
                                    (12)
                                     , 2364-2376. <a href="https://doi.org/10.1021/acs.chemrestox.5b00364" title="DOI URL">https://doi.org/10.1021/acs.chemrestox.5b00364</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.chemrestox.5b00364&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.chemrestox.5b00364%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Research%2520in%2520Toxicology%26atitle%3DToxicity%252BOriginating%252Bfrom%252BThiophene%252BContaining%252BDrugs%25253A%252BExploring%252Bthe%252BMechanism%252Busing%252BQuantum%252BChemical%252BMethods%26aulast%3DJaladanki%26aufirst%3DChaitanya%2BK.%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D01092015%26date%3D10122015%26date%3D21122015%26date%3D17112015%26volume%3D28%26issue%3D12%26spage%3D2364%26epage%3D2376" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ryan P.  Wurz</span>, <span class="hlFld-ContribAuthor ">Liping H.  Pettus</span>, <span class="hlFld-ContribAuthor ">Kate  Ashton</span>, <span class="hlFld-ContribAuthor ">James  Brown</span>, <span class="hlFld-ContribAuthor ">Jian Jeffrey  Chen</span>, <span class="hlFld-ContribAuthor ">Brad  Herberich</span>, <span class="hlFld-ContribAuthor ">Fang-Tsao  Hong</span>, <span class="hlFld-ContribAuthor ">Essa  Hu-Harrington</span>, <span class="hlFld-ContribAuthor ">Tom  Nguyen</span>, <span class="hlFld-ContribAuthor ">David J.  St. Jean, Jr.</span>, <span class="hlFld-ContribAuthor ">Seifu  Tadesse</span>, <span class="hlFld-ContribAuthor ">David  Bauer</span>, <span class="hlFld-ContribAuthor ">Michele  Kubryk</span>, <span class="hlFld-ContribAuthor ">Jinghui  Zhan</span>, <span class="hlFld-ContribAuthor ">Keegan  Cooke</span>, <span class="hlFld-ContribAuthor ">Petia  Mitchell</span>, <span class="hlFld-ContribAuthor ">Kristin L.  Andrews</span>, <span class="hlFld-ContribAuthor ">Faye  Hsieh</span>, <span class="hlFld-ContribAuthor ">Dean  Hickman</span>, <span class="hlFld-ContribAuthor ">Nataraj  Kalyanaraman</span>, <span class="hlFld-ContribAuthor ">Tian  Wu</span>, <span class="hlFld-ContribAuthor ">Darren L.  Reid</span>, <span class="hlFld-ContribAuthor ">Edward K.  Lobenhofer</span>, <span class="hlFld-ContribAuthor ">Dina A.  Andrews</span>, <span class="hlFld-ContribAuthor ">Nancy  Everds</span>, <span class="hlFld-ContribAuthor ">Roberto  Guzman</span>, <span class="hlFld-ContribAuthor ">Andrew T.  Parsons</span>, <span class="hlFld-ContribAuthor ">Simon J.  Hedley</span>, <span class="hlFld-ContribAuthor ">Jason  Tedrow</span>, <span class="hlFld-ContribAuthor ">Oliver R.  Thiel</span>, <span class="hlFld-ContribAuthor ">Matthew  Potter</span>, <span class="hlFld-ContribAuthor ">Robert  Radinsky</span>, <span class="hlFld-ContribAuthor ">Pedro J.  Beltran</span>, and <span class="hlFld-ContribAuthor ">Andrew S.  Tasker</span>  . </span><span class="cited-content_cbyCitation_article-title">Oxopyrido[2,3-d]pyrimidines as Covalent L858R/T790M Mutant Selective Epidermal Growth Factor Receptor (EGFR) Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2015,</strong> <em>6 </em>
                                    (9)
                                     , 987-992. <a href="https://doi.org/10.1021/acsmedchemlett.5b00193" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.5b00193</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.5b00193&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.5b00193%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DOxopyrido%25255B2%25252C3-d%25255Dpyrimidines%252Bas%252BCovalent%252BL858R%25252FT790M%252BMutant%252BSelective%252BEpidermal%252BGrowth%252BFactor%252BReceptor%252B%252528EGFR%252529%252BInhibitors%26aulast%3DWurz%26aufirst%3DRyan%2BP.%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D08052015%26date%3D27072015%26date%3D31072015%26date%3D10092015%26date%3D27072015%26volume%3D6%26issue%3D9%26spage%3D987%26epage%3D992" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zoran  Rankovic</span>  . </span><span class="cited-content_cbyCitation_article-title">CNS Drug Design: Balancing Physicochemical Properties for Optimal Brain Exposure. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (6)
                                     , 2584-2608. <a href="https://doi.org/10.1021/jm501535r" title="DOI URL">https://doi.org/10.1021/jm501535r</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm501535r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm501535r%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DCNS%252BDrug%252BDesign%25253A%252BBalancing%252BPhysicochemical%252BProperties%252Bfor%252BOptimal%252BBrain%252BExposure%26aulast%3DRankovic%26aufirst%3DZoran%26date%3D2015%26date%3D2015%26date%3D2014%26date%3D05102014%26date%3D06012015%26date%3D26032015%26date%3D11122014%26volume%3D58%26issue%3D6%26spage%3D2584%26epage%3D2608" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jon J. G.  Winter</span>, <span class="hlFld-ContribAuthor ">Malcolm  Anderson</span>, <span class="hlFld-ContribAuthor ">Kevin  Blades</span>, <span class="hlFld-ContribAuthor ">Claire  Brassington</span>, <span class="hlFld-ContribAuthor ">Alexander L.  Breeze</span>, <span class="hlFld-ContribAuthor ">Christine  Chresta</span>, <span class="hlFld-ContribAuthor ">Kevin  Embrey</span>, <span class="hlFld-ContribAuthor ">Gary  Fairley</span>, <span class="hlFld-ContribAuthor ">Paul  Faulder</span>, <span class="hlFld-ContribAuthor ">M. Raymond V.  Finlay</span>, <span class="hlFld-ContribAuthor ">Jason G.  Kettle</span>, <span class="hlFld-ContribAuthor ">Thorsten  Nowak</span>, <span class="hlFld-ContribAuthor ">Ross  Overman</span>, <span class="hlFld-ContribAuthor ">S. Joe  Patel</span>, <span class="hlFld-ContribAuthor ">Paula  Perkins</span>, <span class="hlFld-ContribAuthor ">Loredana  Spadola</span>, <span class="hlFld-ContribAuthor ">Jonathan  Tart</span>, <span class="hlFld-ContribAuthor ">Julie A.  Tucker</span>, and <span class="hlFld-ContribAuthor ">Gail  Wrigley</span>  . </span><span class="cited-content_cbyCitation_article-title">Small Molecule Binding Sites on the Ras:SOS Complex Can Be Exploited for Inhibition of Ras Activation. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (5)
                                     , 2265-2274. <a href="https://doi.org/10.1021/jm501660t" title="DOI URL">https://doi.org/10.1021/jm501660t</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm501660t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm501660t%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSmall%252BMolecule%252BBinding%252BSites%252Bon%252Bthe%252BRas%25253ASOS%252BComplex%252BCan%252BBe%252BExploited%252Bfor%252BInhibition%252Bof%252BRas%252BActivation%26aulast%3DWinter%26aufirst%3DJon%2BJ.%2BG.%26date%3D2015%26date%3D2015%26date%3D2014%26date%3D28102014%26date%3D26022015%26date%3D12032015%26date%3D19022015%26volume%3D58%26issue%3D5%26spage%3D2265%26epage%3D2274" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Van Sang  Nguyen</span>, <span class="hlFld-ContribAuthor ">Xin Yi  Loh</span>, <span class="hlFld-ContribAuthor ">Hadhi  Wijaya</span>, <span class="hlFld-ContribAuthor ">Jigang  Wang</span>, <span class="hlFld-ContribAuthor ">Qingsong  Lin</span>, <span class="hlFld-ContribAuthor ">Yulin  Lam</span>, <span class="hlFld-ContribAuthor ">Wai-Shiu Fred  Wong</span>, and <span class="hlFld-ContribAuthor ">Yu Keung  Mok</span>  . </span><span class="cited-content_cbyCitation_article-title">Specificity and Inhibitory Mechanism of Andrographolide and Its Analogues as Antiasthma Agents on NF-κB p50. </span><span class="cited-content_cbyCitation_journal-name">Journal of Natural Products</span><span> <strong>2015,</strong> <em>78 </em>
                                    (2)
                                     , 208-217. <a href="https://doi.org/10.1021/np5007179" title="DOI URL">https://doi.org/10.1021/np5007179</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/np5007179&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fnp5007179%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Natural%2520Products%26atitle%3DSpecificity%252Band%252BInhibitory%252BMechanism%252Bof%252BAndrographolide%252Band%252BIts%252BAnalogues%252Bas%252BAntiasthma%252BAgents%252Bon%252BNF-%2525CE%2525BAB%252Bp50%26aulast%3DNguyen%26aufirst%3DVan%2BSang%26date%3D2015%26date%3D2015%26date%3D2014%26date%3D25092014%26date%3D23012015%26date%3D27022015%26volume%3D78%26issue%3D2%26spage%3D208%26epage%3D217" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ching-Ming  Chang</span>, <span class="hlFld-ContribAuthor ">Jeffy  Chern</span>, <span class="hlFld-ContribAuthor ">Ming-Yi  Chen</span>, <span class="hlFld-ContribAuthor ">Kai-Fa  Huang</span>, <span class="hlFld-ContribAuthor ">Chein-Hung  Chen</span>, <span class="hlFld-ContribAuthor ">Yu-Liang  Yang</span>, and <span class="hlFld-ContribAuthor ">Shih-Hsiung  Wu</span>  . </span><span class="cited-content_cbyCitation_article-title">Avenaciolides: Potential MurA-Targeted Inhibitors Against Peptidoglycan Biosynthesis in Methicillin-Resistant Staphylococcus aureus (MRSA). </span><span class="cited-content_cbyCitation_journal-name">Journal of the American Chemical Society</span><span> <strong>2015,</strong> <em>137 </em>
                                    (1)
                                     , 267-275. <a href="https://doi.org/10.1021/ja510375f" title="DOI URL">https://doi.org/10.1021/ja510375f</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ja510375f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fja510375f%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520American%2520Chemical%2520Society%26atitle%3DAvenaciolides%25253A%252BPotential%252BMurA-Targeted%252BInhibitors%252BAgainst%252BPeptidoglycan%252BBiosynthesis%252Bin%252BMethicillin-Resistant%252BStaphylococcus%252Baureus%252B%252528MRSA%252529%26aulast%3DChang%26aufirst%3DChing-Ming%26date%3D2015%26date%3D2014%26date%3D2014%26date%3D09102014%26date%3D31122014%26date%3D14012015%26date%3D18122014%26volume%3D137%26issue%3D1%26spage%3D267%26epage%3D275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mark E.  Flanagan</span>, <span class="hlFld-ContribAuthor ">Joseph A.  Abramite</span>, <span class="hlFld-ContribAuthor ">Dennis P.  Anderson</span>, <span class="hlFld-ContribAuthor ">Ann  Aulabaugh</span>, <span class="hlFld-ContribAuthor ">Upendra P.  Dahal</span>, <span class="hlFld-ContribAuthor ">Adam M.  Gilbert</span>, <span class="hlFld-ContribAuthor ">Chao  Li</span>, <span class="hlFld-ContribAuthor ">Justin  Montgomery</span>, <span class="hlFld-ContribAuthor ">Stacey R.  Oppenheimer</span>, <span class="hlFld-ContribAuthor ">Tim  Ryder</span>, <span class="hlFld-ContribAuthor ">Brandon P.  Schuff</span>, <span class="hlFld-ContribAuthor ">Daniel P.  Uccello</span>, <span class="hlFld-ContribAuthor ">Gregory S.  Walker</span>, <span class="hlFld-ContribAuthor ">Yan  Wu</span>, <span class="hlFld-ContribAuthor ">Matthew F.  Brown</span>, <span class="hlFld-ContribAuthor ">Jinshan M.  Chen</span>, <span class="hlFld-ContribAuthor ">Matthew M.  Hayward</span>, <span class="hlFld-ContribAuthor ">Mark C.  Noe</span>, <span class="hlFld-ContribAuthor ">R. Scott  Obach</span>, <span class="hlFld-ContribAuthor ">Laurence  Philippe</span>, <span class="hlFld-ContribAuthor ">Veerabahu  Shanmugasundaram</span>, <span class="hlFld-ContribAuthor ">Michael J.  Shapiro</span>, <span class="hlFld-ContribAuthor ">Jeremy  Starr</span>, <span class="hlFld-ContribAuthor ">Justin  Stroh</span>, and <span class="hlFld-ContribAuthor ">Ye  Che</span>  . </span><span class="cited-content_cbyCitation_article-title">Chemical and Computational Methods for the Characterization of Covalent Reactive Groups for the Prospective Design of Irreversible Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (23)
                                     , 10072-10079. <a href="https://doi.org/10.1021/jm501412a" title="DOI URL">https://doi.org/10.1021/jm501412a</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm501412a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm501412a%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DChemical%252Band%252BComputational%252BMethods%252Bfor%252Bthe%252BCharacterization%252Bof%252BCovalent%252BReactive%252BGroups%252Bfor%252Bthe%252BProspective%252BDesign%252Bof%252BIrreversible%252BInhibitors%26aulast%3DFlanagan%26aufirst%3DMark%2BE.%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D17092014%26date%3D26112014%26date%3D11122014%26date%3D06112014%26volume%3D57%26issue%3D23%26spage%3D10072%26epage%3D10079" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Emily J.  Hanan</span>, <span class="hlFld-ContribAuthor ">Charles  Eigenbrot</span>, <span class="hlFld-ContribAuthor ">Marian C.  Bryan</span>, <span class="hlFld-ContribAuthor ">Daniel J.  Burdick</span>, <span class="hlFld-ContribAuthor ">Bryan K.  Chan</span>, <span class="hlFld-ContribAuthor ">Yuan  Chen</span>, <span class="hlFld-ContribAuthor ">Jennafer  Dotson</span>, <span class="hlFld-ContribAuthor ">Robert A.  Heald</span>, <span class="hlFld-ContribAuthor ">Philip S.  Jackson</span>, <span class="hlFld-ContribAuthor ">Hank  La</span>, <span class="hlFld-ContribAuthor ">Michael D.  Lainchbury</span>, <span class="hlFld-ContribAuthor ">Shiva  Malek</span>, <span class="hlFld-ContribAuthor ">Hans E.  Purkey</span>, <span class="hlFld-ContribAuthor ">Gabriele  Schaefer</span>, <span class="hlFld-ContribAuthor ">Stephen  Schmidt</span>, <span class="hlFld-ContribAuthor ">Eileen M.  Seward</span>, <span class="hlFld-ContribAuthor ">Steve  Sideris</span>, <span class="hlFld-ContribAuthor ">Christine  Tam</span>, <span class="hlFld-ContribAuthor ">Shumei  Wang</span>, <span class="hlFld-ContribAuthor ">Siew Kuen  Yeap</span>, <span class="hlFld-ContribAuthor ">Ivana  Yen</span>, <span class="hlFld-ContribAuthor ">Jianping  Yin</span>, <span class="hlFld-ContribAuthor ">Christine  Yu</span>, <span class="hlFld-ContribAuthor ">Inna  Zilberleyb</span>, and <span class="hlFld-ContribAuthor ">Timothy P.  Heffron</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of Selective and Noncovalent Diaminopyrimidine-Based Inhibitors of Epidermal Growth Factor Receptor Containing the T790M Resistance Mutation. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (23)
                                     , 10176-10191. <a href="https://doi.org/10.1021/jm501578n" title="DOI URL">https://doi.org/10.1021/jm501578n</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm501578n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm501578n%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BSelective%252Band%252BNoncovalent%252BDiaminopyrimidine-Based%252BInhibitors%252Bof%252BEpidermal%252BGrowth%252BFactor%252BReceptor%252BContaining%252Bthe%252BT790M%252BResistance%252BMutation%26aulast%3DHanan%26aufirst%3DEmily%2BJ.%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D13102014%26date%3D20112014%26date%3D11122014%26date%3D10112014%26volume%3D57%26issue%3D23%26spage%3D10176%26epage%3D10191" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christoph  Nitsche</span>, <span class="hlFld-ContribAuthor ">Steven  Holloway</span>, <span class="hlFld-ContribAuthor ">Tanja  Schirmeister</span>, and <span class="hlFld-ContribAuthor ">Christian D.  Klein</span>  . </span><span class="cited-content_cbyCitation_article-title">Biochemistry and Medicinal Chemistry of the Dengue Virus Protease. </span><span class="cited-content_cbyCitation_journal-name">Chemical Reviews</span><span> <strong>2014,</strong> <em>114 </em>
                                    (22)
                                     , 11348-11381. <a href="https://doi.org/10.1021/cr500233q" title="DOI URL">https://doi.org/10.1021/cr500233q</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/cr500233q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fcr500233q%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Reviews%26atitle%3DBiochemistry%252Band%252BMedicinal%252BChemistry%252Bof%252Bthe%252BDengue%252BVirus%252BProtease%26aulast%3DNitsche%26aufirst%3DChristoph%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D28042014%26date%3D30092014%26date%3D26112014%26volume%3D114%26issue%3D22%26spage%3D11348%26epage%3D11381" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael C.  Cavalier</span>, <span class="hlFld-ContribAuthor ">Adam D.  Pierce</span>, <span class="hlFld-ContribAuthor ">Paul T.  Wilder</span>, <span class="hlFld-ContribAuthor ">Milad J.  Alasady</span>, <span class="hlFld-ContribAuthor ">Kira G.  Hartman</span>, <span class="hlFld-ContribAuthor ">David B.  Neau</span>, <span class="hlFld-ContribAuthor ">Timothy L.  Foley</span>, <span class="hlFld-ContribAuthor ">Ajit  Jadhav</span>, <span class="hlFld-ContribAuthor ">David J.  Maloney</span>, <span class="hlFld-ContribAuthor ">Anton  Simeonov</span>, <span class="hlFld-ContribAuthor ">Eric A.  Toth</span>, and <span class="hlFld-ContribAuthor ">David J.  Weber</span>  . </span><span class="cited-content_cbyCitation_article-title">Covalent Small Molecule Inhibitors of Ca2+-Bound S100B. </span><span class="cited-content_cbyCitation_journal-name">Biochemistry</span><span> <strong>2014,</strong> <em>53 </em>
                                    (42)
                                     , 6628-6640. <a href="https://doi.org/10.1021/bi5005552" title="DOI URL">https://doi.org/10.1021/bi5005552</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/bi5005552&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fbi5005552%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemistry%26atitle%3DCovalent%252BSmall%252BMolecule%252BInhibitors%252Bof%252BCa2%25252B-Bound%252BS100B%26aulast%3DCavalier%26aufirst%3DMichael%2BC.%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D09052014%26date%3D30092014%26date%3D14102014%26date%3D28102014%26date%3D30092014%26volume%3D53%26issue%3D42%26spage%3D6628%26epage%3D6640" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shyam  Krishnan</span>, <span class="hlFld-ContribAuthor ">Rand M.  Miller</span>, <span class="hlFld-ContribAuthor ">Boxue  Tian</span>, <span class="hlFld-ContribAuthor ">R. Dyche  Mullins</span>, <span class="hlFld-ContribAuthor ">Matthew P.  Jacobson</span>, and <span class="hlFld-ContribAuthor ">Jack  Taunton</span>  . </span><span class="cited-content_cbyCitation_article-title">Design of Reversible, Cysteine-Targeted Michael Acceptors Guided by Kinetic and Computational Analysis. </span><span class="cited-content_cbyCitation_journal-name">Journal of the American Chemical Society</span><span> <strong>2014,</strong> <em>136 </em>
                                    (36)
                                     , 12624-12630. <a href="https://doi.org/10.1021/ja505194w" title="DOI URL">https://doi.org/10.1021/ja505194w</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ja505194w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fja505194w%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520American%2520Chemical%2520Society%26atitle%3DDesign%252Bof%252BReversible%25252C%252BCysteine-Targeted%252BMichael%252BAcceptors%252BGuided%252Bby%252BKinetic%252Band%252BComputational%252BAnalysis%26aulast%3DKrishnan%26aufirst%3DShyam%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D23052014%26date%3D02092014%26date%3D10092014%26date%3D25082014%26volume%3D136%26issue%3D36%26spage%3D12624%26epage%3D12630" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xitao  Li</span>, <span class="hlFld-ContribAuthor ">Yingying  Zuo</span>, <span class="hlFld-ContribAuthor ">Guanghui  Tang</span>, <span class="hlFld-ContribAuthor ">Yan  Wang</span>, <span class="hlFld-ContribAuthor ">Yiqing  Zhou</span>, <span class="hlFld-ContribAuthor ">Xueying  Wang</span>, <span class="hlFld-ContribAuthor ">Tianlin  Guo</span>, <span class="hlFld-ContribAuthor ">Mengying  Xia</span>, <span class="hlFld-ContribAuthor ">Ning  Ding</span>, and <span class="hlFld-ContribAuthor ">Zhengying  Pan</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of a Series of 2,5-Diaminopyrimidine Covalent Irreversible Inhibitors of Bruton’s Tyrosine Kinase with in Vivo Antitumor Activity. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (12)
                                     , 5112-5128. <a href="https://doi.org/10.1021/jm4017762" title="DOI URL">https://doi.org/10.1021/jm4017762</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm4017762&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm4017762%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Ba%252BSeries%252Bof%252B2%25252C5-Diaminopyrimidine%252BCovalent%252BIrreversible%252BInhibitors%252Bof%252BBruton%2525E2%252580%252599s%252BTyrosine%252BKinase%252Bwith%252Bin%252BVivo%252BAntitumor%252BActivity%26aulast%3DLi%26aufirst%3DXitao%26date%3D2014%26date%3D2014%26date%3D2013%26date%3D16112013%26date%3D10062014%26date%3D26062014%26volume%3D57%26issue%3D12%26spage%3D5112%26epage%3D5128" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jennifer L.  Furman</span>, <span class="hlFld-ContribAuthor ">Mingchao  Kang</span>, <span class="hlFld-ContribAuthor ">Seihyun  Choi</span>, <span class="hlFld-ContribAuthor ">Yu  Cao</span>, <span class="hlFld-ContribAuthor ">Erik D.  Wold</span>, <span class="hlFld-ContribAuthor ">Sophie B.  Sun</span>, <span class="hlFld-ContribAuthor ">Vaughn V.  Smider</span>, <span class="hlFld-ContribAuthor ">Peter G.  Schultz</span>, and <span class="hlFld-ContribAuthor ">Chan Hyuk  Kim</span>  . </span><span class="cited-content_cbyCitation_article-title">A Genetically Encoded aza-Michael Acceptor for Covalent Cross-Linking of Protein–Receptor Complexes. </span><span class="cited-content_cbyCitation_journal-name">Journal of the American Chemical Society</span><span> <strong>2014,</strong> <em>136 </em>
                                    (23)
                                     , 8411-8417. <a href="https://doi.org/10.1021/ja502851h" title="DOI URL">https://doi.org/10.1021/ja502851h</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ja502851h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fja502851h%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520American%2520Chemical%2520Society%26atitle%3DA%252BGenetically%252BEncoded%252Baza-Michael%252BAcceptor%252Bfor%252BCovalent%252BCross-Linking%252Bof%252BProtein%2525E2%252580%252593Receptor%252BComplexes%26aulast%3DFurman%26aufirst%3DJennifer%2BL.%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D25032014%26date%3D30052014%26date%3D11062014%26date%3D20052014%26volume%3D136%26issue%3D23%26spage%3D8411%26epage%3D8417" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jindřich  Fanfrlík</span>, <span class="hlFld-ContribAuthor ">Pathik S  Brahmkshatriya</span>, <span class="hlFld-ContribAuthor ">Jan  Řezáč</span>, <span class="hlFld-ContribAuthor ">Adéla  Jílková</span>, <span class="hlFld-ContribAuthor ">Martin  Horn</span>, <span class="hlFld-ContribAuthor ">Michael  Mareš</span>, <span class="hlFld-ContribAuthor ">Pavel  Hobza</span>, and <span class="hlFld-ContribAuthor ">Martin  Lepšík</span>  . </span><span class="cited-content_cbyCitation_article-title">Quantum Mechanics-Based Scoring Rationalizes the Irreversible Inactivation of Parasitic Schistosoma mansoni Cysteine Peptidase by Vinyl Sulfone Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Physical Chemistry B</span><span> <strong>2013,</strong> <em>117 </em>
                                    (48)
                                     , 14973-14982. <a href="https://doi.org/10.1021/jp409604n" title="DOI URL">https://doi.org/10.1021/jp409604n</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jp409604n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjp409604n%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Physical%2520Chemistry%2520B%26atitle%3DQuantum%252BMechanics-Based%252BScoring%252BRationalizes%252Bthe%252BIrreversible%252BInactivation%252Bof%252BParasitic%252BSchistosoma%252Bmansoni%252BCysteine%252BPeptidase%252Bby%252BVinyl%252BSulfone%252BInhibitors%26aulast%3DFanfrl%25C3%25ADk%26aufirst%3DJind%25C5%2599ich%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D26092013%26date%3D03112013%26date%3D21112013%26date%3D05122013%26date%3D06112013%26volume%3D117%26issue%3D48%26spage%3D14973%26epage%3D14982" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Upendra P.  Dahal</span>, <span class="hlFld-ContribAuthor ">R. Scott  Obach</span>, and <span class="hlFld-ContribAuthor ">Adam M.  Gilbert</span>  . </span><span class="cited-content_cbyCitation_article-title">Benchmarking in Vitro Covalent Binding Burden As a Tool To Assess Potential Toxicity Caused by Nonspecific Covalent Binding of Covalent Drugs. </span><span class="cited-content_cbyCitation_journal-name">Chemical Research in Toxicology</span><span> <strong>2013,</strong> <em>26 </em>
                                    (11)
                                     , 1739-1745. <a href="https://doi.org/10.1021/tx400301q" title="DOI URL">https://doi.org/10.1021/tx400301q</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/tx400301q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Ftx400301q%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Research%2520in%2520Toxicology%26atitle%3DBenchmarking%252Bin%252BVitro%252BCovalent%252BBinding%252BBurden%252BAs%252Ba%252BTool%252BTo%252BAssess%252BPotential%252BToxicity%252BCaused%252Bby%252BNonspecific%252BCovalent%252BBinding%252Bof%252BCovalent%252BDrugs%26aulast%3DDahal%26aufirst%3DUpendra%2BP.%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D19082013%26date%3D28102013%26date%3D18112013%26date%3D10102013%26volume%3D26%26issue%3D11%26spage%3D1739%26epage%3D1745" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jennifer M.  Smith</span>, <span class="hlFld-ContribAuthor ">Yasaman  Jami Alahmadi</span>, and <span class="hlFld-ContribAuthor ">Christopher N.  Rowley</span>  . </span><span class="cited-content_cbyCitation_article-title">Range-Separated DFT Functionals are Necessary to Model Thio-Michael Additions. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Theory and Computation</span><span> <strong>2013,</strong> <em>9 </em>
                                    (11)
                                     , 4860-4865. <a href="https://doi.org/10.1021/ct400773k" title="DOI URL">https://doi.org/10.1021/ct400773k</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ct400773k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fct400773k%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Theory%2520and%2520Computation%26atitle%3DRange-Separated%252BDFT%252BFunctionals%252Bare%252BNecessary%252Bto%252BModel%252BThio-Michael%252BAdditions%26aulast%3DSmith%26aufirst%3DJennifer%2BM.%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D31082013%26date%3D16102013%26date%3D12112013%26date%3D27092013%26volume%3D9%26issue%3D11%26spage%3D4860%26epage%3D4865" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jianwei  Wu</span>, <span class="hlFld-ContribAuthor ">Wenteng  Chen</span>, <span class="hlFld-ContribAuthor ">Guangxin  Xia</span>, <span class="hlFld-ContribAuthor ">Jing  Zhang</span>, <span class="hlFld-ContribAuthor ">Jiaan  Shao</span>, <span class="hlFld-ContribAuthor ">Biqin  Tan</span>, <span class="hlFld-ContribAuthor ">Chunchun  Zhang</span>, <span class="hlFld-ContribAuthor ">Wanwan  Yu</span>, <span class="hlFld-ContribAuthor ">Qinjie  Weng</span>, <span class="hlFld-ContribAuthor ">Haiyan  Liu</span>, <span class="hlFld-ContribAuthor ">Miao  Hu</span>, <span class="hlFld-ContribAuthor ">Hailin  Deng</span>, <span class="hlFld-ContribAuthor ">Yu  Hao</span>, <span class="hlFld-ContribAuthor ">Jingkang  Shen</span>, and <span class="hlFld-ContribAuthor ">Yongping  Yu</span>  . </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis, and Biological Evaluation of Novel Conformationally Constrained Inhibitors Targeting EGFR. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2013,</strong> <em>4 </em>
                                    (10)
                                     , 974-978. <a href="https://doi.org/10.1021/ml4002437" title="DOI URL">https://doi.org/10.1021/ml4002437</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ml4002437&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fml4002437%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDesign%25252C%252BSynthesis%25252C%252Band%252BBiological%252BEvaluation%252Bof%252BNovel%252BConformationally%252BConstrained%252BInhibitors%252BTargeting%252BEGFR%26aulast%3DWu%26aufirst%3DJianwei%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D27062013%26date%3D06082013%26date%3D09082013%26date%3D10102013%26date%3D06082013%26volume%3D4%26issue%3D10%26spage%3D974%26epage%3D978" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Elizabeth  Dunny</span>, <span class="hlFld-ContribAuthor ">William  Doherty</span>, <span class="hlFld-ContribAuthor ">Paul  Evans</span>, <span class="hlFld-ContribAuthor ">J. Paul G.  Malthouse</span>, <span class="hlFld-ContribAuthor ">Derek  Nolan</span>, and <span class="hlFld-ContribAuthor ">Andrew J. S.  Knox</span>  . </span><span class="cited-content_cbyCitation_article-title">Vinyl Sulfone-Based Peptidomimetics as Anti-Trypanosomal Agents: Design, Synthesis, Biological and Computational Evaluation. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2013,</strong> <em>56 </em>
                                    (17)
                                     , 6638-6650. <a href="https://doi.org/10.1021/jm400294w" title="DOI URL">https://doi.org/10.1021/jm400294w</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm400294w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm400294w%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DVinyl%252BSulfone-Based%252BPeptidomimetics%252Bas%252BAnti-Trypanosomal%252BAgents%25253A%252BDesign%25252C%252BSynthesis%25252C%252BBiological%252Band%252BComputational%252BEvaluation%26aulast%3DDunny%26aufirst%3DElizabeth%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D25022013%26date%3D03092013%26date%3D12092013%26date%3D16082013%26volume%3D56%26issue%3D17%26spage%3D6638%26epage%3D6650" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shuhei  Kawamura</span>, <span class="hlFld-ContribAuthor ">Yuka  Unno</span>, <span class="hlFld-ContribAuthor ">Motohiro  Tanaka</span>, <span class="hlFld-ContribAuthor ">Takuma  Sasaki</span>, <span class="hlFld-ContribAuthor ">Akihito  Yamano</span>, <span class="hlFld-ContribAuthor ">Takatsugu  Hirokawa</span>, <span class="hlFld-ContribAuthor ">Tomoshi  Kameda</span>, <span class="hlFld-ContribAuthor ">Akira  Asai</span>, <span class="hlFld-ContribAuthor ">Mitsuhiro  Arisawa</span>, and <span class="hlFld-ContribAuthor ">Satoshi  Shuto</span>  . </span><span class="cited-content_cbyCitation_article-title">Investigation of the Noncovalent Binding Mode of Covalent Proteasome Inhibitors around the Transition State by Combined Use of Cyclopropylic Strain-Based Conformational Restriction and Computational Modeling. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2013,</strong> <em>56 </em>
                                    (14)
                                     , 5829-5842. <a href="https://doi.org/10.1021/jm400542h" title="DOI URL">https://doi.org/10.1021/jm400542h</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm400542h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm400542h%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DInvestigation%252Bof%252Bthe%252BNoncovalent%252BBinding%252BMode%252Bof%252BCovalent%252BProteasome%252BInhibitors%252Baround%252Bthe%252BTransition%252BState%252Bby%252BCombined%252BUse%252Bof%252BCyclopropylic%252BStrain-Based%252BConformational%252BRestriction%252Band%252BComputational%252BModeling%26aulast%3DKawamura%26aufirst%3DShuhei%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D15042013%26date%3D09072013%26date%3D25072013%26date%3D25062013%26volume%3D56%26issue%3D14%26spage%3D5829%26epage%3D5842" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bo  Wen</span>, <span class="hlFld-ContribAuthor ">Joseph K.  Hexum</span>, <span class="hlFld-ContribAuthor ">John C.  Widen</span>, <span class="hlFld-ContribAuthor ">Daniel A.  Harki</span>, and <span class="hlFld-ContribAuthor ">Kay M.  Brummond</span>  . </span><span class="cited-content_cbyCitation_article-title">A Redox Economical Synthesis of Bioactive 6,12-Guaianolides. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2013,</strong> <em>15 </em>
                                    (11)
                                     , 2644-2647. <a href="https://doi.org/10.1021/ol400904y" title="DOI URL">https://doi.org/10.1021/ol400904y</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ol400904y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fol400904y%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DA%252BRedox%252BEconomical%252BSynthesis%252Bof%252BBioactive%252B6%25252C12-Guaianolides%26aulast%3DWen%26aufirst%3DBo%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D02042013%26date%3D10052013%26date%3D07062013%26volume%3D15%26issue%3D11%26spage%3D2644%26epage%3D2647" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christopher C.  Arico-Muendel</span>, <span class="hlFld-ContribAuthor ">Heather  Blanchette</span>, <span class="hlFld-ContribAuthor ">Dennis R.  Benjamin</span>, <span class="hlFld-ContribAuthor ">Teresa M.  Caiazzo</span>, <span class="hlFld-ContribAuthor ">Paolo A.  Centrella</span>, <span class="hlFld-ContribAuthor ">Jennifer  DeLorey</span>, <span class="hlFld-ContribAuthor ">Elisabeth G.  Doyle</span>, <span class="hlFld-ContribAuthor ">Steven R.  Johnson</span>, <span class="hlFld-ContribAuthor ">Matthew T.  Labenski</span>, <span class="hlFld-ContribAuthor ">Barry A.  Morgan</span>, <span class="hlFld-ContribAuthor ">Gary  O’Donovan</span>, <span class="hlFld-ContribAuthor ">Amy A.  Sarjeant</span>, <span class="hlFld-ContribAuthor ">Steven  Skinner</span>, <span class="hlFld-ContribAuthor ">Charles D.  Thompson</span>, <span class="hlFld-ContribAuthor ">Sarah T.  Griffin</span>, <span class="hlFld-ContribAuthor ">William  Westlin</span>, and <span class="hlFld-ContribAuthor ">Kerry F.  White</span>  . </span><span class="cited-content_cbyCitation_article-title">Orally Active Fumagillin Analogues: Transformations of a Reactive Warhead in the Gastric Environment. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2013,</strong> <em>4 </em>
                                    (4)
                                     , 381-386. <a href="https://doi.org/10.1021/ml3003633" title="DOI URL">https://doi.org/10.1021/ml3003633</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ml3003633&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fml3003633%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DOrally%252BActive%252BFumagillin%252BAnalogues%25253A%252BTransformations%252Bof%252Ba%252BReactive%252BWarhead%252Bin%252Bthe%252BGastric%252BEnvironment%26aulast%3DArico-Muendel%26aufirst%3DChristopher%2BC.%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D2012%26date%3D26102012%26date%3D22022013%26date%3D04032013%26date%3D11042013%26date%3D22022013%26volume%3D4%26issue%3D4%26spage%3D381%26epage%3D386" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rand M.  Miller</span>, <span class="hlFld-ContribAuthor ">Ville O.  Paavilainen</span>, <span class="hlFld-ContribAuthor ">Shyam  Krishnan</span>, <span class="hlFld-ContribAuthor ">Iana M.  Serafimova</span>, and <span class="hlFld-ContribAuthor ">Jack  Taunton</span>  . </span><span class="cited-content_cbyCitation_article-title">Electrophilic Fragment-Based Design of Reversible Covalent Kinase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of the American Chemical Society</span><span> <strong>2013,</strong> <em>135 </em>
                                    (14)
                                     , 5298-5301. <a href="https://doi.org/10.1021/ja401221b" title="DOI URL">https://doi.org/10.1021/ja401221b</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ja401221b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fja401221b%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520American%2520Chemical%2520Society%26atitle%3DElectrophilic%252BFragment-Based%252BDesign%252Bof%252BReversible%252BCovalent%252BKinase%252BInhibitors%26aulast%3DMiller%26aufirst%3DRand%2BM.%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D03022013%26date%3D29032013%26date%3D10042013%26volume%3D135%26issue%3D14%26spage%3D5298%26epage%3D5301" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrea D.  Thompson</span>, <span class="hlFld-ContribAuthor ">Amanda  Dugan</span>, <span class="hlFld-ContribAuthor ">Jason E.  Gestwicki</span>, and <span class="hlFld-ContribAuthor ">Anna K.  Mapp</span>  . </span><span class="cited-content_cbyCitation_article-title">Fine-Tuning Multiprotein Complexes Using Small Molecules. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Biology</span><span> <strong>2012,</strong> <em>7 </em>
                                    (8)
                                     , 1311-1320. <a href="https://doi.org/10.1021/cb300255p" title="DOI URL">https://doi.org/10.1021/cb300255p</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/cb300255p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fcb300255p%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Biology%26atitle%3DFine-Tuning%252BMultiprotein%252BComplexes%252BUsing%252BSmall%252BMolecules%26aulast%3DThompson%26aufirst%3DAndrea%2BD.%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D23052012%26date%3D23062012%26date%3D23072012%26date%3D17082012%26date%3D24062012%26volume%3D7%26issue%3D8%26spage%3D1311%26epage%3D1320" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tjeerd  Barf</span> and <span class="hlFld-ContribAuthor ">Allard  Kaptein</span>  . </span><span class="cited-content_cbyCitation_article-title">Irreversible Protein Kinase Inhibitors: Balancing the Benefits and Risks. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2012,</strong> <em>55 </em>
                                    (14)
                                     , 6243-6262. <a href="https://doi.org/10.1021/jm3003203" title="DOI URL">https://doi.org/10.1021/jm3003203</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm3003203&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm3003203%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DIrreversible%252BProtein%252BKinase%252BInhibitors%25253A%252BBalancing%252Bthe%252BBenefits%252Band%252BRisks%26aulast%3DBarf%26aufirst%3DTjeerd%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D07032012%26date%3D08062012%26date%3D26072012%26date%3D23052012%26volume%3D55%26issue%3D14%26spage%3D6243%26epage%3D6262" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yan  Lou</span>, <span class="hlFld-ContribAuthor ">Timothy D.  Owens</span>, <span class="hlFld-ContribAuthor ">Andreas  Kuglstatter</span>, <span class="hlFld-ContribAuthor ">Rama K.  Kondru</span>, and <span class="hlFld-ContribAuthor ">David M.  Goldstein</span>  . </span><span class="cited-content_cbyCitation_article-title">Bruton’s Tyrosine Kinase Inhibitors: Approaches to Potent and Selective Inhibition, Preclinical and Clinical Evaluation for Inflammatory Diseases and B Cell Malignancies. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2012,</strong> <em>55 </em>
                                    (10)
                                     , 4539-4550. <a href="https://doi.org/10.1021/jm300035p" title="DOI URL">https://doi.org/10.1021/jm300035p</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm300035p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm300035p%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DBruton%2525E2%252580%252599s%252BTyrosine%252BKinase%252BInhibitors%25253A%252BApproaches%252Bto%252BPotent%252Band%252BSelective%252BInhibition%25252C%252BPreclinical%252Band%252BClinical%252BEvaluation%252Bfor%252BInflammatory%252BDiseases%252Band%252BB%252BCell%252BMalignancies%26aulast%3DLou%26aufirst%3DYan%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D10012012%26date%3D21032012%26date%3D24052012%26date%3D06032012%26volume%3D55%26issue%3D10%26spage%3D4539%26epage%3D4550" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shaohua  Chang</span>, <span class="hlFld-ContribAuthor ">Lianwen  Zhang</span>, <span class="hlFld-ContribAuthor ">Shilin  Xu</span>, <span class="hlFld-ContribAuthor ">Jinfeng  Luo</span>, <span class="hlFld-ContribAuthor ">Xiaoyun  Lu</span>, <span class="hlFld-ContribAuthor ">Zhang  Zhang</span>, <span class="hlFld-ContribAuthor ">Tianfeng  Xu</span>, <span class="hlFld-ContribAuthor ">Yingxue  Liu</span>, <span class="hlFld-ContribAuthor ">Zhengchao  Tu</span>, <span class="hlFld-ContribAuthor ">Yong  Xu</span>, <span class="hlFld-ContribAuthor ">Xiaomei  Ren</span>, <span class="hlFld-ContribAuthor ">Meiyu  Geng</span>, <span class="hlFld-ContribAuthor ">Jian  Ding</span>, <span class="hlFld-ContribAuthor ">Duanqing  Pei</span>, and <span class="hlFld-ContribAuthor ">Ke  Ding</span>  . </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis, and Biological Evaluation of Novel Conformationally Constrained Inhibitors Targeting Epidermal Growth Factor Receptor Threonine790 → Methionine790 Mutant. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2012,</strong> <em>55 </em>
                                    (6)
                                     , 2711-2723. <a href="https://doi.org/10.1021/jm201591k" title="DOI URL">https://doi.org/10.1021/jm201591k</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm201591k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm201591k%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252BSynthesis%25252C%252Band%252BBiological%252BEvaluation%252Bof%252BNovel%252BConformationally%252BConstrained%252BInhibitors%252BTargeting%252BEpidermal%252BGrowth%252BFactor%252BReceptor%252BThreonine790%252B%2525E2%252586%252592%252BMethionine790%252BMutant%26aulast%3DChang%26aufirst%3DShaohua%26date%3D2012%26date%3D2012%26date%3D2011%26date%3D25112011%26date%3D01032012%26date%3D22032012%26date%3D16022012%26volume%3D55%26issue%3D6%26spage%3D2711%26epage%3D2723" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kevin X.  Chen</span>, <span class="hlFld-ContribAuthor ">Charles A.  Lesburg</span>, <span class="hlFld-ContribAuthor ">Bancha  Vibulbhan</span>, <span class="hlFld-ContribAuthor ">Weiying  Yang</span>, <span class="hlFld-ContribAuthor ">Tin-Yau  Chan</span>, <span class="hlFld-ContribAuthor ">Srikanth  Venkatraman</span>, <span class="hlFld-ContribAuthor ">Francisco  Velazquez</span>, <span class="hlFld-ContribAuthor ">Qingbei  Zeng</span>, <span class="hlFld-ContribAuthor ">Frank  Bennett</span>, <span class="hlFld-ContribAuthor ">Gopinadhan N.  Anilkumar</span>, <span class="hlFld-ContribAuthor ">Jose  Duca</span>, <span class="hlFld-ContribAuthor ">Yueheng  Jiang</span>, <span class="hlFld-ContribAuthor ">Patrick  Pinto</span>, <span class="hlFld-ContribAuthor ">Li  Wang</span>, <span class="hlFld-ContribAuthor ">Yuhua  Huang</span>, <span class="hlFld-ContribAuthor ">Oleg  Selyutin</span>, <span class="hlFld-ContribAuthor ">Stephen  Gavalas</span>, <span class="hlFld-ContribAuthor ">Haiyan  Pu</span>, <span class="hlFld-ContribAuthor ">Sony  Agrawal</span>, <span class="hlFld-ContribAuthor ">Boris  Feld</span>, <span class="hlFld-ContribAuthor ">Hsueh-Cheng  Huang</span>, <span class="hlFld-ContribAuthor ">Cheng  Li</span>, <span class="hlFld-ContribAuthor ">Kuo-Chi  Cheng</span>, <span class="hlFld-ContribAuthor ">Neng-Yang  Shih</span>, <span class="hlFld-ContribAuthor ">Joseph A.  Kozlowski</span>, <span class="hlFld-ContribAuthor ">Stuart B.  Rosenblum</span>, and <span class="hlFld-ContribAuthor ">F. George  Njoroge</span>  . </span><span class="cited-content_cbyCitation_article-title">A Novel Class of Highly Potent Irreversible Hepatitis C Virus NS5B Polymerase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2012,</strong> <em>55 </em>
                                    (5)
                                     , 2089-2101. <a href="https://doi.org/10.1021/jm201322r" title="DOI URL">https://doi.org/10.1021/jm201322r</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm201322r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm201322r%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DA%252BNovel%252BClass%252Bof%252BHighly%252BPotent%252BIrreversible%252BHepatitis%252BC%252BVirus%252BNS5B%252BPolymerase%252BInhibitors%26aulast%3DChen%26aufirst%3DKevin%2BX.%26date%3D2012%26date%3D2012%26date%3D2011%26date%3D03102011%26date%3D22022012%26date%3D08032012%26date%3D16012012%26volume%3D55%26issue%3D5%26spage%3D2089%26epage%3D2101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Francois  Grillet</span>, <span class="hlFld-ContribAuthor ">Chaofeng  Huang</span>, and <span class="hlFld-ContribAuthor ">Kay M.  Brummond</span>  . </span><span class="cited-content_cbyCitation_article-title">An Allenic Pauson–Khand Approach to 6,12-Guaianolides. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2011,</strong> <em>13 </em>
                                    (23)
                                     , 6304-6307. <a href="https://doi.org/10.1021/ol2028515" title="DOI URL">https://doi.org/10.1021/ol2028515</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ol2028515&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fol2028515%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DAn%252BAllenic%252BPauson%2525E2%252580%252593Khand%252BApproach%252Bto%252B6%25252C12-Guaianolides%26aulast%3DGrillet%26aufirst%3DFrancois%26date%3D2011%26date%3D2011%26date%3D2011%26date%3D22102011%26date%3D09112011%26date%3D02122011%26volume%3D13%26issue%3D23%26spage%3D6304%26epage%3D6307" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Agata  Krasowski</span>, <span class="hlFld-ContribAuthor ">Daniel  Muthas</span>, <span class="hlFld-ContribAuthor ">Aurijit  Sarkar</span>, <span class="hlFld-ContribAuthor ">Stefan  Schmitt</span>, and <span class="hlFld-ContribAuthor ">Ruth  Brenk</span>  . </span><span class="cited-content_cbyCitation_article-title">DrugPred: A Structure-Based Approach To Predict Protein Druggability Developed Using an Extensive Nonredundant Data Set. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2011,</strong> <em>51 </em>
                                    (11)
                                     , 2829-2842. <a href="https://doi.org/10.1021/ci200266d" title="DOI URL">https://doi.org/10.1021/ci200266d</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ci200266d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fci200266d%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DDrugPred%25253A%252BA%252BStructure-Based%252BApproach%252BTo%252BPredict%252BProtein%252BDruggability%252BDeveloped%252BUsing%252Ban%252BExtensive%252BNonredundant%252BData%252BSet%26aulast%3DKrasowski%26aufirst%3DAgata%26date%3D2011%26date%3D2011%26date%3D2011%26date%3D14062011%26date%3D13102011%26date%3D28112011%26volume%3D51%26issue%3D11%26spage%3D2829%26epage%3D2842" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Giulia  Palermo</span>, <span class="hlFld-ContribAuthor ">Davide  Branduardi</span>, <span class="hlFld-ContribAuthor ">Matteo  Masetti</span>, <span class="hlFld-ContribAuthor ">Alessio  Lodola</span>, <span class="hlFld-ContribAuthor ">Marco  Mor</span>, <span class="hlFld-ContribAuthor ">Daniele  Piomelli</span>, <span class="hlFld-ContribAuthor ">Andrea  Cavalli</span>, and <span class="hlFld-ContribAuthor ">Marco  De Vivo</span>  . </span><span class="cited-content_cbyCitation_article-title">Covalent Inhibitors of Fatty Acid Amide Hydrolase: A Rationale for the Activity of Piperidine and Piperazine Aryl Ureas. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2011,</strong> <em>54 </em>
                                    (19)
                                     , 6612-6623. <a href="https://doi.org/10.1021/jm2004283" title="DOI URL">https://doi.org/10.1021/jm2004283</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm2004283&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm2004283%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DCovalent%252BInhibitors%252Bof%252BFatty%252BAcid%252BAmide%252BHydrolase%25253A%252BA%252BRationale%252Bfor%252Bthe%252BActivity%252Bof%252BPiperidine%252Band%252BPiperazine%252BAryl%252BUreas%26aulast%3DPalermo%26aufirst%3DGiulia%26date%3D2011%26date%3D2011%26date%3D2011%26date%3D14042011%26date%3D08092011%26date%3D13102011%26date%3D11082011%26volume%3D54%26issue%3D19%26spage%3D6612%26epage%3D6623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maria Isabel  Montañez</span>, <span class="hlFld-ContribAuthor ">Cristobalina  Mayorga</span>, <span class="hlFld-ContribAuthor ">Maria Jose  Torres</span>, <span class="hlFld-ContribAuthor ">Adriana  Ariza</span>, <span class="hlFld-ContribAuthor ">Miguel  Blanca</span>, and <span class="hlFld-ContribAuthor ">Ezequiel  Perez-Inestrosa</span>  . </span><span class="cited-content_cbyCitation_article-title">Synthetic Approach to Gain Insight into Antigenic Determinants of Cephalosporins: In Vitro Studies of Chemical Structure−IgE Molecular Recognition Relationships. </span><span class="cited-content_cbyCitation_journal-name">Chemical Research in Toxicology</span><span> <strong>2011,</strong> <em>24 </em>
                                    (5)
                                     , 706-717. <a href="https://doi.org/10.1021/tx100446g" title="DOI URL">https://doi.org/10.1021/tx100446g</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/tx100446g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Ftx100446g%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Research%2520in%2520Toxicology%26atitle%3DSynthetic%252BApproach%252Bto%252BGain%252BInsight%252Binto%252BAntigenic%252BDeterminants%252Bof%252BCephalosporins%25253A%252BIn%252BVitro%252BStudies%252Bof%252BChemical%252BStructure%2525E2%252588%252592IgE%252BMolecular%252BRecognition%252BRelationships%26aulast%3DMonta%25C3%25B1ez%26aufirst%3DMaria%2BIsabel%26date%3D2011%26date%3D2011%26date%3D2010%26date%3D21122010%26date%3D31032011%26date%3D16052011%26date%3D22032011%26volume%3D24%26issue%3D5%26spage%3D706%26epage%3D717" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Falgun  Shah</span>, <span class="hlFld-ContribAuthor ">Prasenjit  Mukherjee</span>, <span class="hlFld-ContribAuthor ">Jiri  Gut</span>, <span class="hlFld-ContribAuthor ">Jennifer  Legac</span>, <span class="hlFld-ContribAuthor ">Philip J.  Rosenthal</span>, <span class="hlFld-ContribAuthor ">Babu L.  Tekwani</span>, and <span class="hlFld-ContribAuthor ">Mitchell A.  Avery</span>  . </span><span class="cited-content_cbyCitation_article-title">Identification of Novel Malarial Cysteine Protease Inhibitors Using Structure-Based Virtual Screening of a Focused Cysteine Protease Inhibitor Library. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2011,</strong> <em>51 </em>
                                    (4)
                                     , 852-864. <a href="https://doi.org/10.1021/ci200029y" title="DOI URL">https://doi.org/10.1021/ci200029y</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ci200029y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fci200029y%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DIdentification%252Bof%252BNovel%252BMalarial%252BCysteine%252BProtease%252BInhibitors%252BUsing%252BStructure-Based%252BVirtual%252BScreening%252Bof%252Ba%252BFocused%252BCysteine%252BProtease%252BInhibitor%252BLibrary%26aulast%3DShah%26aufirst%3DFalgun%26date%3D2011%26date%3D2011%26date%3D2010%26date%3D09112010%26date%3D23032011%26date%3D25042011%26volume%3D51%26issue%3D4%26spage%3D852%26epage%3D864" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Emeline  Leproult</span>, <span class="hlFld-ContribAuthor ">Sofia  Barluenga</span>, <span class="hlFld-ContribAuthor ">Dino  Moras</span>, <span class="hlFld-ContribAuthor ">Jean-Marie  Wurtz</span>, and <span class="hlFld-ContribAuthor ">Nicolas  Winssinger</span>  . </span><span class="cited-content_cbyCitation_article-title">Cysteine Mapping in Conformationally Distinct Kinase Nucleotide Binding Sites: Application to the Design of Selective Covalent Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2011,</strong> <em>54 </em>
                                    (5)
                                     , 1347-1355. <a href="https://doi.org/10.1021/jm101396q" title="DOI URL">https://doi.org/10.1021/jm101396q</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm101396q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm101396q%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DCysteine%252BMapping%252Bin%252BConformationally%252BDistinct%252BKinase%252BNucleotide%252BBinding%252BSites%25253A%252BApplication%252Bto%252Bthe%252BDesign%252Bof%252BSelective%252BCovalent%252BInhibitors%26aulast%3DLeproult%26aufirst%3DEmeline%26date%3D2011%26date%3D2011%26date%3D2010%26date%3D28102010%26date%3D15022011%26date%3D10032011%26volume%3D54%26issue%3D5%26spage%3D1347%26epage%3D1355" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yanzi  Zhou</span>, <span class="hlFld-ContribAuthor ">Shenglong  Wang</span> and <span class="hlFld-ContribAuthor ">Yingkai  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Catalytic Reaction Mechanism of Acetylcholinesterase Determined by Born−Oppenheimer Ab Initio QM/MM Molecular Dynamics Simulations. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Physical Chemistry B</span><span> <strong>2010,</strong> <em>114 </em>
                                    (26)
                                     , 8817-8825. <a href="https://doi.org/10.1021/jp104258d" title="DOI URL">https://doi.org/10.1021/jp104258d</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jp104258d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjp104258d%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Physical%2520Chemistry%2520B%26atitle%3DCatalytic%252BReaction%252BMechanism%252Bof%252BAcetylcholinesterase%252BDetermined%252Bby%252BBorn%2525E2%252588%252592Oppenheimer%252BAb%252BInitio%252BQM%25252FMM%252BMolecular%252BDynamics%252BSimulations%26aulast%3DZhou%26aufirst%3DYanzi%26date%3D2010%26date%3D2010%26date%3D2010%26date%3D2010%26date%3D10%252005%25202010%26date%3D2%252006%25202010%26date%3D15062010%26date%3D08072010%26volume%3D114%26issue%3D26%26spage%3D8817%26epage%3D8825" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Janice  Lawandi</span>, <span class="hlFld-ContribAuthor ">Sandrine  Gerber-Lemaire</span>, <span class="hlFld-ContribAuthor ">Lucienne  Juillerat-Jeanneret</span> and <span class="hlFld-ContribAuthor ">Nicolas  Moitessier</span>  . </span><span class="cited-content_cbyCitation_article-title">Inhibitors of Prolyl Oligopeptidases for the Therapy of Human Diseases: Defining Diseases and Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2010,</strong> <em>53 </em>
                                    (9)
                                     , 3423-3438. <a href="https://doi.org/10.1021/jm901104g" title="DOI URL">https://doi.org/10.1021/jm901104g</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm901104g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm901104g%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DInhibitors%252Bof%252BProlyl%252BOligopeptidases%252Bfor%252Bthe%252BTherapy%252Bof%252BHuman%252BDiseases%25253A%252BDefining%252BDiseases%252Band%252BInhibitors%26aulast%3DLawandi%26aufirst%3DJanice%26date%3D2010%26date%3D2010%26date%3D2009%26date%3D24072009%26date%3D08012010%26date%3D13052010%26volume%3D53%26issue%3D9%26spage%3D3423%26epage%3D3438" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Caterina  Carmi</span>, <span class="hlFld-ContribAuthor ">Andrea  Cavazzoni</span>, <span class="hlFld-ContribAuthor ">Stefano  Vezzosi</span>, <span class="hlFld-ContribAuthor ">Fabrizio  Bordi</span>, <span class="hlFld-ContribAuthor ">Federica  Vacondio</span>, <span class="hlFld-ContribAuthor ">Claudia  Silva</span>, <span class="hlFld-ContribAuthor ">Silvia  Rivara</span>, <span class="hlFld-ContribAuthor ">Alessio  Lodola</span>, <span class="hlFld-ContribAuthor ">Roberta R.  Alfieri</span>, <span class="hlFld-ContribAuthor ">Silvia  La Monica</span>, <span class="hlFld-ContribAuthor ">Maricla  Galetti</span>, <span class="hlFld-ContribAuthor ">Andrea  Ardizzoni</span>, <span class="hlFld-ContribAuthor ">Pier Giorgio  Petronini</span> and <span class="hlFld-ContribAuthor ">Marco  Mor</span>  . </span><span class="cited-content_cbyCitation_article-title">Novel Irreversible Epidermal Growth Factor Receptor Inhibitors by Chemical Modulation of the Cysteine-Trap Portion. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2010,</strong> <em>53 </em>
                                    (5)
                                     , 2038-2050. <a href="https://doi.org/10.1021/jm901558p" title="DOI URL">https://doi.org/10.1021/jm901558p</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm901558p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm901558p%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNovel%252BIrreversible%252BEpidermal%252BGrowth%252BFactor%252BReceptor%252BInhibitors%252Bby%252BChemical%252BModulation%252Bof%252Bthe%252BCysteine-Trap%252BPortion%26aulast%3DCarmi%26aufirst%3DCaterina%26date%3D2010%26date%3D2010%26date%3D2009%26date%3D21102009%26date%3D12022010%26date%3D11032010%26volume%3D53%26issue%3D5%26spage%3D2038%26epage%3D2050" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Peng-Yu  Yang</span>, <span class="hlFld-ContribAuthor ">Kai  Liu</span>, <span class="hlFld-ContribAuthor ">Mun Hong  Ngai</span>, <span class="hlFld-ContribAuthor ">Martin J.  Lear</span>, <span class="hlFld-ContribAuthor ">Markus R.  Wenk</span> and <span class="hlFld-ContribAuthor ">Shao Q.  Yao</span>  . </span><span class="cited-content_cbyCitation_article-title">Activity-Based Proteome Profiling of Potential Cellular Targets of Orlistat − An FDA-Approved Drug with Anti-Tumor Activities. </span><span class="cited-content_cbyCitation_journal-name">Journal of the American Chemical Society</span><span> <strong>2010,</strong> <em>132 </em>
                                    (2)
                                     , 656-666. <a href="https://doi.org/10.1021/ja907716f" title="DOI URL">https://doi.org/10.1021/ja907716f</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ja907716f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fja907716f%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520American%2520Chemical%2520Society%26atitle%3DActivity-Based%252BProteome%252BProfiling%252Bof%252BPotential%252BCellular%252BTargets%252Bof%252BOrlistat%252B%2525E2%252588%252592%252BAn%252BFDA-Approved%252BDrug%252Bwith%252BAnti-Tumor%252BActivities%26aulast%3DYang%26aufirst%3DPeng-Yu%26date%3D2010%26date%3D2009%26date%3D2009%26date%3D10%252009%25202009%26date%3D22122009%26date%3D20012010%26volume%3D132%26issue%3D2%26spage%3D656%26epage%3D666" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Cheng  Zhang</span>, <span class="hlFld-ContribAuthor ">Hu  Yue</span>, <span class="hlFld-ContribAuthor ">Ping  Sun</span>, <span class="hlFld-ContribAuthor ">Lei  Hua</span>, <span class="hlFld-ContribAuthor ">Shuli  Liang</span>, <span class="hlFld-ContribAuthor ">Yitao  Ou</span>, <span class="hlFld-ContribAuthor ">Dan  Wu</span>, <span class="hlFld-ContribAuthor ">Xinyi  Wu</span>, <span class="hlFld-ContribAuthor ">Hao  Chen</span>, <span class="hlFld-ContribAuthor ">Ying  Hao</span>, <span class="hlFld-ContribAuthor ">Wenhui  Hu</span>, <span class="hlFld-ContribAuthor ">Zhongjin  Yang</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of chalcone analogues as novel NLRP3 inflammasome inhibitors with potent anti-inflammation activities. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>219 </em>, 113417. <a href="https://doi.org/10.1016/j.ejmech.2021.113417" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113417</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113417&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113417%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bchalcone%252Banalogues%252Bas%252Bnovel%252BNLRP3%252Binflammasome%252Binhibitors%252Bwith%252Bpotent%252Banti-inflammation%252Bactivities%26aulast%3DZhang%26aufirst%3DCheng%26date%3D2021%26volume%3D219%26spage%3D113417" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Thomas D.  Meek</span>. </span><span class="cited-content_cbyCitation_article-title">Enzymes as Drug Targets. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 1-51. <a href="https://doi.org/10.1002/0471266949.bmc260" title="DOI URL">https://doi.org/10.1002/0471266949.bmc260</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/0471266949.bmc260&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F0471266949.bmc260%26sid%3Dliteratum%253Aachs%26atitle%3DEnzymes%252Bas%252BDrug%252BTargets%26aulast%3DMeek%26aufirst%3DThomas%2BD.%26date%3D2021%26date%3D2021%26spage%3D1%26epage%3D51%26pub%3DWiley%26atitle%3DBurger%252527s%252BMedicinal%252BChemistry%252Band%252BDrug%252BDiscovery%26aulast%3DAbraham%26aufirst%3DDonald%2BJ.%26date%3D2003%26date%3D2003%26volume%3D21" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Li  Li</span>, <span class="hlFld-ContribAuthor ">Nannan  Chen</span>, <span class="hlFld-ContribAuthor ">Dandan  Xia</span>, <span class="hlFld-ContribAuthor ">Shicheng  Xu</span>, <span class="hlFld-ContribAuthor ">Wei  Dai</span>, <span class="hlFld-ContribAuthor ">Yuanyuan  Tong</span>, <span class="hlFld-ContribAuthor ">Lei  Wang</span>, <span class="hlFld-ContribAuthor ">Zhengyu  Jiang</span>, <span class="hlFld-ContribAuthor ">Qidong  You</span>, <span class="hlFld-ContribAuthor ">Xiaoli  Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of a covalent inhibitor of heat shock protein 90 with antitumor activity that blocks the co-chaperone binding via C-terminal modification. </span><span class="cited-content_cbyCitation_journal-name">Cell Chemical Biology</span><span> <strong>2021,</strong> <em>104 </em><a href="https://doi.org/10.1016/j.chembiol.2021.03.016" title="DOI URL">https://doi.org/10.1016/j.chembiol.2021.03.016</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.chembiol.2021.03.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.chembiol.2021.03.016%26sid%3Dliteratum%253Aachs%26jtitle%3DCell%2520Chemical%2520Biology%26atitle%3DDiscovery%252Bof%252Ba%252Bcovalent%252Binhibitor%252Bof%252Bheat%252Bshock%252Bprotein%252B90%252Bwith%252Bantitumor%252Bactivity%252Bthat%252Bblocks%252Bthe%252Bco-chaperone%252Bbinding%252Bvia%252BC-terminal%252Bmodification%26aulast%3DLi%26aufirst%3DLi%26date%3D2021%26volume%3D104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Thomas A.  Baillie</span>. </span><span class="cited-content_cbyCitation_article-title">Approaches to mitigate the risk of serious adverse reactions in covalent drug design. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Drug Discovery</span><span> <strong>2021,</strong> <em>16 </em>
                                    (3)
                                     , 275-287. <a href="https://doi.org/10.1080/17460441.2021.1832079" title="DOI URL">https://doi.org/10.1080/17460441.2021.1832079</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/17460441.2021.1832079&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F17460441.2021.1832079%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Drug%2520Discovery%26atitle%3DApproaches%252Bto%252Bmitigate%252Bthe%252Brisk%252Bof%252Bserious%252Badverse%252Breactions%252Bin%252Bcovalent%252Bdrug%252Bdesign%26aulast%3DBaillie%26aufirst%3DThomas%2BA.%26date%3D2021%26date%3D2020%26volume%3D16%26issue%3D3%26spage%3D275%26epage%3D287" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hongyan  Du</span>, <span class="hlFld-ContribAuthor ">Junbo  Gao</span>, <span class="hlFld-ContribAuthor ">Gaoqi  Weng</span>, <span class="hlFld-ContribAuthor ">Junjie  Ding</span>, <span class="hlFld-ContribAuthor ">Xin  Chai</span>, <span class="hlFld-ContribAuthor ">Jinping  Pang</span>, <span class="hlFld-ContribAuthor ">Yu  Kang</span>, <span class="hlFld-ContribAuthor ">Dan  Li</span>, <span class="hlFld-ContribAuthor ">Dongsheng  Cao</span>, <span class="hlFld-ContribAuthor ">Tingjun  Hou</span>. </span><span class="cited-content_cbyCitation_article-title">CovalentInDB: a comprehensive database facilitating the discovery of covalent inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Nucleic Acids Research</span><span> <strong>2021,</strong> <em>49 </em>
                                    (D1)
                                     , D1122-D1129. <a href="https://doi.org/10.1093/nar/gkaa876" title="DOI URL">https://doi.org/10.1093/nar/gkaa876</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1093/nar/gkaa876&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1093%2Fnar%2Fgkaa876%26sid%3Dliteratum%253Aachs%26jtitle%3DNucleic%2520Acids%2520Research%26atitle%3DCovalentInDB%25253A%252Ba%252Bcomprehensive%252Bdatabase%252Bfacilitating%252Bthe%252Bdiscovery%252Bof%252Bcovalent%252Binhibitors%26aulast%3DDu%26aufirst%3DHongyan%26date%3D2021%26date%3D2020%26volume%3D49%26issue%3DD1%26spage%3DD1122%26epage%3DD1129" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Viktoriya Y.  Berdan</span>, <span class="hlFld-ContribAuthor ">Paul C.  Klauser</span>, <span class="hlFld-ContribAuthor ">Lei  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Covalent peptides and proteins for therapeutics. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2021,</strong> <em>29 </em>, 115896. <a href="https://doi.org/10.1016/j.bmc.2020.115896" title="DOI URL">https://doi.org/10.1016/j.bmc.2020.115896</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2020.115896&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2020.115896%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DCovalent%252Bpeptides%252Band%252Bproteins%252Bfor%252Btherapeutics%26aulast%3DBerdan%26aufirst%3DViktoriya%2BY.%26date%3D2021%26volume%3D29%26spage%3D115896" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yuka  Otsuka</span>, <span class="hlFld-ContribAuthor ">Michael V.  Airola</span>, <span class="hlFld-ContribAuthor ">Yong-Mi  Choi</span>, <span class="hlFld-ContribAuthor ">Nicolas  Coant</span>, <span class="hlFld-ContribAuthor ">Justin  Snider</span>, <span class="hlFld-ContribAuthor ">Chris  Cariello</span>, <span class="hlFld-ContribAuthor ">Essa M.  Saied</span>, <span class="hlFld-ContribAuthor ">Christoph  Arenz</span>, <span class="hlFld-ContribAuthor ">Thomas  Bannister</span>, <span class="hlFld-ContribAuthor ">Ron  Rahaim</span>, <span class="hlFld-ContribAuthor ">Yusuf A.  Hannun</span>, <span class="hlFld-ContribAuthor ">Justin  Shumate</span>, <span class="hlFld-ContribAuthor ">Louis  Scampavia</span>, <span class="hlFld-ContribAuthor ">John D.  Haley</span>, <span class="hlFld-ContribAuthor ">Timothy P.  Spicer</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of Small-Molecule Inhibitors of Neutral Ceramidase (nCDase) via Target-Based High-Throughput Screening. </span><span class="cited-content_cbyCitation_journal-name">SLAS DISCOVERY: Advancing the Science of Drug Discovery</span><span> <strong>2021,</strong> <em>26 </em>
                                    (1)
                                     , 113-121. <a href="https://doi.org/10.1177/2472555220945283" title="DOI URL">https://doi.org/10.1177/2472555220945283</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1177/2472555220945283&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1177%2F2472555220945283%26sid%3Dliteratum%253Aachs%26jtitle%3DSLAS%2520DISCOVERY%253A%2520Advancing%2520the%2520Science%2520of%2520Drug%2520Discovery%26atitle%3DIdentification%252Bof%252BSmall-Molecule%252BInhibitors%252Bof%252BNeutral%252BCeramidase%252B%252528nCDase%252529%252Bvia%252BTarget-Based%252BHigh-Throughput%252BScreening%26aulast%3DOtsuka%26aufirst%3DYuka%26date%3D2021%26date%3D2020%26volume%3D26%26issue%3D1%26spage%3D113%26epage%3D121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Elena De  Vita</span>. </span><span class="cited-content_cbyCitation_article-title">10 years into the resurgence of covalent drugs. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2021,</strong> <em>13 </em>
                                    (2)
                                     , 193-210. <a href="https://doi.org/10.4155/fmc-2020-0236" title="DOI URL">https://doi.org/10.4155/fmc-2020-0236</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc-2020-0236&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc-2020-0236%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3D10%252Byears%252Binto%252Bthe%252Bresurgence%252Bof%252Bcovalent%252Bdrugs%26aulast%3DVita%26aufirst%3DElena%2BDe%26date%3D2021%26volume%3D13%26issue%3D2%26spage%3D193%26epage%3D210" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sako  Mirzaie</span>, <span class="hlFld-ContribAuthor ">Fatemeh  Abdi</span>, <span class="hlFld-ContribAuthor ">Amin  GhavamiNejad</span>, <span class="hlFld-ContribAuthor ">Brian  Lu</span>, <span class="hlFld-ContribAuthor ">Xiao Yu  Wu</span>. </span><span class="cited-content_cbyCitation_article-title">Covalent Antiviral Agents. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 285-312. <a href="https://doi.org/10.1007/978-981-16-0267-2_11" title="DOI URL">https://doi.org/10.1007/978-981-16-0267-2_11</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-981-16-0267-2_11&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-981-16-0267-2_11%26sid%3Dliteratum%253Aachs%26atitle%3DCovalent%252BAntiviral%252BAgents%26aulast%3DMirzaie%26aufirst%3DSako%26date%3D2021%26date%3D2021%26spage%3D285%26epage%3D312%26pub%3DSpringer%2520Singapore%26atitle%3DAntiviral%252BDrug%252BDiscovery%252Band%252BDevelopment%26aulast%3DLiu%26aufirst%3DXinyong%26date%3D2021%26volume%3D1322" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Barr  Tivon</span>, <span class="hlFld-ContribAuthor ">Ronen  Gabizon</span>, <span class="hlFld-ContribAuthor ">Bente A.  Somsen</span>, <span class="hlFld-ContribAuthor ">Peter J.  Cossar</span>, <span class="hlFld-ContribAuthor ">Christian  Ottmann</span>, <span class="hlFld-ContribAuthor ">Nir  London</span>. </span><span class="cited-content_cbyCitation_article-title">Covalent flexible peptide docking in Rosetta. </span><span class="cited-content_cbyCitation_journal-name">Chemical Science</span><span> <strong>2021,</strong> <em>1 </em><a href="https://doi.org/10.1039/D1SC02322E" title="DOI URL">https://doi.org/10.1039/D1SC02322E</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D1SC02322E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD1SC02322E%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Science%26atitle%3DCovalent%252Bflexible%252Bpeptide%252Bdocking%252Bin%252BRosetta%26aulast%3DTivon%26aufirst%3DBarr%26date%3D2021%26date%3D2021%26volume%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">William  Doherty</span>, <span class="hlFld-ContribAuthor ">Nikoletta  Adler</span>, <span class="hlFld-ContribAuthor ">Thomas J.  Butler</span>, <span class="hlFld-ContribAuthor ">Andrew J.S.  Knox</span>, <span class="hlFld-ContribAuthor ">Paul  Evans</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and optimisation of P3 substituted vinyl sulfone-based inhibitors as anti-trypanosomal agents. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2020,</strong> <em>28 </em>
                                    (23)
                                     , 115774. <a href="https://doi.org/10.1016/j.bmc.2020.115774" title="DOI URL">https://doi.org/10.1016/j.bmc.2020.115774</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2020.115774&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2020.115774%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Boptimisation%252Bof%252BP3%252Bsubstituted%252Bvinyl%252Bsulfone-based%252Binhibitors%252Bas%252Banti-trypanosomal%252Bagents%26aulast%3DDoherty%26aufirst%3DWilliam%26date%3D2020%26volume%3D28%26issue%3D23%26spage%3D115774" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrea  Galbiati</span>, <span class="hlFld-ContribAuthor ">Aureliano  Zana</span>, <span class="hlFld-ContribAuthor ">Paola  Conti</span>. </span><span class="cited-content_cbyCitation_article-title">Covalent inhibitors of GAPDH: From unspecific warheads to selective compounds. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>207 </em>, 112740. <a href="https://doi.org/10.1016/j.ejmech.2020.112740" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112740</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112740&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112740%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DCovalent%252Binhibitors%252Bof%252BGAPDH%25253A%252BFrom%252Bunspecific%252Bwarheads%252Bto%252Bselective%252Bcompounds%26aulast%3DGalbiati%26aufirst%3DAndrea%26date%3D2020%26volume%3D207%26spage%3D112740" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yun-Dong  Fu</span>, <span class="hlFld-ContribAuthor ">Ming-Jie  Huang</span>, <span class="hlFld-ContribAuthor ">Jia-Wen  Guo</span>, <span class="hlFld-ContribAuthor ">Ya-Zhen  You</span>, <span class="hlFld-ContribAuthor ">Hong-Min  Liu</span>, <span class="hlFld-ContribAuthor ">Li-Hua  Huang</span>, <span class="hlFld-ContribAuthor ">Bin  Yu</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting histone demethylase KDM5B for cancer treatment. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>208 </em>, 112760. <a href="https://doi.org/10.1016/j.ejmech.2020.112760" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112760</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112760&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112760%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DTargeting%252Bhistone%252Bdemethylase%252BKDM5B%252Bfor%252Bcancer%252Btreatment%26aulast%3DFu%26aufirst%3DYun-Dong%26date%3D2020%26volume%3D208%26spage%3D112760" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chizuru  Miura</span>, <span class="hlFld-ContribAuthor ">Naoya  Shindo</span>, <span class="hlFld-ContribAuthor ">Kei  Okamoto</span>, <span class="hlFld-ContribAuthor ">Keiko  Kuwata</span>, <span class="hlFld-ContribAuthor ">Akio  Ojida</span>. </span><span class="cited-content_cbyCitation_article-title">Fragment-Based Discovery of Irreversible Covalent Inhibitors of Cysteine Proteases Using Chlorofluoroacetamide Library. </span><span class="cited-content_cbyCitation_journal-name">Chemical and Pharmaceutical Bulletin</span><span> <strong>2020,</strong> <em>68 </em>
                                    (11)
                                     , 1074-1081. <a href="https://doi.org/10.1248/cpb.c20-00547" title="DOI URL">https://doi.org/10.1248/cpb.c20-00547</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1248/cpb.c20-00547&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1248%2Fcpb.c20-00547%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520and%2520Pharmaceutical%2520Bulletin%26atitle%3DFragment-Based%252BDiscovery%252Bof%252BIrreversible%252BCovalent%252BInhibitors%252Bof%252BCysteine%252BProteases%252BUsing%252BChlorofluoroacetamide%252BLibrary%26aulast%3DMiura%26aufirst%3DChizuru%26date%3D2020%26volume%3D68%26issue%3D11%26spage%3D1074%26epage%3D1081" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yuemin  Bian</span>, <span class="hlFld-ContribAuthor ">Jaden Jungho  Jun</span>, <span class="hlFld-ContribAuthor ">Jacob  Cuyler</span>, <span class="hlFld-ContribAuthor ">Xiang-Qun  Xie</span>. </span><span class="cited-content_cbyCitation_article-title">Covalent allosteric modulation: An emerging strategy for GPCRs drug discovery. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>206 </em>, 112690. <a href="https://doi.org/10.1016/j.ejmech.2020.112690" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112690</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112690&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112690%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DCovalent%252Ballosteric%252Bmodulation%25253A%252BAn%252Bemerging%252Bstrategy%252Bfor%252BGPCRs%252Bdrug%252Bdiscovery%26aulast%3DBian%26aufirst%3DYuemin%26date%3D2020%26volume%3D206%26spage%3D112690" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Victor  Carramiñana</span>, <span class="hlFld-ContribAuthor ">Ana M.  Ochoa de Retana</span>, <span class="hlFld-ContribAuthor ">Francisco  Palacios</span>, <span class="hlFld-ContribAuthor ">Jesús M.  de los Santos</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of α-Aminophosphonic Acid Derivatives Through the Addition of O- and S-Nucleophiles to 2H-Azirines and Their Antiproliferative Effect on A549 Human Lung Adenocarcinoma Cells. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2020,</strong> <em>25 </em>
                                    (15)
                                     , 3332. <a href="https://doi.org/10.3390/molecules25153332" title="DOI URL">https://doi.org/10.3390/molecules25153332</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules25153332&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules25153332%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DSynthesis%252Bof%252B%2525CE%2525B1-Aminophosphonic%252BAcid%252BDerivatives%252BThrough%252Bthe%252BAddition%252Bof%252BO-%252Band%252BS-Nucleophiles%252Bto%252B2H-Azirines%252Band%252BTheir%252BAntiproliferative%252BEffect%252Bon%252BA549%252BHuman%252BLung%252BAdenocarcinoma%252BCells%26aulast%3DCarrami%25C3%25B1ana%26aufirst%3DVictor%26date%3D2020%26date%3D2020%26volume%3D25%26issue%3D15%26spage%3D3332" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Thomas A.  Baillie</span>. </span><span class="cited-content_cbyCitation_article-title">Drug–protein adducts: past, present, and future. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Chemistry Research</span><span> <strong>2020,</strong> <em>29 </em>
                                    (7)
                                     , 1093-1104. <a href="https://doi.org/10.1007/s00044-020-02567-8" title="DOI URL">https://doi.org/10.1007/s00044-020-02567-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00044-020-02567-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00044-020-02567-8%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Chemistry%2520Research%26atitle%3DDrug%2525E2%252580%252593protein%252Badducts%25253A%252Bpast%25252C%252Bpresent%25252C%252Band%252Bfuture%26aulast%3DBaillie%26aufirst%3DThomas%2BA.%26date%3D2020%26date%3D2020%26volume%3D29%26issue%3D7%26spage%3D1093%26epage%3D1104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Aaron  Keeley</span>, <span class="hlFld-ContribAuthor ">László  Petri</span>, <span class="hlFld-ContribAuthor ">Péter  Ábrányi-Balogh</span>, <span class="hlFld-ContribAuthor ">György M.  Keserű</span>. </span><span class="cited-content_cbyCitation_article-title">Covalent fragment libraries in drug discovery. </span><span class="cited-content_cbyCitation_journal-name">Drug Discovery Today</span><span> <strong>2020,</strong> <em>25 </em>
                                    (6)
                                     , 983-996. <a href="https://doi.org/10.1016/j.drudis.2020.03.016" title="DOI URL">https://doi.org/10.1016/j.drudis.2020.03.016</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.drudis.2020.03.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.drudis.2020.03.016%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Discovery%2520Today%26atitle%3DCovalent%252Bfragment%252Blibraries%252Bin%252Bdrug%252Bdiscovery%26aulast%3DKeeley%26aufirst%3DAaron%26date%3D2020%26volume%3D25%26issue%3D6%26spage%3D983%26epage%3D996" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lorna  Conway</span>, <span class="hlFld-ContribAuthor ">Anna  Riccio</span>, <span class="hlFld-ContribAuthor ">M. Gabriella  Santoro</span>, <span class="hlFld-ContribAuthor ">Paul  Evans</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of the 4-aza cyclopentenone analogue of Δ12,14-15-deoxy-PGJ2 and S-cysteine adducts. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2020,</strong> <em>61 </em>
                                    (25)
                                     , 151969. <a href="https://doi.org/10.1016/j.tetlet.2020.151969" title="DOI URL">https://doi.org/10.1016/j.tetlet.2020.151969</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2020.151969&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2020.151969%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DSynthesis%252Bof%252Bthe%252B4-aza%252Bcyclopentenone%252Banalogue%252Bof%252B%2525CE%25259412%25252C14-15-deoxy-PGJ2%252Band%252BS-cysteine%252Badducts%26aulast%3DConway%26aufirst%3DLorna%26date%3D2020%26volume%3D61%26issue%3D25%26spage%3D151969" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ayah  Abdeldayem</span>, <span class="hlFld-ContribAuthor ">Yasir S.  Raouf</span>, <span class="hlFld-ContribAuthor ">Stefan N.  Constantinescu</span>, <span class="hlFld-ContribAuthor ">Richard  Moriggl</span>, <span class="hlFld-ContribAuthor ">Patrick T.  Gunning</span>. </span><span class="cited-content_cbyCitation_article-title">Advances in covalent kinase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Chemical Society Reviews</span><span> <strong>2020,</strong> <em>49 </em>
                                    (9)
                                     , 2617-2687. <a href="https://doi.org/10.1039/C9CS00720B" title="DOI URL">https://doi.org/10.1039/C9CS00720B</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9CS00720B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9CS00720B%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Society%2520Reviews%26atitle%3DAdvances%252Bin%252Bcovalent%252Bkinase%252Binhibitors%26aulast%3DAbdeldayem%26aufirst%3DAyah%26date%3D2020%26date%3D2020%26volume%3D49%26issue%3D9%26spage%3D2617%26epage%3D2687" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Philipp  Klein</span>, <span class="hlFld-ContribAuthor ">Fabian  Barthels</span>, <span class="hlFld-ContribAuthor ">Patrick  Johe</span>, <span class="hlFld-ContribAuthor ">Annika  Wagner</span>, <span class="hlFld-ContribAuthor ">Stefan  Tenzer</span>, <span class="hlFld-ContribAuthor ">Ute  Distler</span>, <span class="hlFld-ContribAuthor ">Thien Anh  Le</span>, <span class="hlFld-ContribAuthor ">Paul  Schmid</span>, <span class="hlFld-ContribAuthor ">Volker  Engel</span>, <span class="hlFld-ContribAuthor ">Bernd  Engels</span>, <span class="hlFld-ContribAuthor ">Ute A.  Hellmich</span>, <span class="hlFld-ContribAuthor ">Till  Opatz</span>, <span class="hlFld-ContribAuthor ">Tanja  Schirmeister</span>. </span><span class="cited-content_cbyCitation_article-title">Naphthoquinones as Covalent Reversible Inhibitors of Cysteine Proteases—Studies on Inhibition Mechanism and Kinetics. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2020,</strong> <em>25 </em>
                                    (9)
                                     , 2064. <a href="https://doi.org/10.3390/molecules25092064" title="DOI URL">https://doi.org/10.3390/molecules25092064</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules25092064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules25092064%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DNaphthoquinones%252Bas%252BCovalent%252BReversible%252BInhibitors%252Bof%252BCysteine%252BProteases%2525E2%252580%252594Studies%252Bon%252BInhibition%252BMechanism%252Band%252BKinetics%26aulast%3DKlein%26aufirst%3DPhilipp%26date%3D2020%26date%3D2020%26volume%3D25%26issue%3D9%26spage%3D2064" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Samuel E.  Dalton</span>, <span class="hlFld-ContribAuthor ">Sebastien  Campos</span>. </span><span class="cited-content_cbyCitation_article-title">Covalent Small Molecules as Enabling Platforms for Drug Discovery. </span><span class="cited-content_cbyCitation_journal-name">ChemBioChem</span><span> <strong>2020,</strong> <em>21 </em>
                                    (8)
                                     , 1080-1100. <a href="https://doi.org/10.1002/cbic.201900674" title="DOI URL">https://doi.org/10.1002/cbic.201900674</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cbic.201900674&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcbic.201900674%26sid%3Dliteratum%253Aachs%26jtitle%3DChemBioChem%26atitle%3DCovalent%252BSmall%252BMolecules%252Bas%252BEnabling%252BPlatforms%252Bfor%252BDrug%252BDiscovery%26aulast%3DDalton%26aufirst%3DSamuel%2BE.%26date%3D2020%26date%3D2020%26volume%3D21%26issue%3D8%26spage%3D1080%26epage%3D1100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Philipp  Klein</span>, <span class="hlFld-ContribAuthor ">Patrick  Johe</span>, <span class="hlFld-ContribAuthor ">Annika  Wagner</span>, <span class="hlFld-ContribAuthor ">Sascha  Jung</span>, <span class="hlFld-ContribAuthor ">Jonas  Kühlborn</span>, <span class="hlFld-ContribAuthor ">Fabian  Barthels</span>, <span class="hlFld-ContribAuthor ">Stefan  Tenzer</span>, <span class="hlFld-ContribAuthor ">Ute  Distler</span>, <span class="hlFld-ContribAuthor ">Waldemar  Waigel</span>, <span class="hlFld-ContribAuthor ">Bernd  Engels</span>, <span class="hlFld-ContribAuthor ">Ute A.  Hellmich</span>, <span class="hlFld-ContribAuthor ">Till  Opatz</span>, <span class="hlFld-ContribAuthor ">Tanja  Schirmeister</span>. </span><span class="cited-content_cbyCitation_article-title">New Cysteine Protease Inhibitors: Electrophilic (Het)arenes and Unexpected Prodrug Identification for the Trypanosoma Protease Rhodesain. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2020,</strong> <em>25 </em>
                                    (6)
                                     , 1451. <a href="https://doi.org/10.3390/molecules25061451" title="DOI URL">https://doi.org/10.3390/molecules25061451</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules25061451&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules25061451%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DNew%252BCysteine%252BProtease%252BInhibitors%25253A%252BElectrophilic%252B%252528Het%252529arenes%252Band%252BUnexpected%252BProdrug%252BIdentification%252Bfor%252Bthe%252BTrypanosoma%252BProtease%252BRhodesain%26aulast%3DKlein%26aufirst%3DPhilipp%26date%3D2020%26date%3D2020%26volume%3D25%26issue%3D6%26spage%3D1451" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ernest  Awoonor‐Williams</span>, <span class="hlFld-ContribAuthor ">William C.  Isley</span>, <span class="hlFld-ContribAuthor ">Stephen G.  Dale</span>, <span class="hlFld-ContribAuthor ">Erin R.  Johnson</span>, <span class="hlFld-ContribAuthor ">Haibo  Yu</span>, <span class="hlFld-ContribAuthor ">Axel D.  Becke</span>, <span class="hlFld-ContribAuthor ">Benoît  Roux</span>, <span class="hlFld-ContribAuthor ">Christopher N.  Rowley</span>. </span><span class="cited-content_cbyCitation_article-title">Quantum Chemical Methods for Modeling Covalent Modification of Biological Thiols. </span><span class="cited-content_cbyCitation_journal-name">Journal of Computational Chemistry</span><span> <strong>2020,</strong> <em>41 </em>
                                    (5)
                                     , 427-438. <a href="https://doi.org/10.1002/jcc.26064" title="DOI URL">https://doi.org/10.1002/jcc.26064</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jcc.26064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjcc.26064%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Computational%2520Chemistry%26atitle%3DQuantum%252BChemical%252BMethods%252Bfor%252BModeling%252BCovalent%252BModification%252Bof%252BBiological%252BThiols%26aulast%3DAwoonor%25E2%2580%2590Williams%26aufirst%3DErnest%26date%3D2020%26date%3D2019%26volume%3D41%26issue%3D5%26spage%3D427%26epage%3D438" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bo  Sun</span>, <span class="hlFld-ContribAuthor ">Xiaowen  Liu</span>, <span class="hlFld-ContribAuthor ">Xu  Zheng</span>, <span class="hlFld-ContribAuthor ">Changyuan  Wang</span>, <span class="hlFld-ContribAuthor ">Qiang  Meng</span>, <span class="hlFld-ContribAuthor ">Huijun  Sun</span>, <span class="hlFld-ContribAuthor ">Xiaohong  Shu</span>, <span class="hlFld-ContribAuthor ">Kexin  Liu</span>, <span class="hlFld-ContribAuthor ">Xiuli  Sun</span>, <span class="hlFld-ContribAuthor ">Yanxia  Li</span>, <span class="hlFld-ContribAuthor ">Xiaodong  Ma</span>. </span><span class="cited-content_cbyCitation_article-title">Novel Pyrimidines as Multitarget Protein Tyrosine Kinase Inhibitors for the Treatment of Idiopathic Pulmonary Fibrosis (IPF). </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2020,</strong> <em>15 </em>
                                    (2)
                                     , 182-187. <a href="https://doi.org/10.1002/cmdc.201900606" title="DOI URL">https://doi.org/10.1002/cmdc.201900606</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201900606&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201900606%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DNovel%252BPyrimidines%252Bas%252BMultitarget%252BProtein%252BTyrosine%252BKinase%252BInhibitors%252Bfor%252Bthe%252BTreatment%252Bof%252BIdiopathic%252BPulmonary%252BFibrosis%252B%252528IPF%252529%26aulast%3DSun%26aufirst%3DBo%26date%3D2020%26date%3D2019%26volume%3D15%26issue%3D2%26spage%3D182%26epage%3D187" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mauro  Angiolini</span>. </span><span class="cited-content_cbyCitation_article-title">The Role of Structural Biology in Kinase Inhibitor Drug Discovery Success. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 363-393. <a href="https://doi.org/10.1002/9781118681121.ch16" title="DOI URL">https://doi.org/10.1002/9781118681121.ch16</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9781118681121.ch16&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9781118681121.ch16%26sid%3Dliteratum%253Aachs%26atitle%3DThe%252BRole%252Bof%252BStructural%252BBiology%252Bin%252BKinase%252BInhibitor%252BDrug%252BDiscovery%252BSuccess%26aulast%3DAngiolini%26aufirst%3DMauro%26date%3D2020%26date%3D2020%26spage%3D363%26epage%3D393%26pub%3DWiley%26atitle%3DStructural%252BBiology%252Bin%252BDrug%252BDiscovery%26aulast%3DRenaud%26aufirst%3DJean%25E2%2580%2590Paul%26date%3D2020%26date%3D2020%26volume%3D39" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Victor  Carramiñana</span>, <span class="hlFld-ContribAuthor ">Ana M.  Ochoa de Retana</span>, <span class="hlFld-ContribAuthor ">Jesús M.  de los Santos</span>, <span class="hlFld-ContribAuthor ">Francisco  Palacios</span>. </span><span class="cited-content_cbyCitation_article-title">First synthesis of merged hybrids phosphorylated azirino[2,1-b]benzo[e][1,3]oxazine derivatives as anticancer agents. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>185 </em>, 111771. <a href="https://doi.org/10.1016/j.ejmech.2019.111771" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.111771</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.111771&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.111771%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DFirst%252Bsynthesis%252Bof%252Bmerged%252Bhybrids%252Bphosphorylated%252Bazirino%25255B2%25252C1-b%25255Dbenzo%25255Be%25255D%25255B1%25252C3%25255Doxazine%252Bderivatives%252Bas%252Banticancer%252Bagents%26aulast%3DCarrami%25C3%25B1ana%26aufirst%3DVictor%26date%3D2020%26volume%3D185%26spage%3D111771" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mahsa  Toolabi</span>, <span class="hlFld-ContribAuthor ">Setareh  Moghimi</span>, <span class="hlFld-ContribAuthor ">Tayebeh Oghabi  Bakhshaiesh</span>, <span class="hlFld-ContribAuthor ">Somayeh  Salarinejad</span>, <span class="hlFld-ContribAuthor ">Ayoub  Aghcheli</span>, <span class="hlFld-ContribAuthor ">Zaman  Hasanvand</span>, <span class="hlFld-ContribAuthor ">Elahe  Nazeri</span>, <span class="hlFld-ContribAuthor ">Ali  Khalaj</span>, <span class="hlFld-ContribAuthor ">Rezvan  Esmaeili</span>, <span class="hlFld-ContribAuthor ">Alireza  Foroumadi</span>. </span><span class="cited-content_cbyCitation_article-title">6-Cinnamoyl-4-arylaminothienopyrimidines as highly potent cytotoxic agents: Design, synthesis and structure-activity relationship studies. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>185 </em>, 111786. <a href="https://doi.org/10.1016/j.ejmech.2019.111786" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.111786</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.111786&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.111786%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3D6-Cinnamoyl-4-arylaminothienopyrimidines%252Bas%252Bhighly%252Bpotent%252Bcytotoxic%252Bagents%25253A%252BDesign%25252C%252Bsynthesis%252Band%252Bstructure-activity%252Brelationship%252Bstudies%26aulast%3DToolabi%26aufirst%3DMahsa%26date%3D2020%26volume%3D185%26spage%3D111786" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sravani  Sana</span>, <span class="hlFld-ContribAuthor ">Ramya  Tokala</span>, <span class="hlFld-ContribAuthor ">Deepti Madanlal  Bajaj</span>, <span class="hlFld-ContribAuthor ">Narayana  Nagesh</span>, <span class="hlFld-ContribAuthor ">Kiran Kumar  Bokara</span>, <span class="hlFld-ContribAuthor ">Gaddam  Kiranmai</span>, <span class="hlFld-ContribAuthor ">Uppu Jaya  Lakshmi</span>, <span class="hlFld-ContribAuthor ">Swapna  Vadlamani</span>, <span class="hlFld-ContribAuthor ">Venu  Talla</span>, <span class="hlFld-ContribAuthor ">Nagula  Shankaraiah</span>. </span><span class="cited-content_cbyCitation_article-title">Design and synthesis of substituted dihydropyrimidinone derivatives as cytotoxic and tubulin polymerization inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2019,</strong> <em>93 </em>, 103317. <a href="https://doi.org/10.1016/j.bioorg.2019.103317" title="DOI URL">https://doi.org/10.1016/j.bioorg.2019.103317</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2019.103317&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2019.103317%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DDesign%252Band%252Bsynthesis%252Bof%252Bsubstituted%252Bdihydropyrimidinone%252Bderivatives%252Bas%252Bcytotoxic%252Band%252Btubulin%252Bpolymerization%252Binhibitors%26aulast%3DSana%26aufirst%3DSravani%26date%3D2019%26volume%3D93%26spage%3D103317" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daniel Nascimento  do Amaral</span>, <span class="hlFld-ContribAuthor ">Jonas  Lategahn</span>, <span class="hlFld-ContribAuthor ">Harold Hilarion  Fokoue</span>, <span class="hlFld-ContribAuthor ">Eduardo Miguez Bastos  da Silva</span>, <span class="hlFld-ContribAuthor ">Carlos Mauricio R.  Sant’Anna</span>, <span class="hlFld-ContribAuthor ">Daniel  Rauh</span>, <span class="hlFld-ContribAuthor ">Eliezer J.  Barreiro</span>, <span class="hlFld-ContribAuthor ">Stefan  Laufer</span>, <span class="hlFld-ContribAuthor ">Lidia Moreira  Lima</span>. </span><span class="cited-content_cbyCitation_article-title">A novel scaffold for EGFR inhibition: Introducing N-(3-(3-phenylureido)quinoxalin-6-yl) acrylamide derivatives. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2019,</strong> <em>9 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41598-018-36846-7" title="DOI URL">https://doi.org/10.1038/s41598-018-36846-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41598-018-36846-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41598-018-36846-7%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DA%252Bnovel%252Bscaffold%252Bfor%252BEGFR%252Binhibition%25253A%252BIntroducing%252BN-%2525283-%2525283-phenylureido%252529quinoxalin-6-yl%252529%252Bacrylamide%252Bderivatives%26aulast%3Ddo%2BAmaral%26aufirst%3DDaniel%2BNascimento%26date%3D2019%26date%3D2019%26volume%3D9%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vincent S.  Shaw</span>, <span class="hlFld-ContribAuthor ">Mohammadjavad  Mohammadi</span>, <span class="hlFld-ContribAuthor ">Josiah A.  Quinn</span>, <span class="hlFld-ContribAuthor ">Harish  Vashisth</span>, <span class="hlFld-ContribAuthor ">Richard R.  Neubig</span>. </span><span class="cited-content_cbyCitation_article-title">An Interhelical Salt Bridge Controls Flexibility and Inhibitor Potency for Regulators of G-protein Signaling Proteins 4, 8, and 19. </span><span class="cited-content_cbyCitation_journal-name">Molecular Pharmacology</span><span> <strong>2019,</strong> <em>96 </em>
                                    (6)
                                     , 683-691. <a href="https://doi.org/10.1124/mol.119.117176" title="DOI URL">https://doi.org/10.1124/mol.119.117176</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1124/mol.119.117176&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1124%2Fmol.119.117176%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Pharmacology%26atitle%3DAn%252BInterhelical%252BSalt%252BBridge%252BControls%252BFlexibility%252Band%252BInhibitor%252BPotency%252Bfor%252BRegulators%252Bof%252BG-protein%252BSignaling%252BProteins%252B4%25252C%252B8%25252C%252Band%252B19%26aulast%3DShaw%26aufirst%3DVincent%2BS.%26date%3D2019%26date%3D2019%26volume%3D96%26issue%3D6%26spage%3D683%26epage%3D691" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mariafrancesca  Scalise</span>, <span class="hlFld-ContribAuthor ">Lara  Console</span>, <span class="hlFld-ContribAuthor ">Michele  Galluccio</span>, <span class="hlFld-ContribAuthor ">Lorena  Pochini</span>, <span class="hlFld-ContribAuthor ">Annamaria  Tonazzi</span>, <span class="hlFld-ContribAuthor ">Nicola  Giangregorio</span>, <span class="hlFld-ContribAuthor ">Cesare  Indiveri</span>. </span><span class="cited-content_cbyCitation_article-title">Exploiting Cysteine Residues of SLC Membrane Transporters as Targets for Drugs. </span><span class="cited-content_cbyCitation_journal-name">SLAS DISCOVERY: Advancing the Science of Drug Discovery</span><span> <strong>2019,</strong> <em>24 </em>
                                    (9)
                                     , 867-881. <a href="https://doi.org/10.1177/2472555219856601" title="DOI URL">https://doi.org/10.1177/2472555219856601</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1177/2472555219856601&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1177%2F2472555219856601%26sid%3Dliteratum%253Aachs%26jtitle%3DSLAS%2520DISCOVERY%253A%2520Advancing%2520the%2520Science%2520of%2520Drug%2520Discovery%26atitle%3DExploiting%252BCysteine%252BResidues%252Bof%252BSLC%252BMembrane%252BTransporters%252Bas%252BTargets%252Bfor%252BDrugs%26aulast%3DScalise%26aufirst%3DMariafrancesca%26date%3D2019%26date%3D2019%26volume%3D24%26issue%3D9%26spage%3D867%26epage%3D881" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kristine  Senkane</span>, <span class="hlFld-ContribAuthor ">Ekaterina V.  Vinogradova</span>, <span class="hlFld-ContribAuthor ">Radu M.  Suciu</span>, <span class="hlFld-ContribAuthor ">Vincent M.  Crowley</span>, <span class="hlFld-ContribAuthor ">Balyn W.  Zaro</span>, <span class="hlFld-ContribAuthor ">J. Michael  Bradshaw</span>, <span class="hlFld-ContribAuthor ">Ken A.  Brameld</span>, <span class="hlFld-ContribAuthor ">Benjamin F.  Cravatt</span>. </span><span class="cited-content_cbyCitation_article-title">The Proteome‐Wide Potential for Reversible Covalency at Cysteine. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie International Edition</span><span> <strong>2019,</strong> <em>58 </em>
                                    (33)
                                     , 11385-11389. <a href="https://doi.org/10.1002/anie.201905829" title="DOI URL">https://doi.org/10.1002/anie.201905829</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/anie.201905829&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fanie.201905829%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%2520International%2520Edition%26atitle%3DThe%252BProteome%2525E2%252580%252590Wide%252BPotential%252Bfor%252BReversible%252BCovalency%252Bat%252BCysteine%26aulast%3DSenkane%26aufirst%3DKristine%26date%3D2019%26volume%3D58%26issue%3D33%26spage%3D11385%26epage%3D11389" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div><a href="#" data-source="/pb/widgets/cited-by?doi=10.1021%2Fjm8008597&amp;widgetId=9cf770f4-a9a2-46e0-bd29-3da15bcf4ae0&amp;pbContext=%3Barticle%3Aarticle%3A10.1021%2Fjm8008597%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2009.52.issue-5%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text&amp;citedByCount=250&amp;pagesCount=3&amp;pageNumber=2" title="Load more citations" class="button_primary float-right cited-by__see-more mb-5"><i aria-hidden="”true”" class="icon-angle-double-down"></i><span>Load more citations</span></a></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="fig1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/medium/jm-2008-008597_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/large/jm-2008-008597_0003.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Postulated mechanism for drug hypersensitivity reactions. This pathway can be achieved by either a reactive parent compound or a metabolite.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/large/jm-2008-008597_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8008597&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/medium/jm-2008-008597_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/large/jm-2008-008597_0004.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Chemical structures of the compounds described in Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>. Structures in green indicate prodrugs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/large/jm-2008-008597_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8008597&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/medium/jm-2008-008597_0021.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/large/jm-2008-008597_0021.jpeg" id="rightTab-gs1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Depiction of the Reversible Inhibition of Triacylglycerol Lipase by Orlistat<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/large/jm-2008-008597_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8008597&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>The catalytic triad (Asp176, His263, and Ser152) is also illustrated.</p></p></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/medium/jm-2008-008597_0022.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/large/jm-2008-008597_0022.jpeg" id="rightTab-gs2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Depiction of the Acylation of Serine-Type <span class="smallcaps smallerCapital">d</span>-Ala-<span class="smallcaps smallerCapital">d</span>-ala Carboxypeptidase by Amoxicillin</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/large/jm-2008-008597_0022.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8008597&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/medium/jm-2008-008597_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/large/jm-2008-008597_0005.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Examples of some β-lactam inhibitors of serine-type <span class="smallcaps smallerCapital">d</span>-ala-<span class="smallcaps smallerCapital">d</span>-ala carboxypeptidase.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/large/jm-2008-008597_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8008597&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/medium/jm-2008-008597_0023.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/large/jm-2008-008597_0023.jpeg" id="rightTab-gs3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Depiction of the Acylation of β-Lactamase by Clavulanate</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/large/jm-2008-008597_0023.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8008597&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/medium/jm-2008-008597_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/large/jm-2008-008597_0006.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Examples of some β-lactam inhibitors of β-lactamase.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/large/jm-2008-008597_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8008597&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/medium/jm-2008-008597_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/large/jm-2008-008597_0007.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Covalent and competitive AChE inhibitors used to treat Alzheimer’s disease.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/large/jm-2008-008597_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8008597&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/medium/jm-2008-008597_0024.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/large/jm-2008-008597_0024.jpeg" id="rightTab-gs4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Proposed Mechanism for the Inhibition of Vitamin K Epoxide Reductase by Warfarin</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/large/jm-2008-008597_0024.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8008597&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch5" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/medium/jm-2008-008597_0025.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/large/jm-2008-008597_0025.jpeg" id="rightTab-gs5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Proposed Mechanism for Formation of the Isoniazid−NADP Adduct</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/large/jm-2008-008597_0025.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8008597&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch6" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/medium/jm-2008-008597_0026.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/large/jm-2008-008597_0026.jpeg" id="rightTab-gs6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Inhibition of Aldehyde Dehydrogenase by Disulfiram</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/large/jm-2008-008597_0026.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8008597&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch7" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/medium/jm-2008-008597_0027.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/large/jm-2008-008597_0027.jpeg" id="rightTab-gs7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 7. Mechanism for Formation of the PLP−Cycloserine Adduct <b>14</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/large/jm-2008-008597_0027.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8008597&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch8" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Scheme 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/medium/jm-2008-008597_0028.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/large/jm-2008-008597_0028.jpeg" id="rightTab-gs8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 8. Proposed Mechanism of Adduct Formation of Vigabatrin with PLP</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/large/jm-2008-008597_0028.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8008597&amp;id=sch8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch9" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Scheme 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/medium/jm-2008-008597_0029.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/large/jm-2008-008597_0029.jpeg" id="rightTab-gs9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 9. Inhibition of Aromatase by the Endogenous Ligand Androstenedione</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/large/jm-2008-008597_0029.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8008597&amp;id=sch9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/medium/jm-2008-008597_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/large/jm-2008-008597_0008.jpeg" id="rightTab-gr16" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Representation of the binding of bortezomib (shown in blue) in the active site of yeast 20S proteaseome. Hydrogen bonds are indicated by the dashed lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/large/jm-2008-008597_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8008597&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/medium/jm-2008-008597_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/large/jm-2008-008597_0009.jpeg" id="rightTab-gr17" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. H<sup>+</sup>/K<sup>+</sup> ATPase inhibitors omeprazole <b>1n</b>, esomeprazole, and lansoprazole.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/large/jm-2008-008597_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8008597&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch10" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Scheme 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/medium/jm-2008-008597_0030.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/large/jm-2008-008597_0030.jpeg" id="rightTab-gs10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 10. Inhibition of H<sup>+</sup>/K<sup>+</sup> ATPase by Omeprazole</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/large/jm-2008-008597_0030.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8008597&amp;id=sch10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch11" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Scheme 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/medium/jm-2008-008597_0031.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/large/jm-2008-008597_0031.jpeg" id="rightTab-gs11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 11. Proposed Mechanism of Clopidogrel Inhibition of P2Y<sub>12</sub> Purinoceptor</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/large/jm-2008-008597_0031.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8008597&amp;id=sch11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/medium/jm-2008-008597_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/large/jm-2008-008597_0010.jpeg" id="rightTab-gr20" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Thyroxine 5′-deiodinase−PTU adduct.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/large/jm-2008-008597_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8008597&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="19" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/medium/jm-2008-008597_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/large/jm-2008-008597_0011.jpeg" id="rightTab-gr21" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Proposed <b>1q</b>−protein hemiketal adduct.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/large/jm-2008-008597_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8008597&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig10" data-index="20" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/medium/jm-2008-008597_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/large/jm-2008-008597_0012.jpeg" id="rightTab-gr22" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Ribonucleoside diphosphate reductase inhibitors gemcitabine (<b>1r)</b>, cladribine, and fludarabine.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/large/jm-2008-008597_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8008597&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch12" data-index="21" class="article__inlineFigure"><h2 class="fig-label">Scheme 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/medium/jm-2008-008597_0032.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/large/jm-2008-008597_0032.jpeg" id="rightTab-gs12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 12. Proposed Mechanism for the Inhibition of Ribonucleoside Diphosphate Reductase by Gemcitabine</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/large/jm-2008-008597_0032.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8008597&amp;id=sch12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig11" data-index="22" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/medium/jm-2008-008597_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/large/jm-2008-008597_0013.jpeg" id="rightTab-gr24" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Thymidylate synthase inhibitors floxuridine <b>1s</b>, capecitabine, and fluorouracil.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/large/jm-2008-008597_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8008597&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch13" data-index="23" class="article__inlineFigure"><h2 class="fig-label">Scheme 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/medium/jm-2008-008597_0033.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/large/jm-2008-008597_0033.jpeg" id="rightTab-gs13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 13. Proposed Inhibition of Thymidylate Synthase by Floxuridine<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/large/jm-2008-008597_0033.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8008597&amp;id=sch13"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>CH<sub>2</sub>FAH<sub>4</sub> denotes the cofactor 5,10-CH<sub>2</sub>FAH<sub>4</sub>.</p></p></figure><figure data-id="fig12" data-index="24" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/medium/jm-2008-008597_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/large/jm-2008-008597_0014.jpeg" id="rightTab-gr26" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. Schematic representation of the key interactions in the proposed binding model of <b>1t</b> (shown in blue) bound to EGFR. Bonding distances (Å) are indicated by the dotted lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/large/jm-2008-008597_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8008597&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig13" data-index="25" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/medium/jm-2008-008597_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/large/jm-2008-008597_0015.jpeg" id="rightTab-gr27" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. EGFR inhibitors gefitinib and erlotinib and ErbB2 inhibitor lapatinib.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/large/jm-2008-008597_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8008597&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig14" data-index="26" class="article__inlineFigure"><h2 class="fig-label">Figure 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/medium/jm-2008-008597_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/large/jm-2008-008597_0016.jpeg" id="rightTab-gr28" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 14. 5-α-Reductase inhibitors finasteride (<b>1u</b>) and dutasteride.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/large/jm-2008-008597_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8008597&amp;id=fig14"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch14" data-index="27" class="article__inlineFigure"><h2 class="fig-label">Scheme 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/medium/jm-2008-008597_0034.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/large/jm-2008-008597_0034.jpeg" id="rightTab-gs14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 14. Proposed Mechanism of Inhibition of 5-α-Reductase by Finasteride<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/large/jm-2008-008597_0034.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8008597&amp;id=sch14"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>PADRP = phosphoadenosine diphosphoribose.</p></p></figure><figure data-id="fig15" data-index="28" class="article__inlineFigure"><h2 class="fig-label">Figure 15</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/medium/jm-2008-008597_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/large/jm-2008-008597_0017.jpeg" id="rightTab-gr30" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 15. MAO-B inhibitors selegiline <b>1v</b> and rasagiline used to treat Alzheimer’s disease.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/large/jm-2008-008597_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8008597&amp;id=fig15"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch15" data-index="29" class="article__inlineFigure"><h2 class="fig-label">Scheme 15</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/medium/jm-2008-008597_0035.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/large/jm-2008-008597_0035.jpeg" id="rightTab-gs15" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 15. One of the Proposed Mechanisms for Formation of the FAD−Selegiline Adduct (Bound through N5 of the Isolloxazone Moiety)<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/large/jm-2008-008597_0035.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8008597&amp;id=sch15"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>MAO-F indicates the MAO−flavin moiety.</p></p></figure><figure data-id="fig16" data-index="30" class="article__inlineFigure"><h2 class="fig-label">Figure 16</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/medium/jm-2008-008597_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/large/jm-2008-008597_0018.jpeg" id="rightTab-gr32" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 16. DPP-IV inhibitors vildagliptin (<b>1w</b>), saxagliptin, and sitagliptin.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/large/jm-2008-008597_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8008597&amp;id=fig16"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig17" data-index="31" class="article__inlineFigure"><h2 class="fig-label">Figure 17</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/medium/jm-2008-008597_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/large/jm-2008-008597_0019.jpeg" id="rightTab-gr33" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 17. Representation of the crystal structure of a pyrrolidine nitrile bound to DPP-IV. It is predicted that vildagliptin and other pyrollidine nitriles bind in a similar fashion.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/large/jm-2008-008597_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8008597&amp;id=fig17"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig18" data-index="32" class="article__inlineFigure"><h2 class="fig-label">Figure 18</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/medium/jm-2008-008597_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/large/jm-2008-008597_0020.jpeg" id="rightTab-gr34" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 18. Schematic representation of the binding mode of a related Cat K inhibitor, shown in blue (based on the crystal structure). Hydrogen bonds are indicated by dotted lines, and values are given in angstrom.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/large/jm-2008-008597_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8008597&amp;id=fig18"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="cht1" data-index="33" class="article__inlineFigure"><h2 class="fig-label">Chart 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/medium/jm-2008-008597_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/large/jm-2008-008597_0001.jpeg" id="rightTab-gc1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 1. Graphical Representation of the Diversity of Target Types</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/large/jm-2008-008597_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8008597&amp;id=cht1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="cht2" data-index="34" class="article__inlineFigure"><h2 class="fig-label">Chart 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/medium/jm-2008-008597_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/large/jm-2008-008597_0002.jpeg" id="rightTab-gc2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 2. Breakdown of Protein Functionality Modified by Covalent Drug</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-5/jm8008597/production/images/large/jm-2008-008597_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8008597&amp;id=cht2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i61">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_45776" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_45776" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 72 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Evans, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watt, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicoll-Griffith, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baillie, T. A.</span><span> </span><span class="NLM_article-title">Drug−Protein Adducts. An Industry Perspective on Minimizing the Potential for Drug Bioactivation in Drug Discovery and Development</span> <span class="citation_source-journal">Chem. Res. Toxocol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">3</span><span class="NLM_x">–</span> <span class="NLM_lpage">16</span></span><div class="citationLinks">[<a href="/doi/10.1021/tx034170b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=32&amp;doi=10.1021%2Fjm8008597&amp;key=1%3ACAS%3A528%3ADC%252BD3sXps1ymtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2004&pages=3-16&author=D.+C.+Evansauthor=A.+P.+Wattauthor=D.+A.+Nicoll-Griffithauthor=T.+A.+Baillie&title=Drug%E2%88%92Protein+Adducts.+An+Industry+Perspective+on+Minimizing+the+Potential+for+Drug+Bioactivation+in+Drug+Discovery+and+Development"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1aR"><div class="casContent"><span class="casTitleNuber">1a</span><div class="casTitle"><span class="NLM_cas:atitle">Drug-Protein Adducts: An Industry Perspective on Minimizing the Potential for Drug Bioactivation in Drug Discovery and Development</span></div><div class="casAuthors">Evans, David C.; Watt, Alan P.; Nicoll-Griffith, Deborah A.; Baillie, Thomas A.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">3-16</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  It is generally accepted that there is neither a well-defined nor a consistent link between the formation of drug-protein adducts and organ toxicity.  Because the potential does exist, however, for these processes to be causally related, the general strategy at Merck Research Labs. has been to minimize reactive metabolite formation to the extent possible by appropriate structural modification during the lead optimization stage.  This requires a flexible approach to defining bioactivation issues in a variety of metab. vectors and typically involves the initial use of small mol. trapping agents to define the potential for bioactivation.  At some point, however, there is a requirement to synthesize a radiolabeled tracer and to undertake covalent binding studies in vitro, usually in liver microsomal (and sometimes hepatocyte) prepns. from preclin. species and human, and also in vivo, typically in the rat.  This paper serves to provide one pragmatic approach to addressing the issue of bioactivation from an industry viewpoint based on protocols adopted by Merck Research Labs.  The availability of a dedicated Labeled Compd. Synthesis group, coupled to a close working relationship between Drug Metab. and Medicinal Chem., represents a framework within which this perspective becomes viable; the overall aim is to bring safer drugs to patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOsPmSgJDD8rVg90H21EOLACvtfcHk0lijxB1CBZ1uFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXps1ymtbg%253D&md5=9ab130c5462b2245e2f4c783afb01d1d</span></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=10.1021%2Ftx034170b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx034170b%26sid%3Dliteratum%253Aachs%26aulast%3DEvans%26aufirst%3DD.%2BC.%26aulast%3DWatt%26aufirst%3DA.%2BP.%26aulast%3DNicoll-Griffith%26aufirst%3DD.%2BA.%26aulast%3DBaillie%26aufirst%3DT.%2BA.%26atitle%3DDrug%25E2%2588%2592Protein%2520Adducts.%2520An%2520Industry%2520Perspective%2520on%2520Minimizing%2520the%2520Potential%2520for%2520Drug%2520Bioactivation%2520in%2520Drug%2520Discovery%2520and%2520Development%26jtitle%3DChem.%2520Res.%2520Toxocol.%26date%3D2004%26volume%3D17%26spage%3D3%26epage%3D16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit1b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Kalgutkar, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardner, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Obach, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaffer, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Callegari, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henne, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mutlib, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dalvie, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Donnel, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harriman, S. P.</span><span> </span><span class="NLM_article-title">A Comprehensive Listing of Bioactivation Pathways of Organic Functional Groups</span> <span class="citation_source-journal">Curr. Drug Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">161</span><span class="NLM_x">–</span> <span class="NLM_lpage">225</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=16&amp;doi=10.1021%2Fjm8008597&amp;key=10.2174%2F1389200054021799" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=8&amp;doi=10.1021%2Fjm8008597&amp;key=15975040" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=32&amp;doi=10.1021%2Fjm8008597&amp;key=1%3ACAS%3A528%3ADC%252BD2MXkvF2is7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2005&pages=161-225&author=A.+S.+Kalgutkarauthor=I.+Gardnerauthor=R.+S.+Obachauthor=C.+L.+Shafferauthor=E.+Callegariauthor=K.+R.+Henneauthor=A.+E.+Mutlibauthor=D.+K.+Dalvieauthor=J.+S.+Leeauthor=Y.+Nakaiauthor=J.+P.+O%E2%80%99Donnelauthor=J.+Boerauthor=S.+P.+Harriman&title=A+Comprehensive+Listing+of+Bioactivation+Pathways+of+Organic+Functional+Groups"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1bR"><div class="casContent"><span class="casTitleNuber">1b</span><div class="casTitle"><span class="NLM_cas:atitle">A comprehensive listing of bioactivation pathways of organic functional groups</span></div><div class="casAuthors">Kalgutkar, Amit S.; Gardner, Iain; Obach, R. Scott; Shaffer, Christopher L.; Callegari, Ernesto; Henne, Kirk R.; Mutlib, Abdul E.; Dalvie, Deepak K.; Lee, Jae S.; Nakai, Yasuhiro; O'Donnell, John P.; Boer, Jason; Harriman, Shawn P.</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Metabolism</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">161-225</span>CODEN:
                <span class="NLM_cas:coden">CDMUBU</span>;
        ISSN:<span class="NLM_cas:issn">1389-2002</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The occurrence of idiosyncratic adverse drug reactions during late clin. trials or after a drug has been released can lead to a severe restriction in its use and even in its withdrawal.  Metabolic activation of relatively inert functional groups to reactive electrophilic intermediates is considered to be an obligatory event in the etiol. of many drug-induced adverse reactions.  Therefore, a thorough examn. of the biochem. reactivity of functional groups/structural motifs in all new drug candidates is essential from a safety standpoint.  A major theme attempted in this review is the comprehensive cataloging of all of the known bioactivation pathways of functional groups or structural motifs commonly utilized in drug design efforts.  Potential strategies in the detection of reactive intermediates in biochem. systems are also discussed.  The intention of this review is not to "black list" functional groups or to immediately discard compds. based on their potential to form reactive metabolites, but rather to serve as a resource describing the structural diversity of these functionalities as well as exptl. approaches that could be taken to evaluate whether a "structural alert" in a new drug candidate undergoes bioactivation to reactive metabolites.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOVj7cmxfwXrVg90H21EOLACvtfcHk0lijxB1CBZ1uFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXkvF2is7k%253D&md5=b16dfc2de97c40a11218ecc3043bed66</span></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=10.2174%2F1389200054021799&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1389200054021799%26sid%3Dliteratum%253Aachs%26aulast%3DKalgutkar%26aufirst%3DA.%2BS.%26aulast%3DGardner%26aufirst%3DI.%26aulast%3DObach%26aufirst%3DR.%2BS.%26aulast%3DShaffer%26aufirst%3DC.%2BL.%26aulast%3DCallegari%26aufirst%3DE.%26aulast%3DHenne%26aufirst%3DK.%2BR.%26aulast%3DMutlib%26aufirst%3DA.%2BE.%26aulast%3DDalvie%26aufirst%3DD.%2BK.%26aulast%3DLee%26aufirst%3DJ.%2BS.%26aulast%3DNakai%26aufirst%3DY.%26aulast%3DO%25E2%2580%2599Donnel%26aufirst%3DJ.%2BP.%26aulast%3DBoer%26aufirst%3DJ.%26aulast%3DHarriman%26aufirst%3DS.%2BP.%26atitle%3DA%2520Comprehensive%2520Listing%2520of%2520Bioactivation%2520Pathways%2520of%2520Organic%2520Functional%2520Groups%26jtitle%3DCurr.%2520Drug%2520Metab.%26date%3D2005%26volume%3D6%26spage%3D161%26epage%3D225" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit1c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Liebler, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guengerich, F. P.</span><span> </span><span class="NLM_article-title">Elucidating Mechanisms of Drug-Induced Toxicity</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">410</span><span class="NLM_x">–</span> <span class="NLM_lpage">420</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=16&amp;doi=10.1021%2Fjm8008597&amp;key=10.1038%2Fnrd1720" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=8&amp;doi=10.1021%2Fjm8008597&amp;key=15864270" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=32&amp;doi=10.1021%2Fjm8008597&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjs1OktL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2005&pages=410-420&author=D.+C.+Lieblerauthor=F.+P.+Guengerich&title=Elucidating+Mechanisms+of+Drug-Induced+Toxicity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1cR"><div class="casContent"><span class="casTitleNuber">1c</span><div class="casTitle"><span class="NLM_cas:atitle">Elucidating mechanisms of drug-induced toxicity</span></div><div class="casAuthors">Liebler, Daniel C.; Guengerich, F. Peter</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">410-420</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The early and high-throughput application of assays for non-genetic toxicity is of great interest to the pharmaceutical industry, although few systems have been validated as being of good predictive value.  New technologies could enable toxicity to be studied in the context of systems biol.  An important factor to be considered is the metab. of drugs to reactive intermediates.  Chem. reactions of these with cell and tissue nucleophiles are relatively well understood, but predicting how biol. modifications will affect signaling and regulatory networks remains a challenge.  Some of these pathways could be useful as sentinels for toxicity.  This article will cover some examples of drug toxicity and the prospects for future technol. development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAyrioYqM9jLVg90H21EOLACvtfcHk0lijxB1CBZ1uFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjs1OktL0%253D&md5=3339fb52b3c68682033ad0334de15cae</span></div><a href="/servlet/linkout?suffix=cit1c&amp;dbid=16384&amp;doi=10.1038%2Fnrd1720&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd1720%26sid%3Dliteratum%253Aachs%26aulast%3DLiebler%26aufirst%3DD.%2BC.%26aulast%3DGuengerich%26aufirst%3DF.%2BP.%26atitle%3DElucidating%2520Mechanisms%2520of%2520Drug-Induced%2520Toxicity%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2005%26volume%3D4%26spage%3D410%26epage%3D420" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit1d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Wiliams, D. P.</span><span> </span><span class="NLM_article-title">Toxicophores: Investigations in Drug Safety</span> <span class="citation_source-journal">Toxicology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">226</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">11</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=226&publication_year=2006&pages=1-11&author=D.+P.+Wiliams&title=Toxicophores%3A+Investigations+in+Drug+Safety"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWiliams%26aufirst%3DD.%2BP.%26atitle%3DToxicophores%253A%2520Investigations%2520in%2520Drug%2520Safety%26jtitle%3DToxicology%26date%3D2006%26volume%3D226%26spage%3D1%26epage%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit1e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Park, B., K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pirmohamed, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitteringham, N., R.</span><span> </span><span class="NLM_article-title">Role of Drug Disposition in Drug Hypersensitivity: A Chemical, Molecular and Clinical Perspective</span> <span class="citation_source-journal">Chem. Res. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">969</span><span class="NLM_x">–</span> <span class="NLM_lpage">988</span></span><div class="citationLinks">[<a href="/doi/10.1021/tx980058f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=1998&pages=969-988&author=B.%2C+K.+Parkauthor=M.+Pirmohamedauthor=N.%2C+R.+Kitteringham&title=Role+of+Drug+Disposition+in+Drug+Hypersensitivity%3A+A+Chemical%2C+Molecular+and+Clinical+Perspective"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1e&amp;dbid=16384&amp;doi=10.1021%2Ftx980058f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx980058f%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DB.%252C%2BK.%26aulast%3DPirmohamed%26aufirst%3DM.%26aulast%3DKitteringham%26aufirst%3DN.%252C%2BR.%26atitle%3DRole%2520of%2520Drug%2520Disposition%2520in%2520Drug%2520Hypersensitivity%253A%2520A%2520Chemical%252C%2520Molecular%2520and%2520Clinical%2520Perspective%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D1998%26volume%3D11%26spage%3D969%26epage%3D988" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Naisbitt, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gordon, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pirmohamed, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, K. B.</span><span> </span><span class="NLM_article-title">Immunological Principles of Adverse Drug Reactions</span> <span class="citation_source-journal">Drug Safety</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">483</span><span class="NLM_x">–</span> <span class="NLM_lpage">507</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2000&pages=483-507&author=D.+J.+Naisbittauthor=S.+F.+Gordonauthor=M.+Pirmohamedauthor=K.+B.+Park&title=Immunological+Principles+of+Adverse+Drug+Reactions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNaisbitt%26aufirst%3DD.%2BJ.%26aulast%3DGordon%26aufirst%3DS.%2BF.%26aulast%3DPirmohamed%26aufirst%3DM.%26aulast%3DPark%26aufirst%3DK.%2BB.%26atitle%3DImmunological%2520Principles%2520of%2520Adverse%2520Drug%2520Reactions%26jtitle%3DDrug%2520Safety%26date%3D2000%26volume%3D23%26spage%3D483%26epage%3D507" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit2b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Leubke, R.; House, R.; Kimber, I.</span><span> </span><span class="NLM_article-title">Drug Allergy in Immunotoxicology and Immunopharmacology</span>. In  <span class="citation_source-book">Target Organs Toxicology Series</span>, 3rd ed.; <span class="NLM_publisher-name">CRC Press</span>: <span class="NLM_publisher-loc">Boca Raton, FL</span>,<span class="NLM_x"> </span><span class="NLM_year">2007</span><span class="NLM_x">; </span>Chapter 36, pp  <span class="NLM_fpage">623</span>− <span class="NLM_lpage">632</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&pages=623-632&author=R.+Leubke&author=R.+House&author=I.+Kimber&title=Target+Organs+Toxicology+Series"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DLeubke%26aufirst%3DR.%26atitle%3DDrug%2520Allergy%2520in%2520Immunotoxicology%2520and%2520Immunopharmacology%26btitle%3DTarget%2520Organs%2520Toxicology%2520Series%26pub%3DCRC%2520Press%26date%3D2007%26spage%3D623%26epage%3D632" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Tirmenstein, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, S. D.</span><span> </span><span class="NLM_article-title">Subcellular Finding and Effects on Calcium Homeostasis Produced by Acetaminophen and a Nonhepatotoxic Regioisomer, 3′-Hydroxyacetanilide, in Mouse Liver</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">264</span><span class="NLM_x">, </span> <span class="NLM_fpage">9814</span><span class="NLM_x">–</span> <span class="NLM_lpage">9819</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=264&publication_year=1989&pages=9814-9819&author=M.+A.+Tirmensteinauthor=S.+D.+Nelson&title=Subcellular+Finding+and+Effects+on+Calcium+Homeostasis+Produced+by+Acetaminophen+and+a+Nonhepatotoxic+Regioisomer%2C+3%E2%80%B2-Hydroxyacetanilide%2C+in+Mouse+Liver"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTirmenstein%26aufirst%3DM.%2BA.%26aulast%3DNelson%26aufirst%3DS.%2BD.%26atitle%3DSubcellular%2520Finding%2520and%2520Effects%2520on%2520Calcium%2520Homeostasis%2520Produced%2520by%2520Acetaminophen%2520and%2520a%2520Nonhepatotoxic%2520Regioisomer%252C%25203%25E2%2580%25B2-Hydroxyacetanilide%252C%2520in%2520Mouse%2520Liver%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1989%26volume%3D264%26spage%3D9814%26epage%3D9819" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit3b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Cohen, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pumford, N. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khairallah, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boekelheide, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pohl, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amouzadeh, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hinson, J. A.</span><span> </span><span class="NLM_article-title">Selective Protein Covalent Binding and Target Organ Toxicity</span> <span class="citation_source-journal">Toxicol. Appl. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">143</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">12</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=16&amp;doi=10.1021%2Fjm8008597&amp;key=10.1006%2Ftaap.1996.8074" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=8&amp;doi=10.1021%2Fjm8008597&amp;key=9073586" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=32&amp;doi=10.1021%2Fjm8008597&amp;key=1%3ACAS%3A528%3ADyaK2sXhvVSjs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=143&publication_year=1997&pages=1-12&author=S.+D.+Cohenauthor=N.+R.+Pumfordauthor=E.+A.+Khairallahauthor=K.+Boekelheideauthor=L.+R.+Pohlauthor=H.+R.+Amouzadehauthor=J.+A.+Hinson&title=Selective+Protein+Covalent+Binding+and+Target+Organ+Toxicity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3bR"><div class="casContent"><span class="casTitleNuber">3b</span><div class="casTitle"><span class="NLM_cas:atitle">Selective protein covalent binding and target organ toxicity</span></div><div class="casAuthors">Cohen, Steven D.; Pumford, Neil R.; Khairallah, Edward A.; Boekelheide, Kim; Pohl, Lance R.; Amouzadeh, H. R.; Hinson, Jack A.</div><div class="citationInfo"><span class="NLM_cas:title">Toxicology and Applied Pharmacology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">143</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-12</span>CODEN:
                <span class="NLM_cas:coden">TXAPA9</span>;
        ISSN:<span class="NLM_cas:issn">0041-008X</span>.
    
            (<span class="NLM_cas:orgname">Academic</span>)
        </div><div class="casAbstract">A review and discussion with many refs.  Protein covalent binding by xenobiotic metabolites has long been assocd. with target organ toxicity but mechanistic involvement of such binding has not been widely demonstrated.  Modern biochem., mol., and immunochem. approaches have facilitated identification of specific protein targets of xenobiotic covalent binding.  Such studies have revealed that protein covalent binding is not random, but rather selective with respect to the proteins targeted.  Selective binding to specific cellular target proteins may better correlate with toxicity than total protein covalent binding.  Current research is directed at characterizing and identifying the targeted proteins and clarifying the effect of such binding on their structure, function, and potential roles in target organ toxicity.  The approaches employed to detect and identify the targeted proteins are described.  Metabolites of acetaminophen, halothane, and 2,5-hexanedione form covalently bound adducts to recently identified protein targets.  The selective binding may influence homeostatic or other cellular responses which in turn contribute to drug toxicity, hypersensitivity, or autoimmunity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGps8YnY6hReKLVg90H21EOLACvtfcHk0lilXxwEgC5A-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXhvVSjs74%253D&md5=819153f53ae0570c3a1af4e95e6a6af9</span></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=10.1006%2Ftaap.1996.8074&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Ftaap.1996.8074%26sid%3Dliteratum%253Aachs%26aulast%3DCohen%26aufirst%3DS.%2BD.%26aulast%3DPumford%26aufirst%3DN.%2BR.%26aulast%3DKhairallah%26aufirst%3DE.%2BA.%26aulast%3DBoekelheide%26aufirst%3DK.%26aulast%3DPohl%26aufirst%3DL.%2BR.%26aulast%3DAmouzadeh%26aufirst%3DH.%2BR.%26aulast%3DHinson%26aufirst%3DJ.%2BA.%26atitle%3DSelective%2520Protein%2520Covalent%2520Binding%2520and%2520Target%2520Organ%2520Toxicity%26jtitle%3DToxicol.%2520Appl.%2520Pharmacol.%26date%3D1997%26volume%3D143%26spage%3D1%26epage%3D12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><div class="note"><p class="first last">As the FDA does not require data on covalent binding studies with serum proteins or assessments of intrinsic reactivity with nucleophiles such as glutathione, there is little, if any, information available on these properties of the approved or investigational drugs.</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=As+the+FDA+does+not+require+data+on+covalent+binding+studies+with+serum+proteins+or+assessments+of+intrinsic+reactivity+with+nucleophiles+such+as+glutathione%2C+there+is+little%2C+if+any%2C+information+available+on+these+properties+of+the+approved+or+investigational+drugs."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><div class="note"><p class="first last">A drug that binds by strong metal chelation is allopurinol, the xanthine oxidase (molybdenum) chelator. Allopurinol is oxidized to the active form alloxanthine, which tightly binds to the partially reduced molybdenum center of the enzyme. This event makes binding functionally irreversible, however, through a dative bond.</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=A+drug+that+binds+by+strong+metal+chelation+is+allopurinol%2C+the+xanthine+oxidase+%28molybdenum%29+chelator.+Allopurinol+is+oxidized+to+the+active+form+alloxanthine%2C+which+tightly+binds+to+the+partially+reduced+molybdenum+center+of+the+enzyme.+This+event+makes+binding+functionally+irreversible%2C+however%2C+through+a+dative+bond."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5a"><span><span class="NLM_contrib-group">Truglio, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Theis, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leimkuhler, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rappa, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajagopalan, K. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kisker, C.</span><span> </span><span class="NLM_article-title">Crystal Structures of the Active and Alloxanthine-Inhibited Forms of Xanthine Dehydrogenase from <i>Rhodobacter capsulatus</i></span> <span class="citation_source-journal">Structure</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">115</span><span class="NLM_x">–</span> <span class="NLM_lpage">125</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2002&pages=115-125&author=J.+J.+Truglioauthor=K.+Theisauthor=S.+Leimkuhlerauthor=R.+Rappaauthor=K.+V.+Rajagopalanauthor=C.+Kisker&title=Crystal+Structures+of+the+Active+and+Alloxanthine-Inhibited+Forms+of+Xanthine+Dehydrogenase+from+Rhodobacter+capsulatus"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTruglio%26aufirst%3DJ.%2BJ.%26aulast%3DTheis%26aufirst%3DK.%26aulast%3DLeimkuhler%26aufirst%3DS.%26aulast%3DRappa%26aufirst%3DR.%26aulast%3DRajagopalan%26aufirst%3DK.%2BV.%26aulast%3DKisker%26aufirst%3DC.%26atitle%3DCrystal%2520Structures%2520of%2520the%2520Active%2520and%2520Alloxanthine-Inhibited%2520Forms%2520of%2520Xanthine%2520Dehydrogenase%2520from%2520Rhodobacter%2520capsulatus%26jtitle%3DStructure%26date%3D2002%26volume%3D10%26spage%3D115%26epage%3D125" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="note"><p class="first last">For other references, see the following:</p></div><div class="NLM_citation" id="rightTab-cit5c"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Rastelli, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Costantino, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albasani, A.</span><span> </span><span class="NLM_article-title">A Model of the Interaction of Substrates and Inhibitors with Xanthine Oxidase</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">119</span><span class="NLM_x">, </span> <span class="NLM_fpage">3007</span><span class="NLM_x">–</span> <span class="NLM_lpage">3016</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja962309h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=1997&pages=3007-3016&author=G.+Rastelliauthor=L.+Costantinoauthor=A.+Albasani&title=A+Model+of+the+Interaction+of+Substrates+and+Inhibitors+with+Xanthine+Oxidase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5c&amp;dbid=16384&amp;doi=10.1021%2Fja962309h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja962309h%26sid%3Dliteratum%253Aachs%26aulast%3DRastelli%26aufirst%3DG.%26aulast%3DCostantino%26aufirst%3DL.%26aulast%3DAlbasani%26aufirst%3DA.%26atitle%3DA%2520Model%2520of%2520the%2520Interaction%2520of%2520Substrates%2520and%2520Inhibitors%2520with%2520Xanthine%2520Oxidase%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1997%26volume%3D119%26spage%3D3007%26epage%3D3016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5d"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Spector, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johns, D. G.</span><span> </span><span class="NLM_article-title">Stoichiometric Inhibition of Reduced Xanthine Oxidase by Hydrioyrazolo[3,4-<i>d</i>]pyrimidines</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1970</span><span class="NLM_x">, </span> <span class="NLM_volume">245</span><span class="NLM_x">, </span> <span class="NLM_fpage">5079</span><span class="NLM_x">–</span> <span class="NLM_lpage">5085</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=245&publication_year=1970&pages=5079-5085&author=T.+Spectorauthor=D.+G.+Johns&title=Stoichiometric+Inhibition+of+Reduced+Xanthine+Oxidase+by+Hydrioyrazolo%5B3%2C4-d%5Dpyrimidines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSpector%26aufirst%3DT.%26aulast%3DJohns%26aufirst%3DD.%2BG.%26atitle%3DStoichiometric%2520Inhibition%2520of%2520Reduced%2520Xanthine%2520Oxidase%2520by%2520Hydrioyrazolo%255B3%252C4-d%255Dpyrimidines%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1970%26volume%3D245%26spage%3D5079%26epage%3D5085" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><div class="note"><p class="first last">For example, see the following:</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=For+example%2C+see+the+following%3A"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6a"><span><span class="NLM_contrib-group">Furman, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">St. Clair, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spector, T.</span><span> </span><span class="NLM_article-title">Acyclovir Triphosphate Is a Suicide Inactivator of the Herpes Simplex Virus DNA Polymerase</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1984</span><span class="NLM_x">, </span> <span class="NLM_volume">259</span><span class="NLM_x">, </span> <span class="NLM_fpage">9575</span><span class="NLM_x">–</span> <span class="NLM_lpage">9579</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=259&publication_year=1984&pages=9575-9579&author=P.+A.+Furmanauthor=M.+H.+St.+Clairauthor=T.+Spector&title=Acyclovir+Triphosphate+Is+a+Suicide+Inactivator+of+the+Herpes+Simplex+Virus+DNA+Polymerase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFurman%26aufirst%3DP.%2BA.%26aulast%3DSt.%2BClair%26aufirst%3DM.%2BH.%26aulast%3DSpector%26aufirst%3DT.%26atitle%3DAcyclovir%2520Triphosphate%2520Is%2520a%2520Suicide%2520Inactivator%2520of%2520the%2520Herpes%2520Simplex%2520Virus%2520DNA%2520Polymerase%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1984%26volume%3D259%26spage%3D9575%26epage%3D9579" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><div class="note"><p class="first last">For a review of prodrugs, see the following:</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=For+a+review+of+prodrugs%2C+see+the+following%3A"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit7a"><span><span class="NLM_contrib-group">Ettmayer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amidon, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clement, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Testa, B.</span><span> </span><span class="NLM_article-title">Lessons Learned from Marketed and Investigational Prodrugs</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">2393</span><span class="NLM_x">–</span> <span class="NLM_lpage">2404</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0303812" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=32&amp;doi=10.1021%2Fjm8008597&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjtVSqsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=2393-2404&author=P.+Ettmayerauthor=G.+L.+Amidonauthor=B.+Clementauthor=B.+Testa&title=Lessons+Learned+from+Marketed+and+Investigational+Prodrugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7aR"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Lessons Learned from Marketed and Investigational Prodrugs</span></div><div class="casAuthors">Ettmayer, Peter; Amidon, Gordon L.; Clement, Bernd; Testa, Bernard</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2393-2404</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  This article provide arguments and guidelines for the early recourse to, and successful application of, a prodrug strategy in drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpw0Hg--zru8LVg90H21EOLACvtfcHk0lg8ZmD_5UZOLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjtVSqsbY%253D&md5=839aadef2d64e14b5e311c2e8e8d9b83</span></div><a href="/servlet/linkout?suffix=cit7a&amp;dbid=16384&amp;doi=10.1021%2Fjm0303812&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0303812%26sid%3Dliteratum%253Aachs%26aulast%3DEttmayer%26aufirst%3DP.%26aulast%3DAmidon%26aufirst%3DG.%2BL.%26aulast%3DClement%26aufirst%3DB.%26aulast%3DTesta%26aufirst%3DB.%26atitle%3DLessons%2520Learned%2520from%2520Marketed%2520and%2520Investigational%2520Prodrugs%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D2393%26epage%3D2404" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="note"><p class="first last">An overview of enzymes targeted by covalent modulators can be found in</p></div><div class="NLM_citation" id="rightTab-cit8a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Robertson, J. G.</span><span> </span><span class="NLM_article-title">Mechanistic Basis of Enzyme−Target Drugs</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">5561</span><span class="NLM_x">–</span> <span class="NLM_lpage">5571</span><div class="note"><p class="first last">including supplemental data</p></div></span><div class="citationLinks">[<a href="/doi/10.1021/bi050247e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2005&pages=5561-5571&author=J.+G.+Robertson&title=Mechanistic+Basis+of+Enzyme%E2%88%92Target+Drugs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8a&amp;dbid=16384&amp;doi=10.1021%2Fbi050247e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi050247e%26sid%3Dliteratum%253Aachs%26aulast%3DRobertson%26aufirst%3DJ.%2BG.%26atitle%3DMechanistic%2520Basis%2520of%2520Enzyme%25E2%2588%2592Target%2520Drugs%26jtitle%3DBiochemistry%26date%3D2005%26volume%3D44%26spage%3D5561%26epage%3D5571" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit8b"><span><div class="note"><p class="first last">For a general review covering irreversible inhibitors, see review chapter:</p></div><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Tipton, K. F.</span> <span class="citation_source-book">Enzymes: Irreversible Inhibition in Handbook of Proteins</span>; <span class="NLM_publisher-name">John Wiley & Sons Ltd.</span>: <span class="NLM_publisher-loc">Chichester, U.K.</span>,<span class="NLM_x"> </span><span class="NLM_year">2007</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">490</span>− <span class="NLM_lpage">503</span>. <div class="note"><p class="first last">Target-specific reviews include the following:</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&pages=490-503&author=K.+F.+Tipton&title=Enzymes%3A+Irreversible+Inhibition+in+Handbook+of+Proteins"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DTipton%26aufirst%3DK.%2BF.%26btitle%3DEnzymes%253A%2520Irreversible%2520Inhibition%2520in%2520Handbook%2520of%2520Proteins%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%2520Ltd%26date%3D2007%26spage%3D490%26epage%3D503" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit8c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Powers, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asgian, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ekici, O. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, K. E.</span><span> </span><span class="NLM_article-title">Irreversible Inhibitors of Serine, Cysteine, and Threonine Proteases</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">4639</span><span class="NLM_x">–</span> <span class="NLM_lpage">4750</span></span><div class="citationLinks">[<a href="/doi/10.1021/cr010182v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref8/cit8c&amp;dbid=32&amp;doi=10.1021%2Fjm8008597&amp;key=1%3ACAS%3A528%3ADC%252BD38XosFSnsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2002&pages=4639-4750&author=J.+C.+Powersauthor=J.+L.+Asgianauthor=O.+D.+Ekiciauthor=K.+E.+James&title=Irreversible+Inhibitors+of+Serine%2C+Cysteine%2C+and+Threonine+Proteases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8cR"><div class="casContent"><span class="casTitleNuber">8c</span><div class="casTitle"><span class="NLM_cas:atitle">Irreversible inhibitors of serine, cysteine, and threonine proteases</span></div><div class="casAuthors">Powers, James C.; Asgian, Juliana L.; Ekici, Oezlem Dogan; James, Karen Ellis</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">4639-4750</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Topics discussed include alkylating, acylating, phosphonylating, and sulfonylating agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGorivaxGhmhirVg90H21EOLACvtfcHk0lg8ZmD_5UZOLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XosFSnsr4%253D&md5=eb21ff0297b87537a7d459c92f13c75d</span></div><a href="/servlet/linkout?suffix=cit8c&amp;dbid=16384&amp;doi=10.1021%2Fcr010182v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr010182v%26sid%3Dliteratum%253Aachs%26aulast%3DPowers%26aufirst%3DJ.%2BC.%26aulast%3DAsgian%26aufirst%3DJ.%2BL.%26aulast%3DEkici%26aufirst%3DO.%2BD.%26aulast%3DJames%26aufirst%3DK.%2BE.%26atitle%3DIrreversible%2520Inhibitors%2520of%2520Serine%252C%2520Cysteine%252C%2520and%2520Threonine%2520Proteases%26jtitle%3DChem.%2520Rev.%26date%3D2002%26volume%3D102%26spage%3D4639%26epage%3D4750" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit8d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Bridges, A. J.</span><span> </span><span class="NLM_article-title">The Rationale and Strategy Used To Develop a Series of Highly Potent, Irreversible, Inhibitors of the Epidermal Growth Factor Receptor Family of Tyrosine Kinase</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">825</span><span class="NLM_x">–</span> <span class="NLM_lpage">843</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8d&amp;dbid=8&amp;doi=10.1021%2Fjm8008597&amp;key=10495354" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8d&amp;dbid=32&amp;doi=10.1021%2Fjm8008597&amp;key=1%3ACAS%3A528%3ADyaK1MXlvFWqtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1999&pages=825-843&author=A.+J.+Bridges&title=The+Rationale+and+Strategy+Used+To+Develop+a+Series+of+Highly+Potent%2C+Irreversible%2C+Inhibitors+of+the+Epidermal+Growth+Factor+Receptor+Family+of+Tyrosine+Kinase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8dR"><div class="casContent"><span class="casTitleNuber">8d</span><div class="casTitle"><span class="NLM_cas:atitle">The rationale and strategy used to develop a series of highly potent, irreversible, inhibitors of the Epidermal Growth Factor receptor family of tyrosine kinases</span></div><div class="casAuthors">Bridges, A. J.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">825-843</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers</span>)
        </div><div class="casAbstract">A review with 122 refs.  The Epidermal Growth Factor receptor (EGFr) was one of the first oncogenes identified, and it, or its ligands Epidermal Growth Factor (EGF) and Transforming Growth Factor α (TGFα) are overexpressed in most clin. tumors.  As EGF and TGFα are potent mitogens, it appeared that inhibition of EGFr signaling would be a viable anti-proliferative strategy.  Screening found several classes of EGFr inhibitor, one of which, the indolinethiones was developed.  The SAR, in common with that of other first generation tyrosine kinase (TK) inhibitors was flat, and potency was poor.  Rescreening in presence of a thiol, to remove chem. reactive species, identified only two leads, a pyridopyrimidine and a quinazoline.  These were developed into a very broad class of EGFr inhibitors, with great potency and selectivity for EGFr, but poor physicochem. properties, and little if any in vivo anti-tumor activity.  Meanwhile the complex role of other members of the EGFr TK family in oncogenesis, was becoming apparent, suggesting that the whole EGFr family should be inhibited.  The difficulty of finding potent compds. with acceptable pharmacokinetics also suggested that irreversible inhibitors of the TK might produce better in vivo profiles.  Modeling suggested that the unusual Cys773 residue might be reached from the 6/7-positions of quinazoline and pyridopyrimidine inhibitors.  Inhibitors with acrylamides at these positions proved to be irreversible alkylating agents for both EGFr and erbB-2 with cellular inhibitory activities in the low nanomolar range, and very potent in vivo antitumor activity.  Optimized inhibitors had exceptionally potent oral antitumor activity, with negligible cytotoxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCfxlExE175LVg90H21EOLACvtfcHk0li5T5HYmt9Vog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXlvFWqtb8%253D&md5=36f387aecf4c6e676591383bf25a10ca</span></div><a href="/servlet/linkout?suffix=cit8d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBridges%26aufirst%3DA.%2BJ.%26atitle%3DThe%2520Rationale%2520and%2520Strategy%2520Used%2520To%2520Develop%2520a%2520Series%2520of%2520Highly%2520Potent%252C%2520Irreversible%252C%2520Inhibitors%2520of%2520the%2520Epidermal%2520Growth%2520Factor%2520Receptor%2520Family%2520of%2520Tyrosine%2520Kinase%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D1999%26volume%3D6%26spage%3D825%26epage%3D843" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit8e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Ghisa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wenz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thorpe, C.</span><span> </span><span class="NLM_article-title">Suicide Substrates as Irreversible Inhibitors of Flavoenzymes</span> <span class="citation_source-journal">Enzyme Inhib., Proc. Meet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1980</span><span class="NLM_x">, </span> <span class="NLM_fpage">43</span><span class="NLM_x">–</span> <span class="NLM_lpage">60</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1980&pages=43-60&author=S.+Ghisaauthor=A.+Wenzauthor=C.+Thorpe&title=Suicide+Substrates+as+Irreversible+Inhibitors+of+Flavoenzymes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGhisa%26aufirst%3DS.%26aulast%3DWenz%26aufirst%3DA.%26aulast%3DThorpe%26aufirst%3DC.%26atitle%3DSuicide%2520Substrates%2520as%2520Irreversible%2520Inhibitors%2520of%2520Flavoenzymes%26jtitle%3DEnzyme%2520Inhib.%252C%2520Proc.%2520Meet.%26date%3D1980%26spage%3D43%26epage%3D60" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Fung, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thornton, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mybeck, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J. H.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hornbuckle, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muniz, E.</span><span> </span><span class="NLM_article-title">Evaluation of the Characteristics of Safety Withdrawl of Prescription Drugs from Worldwide Pharmaceutical Markets: 1960 to 1999</span> <span class="citation_source-journal">Drug. Inf. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">293</span><span class="NLM_x">–</span> <span class="NLM_lpage">317</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=16&amp;doi=10.1021%2Fjm8008597&amp;key=10.1177%2F009286150103500134" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2001&pages=293-317&author=M.+Fungauthor=A.+Thorntonauthor=K.+Mybeckauthor=J.+H.-H.+Wuauthor=K.+Hornbuckleauthor=E.+Muniz&title=Evaluation+of+the+Characteristics+of+Safety+Withdrawl+of+Prescription+Drugs+from+Worldwide+Pharmaceutical+Markets%3A+1960+to+1999"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9a&amp;dbid=16384&amp;doi=10.1177%2F009286150103500134&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F009286150103500134%26sid%3Dliteratum%253Aachs%26aulast%3DFung%26aufirst%3DM.%26aulast%3DThornton%26aufirst%3DA.%26aulast%3DMybeck%26aufirst%3DK.%26aulast%3DWu%26aufirst%3DJ.%2BH.-H.%26aulast%3DHornbuckle%26aufirst%3DK.%26aulast%3DMuniz%26aufirst%3DE.%26atitle%3DEvaluation%2520of%2520the%2520Characteristics%2520of%2520Safety%2520Withdrawl%2520of%2520Prescription%2520Drugs%2520from%2520Worldwide%2520Pharmaceutical%2520Markets%253A%25201960%2520to%25201999%26jtitle%3DDrug.%2520Inf.%2520J.%26date%3D2001%26volume%3D35%26spage%3D293%26epage%3D317" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit9b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Schuster, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laggner, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langer, T.</span><span> </span><span class="NLM_article-title">Why Drugs Fail. A Study on Side Effects in New Chemical Entities</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">3545</span><span class="NLM_x">–</span> <span class="NLM_lpage">3559</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=16&amp;doi=10.1021%2Fjm8008597&amp;key=10.2174%2F138161205774414510" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=8&amp;doi=10.1021%2Fjm8008597&amp;key=16248807" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=32&amp;doi=10.1021%2Fjm8008597&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVWrs7rE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2005&pages=3545-3559&author=D.+Schusterauthor=C.+Laggnerauthor=T.+Langer&title=Why+Drugs+Fail.+A+Study+on+Side+Effects+in+New+Chemical+Entities"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9bR"><div class="casContent"><span class="casTitleNuber">9b</span><div class="casTitle"><span class="NLM_cas:atitle">Why drugs fail - a study on side effects in new chemical entities</span></div><div class="casAuthors">Schuster, D.; Laggner, C.; Langer, T.</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">27</span>),
    <span class="NLM_cas:pages">3545-3559</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Our study focuses on the reasons for market withdrawals of drugs and drug development project terminations in clin. phases I-III from 1992 to 2002.  Over 90% of the market withdrawals were caused by drug toxicity.  Hepatotoxicity and cardiovascular toxicity proved to be the major causes for two out of three market withdrawals in the resp. time period.  In clin. phases I-III 43% of drug development project terminations were due to insufficient efficacy of the investigated compd.  The second important issue, which caused one third of the projects to be closed, was toxicity.  ADME parameters and economic and other reasons played a minor role.  The results of our study indicate that compared with previous studies on this subject, no major improvements have been achieved in the last decade.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrL6dIqIHxrybVg90H21EOLACvtfcHk0li5T5HYmt9Vog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVWrs7rE&md5=1bef8ba43d434392969566c3e6052cf8</span></div><a href="/servlet/linkout?suffix=cit9b&amp;dbid=16384&amp;doi=10.2174%2F138161205774414510&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161205774414510%26sid%3Dliteratum%253Aachs%26aulast%3DSchuster%26aufirst%3DD.%26aulast%3DLaggner%26aufirst%3DC.%26aulast%3DLanger%26aufirst%3DT.%26atitle%3DWhy%2520Drugs%2520Fail.%2520A%2520Study%2520on%2520Side%2520Effects%2520in%2520New%2520Chemical%2520Entities%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2005%26volume%3D11%26spage%3D3545%26epage%3D3559" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Amacher, D. E.</span><span> </span><span class="NLM_article-title">Reactive Intermediates and the Pathogenesis of Adverse Drug Reactions: The Toxicology Perspective</span> <span class="citation_source-journal">Curr. Drug Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">219</span><span class="NLM_x">–</span> <span class="NLM_lpage">229</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm8008597&amp;key=10.2174%2F138920006776359284" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm8008597&amp;key=16611018" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm8008597&amp;key=1%3ACAS%3A528%3ADC%252BD28Xjs12jt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2006&pages=219-229&author=D.+E.+Amacher&title=Reactive+Intermediates+and+the+Pathogenesis+of+Adverse+Drug+Reactions%3A+The+Toxicology+Perspective"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Reactive intermediates and the pathogenesis of adverse drug reactions: the toxicology perspective</span></div><div class="casAuthors">Amacher, David E.</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Metabolism</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">219-229</span>CODEN:
                <span class="NLM_cas:coden">CDMUBU</span>;
        ISSN:<span class="NLM_cas:issn">1389-2002</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Severe adverse drug responses are infrequent but occasionally serious events that are not readily predictable at the preclin. development level using only non-human or in vitro models.  A common characteristic of the more serious toxicities is generation of short-lived and highly reactive electrophilic species in some individuals.  The objective here is to review the literature for toxicol. mechanisms that underlie known adverse drug reactions and then categorize the biol. consequences of reactive chem. intermediates and radicals in terms of human risk factors and known metabolic variables.  Xenobiotics described as being assocd. with rare but potentially serious adverse events affecting liver, skin, or causing blood dyscrasias tend to have three of four essential characteristics, (1) they are capable of forming short-lived reactive intermediates (RI) or free radicals in target tissues under ideal conditions that are distinct from primary metabolic products, (2) these RI escape/overwhelm the detoxification mechanisms assocd. with the site of origin or form toxic conjugates, (3) the unconjugated RI must either selectively damage crit. proteins or other key macromols. or (4) the RI acts as a hapten and stimulates an immunol. (hypersensitivity) response or overcomes tolerance.  Some risk factors may increase the probability of susceptibility, but this remains an active area of research.  Because of the complexity of the pathogenesis of some injuries and the role of individual factors, no highly predictive in vitro screening methods are available; however, several methods are evolving that may be used to reveal mechanisms of action when a serious adverse effect is encountered.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoze87op4UtTbVg90H21EOLACvtfcHk0li5T5HYmt9Vog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xjs12jt7w%253D&md5=42251ea18356164392b8b95386ffd06a</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.2174%2F138920006776359284&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138920006776359284%26sid%3Dliteratum%253Aachs%26aulast%3DAmacher%26aufirst%3DD.%2BE.%26atitle%3DReactive%2520Intermediates%2520and%2520the%2520Pathogenesis%2520of%2520Adverse%2520Drug%2520Reactions%253A%2520The%2520Toxicology%2520Perspective%26jtitle%3DCurr.%2520Drug%2520Metab.%26date%3D2006%26volume%3D7%26spage%3D219%26epage%3D229" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Hadvary, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sidler, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meister, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vetter, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolfer, H.</span><span> </span><span class="NLM_article-title">The Lipase Inhibitor Tetrahydrolipstatin Binds Covalently to the Putative Active Site Serine of Pancreatic Lipase</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">266</span><span class="NLM_x">, </span> <span class="NLM_fpage">2021</span><span class="NLM_x">–</span> <span class="NLM_lpage">2027</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=266&publication_year=1991&pages=2021-2027&author=P.+Hadvaryauthor=W.+Sidlerauthor=W.+Meisterauthor=W.+Vetterauthor=H.+Wolfer&title=The+Lipase+Inhibitor+Tetrahydrolipstatin+Binds+Covalently+to+the+Putative+Active+Site+Serine+of+Pancreatic+Lipase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHadvary%26aufirst%3DP.%26aulast%3DSidler%26aufirst%3DW.%26aulast%3DMeister%26aufirst%3DW.%26aulast%3DVetter%26aufirst%3DW.%26aulast%3DWolfer%26aufirst%3DH.%26atitle%3DThe%2520Lipase%2520Inhibitor%2520Tetrahydrolipstatin%2520Binds%2520Covalently%2520to%2520the%2520Putative%2520Active%2520Site%2520Serine%2520of%2520Pancreatic%2520Lipase%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1991%26volume%3D266%26spage%3D2021%26epage%3D2027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Guerciolini, R.</span><span> </span><span class="NLM_article-title">Mode of Action of Orlistat</span> <span class="citation_source-journal">Int. J. Obes.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl. 3</span><span class="NLM_x">) </span> <span class="NLM_fpage">S12</span><span class="NLM_x">–</span> <span class="NLM_lpage">S23</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=1997&pages=S12-S23&issue=Suppl.+3&author=R.+Guerciolini&title=Mode+of+Action+of+Orlistat"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGuerciolini%26aufirst%3DR.%26atitle%3DMode%2520of%2520Action%2520of%2520Orlistat%26jtitle%3DInt.%2520J.%2520Obes.%26date%3D1997%26volume%3D21%26issue%3DSuppl.%25203%26spage%3DS12%26epage%3DS23" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Lu, W.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kincaid, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bauer, M. D.</span><span> </span><span class="NLM_article-title">Kinetics of β-Lactam Interactions with Penicillin-Susceptible and -Resistant Penicillin-Binding Protein 2× Proteins from <i>Streptococcus pneumoniae</i>: Involvement of Acylation and Deacylation in β-Lactam Resistance</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">276</span><span class="NLM_x">, </span> <span class="NLM_fpage">31494</span><span class="NLM_x">–</span> <span class="NLM_lpage">31501</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2001&pages=31494-31501&author=W.-P.+Luauthor=E.+Kincaidauthor=Y.+Sunauthor=M.+D.+Bauer&title=Kinetics+of+%CE%B2-Lactam+Interactions+with+Penicillin-Susceptible+and+-Resistant+Penicillin-Binding+Protein+2%C3%97+Proteins+from+Streptococcus+pneumoniae%3A+Involvement+of+Acylation+and+Deacylation+in+%CE%B2-Lactam+Resistance"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DW.-P.%26aulast%3DKincaid%26aufirst%3DE.%26aulast%3DSun%26aufirst%3DY.%26aulast%3DBauer%26aufirst%3DM.%2BD.%26atitle%3DKinetics%2520of%2520%25CE%25B2-Lactam%2520Interactions%2520with%2520Penicillin-Susceptible%2520and%2520-Resistant%2520Penicillin-Binding%2520Protein%25202%25C3%2597%2520Proteins%2520from%2520Streptococcus%2520pneumoniae%253A%2520Involvement%2520of%2520Acylation%2520and%2520Deacylation%2520in%2520%25CE%25B2-Lactam%2520Resistance%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2001%26volume%3D276%26spage%3D31494%26epage%3D31501" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><div class="note"><p class="first last">Data presented for penicillin allergy.</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Data+presented+for+penicillin+allergy."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit14a"><span><span class="NLM_contrib-group">Bigby, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jick, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jick, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arndt, K.</span><span> </span><span class="NLM_article-title">Drug-Induced Cutaneous Reactions: A Report from the Boston Collaborative Drug Surveillance Program on 15,438 Consecutive Inpatients, 1975 to 1982</span> <span class="citation_source-journal">JAMA, J. Am. Med. Assoc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1986</span><span class="NLM_x">, </span> <span class="NLM_volume">256</span><span class="NLM_x">, </span> <span class="NLM_fpage">3358</span><span class="NLM_x">–</span> <span class="NLM_lpage">3363</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=256&publication_year=1986&pages=3358-3363&author=M.+Bigbyauthor=S.+Jickauthor=H.+Jickauthor=K.+Arndt&title=Drug-Induced+Cutaneous+Reactions%3A+A+Report+from+the+Boston+Collaborative+Drug+Surveillance+Program+on+15%2C438+Consecutive+Inpatients%2C+1975+to+1982"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBigby%26aufirst%3DM.%26aulast%3DJick%26aufirst%3DS.%26aulast%3DJick%26aufirst%3DH.%26aulast%3DArndt%26aufirst%3DK.%26atitle%3DDrug-Induced%2520Cutaneous%2520Reactions%253A%2520A%2520Report%2520from%2520the%2520Boston%2520Collaborative%2520Drug%2520Surveillance%2520Program%2520on%252015%252C438%2520Consecutive%2520Inpatients%252C%25201975%2520to%25201982%26jtitle%3DJAMA%252C%2520J.%2520Am.%2520Med.%2520Assoc.%26date%3D1986%26volume%3D256%26spage%3D3358%26epage%3D3363" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><div class="note"><p class="first last">Although the precise factor(s) have not been identified, it has been shown that ultrafiltration of serum reduces penicillin binding. However, when the ultrafiltered serum was reconstituted with serum ultrafiltrate, the binding capacity was restored to 82% of that of intact serum.</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Although+the+precise+factor%28s%29+have+not+been+identified%2C+it+has+been+shown+that+ultrafiltration+of+serum+reduces+penicillin+binding.+However%2C+when+the+ultrafiltered+serum+was+reconstituted+with+serum+ultrafiltrate%2C+the+binding+capacity+was+restored+to+82%25+of+that+of+intact+serum."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit15a"><span><span class="NLM_contrib-group">Di Piro, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adkinson, N. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamilton, R. G.</span><span> </span><span class="NLM_article-title">Facilitation of Penicillin Haptenation to Serum Proteins</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">1463</span><span class="NLM_x">–</span> <span class="NLM_lpage">1467</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1993&pages=1463-1467&author=J.+T.+Di+Piroauthor=N.+F.+Adkinsonauthor=R.+G.+Hamilton&title=Facilitation+of+Penicillin+Haptenation+to+Serum+Proteins"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDi%2BPiro%26aufirst%3DJ.%2BT.%26aulast%3DAdkinson%26aufirst%3DN.%2BF.%26aulast%3DHamilton%26aufirst%3DR.%2BG.%26atitle%3DFacilitation%2520of%2520Penicillin%2520Haptenation%2520to%2520Serum%2520Proteins%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D1993%26volume%3D37%26spage%3D1463%26epage%3D1467" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Goffin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghuysen, J.-M.</span><span> </span><span class="NLM_article-title">Multimodular Penicillin-Binding Proteins: An Enigmatic Family of Orthologs and Paralogs</span> <span class="citation_source-journal">Microbiol. Mol. Biol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">1079</span><span class="NLM_x">–</span> <span class="NLM_lpage">1093</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm8008597&amp;key=10.1128%2FMMBR.62.4.1079-1093.1998" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm8008597&amp;key=9841666" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm8008597&amp;key=1%3ACAS%3A528%3ADyaK1MXhs1Oguw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=1998&pages=1079-1093&author=C.+Goffinauthor=J.-M.+Ghuysen&title=Multimodular+Penicillin-Binding+Proteins%3A+An+Enigmatic+Family+of+Orthologs+and+Paralogs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Multimodular penicillin-binding proteins: an enigmatic family of orthologs and paralogs</span></div><div class="casAuthors">Goffin, Colette; Ghuysen, Jean-Marie</div><div class="citationInfo"><span class="NLM_cas:title">Microbiology and Molecular Biology Reviews</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1079-1093</span>CODEN:
                <span class="NLM_cas:coden">MMBRF7</span>;
        ISSN:<span class="NLM_cas:issn">1092-2172</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">A review with 74 refs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpf0oL0mHlO07Vg90H21EOLACvtfcHk0libpnyHKNrx1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXhs1Oguw%253D%253D&md5=5014e2f1dc604024faf25a320a7c0134</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1128%2FMMBR.62.4.1079-1093.1998&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMMBR.62.4.1079-1093.1998%26sid%3Dliteratum%253Aachs%26aulast%3DGoffin%26aufirst%3DC.%26aulast%3DGhuysen%26aufirst%3DJ.-M.%26atitle%3DMultimodular%2520Penicillin-Binding%2520Proteins%253A%2520An%2520Enigmatic%2520Family%2520of%2520Orthologs%2520and%2520Paralogs%26jtitle%3DMicrobiol.%2520Mol.%2520Biol.%2520Rev.%26date%3D1998%26volume%3D62%26spage%3D1079%26epage%3D1093" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><div class="note"><p class="first last">As indicated on the FDA drug label.</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=As+indicated+on+the+FDA+drug+label."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Bar-On, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Millard, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dvir, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Enz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sussman, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silman, I.</span><span> </span><span class="NLM_article-title">Kinetic and Structural Studies on the Interaction of Cholinesterases with the Anti-Alzheimer Drug Rivastigmine</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">3555</span><span class="NLM_x">–</span> <span class="NLM_lpage">3564</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi020016x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm8008597&amp;key=1%3ACAS%3A528%3ADC%252BD38Xht1Gktr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2002&pages=3555-3564&author=P.+Bar-Onauthor=C.+B.+Millardauthor=M.+Harelauthor=H.+Dvirauthor=A.+Enzauthor=J.+L.+Sussmanauthor=I.+Silman&title=Kinetic+and+Structural+Studies+on+the+Interaction+of+Cholinesterases+with+the+Anti-Alzheimer+Drug+Rivastigmine"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Kinetic and Structural Studies on the Interaction of Cholinesterases with the Anti-Alzheimer Drug Rivastigmine</span></div><div class="casAuthors">Bar-On, P.; Millard, C. B.; Harel, M.; Dvir, H.; Enz, A.; Sussman, J. L.; Silman, I.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3555-3564</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Rivastigmine, a carbamate inhibitor of acetylcholinesterase, is already in use for treatment of Alzheimer's disease under the trade name of Exelon.  Rivastigmine carbamylates Torpedo californica acetylcholinesterase very slowly (ki = 2.0 M-1 min-1), whereas the bimol. rate const. for inhibition of human acetylcholinesterase is >1600-fold higher (ki = 3300 M-1 min-1).  For human butyrylcholinesterase and for Drosophila melanogaster acetylcholinesterase, carbamylation is even more rapid (ki = 9×104 and 5×105 M-1 min-1, resp.).  Spontaneous reactivation of all four conjugates is very slow, with <10% reactivation being obsd. for the Torpedo enzyme after 48 h.  The crystal structure of the conjugate of rivastigmine with Torpedo acetylcholinesterase was detd. to 2.2 Å resoln.  It revealed that the carbamyl moiety is covalently linked to the active-site serine, with the leaving group, (-)-S-3-[1-(dimethylamino)ethyl]phenol, being retained in the "anionic" site.  A significant movement of the active-site histidine (H440) away from its normal hydrogen-bonded partner, E327, was obsd., resulting in disruption of the catalytic triad.  This movement may provide an explanation for the unusually slow kinetics of reactivation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGJOeQbUGo9bVg90H21EOLACvtfcHk0libpnyHKNrx1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xht1Gktr8%253D&md5=20e7133e9a11db07979d6f6933f00255</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fbi020016x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi020016x%26sid%3Dliteratum%253Aachs%26aulast%3DBar-On%26aufirst%3DP.%26aulast%3DMillard%26aufirst%3DC.%2BB.%26aulast%3DHarel%26aufirst%3DM.%26aulast%3DDvir%26aufirst%3DH.%26aulast%3DEnz%26aufirst%3DA.%26aulast%3DSussman%26aufirst%3DJ.%2BL.%26aulast%3DSilman%26aufirst%3DI.%26atitle%3DKinetic%2520and%2520Structural%2520Studies%2520on%2520the%2520Interaction%2520of%2520Cholinesterases%2520with%2520the%2520Anti-Alzheimer%2520Drug%2520Rivastigmine%26jtitle%3DBiochemistry%26date%3D2002%26volume%3D41%26spage%3D3555%26epage%3D3564" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><div class="note"><p class="first last">COX is required for the production of thromboxane A<sub>2</sub>, a powerful promoter of platelet aggregation.</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=COX+is+required+for+the+production+of+thromboxane+A2%2C+a+powerful+promoter+of+platelet+aggregation."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit19a"><span><span class="NLM_contrib-group">Hennekens, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sechenova, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollar, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serebruany, V. L.</span><span> </span><span class="NLM_article-title">Dose of Aspirin in the Treatment and Prevention of Cardiovascular Disease: Current and Future Directions</span> <span class="citation_source-journal">J. Cardiovasc. Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">170</span><span class="NLM_x">–</span> <span class="NLM_lpage">176</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19a&amp;dbid=16&amp;doi=10.1021%2Fjm8008597&amp;key=10.1177%2F1074248406292263" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19a&amp;dbid=8&amp;doi=10.1021%2Fjm8008597&amp;key=17056829" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19a&amp;dbid=32&amp;doi=10.1021%2Fjm8008597&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtF2ls7vE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2006&pages=170-176&author=C.+H.+Hennekensauthor=O.+Sechenovaauthor=D.+Hollarauthor=V.+L.+Serebruany&title=Dose+of+Aspirin+in+the+Treatment+and+Prevention+of+Cardiovascular+Disease%3A+Current+and+Future+Directions"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19aR"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Dose of aspirin in the treatment and prevention of cardiovascular disease: current and future directions</span></div><div class="casAuthors">Hennekens, Charles H.; Sechenova, Oksana; Hollar, Danielle; Serebruany, Victor L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cardiovascular Pharmacology and Therapeutics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">170-176</span>CODEN:
                <span class="NLM_cas:coden">JCPTFE</span>;
        ISSN:<span class="NLM_cas:issn">1074-2484</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">In meta-analyses of randomized trials of aspirin among patients with prior occlusive vascular disease events (secondary prevention), doses from 75 mg to more than 1500 mg daily provide similar benefits on myocardial infarction, stroke, and cardiovascular death.  In acute myocardial infarction and during acute occlusive stroke, a loading dose of 162.5 to 325 mg is necessary to achieve a rapid clin. antithrombotic effect.  In primary prevention trials, predominantly among men, aspirin (75 mg daily to 325 mg on alternate days) reduced the risk of a first myocardial infarction.  In a large-scale trial in women, aspirin (100 mg on alternate days) reduced risk of a first stroke.  In subgroup analyses of women older than age 65, aspirin significantly reduced first myocardial infarction and ischemic stroke.  Direct comparisons of higher doses may yield addnl. cardiovascular benefits.  At present, daily doses of 75 to 325 mg aspirin are sufficient for long-term treatment and prevention of cardiovascular disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqeOGS_Sm4ZZbVg90H21EOLACvtfcHk0lhPDcMyISHa_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtF2ls7vE&md5=8766490247ede4958dee9bec82526c9d</span></div><a href="/servlet/linkout?suffix=cit19a&amp;dbid=16384&amp;doi=10.1177%2F1074248406292263&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1074248406292263%26sid%3Dliteratum%253Aachs%26aulast%3DHennekens%26aufirst%3DC.%2BH.%26aulast%3DSechenova%26aufirst%3DO.%26aulast%3DHollar%26aufirst%3DD.%26aulast%3DSerebruany%26aufirst%3DV.%2BL.%26atitle%3DDose%2520of%2520Aspirin%2520in%2520the%2520Treatment%2520and%2520Prevention%2520of%2520Cardiovascular%2520Disease%253A%2520Current%2520and%2520Future%2520Directions%26jtitle%3DJ.%2520Cardiovasc.%2520Pharmacol.%2520Ther.%26date%3D2006%26volume%3D11%26spage%3D170%26epage%3D176" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Van der Ouderaa, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buytenhek, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nugteren, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Dorp, D. A.</span><span> </span><span class="NLM_article-title">Acetylation of Prostaglandin Endoperoxide Synthetase with Acetylsalicyclic Acid</span> <span class="citation_source-journal">Eur. J. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1980</span><span class="NLM_x">, </span> <span class="NLM_volume">109</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">8</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm8008597&amp;key=10.1111%2Fj.1432-1033.1980.tb04760.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm8008597&amp;key=6773769" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm8008597&amp;key=1%3ACAS%3A528%3ADyaL3cXkvFWjsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=1980&pages=1-8&author=F.+J.+Van+der+Ouderaaauthor=M.+Buytenhekauthor=D.+H.+Nugterenauthor=D.+A.+Van+Dorp&title=Acetylation+of+Prostaglandin+Endoperoxide+Synthetase+with+Acetylsalicyclic+Acid"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Acetylation of prostaglandin endoperoxide synthetase with acetylsalicylic acid</span></div><div class="casAuthors">Van der Ouderaa, Frans J.; Buytenhek, Marinus; Nugteren, Diederik H.; Van Dorp, David A.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Biochemistry</span>
        (<span class="NLM_cas:date">1980</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-8</span>CODEN:
                <span class="NLM_cas:coden">EJBCAI</span>;
        ISSN:<span class="NLM_cas:issn">0014-2956</span>.
    </div><div class="casAbstract">Incubation of purified prostaglandin endoperoxide synthetase from sheep vesicular glands with aspirin results in a covalent binding of the acetyl group of acetylsalicylic acid to the protein.  During this acetylation, the cyclooxygenase activity is lost, but not the peroxidase activity.  The reaction is completed when almost 1 acetyl group is bound per polypeptide chain (mol. wt. 68,000).  After proteolysis of [3H]acetyl-protein with Pronase, radioactive N-acetylserine was obtained.  Originally, however, the hydroxyl group of an internal serine residue in the chain is acetylated.  The formation of N-acetylserine can be explained by a rapid O → N acetyl shift as soon as the NH2 group of serine is liberated.  A radioactive dipeptide was isolated from a thermolysin digest of the [3H]acetyl-enzyme contg. phenylalanine and serine, phenylalanine being its N-terminal amino acid.  Automatic Edman degrdn. of native and acetylated enzyme showed that only one polypeptide sequence was present: Ala-Asp-Pro-Gly-Ala-Pro-Ala-Pro-Val-Asn-Pro-X-X-Tyr-.  The N-terminal sequence has an apolar character.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0wuoDk91wVrVg90H21EOLACvtfcHk0lhPDcMyISHa_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3cXkvFWjsbo%253D&md5=ed5c961de6abc429907582b3f75642d7</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1111%2Fj.1432-1033.1980.tb04760.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1432-1033.1980.tb04760.x%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2Bder%2BOuderaa%26aufirst%3DF.%2BJ.%26aulast%3DBuytenhek%26aufirst%3DM.%26aulast%3DNugteren%26aufirst%3DD.%2BH.%26aulast%3DVan%2BDorp%26aufirst%3DD.%2BA.%26atitle%3DAcetylation%2520of%2520Prostaglandin%2520Endoperoxide%2520Synthetase%2520with%2520Acetylsalicyclic%2520Acid%26jtitle%3DEur.%2520J.%2520Biochem.%26date%3D1980%26volume%3D109%26spage%3D1%26epage%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Sorensen, H. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mellemkjaer, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blot, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nielsen, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steffensen, F. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLaughlin, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">P Olsen, J. H.</span><span> </span><span class="NLM_article-title">Risk of Upper Gastrointestinal Bleeding Associated with Use of Low-Dose Aspirin</span> <span class="citation_source-journal">Am. J. Gastroenterol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">95</span><span class="NLM_x">, </span> <span class="NLM_fpage">2218</span><span class="NLM_x">–</span> <span class="NLM_lpage">2224</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm8008597&amp;key=11007221" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm8008597&amp;key=1%3ACAS%3A528%3ADC%252BD3cXntFCmtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=2000&pages=2218-2224&author=H.+T.+Sorensenauthor=L.+Mellemkjaerauthor=W.+J.+Blotauthor=G.+L.+Nielsenauthor=F.+H.+Steffensenauthor=J.+K.+McLaughlinauthor=J.+H.+P+Olsen&title=Risk+of+Upper+Gastrointestinal+Bleeding+Associated+with+Use+of+Low-Dose+Aspirin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Risk of upper gastrointestinal bleeding associated with use of low-dose aspirin</span></div><div class="casAuthors">Sorensen, Henrik Toft; Mellemkjaer, Lene; Blot, William J.; Nielsen, Gunnar Lauge; Steffensen, Flemming Hald; McLaughlin, Joseph K.; Olsen, Jorgen H.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Gastroenterology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2218-2224</span>CODEN:
                <span class="NLM_cas:coden">AJGAAR</span>;
        ISSN:<span class="NLM_cas:issn">0002-9270</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">Aspirin products are known to cause irritation and injury to the gastric mucosa.  We examd. the risk of hospitalization for upper gastrointestinal bleeding with use of low-dose aspirin.  This was a cohort study based on record linkage between a population-based prescription database and a hospital discharge registry in North Jutland County, Denmark, from Jan. 1, 1991, to Dec. 31, 1995.  Incidence rates of upper gastrointestinal bleeding in 27,694 users of low-dose aspirin were compared with the incidence rates in the general population in the county.  A total of 207 exclusive users of low-dose aspirin experienced a first episode of upper gastrointestinal bleeding with admission to the hospital during the study period.  The standardized incidence rate ratio was 2.6 (95% confidence interval, 2.2-2.9), 2.3 in women and 2.8 in men.  The standardized incidence rate ratio for combined use of low-dose aspirin and other nonsteroidal anti-inflammatory drugs was 5.6 (95% confidence interval, 4.4-7.0).  The risk was similar among users of noncoated low-dose aspirin (standardized incidence rate ratio, 2.6; 95% confidence interval, 1.8-3.5) and coated low-dose aspirin (standardized incidence rate ratio, 2.6; 95% confidence interval, 2.2-3.0).  Use of low-dose aspirin was assocd. with an increased risk of upper gastrointestinal bleeding, with still higher risks when combined with other nonsteroidal anti-inflammatory drugs.  Enteric coating did not seem to reduce the risk.  The findings from this observational study raise the possibility that prophylactic use of low-dose aspirin may convey an increased risk of gastrointestinal bleeding, which may offset some of its benefits.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRNcV2hS0iDbVg90H21EOLACvtfcHk0lhPDcMyISHa_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXntFCmtr8%253D&md5=8889c58854bf2fd3471d88133bfb9045</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSorensen%26aufirst%3DH.%2BT.%26aulast%3DMellemkjaer%26aufirst%3DL.%26aulast%3DBlot%26aufirst%3DW.%2BJ.%26aulast%3DNielsen%26aufirst%3DG.%2BL.%26aulast%3DSteffensen%26aufirst%3DF.%2BH.%26aulast%3DMcLaughlin%26aufirst%3DJ.%2BK.%26aulast%3DP%2BOlsen%26aufirst%3DJ.%2BH.%26atitle%3DRisk%2520of%2520Upper%2520Gastrointestinal%2520Bleeding%2520Associated%2520with%2520Use%2520of%2520Low-Dose%2520Aspirin%26jtitle%3DAm.%2520J.%2520Gastroenterol.%26date%3D2000%26volume%3D95%26spage%3D2218%26epage%3D2224" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Fasco, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Principe, L. M.</span><span> </span><span class="NLM_article-title"><i>R</i>- and <i>S</i>-Warfarin Inhibition of Vitamin K and Vitamin K 2,3-Epoxide Reductase Activities in the Rat</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1982</span><span class="NLM_x">, </span> <span class="NLM_volume">257</span><span class="NLM_x">, </span> <span class="NLM_fpage">4894</span><span class="NLM_x">–</span> <span class="NLM_lpage">4901</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=257&publication_year=1982&pages=4894-4901&author=M.+J.+Fascoauthor=L.+M.+Principe&title=R-+and+S-Warfarin+Inhibition+of+Vitamin+K+and+Vitamin+K+2%2C3-Epoxide+Reductase+Activities+in+the+Rat"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFasco%26aufirst%3DM.%2BJ.%26aulast%3DPrincipe%26aufirst%3DL.%2BM.%26atitle%3DR-%2520and%2520S-Warfarin%2520Inhibition%2520of%2520Vitamin%2520K%2520and%2520Vitamin%2520K%25202%252C3-Epoxide%2520Reductase%2520Activities%2520in%2520the%2520Rat%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1982%26volume%3D257%26spage%3D4894%26epage%3D4901" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Silverman, R. B.</span><span> </span><span class="NLM_article-title">Model Studies for a Molecular Mechanism of Action of Oral Anticoagulants</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1981</span><span class="NLM_x">, </span> <span class="NLM_volume">103</span><span class="NLM_x">, </span> <span class="NLM_fpage">3910</span><span class="NLM_x">–</span> <span class="NLM_lpage">3915</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja00403a050" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=1981&pages=3910-3915&author=R.+B.+Silverman&title=Model+Studies+for+a+Molecular+Mechanism+of+Action+of+Oral+Anticoagulants"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fja00403a050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00403a050%26sid%3Dliteratum%253Aachs%26aulast%3DSilverman%26aufirst%3DR.%2BB.%26atitle%3DModel%2520Studies%2520for%2520a%2520Molecular%2520Mechanism%2520of%2520Action%2520of%2520Oral%2520Anticoagulants%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1981%26volume%3D103%26spage%3D3910%26epage%3D3915" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Rozwarski, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grant, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barton, D. H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobs, W. R.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sacchettini, J. C.</span><span> </span><span class="NLM_article-title">Modification of the NADH of the Isoniazid Targets (InhA) from <i>Mycobacterium tuberculosis</i></span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">279</span><span class="NLM_x">, </span> <span class="NLM_fpage">98</span><span class="NLM_x">–</span> <span class="NLM_lpage">102</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=1998&pages=98-102&author=D.+A.+Rozwarskiauthor=G.+A.+Grantauthor=D.+H.+R.+Bartonauthor=W.+R.+Jacobsauthor=J.+C.+Sacchettini&title=Modification+of+the+NADH+of+the+Isoniazid+Targets+%28InhA%29+from+Mycobacterium+tuberculosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRozwarski%26aufirst%3DD.%2BA.%26aulast%3DGrant%26aufirst%3DG.%2BA.%26aulast%3DBarton%26aufirst%3DD.%2BH.%2BR.%26aulast%3DJacobs%26aufirst%3DW.%2BR.%26aulast%3DSacchettini%26aufirst%3DJ.%2BC.%26atitle%3DModification%2520of%2520the%2520NADH%2520of%2520the%2520Isoniazid%2520Targets%2520%2528InhA%2529%2520from%2520Mycobacterium%2520tuberculosis%26jtitle%3DScience%26date%3D1998%26volume%3D279%26spage%3D98%26epage%3D102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Zhou, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goh, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duan, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLeod, H. L.</span><span> </span><span class="NLM_article-title">Mechanism-Based Inhibition of Cytochrome P450 3A4 by Therapeutic Drugs</span> <span class="citation_source-journal">Clin. Pharmacokinet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">279</span><span class="NLM_x">–</span> <span class="NLM_lpage">304</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm8008597&amp;key=10.2165%2F00003088-200544030-00005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm8008597&amp;key=15762770" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm8008597&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjs1Kru7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2005&pages=279-304&author=S.+Zhouauthor=S.+Y.+Chanauthor=B.+C.+Gohauthor=E.+Chanauthor=W.+Duanauthor=M.+Huangauthor=H.+L.+McLeod&title=Mechanism-Based+Inhibition+of+Cytochrome+P450+3A4+by+Therapeutic+Drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanism-based inhibition of cytochrome P450 3A4 by therapeutic drugs</span></div><div class="casAuthors">Zhou, Shufeng; Chan, Sui Yung; Goh, Boon Cher; Chan, Eli; Duan, Wei; Huang, Min; McLeod, Howard L.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Pharmacokinetics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">279-304</span>CODEN:
                <span class="NLM_cas:coden">CPKNDH</span>;
        ISSN:<span class="NLM_cas:issn">0312-5963</span>.
    
            (<span class="NLM_cas:orgname">Adis International Ltd.</span>)
        </div><div class="casAbstract">A review.  Consistent with its highest abundance in humans, cytochrome P 450 (CYP) 3A is responsible for the metab. of about 60% of currently known drugs.  However, this unusual low substrate specificity also makes CYP3A4 susceptible to reversible or irreversible inhibition by a variety of drugs.  Mechanism-based inhibition of CYP3A4 is characterized by NADP hydrogen (NADPH)-, time- and concn.-dependent enzyme inactivation, occurring when some drugs are converted by CYP isoenzymes to reactive metabolites capable of irreversibly binding covalently to CYP3A4.  Approaches using in vitro, in silico and in vivo models can be used to study CYP3A4 inactivation by drugs.  Human liver microsomes are always used to est. inactivation kinetic parameters including the concn. required for half-maximal inactivation (KI) and the maximal rate of inactivation at satn. (kinact).  Clin. important mechanism-based CYP3A4 inhibitors include antibacterials (e.g. clarithromycin, erythromycin and isoniazid), anticancer agents (e.g. tamoxifen and irinotecan), anti-HIV agents (e.g. ritonavir and delavirdine), antihypertensives (e.g. dihydralazine, verapamil and diltiazem), sex steroids and their receptor modulators (e.g. gestodene and raloxifene), and several herbal constituents (e.g. bergamottin and glabridin).  Drugs inactivating CYP3A4 often possess several common moieties such as a tertiary amine function, furan ring, and acetylene function.  It appears that the chem. properties of a drug crit. to CYP3A4 inactivation include formation of reactive metabolites by CYP isoenzymes, preponderance of CYP inducers and P-glycoprotein (P-gp) substrate, and occurrence of clin. significant pharmacokinetic interactions with coadministered drugs.  Compared with reversible inhibition of CYP3A4, mechanism-based inhibition of CYP3A4 more frequently cause pharmacokinetic-pharmacodynamic drug-drug interactions, as the inactivated CYP3A4 has to be replaced by newly synthesized CYP3A4 protein.  The resultant drug interactions may lead to adverse drug effects, including some fatal events.  For example, when aforementioned CYP3A4 inhibitors are coadministered with terfenadine, cisapride or astemizole (all CYP3A4 substrates), torsades de pointes (a life-threatening ventricular arrhythmia assocd. with QT prolongation) may occur.  However, predicting drug-drug interactions involving CYP3A4 inactivation is difficult, since the clin. outcomes depend on a no. of factors that are assocd. with drugs and patients.  The apparent pharmacokinetic effect of a mechanism-based inhibitor of CYP3A4 would be a function of its KI, kinact and partition ratio and the zero-order synthesis rate of new or replacement enzyme.  The inactivators for CYP3A4 can be inducers and P-gp substrates/inhibitors, confounding in vitro-in vivo extrapolation.  The clin. significance of CYP3A inhibition for drug safety and efficacy warrants closer understanding of the mechanisms for each inhibitor.  Furthermore, such inactivation may be exploited for therapeutic gain in certain circumstances.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqyCrj3HT5CYLVg90H21EOLACvtfcHk0liiN_ueiCHsQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjs1Kru7o%253D&md5=1fcb85c8111a1959c54f79181a40082b</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.2165%2F00003088-200544030-00005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2165%252F00003088-200544030-00005%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DS.%26aulast%3DChan%26aufirst%3DS.%2BY.%26aulast%3DGoh%26aufirst%3DB.%2BC.%26aulast%3DChan%26aufirst%3DE.%26aulast%3DDuan%26aufirst%3DW.%26aulast%3DHuang%26aufirst%3DM.%26aulast%3DMcLeod%26aufirst%3DH.%2BL.%26atitle%3DMechanism-Based%2520Inhibition%2520of%2520Cytochrome%2520P450%25203A4%2520by%2520Therapeutic%2520Drugs%26jtitle%3DClin.%2520Pharmacokinet.%26date%3D2005%26volume%3D44%26spage%3D279%26epage%3D304" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Hussain, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kar, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Husain, S. A.</span><span> </span><span class="NLM_article-title">Antituberculosis Drug-Induced Hepatitis: Risk Factors, Prevention and Management</span> <span class="citation_source-journal">Indian J. Exp. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">1226</span><span class="NLM_x">–</span> <span class="NLM_lpage">1232</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2003&pages=1226-1232&author=Z.+Hussainauthor=P.+Karauthor=S.+A.+Husain&title=Antituberculosis+Drug-Induced+Hepatitis%3A+Risk+Factors%2C+Prevention+and+Management"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHussain%26aufirst%3DZ.%26aulast%3DKar%26aufirst%3DP.%26aulast%3DHusain%26aufirst%3DS.%2BA.%26atitle%3DAntituberculosis%2520Drug-Induced%2520Hepatitis%253A%2520Risk%2520Factors%252C%2520Prevention%2520and%2520Management%26jtitle%3DIndian%2520J.%2520Exp.%2520Biol.%26date%3D2003%26volume%3D41%26spage%3D1226%26epage%3D1232" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Nagasawa, H. T.; Shirota, F. N.; Demaster, E. G.</span><span> </span><span class="NLM_article-title">Alcoholism: Aldehyde Dehydrogenase Inhibitors as Alcohol Deterrent Agents in Biomedical Chemistry</span>. In  <span class="citation_source-book">Applying Chemical Principles to the Understanding and Treatment of Disease</span>; <span class="NLM_publisher-name">John Wiley & Sons</span>: <span class="NLM_publisher-loc">Hoboken, NJ</span>,<span class="NLM_x"> </span><span class="NLM_year">2000</span><span class="NLM_x">; </span>Chapter 3, pp  <span class="NLM_fpage">73</span>− <span class="NLM_lpage">97</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2000&pages=73-97&author=H.+T.+Nagasawa&author=F.+N.+Shirota&author=E.+G.+Demaster&title=Applying+Chemical+Principles+to+the+Understanding+and+Treatment+of+Disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DNagasawa%26aufirst%3DH.%2BT.%26atitle%3DAlcoholism%253A%2520Aldehyde%2520Dehydrogenase%2520Inhibitors%2520as%2520Alcohol%2520Deterrent%2520Agents%2520in%2520Biomedical%2520Chemistry%26btitle%3DApplying%2520Chemical%2520Principles%2520to%2520the%2520Understanding%2520and%2520Treatment%2520of%2520Disease%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%26date%3D2000%26spage%3D73%26epage%3D97" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Shen, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mays, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lipsky, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naylor, S.</span><span> </span><span class="NLM_article-title">Determination of In-Vivo Adducts of Disulfiram with Mitochondrial Aldehyde Dehydrogenase</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">537</span><span class="NLM_x">–</span> <span class="NLM_lpage">545</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2001&pages=537-545&author=M.+L.+Shenauthor=K.+L.+Johnsonauthor=D.+C.+Maysauthor=J.+J.+Lipskyauthor=S.+Naylor&title=Determination+of+In-Vivo+Adducts+of+Disulfiram+with+Mitochondrial+Aldehyde+Dehydrogenase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShen%26aufirst%3DM.%2BL.%26aulast%3DJohnson%26aufirst%3DK.%2BL.%26aulast%3DMays%26aufirst%3DD.%2BC.%26aulast%3DLipsky%26aufirst%3DJ.%2BJ.%26aulast%3DNaylor%26aufirst%3DS.%26atitle%3DDetermination%2520of%2520In-Vivo%2520Adducts%2520of%2520Disulfiram%2520with%2520Mitochondrial%2520Aldehyde%2520Dehydrogenase%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2001%26volume%3D61%26spage%3D537%26epage%3D545" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Skarzynski, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mistry, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wonacott, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutchinson, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelly, V. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duncan, K.</span><span> </span><span class="NLM_article-title">Structure of UDP <i>N</i>-Actylglucosamine Enolpyruvyl Transferase, an Enzyme Essential for the Synthesis of Bacterial Peptidoglycan, Complexed with Substrate UDP-<i>N</i>-acetylglucosamine and the Drug Fosfomycin</span> <span class="citation_source-journal">Structure</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">1465</span><span class="NLM_x">–</span> <span class="NLM_lpage">1474</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1996&pages=1465-1474&author=T.+Skarzynskiauthor=A.+Mistryauthor=A.+Wonacottauthor=S.+E.+Hutchinsonauthor=V.+A.+Kellyauthor=K.+Duncan&title=Structure+of+UDP+N-Actylglucosamine+Enolpyruvyl+Transferase%2C+an+Enzyme+Essential+for+the+Synthesis+of+Bacterial+Peptidoglycan%2C+Complexed+with+Substrate+UDP-N-acetylglucosamine+and+the+Drug+Fosfomycin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSkarzynski%26aufirst%3DT.%26aulast%3DMistry%26aufirst%3DA.%26aulast%3DWonacott%26aufirst%3DA.%26aulast%3DHutchinson%26aufirst%3DS.%2BE.%26aulast%3DKelly%26aufirst%3DV.%2BA.%26aulast%3DDuncan%26aufirst%3DK.%26atitle%3DStructure%2520of%2520UDP%2520N-Actylglucosamine%2520Enolpyruvyl%2520Transferase%252C%2520an%2520Enzyme%2520Essential%2520for%2520the%2520Synthesis%2520of%2520Bacterial%2520Peptidoglycan%252C%2520Complexed%2520with%2520Substrate%2520UDP-N-acetylglucosamine%2520and%2520the%2520Drug%2520Fosfomycin%26jtitle%3DStructure%26date%3D1996%26volume%3D4%26spage%3D1465%26epage%3D1474" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit29b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Thomas, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ginj, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jelesarov, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amrhein, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macheroux, P.</span><span> </span><span class="NLM_article-title">Role of K22 and R120 in the Covalent Binding of the Antibiotic Fosfomycin and the Substrate-Induced Conformational Change in USP-<i>N</i>-acetylglucosamine Enolpyruvyl Transferase</span> <span class="citation_source-journal">Eur. J. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">271</span><span class="NLM_x">, </span> <span class="NLM_fpage">2682</span><span class="NLM_x">–</span> <span class="NLM_lpage">2690</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29b&amp;dbid=16&amp;doi=10.1021%2Fjm8008597&amp;key=10.1111%2Fj.1432-1033.2004.04196.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29b&amp;dbid=8&amp;doi=10.1021%2Fjm8008597&amp;key=15206933" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29b&amp;dbid=32&amp;doi=10.1021%2Fjm8008597&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlvFOitrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=271&publication_year=2004&pages=2682-2690&author=A.+M.+Thomasauthor=C.+Ginjauthor=I.+Jelesarovauthor=N.+Amrheinauthor=P.+Macheroux&title=Role+of+K22+and+R120+in+the+Covalent+Binding+of+the+Antibiotic+Fosfomycin+and+the+Substrate-Induced+Conformational+Change+in+USP-N-acetylglucosamine+Enolpyruvyl+Transferase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29bR"><div class="casContent"><span class="casTitleNuber">29b</span><div class="casTitle"><span class="NLM_cas:atitle">Role of K22 and R120 in the covalent binding of the antibiotic fosfomycin and the substrate-induced conformational change in UDP-N-acetylglucosamine enolpyruvyl transferase</span></div><div class="casAuthors">Thomas, Alison M.; Ginj, Cristian; Jelesarov, Ilian; Amrhein, Nikolaus; Macheroux, Peter</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Biochemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">271</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">2682-2690</span>CODEN:
                <span class="NLM_cas:coden">EJBCAI</span>;
        ISSN:<span class="NLM_cas:issn">0014-2956</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">UDP-N-acetylglucosamine enolpyruvyl transferase (MurA), catalyzes the first step in the biosynthesis of peptidoglycan, involving the transfer of the intact enolpyruvyl moiety from phosphoenolpyruvate to the 3'-hydroxyl group of UDP-N-acetylglucosamine (UDPNAG).  The enzyme is irreversibly inhibited by the antibiotic fosfomycin.  The inactivation is caused by alkylation of a highly conserved cysteine residue (C115) that participates in the binding of phosphoenolpyruvate.  The three-dimensional structure of the enzyme suggests that two residues may play a decisive role in fosfomycin binding: K22 and R120.  To investigate the role of these residues, we have generated the K22V, K22E, K22R and R120K single mutant proteins as well as the K22V/R120K and K22V/R120V double mutant proteins.  We demonstrated that the K22R mutant protein behaves similarly to wild-type enzyme, whereas the K22E mutant protein failed to form the covalent adduct.  On the other hand, the K22V mutant protein requires the presence of UDPNAG for the formation of the adduct indicating that UDPNAG plays a crucial role in the organization of productive interactions in the active site.  This model receives strong support from heat capacity changes obsd. for the K22V/R120K and R120K mutant proteins; in both mutant proteins, the heat capacity changes are markedly reduced, indicating that their ability to form a closed protein conformation is impeded due to the R120K exchange.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPsQu-rgoH-7Vg90H21EOLACvtfcHk0lj_82sCHZn5ng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlvFOitrs%253D&md5=5921149bf4314955d135fe570397ceef</span></div><a href="/servlet/linkout?suffix=cit29b&amp;dbid=16384&amp;doi=10.1111%2Fj.1432-1033.2004.04196.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1432-1033.2004.04196.x%26sid%3Dliteratum%253Aachs%26aulast%3DThomas%26aufirst%3DA.%2BM.%26aulast%3DGinj%26aufirst%3DC.%26aulast%3DJelesarov%26aufirst%3DI.%26aulast%3DAmrhein%26aufirst%3DN.%26aulast%3DMacheroux%26aufirst%3DP.%26atitle%3DRole%2520of%2520K22%2520and%2520R120%2520in%2520the%2520Covalent%2520Binding%2520of%2520the%2520Antibiotic%2520Fosfomycin%2520and%2520the%2520Substrate-Induced%2520Conformational%2520Change%2520in%2520USP-N-acetylglucosamine%2520Enolpyruvyl%2520Transferase%26jtitle%3DEur.%2520J.%2520Biochem.%26date%3D2004%26volume%3D271%26spage%3D2682%26epage%3D2690" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Fenn, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stamper, G. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morollo, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ringe, D.</span><span> </span><span class="NLM_article-title">A Side Reaction of Alanine Racemase: Transamination of Cycloserine</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">5775</span><span class="NLM_x">–</span> <span class="NLM_lpage">5783</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi027022d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2003&pages=5775-5783&author=T.+Fennauthor=G.+F.+Stamperauthor=A.+A.+Morolloauthor=D.+Ringe&title=A+Side+Reaction+of+Alanine+Racemase%3A+Transamination+of+Cycloserine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fbi027022d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi027022d%26sid%3Dliteratum%253Aachs%26aulast%3DFenn%26aufirst%3DT.%26aulast%3DStamper%26aufirst%3DG.%2BF.%26aulast%3DMorollo%26aufirst%3DA.%2BA.%26aulast%3DRinge%26aufirst%3DD.%26atitle%3DA%2520Side%2520Reaction%2520of%2520Alanine%2520Racemase%253A%2520Transamination%2520of%2520Cycloserine%26jtitle%3DBiochemistry%26date%3D2003%26volume%3D42%26spage%3D5775%26epage%3D5783" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Constable, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pirmohamed, M.</span><span> </span><span class="NLM_article-title">Drugs and the Retina</span> <span class="citation_source-journal">Expert Opin. Drug Saf.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">249</span><span class="NLM_x">–</span> <span class="NLM_lpage">259</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Fjm8008597&amp;key=10.1517%2F14740338.3.3.249" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Fjm8008597&amp;key=15155152" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm8008597&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjsVektLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=249-259&author=S.+Constableauthor=M.+Pirmohamed&title=Drugs+and+the+Retina"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Drugs and the retina</span></div><div class="casAuthors">Constable, Simon; Pirmohamed, Munir</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Safety</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">249-259</span>CODEN:
                <span class="NLM_cas:coden">EODSA9</span>;
        ISSN:<span class="NLM_cas:issn">1474-0338</span>.
    
            (<span class="NLM_cas:orgname">Ashley Publications Ltd.</span>)
        </div><div class="casAbstract">A review.  The retina is relatively protected from systemic drug administration because of the blood-retinal barrier, a highly selective mechanism adapted to providing a regulated homeostatic environment for this highly specialised tissue.  However, a no. of drugs have been assocd. with retinal toxicity.  Vigabatrin, as an adjunctive therapy for the management of partial epilepsy, is assocd. with visual field defects in ∼ 40% of patients.  Hydroxychloroquine, used in the treatment of rheumatoid arthritis and systemic lupus erythematosus, is also assocd. with a retinopathy.  In view of this, ophthalmol. screening and monitoring is recommended during prescription of both of these drugs.  In these cases, the retina is the site for an adverse drug reaction and the dose of therapy may be important in detg. the likelihood of retinal toxicity.  However, in the case of cytomegalovirus retinitis, the retina is the intended site for pharmacol. action.  The treatment of this condition with the antiviral agents ganciclovir, valganciclovir, foscarnet and cidofovir, can also be assocd. with significant systemic toxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5gLxXgO3CiLVg90H21EOLACvtfcHk0lj_82sCHZn5ng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjsVektLc%253D&md5=0f3d29e8726dc1a2894984c667c61c73</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1517%2F14740338.3.3.249&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14740338.3.3.249%26sid%3Dliteratum%253Aachs%26aulast%3DConstable%26aufirst%3DS.%26aulast%3DPirmohamed%26aufirst%3DM.%26atitle%3DDrugs%2520and%2520the%2520Retina%26jtitle%3DExpert%2520Opin.%2520Drug%2520Saf.%26date%3D2004%26volume%3D3%26spage%3D249%26epage%3D259" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Brodie, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Figueroa, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laska, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dewey, S. L.</span><span> </span><span class="NLM_article-title">Safety and Efficacy of γ-Vinyl GABA (GVG) for the Treatment of Methamphetamine and/or Cocaine Addiction</span> <span class="citation_source-journal">Synapse</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">122</span><span class="NLM_x">–</span> <span class="NLM_lpage">125</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2005&pages=122-125&author=J.+D.+Brodieauthor=E.+Figueroaauthor=E.+M.+Laskaauthor=S.+L.+Dewey&title=Safety+and+Efficacy+of+%CE%B3-Vinyl+GABA+%28GVG%29+for+the+Treatment+of+Methamphetamine+and%2For+Cocaine+Addiction"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrodie%26aufirst%3DJ.%2BD.%26aulast%3DFigueroa%26aufirst%3DE.%26aulast%3DLaska%26aufirst%3DE.%2BM.%26aulast%3DDewey%26aufirst%3DS.%2BL.%26atitle%3DSafety%2520and%2520Efficacy%2520of%2520%25CE%25B3-Vinyl%2520GABA%2520%2528GVG%2529%2520for%2520the%2520Treatment%2520of%2520Methamphetamine%2520and%252For%2520Cocaine%2520Addiction%26jtitle%3DSynapse%26date%3D2005%26volume%3D55%26spage%3D122%26epage%3D125" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit32b"><span><span class="NLM_label">(b) </span> Investigational Drugs Database. <a href="http://www.iddb.com" class="extLink">www.iddb.com</a>. Press release entitled “Catalyst Pharmaceutical Partners Reports Third Quarter 2007 Financial Results” detailing plans to initiate vigabatrin (CPP-109) in phase II trials Q1 2008, Catalyst Pharmaceutical Partners, posted on November 14, 2007.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Investigational+Drugs+Database.+www.iddb.com.+Press+release+entitled+%E2%80%9CCatalyst+Pharmaceutical+Partners+Reports+Third+Quarter+2007+Financial+Results%E2%80%9D+detailing+plans+to+initiate+vigabatrin+%28CPP-109%29+in+phase+II+trials+Q1+2008%2C+Catalyst+Pharmaceutical+Partners%2C+posted+on+November+14%2C+2007."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Sheean, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schramm, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eadie, M. J.</span><span> </span><span class="NLM_article-title">Vigabatrin-Plasma Enantiomer Concentrations and Clinical Effects</span> <span class="citation_source-journal">Clin. Exp. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">107</span><span class="NLM_x">–</span> <span class="NLM_lpage">116</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Fjm8008597&amp;key=1343855" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm8008597&amp;key=1%3ACAS%3A280%3ADyaK2c7lsFCgtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=1992&pages=107-116&author=G.+Sheeanauthor=R.+Schrammauthor=D.+S.+Andersonauthor=M.+J.+Eadie&title=Vigabatrin-Plasma+Enantiomer+Concentrations+and+Clinical+Effects"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Vigabatrin--plasma enantiomer concentrations and clinical effects</span></div><div class="casAuthors">Sheean G; Schramm T; Anderson D S; Eadie M J</div><div class="citationInfo"><span class="NLM_cas:title">Clinical and experimental neurology</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">107-16</span>
        ISSN:<span class="NLM_cas:issn">0196-6383</span>.
    </div><div class="casAbstract">Plasma concentrations of the [R]- and [S]- enantiomers of the new anticonvulsant vigabatrin were measured by an enantiospecific gas-liquid chromatographic assay in a group of therapy-resistant epileptic patients in whom racemic vigabatrin was added to their existing antiepileptic drug regimens.  The peak plasma concentrations of the biologically active [S]-enantiomer of vigabatrin were correlated with those of the [R]-enantiomer, with drug dose, seizure frequency and change in score on various tests of psychological function administered prior to and when the subjects were under steady-state conditions following vigabatrin therapy.  Plasma [S]-vigabatrin concentrations correlated with drug dose, [R]-vigabatrin concentration and change in score of certain psychological tests reflecting verbal memory, recall and speed of information processing.  No definite pharmacokinetic interactions were detected, though plasma phenobarbitone concentrations tended to fall during vigabatrin administration.  There were too few data to assess the relation between [S]-vigabatrin concentrations and seizure frequency.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSOWtkpb3eKRyCEBeYuoi7AfW6udTcc2ebeJFsl5of7Grntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2c7lsFCgtQ%253D%253D&md5=a753e43942d7683555e1d1c87b05ea73</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSheean%26aufirst%3DG.%26aulast%3DSchramm%26aufirst%3DR.%26aulast%3DAnderson%26aufirst%3DD.%2BS.%26aulast%3DEadie%26aufirst%3DM.%2BJ.%26atitle%3DVigabatrin-Plasma%2520Enantiomer%2520Concentrations%2520and%2520Clinical%2520Effects%26jtitle%3DClin.%2520Exp.%2520Neurol.%26date%3D1992%26volume%3D29%26spage%3D107%26epage%3D116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">De Biase, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barra, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bossa, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pucci, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">John, R. A.</span><span> </span><span class="NLM_article-title">Chemistry of the Inactivation of 4-Aminobutyrate Aminotransferase by the Antiepileptic Drug Vigabatrin</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">266</span><span class="NLM_x">, </span> <span class="NLM_fpage">20056</span><span class="NLM_x">–</span> <span class="NLM_lpage">20061</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=266&publication_year=1991&pages=20056-20061&author=D.+De+Biaseauthor=D.+Barraauthor=F.+Bossaauthor=P.+Pucciauthor=R.+A.+John&title=Chemistry+of+the+Inactivation+of+4-Aminobutyrate+Aminotransferase+by+the+Antiepileptic+Drug+Vigabatrin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BBiase%26aufirst%3DD.%26aulast%3DBarra%26aufirst%3DD.%26aulast%3DBossa%26aufirst%3DF.%26aulast%3DPucci%26aufirst%3DP.%26aulast%3DJohn%26aufirst%3DR.%2BA.%26atitle%3DChemistry%2520of%2520the%2520Inactivation%2520of%25204-Aminobutyrate%2520Aminotransferase%2520by%2520the%2520Antiepileptic%2520Drug%2520Vigabatrin%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1991%26volume%3D266%26spage%3D20056%26epage%3D20061" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><div class="note"><p class="first last">Interestingly eflornithine (see ref <a onclick="showRef(event, 'cit66a'); return false;" href="javascript:void(0);" class="ref cit66a">66a</a>, Poulin et. al.) utilizes PLP by a similar mechanism but generates the reactive imminium intermediate via decarboxylation and elimination of a fluorine. The nucleophile in this case is a cysteine.</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Interestingly+eflornithine+%28see+ref+66a%2C+Poulin+et.+al.%29+utilizes+PLP+by+a+similar+mechanism+but+generates+the+reactive+imminium+intermediate+via+decarboxylation+and+elimination+of+a+fluorine.+The+nucleophile+in+this+case+is+a+cysteine."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Giudici, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ornati, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Briatico, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buzzetti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lombardi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Salle, E.</span><span> </span><span class="NLM_article-title">6-Methyleneandrost-1,4-diene-3,17-dione (FDE 24304): A New Irreversible Aromatase Inhibtor</span> <span class="citation_source-journal">J. Steroid Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">391</span><span class="NLM_x">–</span> <span class="NLM_lpage">394</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Fjm8008597&amp;key=10.1016%2F0022-4731%2888%2990129-X" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=1998&pages=391-394&author=D.+Giudiciauthor=G.+Ornatiauthor=G.+Briaticoauthor=F.+Buzzettiauthor=P.+Lombardiauthor=E.+Di+Salle&title=6-Methyleneandrost-1%2C4-diene-3%2C17-dione+%28FDE+24304%29%3A+A+New+Irreversible+Aromatase+Inhibtor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2F0022-4731%2888%2990129-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0022-4731%252888%252990129-X%26sid%3Dliteratum%253Aachs%26aulast%3DGiudici%26aufirst%3DD.%26aulast%3DOrnati%26aufirst%3DG.%26aulast%3DBriatico%26aufirst%3DG.%26aulast%3DBuzzetti%26aufirst%3DF.%26aulast%3DLombardi%26aufirst%3DP.%26aulast%3DDi%2BSalle%26aufirst%3DE.%26atitle%3D6-Methyleneandrost-1%252C4-diene-3%252C17-dione%2520%2528FDE%252024304%2529%253A%2520A%2520New%2520Irreversible%2520Aromatase%2520Inhibtor%26jtitle%3DJ.%2520Steroid%2520Biochem.%26date%3D1998%26volume%3D30%26spage%3D391%26epage%3D394" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Brueggemeier, R. W.</span><span> </span><span class="NLM_article-title">Aromatase, Aromatase Inhibitors and Breast Cancer</span> <span class="citation_source-journal">Am. J. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">333</span><span class="NLM_x">–</span> <span class="NLM_lpage">344</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Fjm8008597&amp;key=10.1097%2F00045391-200109000-00007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Fjm8008597&amp;key=11550075" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm8008597&amp;key=1%3ACAS%3A280%3ADC%252BD3MvpvF2luw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2001&pages=333-344&author=R.+W.+Brueggemeier&title=Aromatase%2C+Aromatase+Inhibitors+and+Breast+Cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Aromatase, aromatase inhibitors, and breast cancer</span></div><div class="casAuthors">Brueggemeier R W</div><div class="citationInfo"><span class="NLM_cas:title">American journal of therapeutics</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">333-44</span>
        ISSN:<span class="NLM_cas:issn">1075-2765</span>.
    </div><div class="casAbstract">Estrogens are involved in numerous physiologic processes and have crucial roles in particular disease states, such as mammary carcinomas.  Estradiol, the most potent endogenous estrogen, is biosynthesized from androgens by the cytochrome P-450 enzyme complex called aromatase.  Aromatase is found in breast tissue, and the importance of intratumoral aromatase and local estrogen production is being unraveled.  Inhibition of aromatase is an important approach for reducing growth stimulatory effects of estrogens in hormone-dependent breast cancer.  Effective aromatase inhibitors have been developed as therapeutic agents for controlling estrogen-dependent breast cancer.  Investigations into the development of aromatase inhibitors began in the 1970s and have expanded greatly in the past three decades.  Competitive aromatase inhibitors are molecules that compete with the substrate androstenedione for noncovalent binding to the active site of the enzyme to decrease the amount of product formed.  Steroidal inhibitors that have been developed to date build on the basic androstenedione nucleus and incorporate chemical substituents at varying positions on the steroid.  The structure-activity relationships for steroidal inhibitors have become more refined in the past decade, and only some modifications can be made to the steroid and still keep its affinity for aromatase.  Nonsteroidal aromatase inhibitors can be divided into three classes: aminoglutethimide-like molecules, imidazole/triazole derivatives, and flavonoid analogs.  Mechanism-based aromatase inhibitors are inhibitors that mimic the substrate, are converted by the enzyme to a reactive intermediate, and result in the inactivation of aromatase.  Aromatase inhibitors, both steroidal and nonsteroidal, have shown clinical efficacy for the treatment of breast cancer.  The initial nonselective nature of nonsteroidal inhibitors such as aminoglutethimide has been greatly reduced in the later generations of inhibitors, anastrozole and letrozole.  Mechanism-based steroidal inhibitors such as 4-hydroxyandrostenedione and exemestane produce prolonged aromatase inhibition in patients.  The potent and selective third-generation aromatase inhibitors anastrozole, letrozole, and exemestane are approved for clinical use as second-line endocrine therapy in postmenopausal patients failing antiestrogen therapy alone or multiple hormonal therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTz7HOHQhUMrrmQt-ICR3qNfW6udTcc2ebeJFsl5of7Grntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3MvpvF2luw%253D%253D&md5=3051a7c0d089349231f104168bf6a1dc</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1097%2F00045391-200109000-00007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00045391-200109000-00007%26sid%3Dliteratum%253Aachs%26aulast%3DBrueggemeier%26aufirst%3DR.%2BW.%26atitle%3DAromatase%252C%2520Aromatase%2520Inhibitors%2520and%2520Breast%2520Cancer%26jtitle%3DAm.%2520J.%2520Ther.%26date%3D2001%26volume%3D8%26spage%3D333%26epage%3D344" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Groll, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berkers, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ploegh, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ovaa, H.</span><span> </span><span class="NLM_article-title">Crystal Structure of the Boronic Acid-Based Proteasome Inhibitor Bortezomib in Complex with the Yeast 20S Proteasome</span> <span class="citation_source-journal">Structure</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">451</span><span class="NLM_x">–</span> <span class="NLM_lpage">456</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Fjm8008597&amp;key=10.1016%2Fj.str.2005.11.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Fjm8008597&amp;key=16531229" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Fjm8008597&amp;key=1%3ACAS%3A528%3ADC%252BD28Xit1ylsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2006&pages=451-456&author=M.+Grollauthor=C.+R.+Berkersauthor=H.+L.+Ploeghauthor=H.+Ovaa&title=Crystal+Structure+of+the+Boronic+Acid-Based+Proteasome+Inhibitor+Bortezomib+in+Complex+with+the+Yeast+20S+Proteasome"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal Structure of the Boronic Acid-Based Proteasome Inhibitor Bortezomib in Complex with the Yeast 20S Proteasome</span></div><div class="casAuthors">Groll, Michael; Berkers, Celia R.; Ploegh, Hidde L.; Ovaa, Huib</div><div class="citationInfo"><span class="NLM_cas:title">Structure (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">451-456</span>CODEN:
                <span class="NLM_cas:coden">STRUE6</span>;
        ISSN:<span class="NLM_cas:issn">0969-2126</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Summary: The dipeptide boronic acid bortezomib, also termed VELCADE is a proteasome inhibitor now in use for the treatment of multiple myeloma, and its use for the treatment of other malignancies is being explored.  We detd. the crystal structure of the yeast 20S proteasome in complex with bortezomib to establish the specificity and binding mode of bortezomib to the proteasome's different catalytically active sites.  This structure should enable the rational design of new boronic acid derivs. with improved affinities and specificities for individual active subunits.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpusGzFSuveALVg90H21EOLACvtfcHk0ljhnyfJZhoxVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xit1ylsL8%253D&md5=d5b4e46e5a9f5259cce758770302b4fe</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.str.2005.11.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.str.2005.11.019%26sid%3Dliteratum%253Aachs%26aulast%3DGroll%26aufirst%3DM.%26aulast%3DBerkers%26aufirst%3DC.%2BR.%26aulast%3DPloegh%26aufirst%3DH.%2BL.%26aulast%3DOvaa%26aufirst%3DH.%26atitle%3DCrystal%2520Structure%2520of%2520the%2520Boronic%2520Acid-Based%2520Proteasome%2520Inhibitor%2520Bortezomib%2520in%2520Complex%2520with%2520the%2520Yeast%252020S%2520Proteasome%26jtitle%3DStructure%26date%3D2006%26volume%3D14%26spage%3D451%26epage%3D456" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Besancon, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sachs, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shin, J. M.</span><span> </span><span class="NLM_article-title">Sites of Reaction of the Gastric H,K-ATPase with Extracytoplasmic Thiol Reagents</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">272</span><span class="NLM_x">, </span> <span class="NLM_fpage">22438</span><span class="NLM_x">–</span> <span class="NLM_lpage">22446</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=272&publication_year=1997&pages=22438-22446&author=M.+Besanconauthor=A.+Simonauthor=G.+Sachsauthor=J.+M.+Shin&title=Sites+of+Reaction+of+the+Gastric+H%2CK-ATPase+with+Extracytoplasmic+Thiol+Reagents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBesancon%26aufirst%3DM.%26aulast%3DSimon%26aufirst%3DA.%26aulast%3DSachs%26aufirst%3DG.%26aulast%3DShin%26aufirst%3DJ.%2BM.%26atitle%3DSites%2520of%2520Reaction%2520of%2520the%2520Gastric%2520H%252CK-ATPase%2520with%2520Extracytoplasmic%2520Thiol%2520Reagents%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1997%26volume%3D272%26spage%3D22438%26epage%3D22446" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40a"><span><span class="NLM_contrib-group">Shin, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, Y. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sachs, G.</span><span> </span><span class="NLM_article-title">Chemistry of Covalent Inhibition of the Gastric (H<sup>+</sup>, K<sup>+</sup>)-ATPase by Proton Pump Inhibitors</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">126</span><span class="NLM_x">, </span> <span class="NLM_fpage">7800</span><span class="NLM_x">–</span> <span class="NLM_lpage">7811</span><div class="note"><p class="first last">and references therein</p></div></span><div class="citationLinks">[<a href="/doi/10.1021/ja049607w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=126&publication_year=2004&pages=7800-7811&author=J.+M.+Shinauthor=Y.+M.+Choauthor=G.+Sachs&title=Chemistry+of+Covalent+Inhibition+of+the+Gastric+%28H%2B%2C+K%2B%29-ATPase+by+Proton+Pump+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40a&amp;dbid=16384&amp;doi=10.1021%2Fja049607w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja049607w%26sid%3Dliteratum%253Aachs%26aulast%3DShin%26aufirst%3DJ.%2BM.%26aulast%3DCho%26aufirst%3DY.%2BM.%26aulast%3DSachs%26aufirst%3DG.%26atitle%3DChemistry%2520of%2520Covalent%2520Inhibition%2520of%2520the%2520Gastric%2520%2528H%252B%252C%2520K%252B%2529-ATPase%2520by%2520Proton%2520Pump%2520Inhibitors%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2004%26volume%3D126%26spage%3D7800%26epage%3D7811" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Savi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pereillo, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uzabiaga, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Combalbert, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Picard, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maffrand, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pascal, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herbert, J. M.</span><span> </span><span class="NLM_article-title">Identification and Biological Activity of the Active Metabolite of Clopidogrel</span> <span class="citation_source-journal">Thromb. Haemostasis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">84</span><span class="NLM_x">, </span> <span class="NLM_fpage">891</span><span class="NLM_x">–</span> <span class="NLM_lpage">896</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Fjm8008597&amp;key=10.1055%2Fs-0037-1614133" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Fjm8008597&amp;key=11127873" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Fjm8008597&amp;key=1%3ACAS%3A528%3ADC%252BD3cXovFCjsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2000&pages=891-896&author=P.+Saviauthor=J.+M.+Pereilloauthor=M.+F.+Uzabiagaauthor=J.+Combalbertauthor=C.+Picardauthor=J.+P.+Maffrandauthor=M.+Pascalauthor=J.+M.+Herbert&title=Identification+and+Biological+Activity+of+the+Active+Metabolite+of+Clopidogrel"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Identification and biological activity of the active metabolite of clopidogrel</span></div><div class="casAuthors">Savi, P.; Pereillo, J. M.; Uzabiaga, M. F.; Combalbert, J.; Picard, C.; Maffrand, J. P.; Pascal, M.; Herbert, J. M.</div><div class="citationInfo"><span class="NLM_cas:title">Thrombosis and Haemostasis</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">891-896</span>CODEN:
                <span class="NLM_cas:coden">THHADQ</span>;
        ISSN:<span class="NLM_cas:issn">0340-6245</span>.
    
            (<span class="NLM_cas:orgname">F. K. Schattauer Verlagsgesellschaft mbH</span>)
        </div><div class="casAbstract">Like ticlopidine, the ADP receptor antagonist clopidogrel is inactive in vitro and must be administered i.v. or orally to exhibit antiaggregatory and antithrombotic activities.  We have previously shown that hepatic metab. is necessary for activity.  This study demonstrates that an active metabolite can be generated from human liver microsomes incubated with clopidogrel.  Using several anal. methodologies (LC/MS, NMR, chiral supercrit. fluid chromatog.), we have identified its structure.  In vitro, this highly unstable compd., different from that formed from ticlopidine, exhibited all the biol. activities of clopidogrel obsd. ex vivo: Irreversible inhibition of the binding of 33P-2MeS-ADP to washed human platelets (IC50 = 0.53 μM), selective inhibition of ADP-induced platelet aggregation (IC50 = 1.8 μM) and ADP-induced adenylyl cyclase down-regulation.  The irreversible modification of the ADP-receptor site which is responsible for the biol. activity could be explained by the formation of a disulfide bridge between the reactive thiol group of the active metabolite and a cysteine residue of the platelet ADP receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqp6q3TXPondbVg90H21EOLACvtfcHk0ljhnyfJZhoxVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXovFCjsbs%253D&md5=822a367258ccea5111da1ad6e94847ca</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1055%2Fs-0037-1614133&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-0037-1614133%26sid%3Dliteratum%253Aachs%26aulast%3DSavi%26aufirst%3DP.%26aulast%3DPereillo%26aufirst%3DJ.%2BM.%26aulast%3DUzabiaga%26aufirst%3DM.%2BF.%26aulast%3DCombalbert%26aufirst%3DJ.%26aulast%3DPicard%26aufirst%3DC.%26aulast%3DMaffrand%26aufirst%3DJ.%2BP.%26aulast%3DPascal%26aufirst%3DM.%26aulast%3DHerbert%26aufirst%3DJ.%2BM.%26atitle%3DIdentification%2520and%2520Biological%2520Activity%2520of%2520the%2520Active%2520Metabolite%2520of%2520Clopidogrel%26jtitle%3DThromb.%2520Haemostasis%26date%3D2000%26volume%3D84%26spage%3D891%26epage%3D896" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Cattaneo, M.</span><span> </span><span class="NLM_article-title">ADP Receptors: Inhibitory Strategies for Antiplatelet Therapy</span> <span class="citation_source-journal">Drug News Perspect.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">253</span><span class="NLM_x">–</span> <span class="NLM_lpage">259</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Fjm8008597&amp;key=10.1358%2Fdnp.2006.19.5.985936" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Fjm8008597&amp;key=16941047" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Fjm8008597&amp;key=1%3ACAS%3A528%3ADC%252BD28XpvFejur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2006&pages=253-259&author=M.+Cattaneo&title=ADP+Receptors%3A+Inhibitory+Strategies+for+Antiplatelet+Therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">ADP receptors: inhibitory strategies for antiplatelet therapy</span></div><div class="casAuthors">Cattaneo, Marco</div><div class="citationInfo"><span class="NLM_cas:title">Drug News & Perspectives</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">253-259</span>CODEN:
                <span class="NLM_cas:coden">DNPEED</span>;
        ISSN:<span class="NLM_cas:issn">0214-0934</span>.
    
            (<span class="NLM_cas:orgname">Prous Science</span>)
        </div><div class="casAbstract">A review.  The interaction of adenosine-5'-diphosphate (ADP) with its platelet receptors (P2Y1 and P2Y12) plays a very important role in thrombogenesis.  The thienopyridine ticlopidine was the first specific antagonist of the platelet P2Y12 ADP receptor to be tested in randomized clin. trials for the prevention of arterial thrombotic events.  Although ticlopidine reduces the incidence of vascular events in patients at risk, it also unfortunately has some significant drawbacks: a relatively high incidence of toxic effects, which may be fatal in some cases; delayed onset of action; and a high interindividual variability in response.  A second thienopyridine, clopidogrel, has superseded ticlopidine, because it is also an efficacious antithrombotic drug and is less toxic than ticlopidine.  However, clopidogrel is not completely free from faults: severe toxic effects, albeit occurring much less frequently than with ticlopidine, may still complicate its administration to patients; the onset of pharmacol. action can be accelerated by the use of large loading doses, but may still not be optimal; the high interpatient variability in response remains an important issue.  These concerns justify the continued search for agents that can further improve the clin. outcome of patients with atherosclerosis through greater efficacy and/or safety.  A new thienopyridyl compd., prasugrel, which is characterized by higher potency and faster onset of action compared with clopidogrel, is currently under clin. evaluation.  Two direct and reversible P2Y12 antagonists, cangrelor and AZD6140, feature very rapid onset and reversal of platelet inhibition, which make them attractive alternatives to thienopyridines, esp. when rapid inhibition of platelet aggregation or its quick reversal are required.  Along with new the P2Y12 antagonists, inhibitors of the other platelet receptor for ADP, the antagonists P2Y1, are under development and may prove to be effective antithrombotic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmHmKVThnP17Vg90H21EOLACvtfcHk0ljhnyfJZhoxVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XpvFejur0%253D&md5=0302a0902658503a11691a421fad9c08</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1358%2Fdnp.2006.19.5.985936&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1358%252Fdnp.2006.19.5.985936%26sid%3Dliteratum%253Aachs%26aulast%3DCattaneo%26aufirst%3DM.%26atitle%3DADP%2520Receptors%253A%2520Inhibitory%2520Strategies%2520for%2520Antiplatelet%2520Therapy%26jtitle%3DDrug%2520News%2520Perspect.%26date%3D2006%26volume%3D19%26spage%3D253%26epage%3D259" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><div class="note"><p class="first last"><b>1p</b> also irreversibly inhibits iodine peroxidase, a heme containing enzyme involved in the same biological pathway. This additional inhibitory effect is beneficial in the treatment of hyperthyroidism.</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=1p+also+irreversibly+inhibits+iodine+peroxidase%2C+a+heme+containing+enzyme+involved+in+the+same+biological+pathway.+This+additional+inhibitory+effect+is+beneficial+in+the+treatment+of+hyperthyroidism."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Mugesh, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klotz, L.-O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">du Mont, W.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Becker, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sies, H.</span><span> </span><span class="NLM_article-title">Selenyl Iodide: A New Substrate for Mamallian Thioredoxin Reductase</span> <span class="citation_source-journal">Org. Biomol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">2848</span><span class="NLM_x">–</span> <span class="NLM_lpage">2852</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2003&pages=2848-2852&author=G.+Mugeshauthor=L.-O.+Klotzauthor=W.-W.+du+Montauthor=K.+Beckerauthor=H.+Sies&title=Selenyl+Iodide%3A+A+New+Substrate+for+Mamallian+Thioredoxin+Reductase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMugesh%26aufirst%3DG.%26aulast%3DKlotz%26aufirst%3DL.-O.%26aulast%3Ddu%2BMont%26aufirst%3DW.-W.%26aulast%3DBecker%26aufirst%3DK.%26aulast%3DSies%26aufirst%3DH.%26atitle%3DSelenyl%2520Iodide%253A%2520A%2520New%2520Substrate%2520for%2520Mamallian%2520Thioredoxin%2520Reductase%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2003%26volume%3D1%26spage%3D2848%26epage%3D2852" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Chander, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sulkowski, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenkes, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torbenson, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herlog, H. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bass, E. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gebo, K. A.</span><span> </span><span class="NLM_article-title">Treatment of Chronic Hepatitis C: A Systematic Review</span> <span class="citation_source-journal">Hepatology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl. 5</span><span class="NLM_x">) </span> <span class="NLM_fpage">A135</span><span class="NLM_x">–</span> <span class="NLM_lpage">A144</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2002&pages=A135-A144&issue=Suppl.+5&author=G.+Chanderauthor=M.+S.+Sulkowskiauthor=M.+W.+Jenkesauthor=M.+S.+Torbensonauthor=H.+F.+Herlogauthor=E.+B.+Bassauthor=K.+A.+Gebo&title=Treatment+of+Chronic+Hepatitis+C%3A+A+Systematic+Review"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChander%26aufirst%3DG.%26aulast%3DSulkowski%26aufirst%3DM.%2BS.%26aulast%3DJenkes%26aufirst%3DM.%2BW.%26aulast%3DTorbenson%26aufirst%3DM.%2BS.%26aulast%3DHerlog%26aufirst%3DH.%2BF.%26aulast%3DBass%26aufirst%3DE.%2BB.%26aulast%3DGebo%26aufirst%3DK.%2BA.%26atitle%3DTreatment%2520of%2520Chronic%2520Hepatitis%2520C%253A%2520A%2520Systematic%2520Review%26jtitle%3DHepatology%26date%3D2002%26volume%3D36%26issue%3DSuppl.%25205%26spage%3DA135%26epage%3DA144" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><div class="note"><p class="first last">(HCV) NS3·4A been shown to be essential for the HCV replication in chimpanzees.</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=%28HCV%29+NS3%C2%B74A+been+shown+to+be+essential+for+the+HCV+replication+in+chimpanzees."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit46a"><span><span class="NLM_contrib-group">Kolykhalov, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mihalik, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feinstone, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rice, C. M.</span><span> </span><span class="NLM_article-title">Hepatitis C Virus-Encoded Enzymatic Activities and Conserved RNA Elements in the 3′ Nontranslated Region Are Essential for Virus Replication in Vivo</span> <span class="citation_source-journal">J. Virol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x">, </span> <span class="NLM_fpage">2046</span><span class="NLM_x">–</span> <span class="NLM_lpage">2051</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46a&amp;dbid=16&amp;doi=10.1021%2Fjm8008597&amp;key=10.1128%2FJVI.74.4.2046-2051.2000" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46a&amp;dbid=8&amp;doi=10.1021%2Fjm8008597&amp;key=10644379" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46a&amp;dbid=32&amp;doi=10.1021%2Fjm8008597&amp;key=1%3ACAS%3A528%3ADC%252BD3cXptlGitA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2000&pages=2046-2051&author=A.+A.+Kolykhalovauthor=K.+Mihalikauthor=S.+M.+Feinstoneauthor=C.+M.+Rice&title=Hepatitis+C+Virus-Encoded+Enzymatic+Activities+and+Conserved+RNA+Elements+in+the+3%E2%80%B2+Nontranslated+Region+Are+Essential+for+Virus+Replication+in+Vivo"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46aR"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Hepatitis C virus-encoded enzymatic activities and conserved RNA elements in the 3' nontranslated region are essential for virus replication in vivo</span></div><div class="casAuthors">Kolykhalov, Alexander A.; Mihalik, Kathy; Feinstone, Stephen M.; Rice, Charles M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">2046-2051</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">0022-538X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Hepatitis C virus (HCV) infection is a widespread major human health concern.  Significant obstacles in the study of this virus include the absence of a reliable tissue culture system and a small-animal model.  Recently, full-length HCV cDNA clones were constructed and HCV infection was successfully initiated in 2 chimpanzees by intrahepatic injection of in vitro-transcribed RNA.  In order to validate potential targets for development of anti-HCV therapeutics, 6 mutant derivs. of this prototype infectious clone were constructed.  Four clones contained point mutations ablating the activity of the NS2-3 protease, the NS3-4A serine protease, the NS3 NTPase/helicase, and the NS5B polymerase.  Two addnl. clones contained deletions encompassing all or part of the highly conserved 98-base sequence at the 3' terminus of the HCV genome RNA.  The RNA transcript from each of the 6 clones was injected intrahepatically into a chimpanzee.  No signs of HCV infection were detected in the 8 mo following the injection.  Inoculation of the same animal with nonmutant RNA transcripts resulted in productive HCV infection, as evidenced by viremia, elevated serum alanine aminotransferase, and HCV-specific seroconversion.  These data suggest that these 4 HCV-encoded enzymic activities and the conserved 3' terminal RNA element are essential for productive replication in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcxsUWOuM9sLVg90H21EOLACvtfcHk0lj9UX1_IyNiVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXptlGitA%253D%253D&md5=69facc6778408ae96f31373f78c06600</span></div><a href="/servlet/linkout?suffix=cit46a&amp;dbid=16384&amp;doi=10.1128%2FJVI.74.4.2046-2051.2000&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.74.4.2046-2051.2000%26sid%3Dliteratum%253Aachs%26aulast%3DKolykhalov%26aufirst%3DA.%2BA.%26aulast%3DMihalik%26aufirst%3DK.%26aulast%3DFeinstone%26aufirst%3DS.%2BM.%26aulast%3DRice%26aufirst%3DC.%2BM.%26atitle%3DHepatitis%2520C%2520Virus-Encoded%2520Enzymatic%2520Activities%2520and%2520Conserved%2520RNA%2520Elements%2520in%2520the%25203%25E2%2580%25B2%2520Nontranslated%2520Region%2520Are%2520Essential%2520for%2520Virus%2520Replication%2520in%2520Vivo%26jtitle%3DJ.%2520Virol.%26date%3D2000%26volume%3D74%26spage%3D2046%26epage%3D2051" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Lin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luong, Y.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, Y.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brennan, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fulghum, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsaio, H.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maxwell, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cottrell, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perni, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gates, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwong, A. D.</span><span> </span><span class="NLM_article-title">In Vitro Resistance Studies of Hepatitis C Virus Serine Protease Inhibitors, VX-950 and BILN 2061</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">279</span><span class="NLM_x">, </span> <span class="NLM_fpage">17508</span><span class="NLM_x">–</span> <span class="NLM_lpage">17514</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=17508-17514&author=C.+Linauthor=K.+Linauthor=Y.-P.+Luongauthor=B.+G.+Raoauthor=Y.-Y.+Weiauthor=D.+L.+Brennanauthor=J.+R.+Fulghumauthor=H.-M.+Hsaioauthor=S.+Maauthor=J.+P.+Maxwellauthor=K.+M.+Cottrellauthor=R.+B.+Perniauthor=C.+A.+Gatesauthor=A.+D.+Kwong&title=In+Vitro+Resistance+Studies+of+Hepatitis+C+Virus+Serine+Protease+Inhibitors%2C+VX-950+and+BILN+2061"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DC.%26aulast%3DLin%26aufirst%3DK.%26aulast%3DLuong%26aufirst%3DY.-P.%26aulast%3DRao%26aufirst%3DB.%2BG.%26aulast%3DWei%26aufirst%3DY.-Y.%26aulast%3DBrennan%26aufirst%3DD.%2BL.%26aulast%3DFulghum%26aufirst%3DJ.%2BR.%26aulast%3DHsaio%26aufirst%3DH.-M.%26aulast%3DMa%26aufirst%3DS.%26aulast%3DMaxwell%26aufirst%3DJ.%2BP.%26aulast%3DCottrell%26aufirst%3DK.%2BM.%26aulast%3DPerni%26aufirst%3DR.%2BB.%26aulast%3DGates%26aufirst%3DC.%2BA.%26aulast%3DKwong%26aufirst%3DA.%2BD.%26atitle%3DIn%2520Vitro%2520Resistance%2520Studies%2520of%2520Hepatitis%2520C%2520Virus%2520Serine%2520Protease%2520Inhibitors%252C%2520VX-950%2520and%2520BILN%25202061%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26spage%3D17508%26epage%3D17514" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Heinemann, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Y.-Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chubb, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hertel, L. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grindey, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plunkett, W.</span><span> </span><span class="NLM_article-title">Inhibition of Ribonucleotide Reduction in CCRF-CEM Cells by 2′,2′-Difluorodeoxycytidine</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">567</span><span class="NLM_x">–</span> <span class="NLM_lpage">572</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1990&pages=567-572&author=V.+Heinemannauthor=Y.-Z.+Xuauthor=S.+Chubbauthor=A.+Senauthor=L.+W.+Hertelauthor=G.+B.+Grindeyauthor=W.+Plunkett&title=Inhibition+of+Ribonucleotide+Reduction+in+CCRF-CEM+Cells+by+2%E2%80%B2%2C2%E2%80%B2-Difluorodeoxycytidine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHeinemann%26aufirst%3DV.%26aulast%3DXu%26aufirst%3DY.-Z.%26aulast%3DChubb%26aufirst%3DS.%26aulast%3DSen%26aufirst%3DA.%26aulast%3DHertel%26aufirst%3DL.%2BW.%26aulast%3DGrindey%26aufirst%3DG.%2BB.%26aulast%3DPlunkett%26aufirst%3DW.%26atitle%3DInhibition%2520of%2520Ribonucleotide%2520Reduction%2520in%2520CCRF-CEM%2520Cells%2520by%25202%25E2%2580%25B2%252C2%25E2%2580%25B2-Difluorodeoxycytidine%26jtitle%3DMol.%2520Pharmacol.%26date%3D1990%26volume%3D38%26spage%3D567%26epage%3D572" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Baker, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banzon, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bollinger, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stubbe, J.</span><span> </span><span class="NLM_article-title">2′-Deoxy-2′-methylenecytidine and 2′-Deoxy-2′,2′-difluorocytidine 5′-Diphosphates: Potent Mechanism-Based Inhibitors of Ribonucleotide Reductase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">1879</span><span class="NLM_x">–</span> <span class="NLM_lpage">1884</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00110a019" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1991&pages=1879-1884&author=C.+H.+Bakerauthor=J.+Banzonauthor=J.+M.+Bollingerauthor=J.+Stubbe&title=2%E2%80%B2-Deoxy-2%E2%80%B2-methylenecytidine+and+2%E2%80%B2-Deoxy-2%E2%80%B2%2C2%E2%80%B2-difluorocytidine+5%E2%80%B2-Diphosphates%3A+Potent+Mechanism-Based+Inhibitors+of+Ribonucleotide+Reductase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1021%2Fjm00110a019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00110a019%26sid%3Dliteratum%253Aachs%26aulast%3DBaker%26aufirst%3DC.%2BH.%26aulast%3DBanzon%26aufirst%3DJ.%26aulast%3DBollinger%26aufirst%3DJ.%2BM.%26aulast%3DStubbe%26aufirst%3DJ.%26atitle%3D2%25E2%2580%25B2-Deoxy-2%25E2%2580%25B2-methylenecytidine%2520and%25202%25E2%2580%25B2-Deoxy-2%25E2%2580%25B2%252C2%25E2%2580%25B2-difluorocytidine%25205%25E2%2580%25B2-Diphosphates%253A%2520Potent%2520Mechanism-Based%2520Inhibitors%2520of%2520Ribonucleotide%2520Reductase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1991%26volume%3D34%26spage%3D1879%26epage%3D1884" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Santi, D. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McHenry, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sommer, H.</span><span> </span><span class="NLM_article-title">Mechanism of Interaction of Thymidylate Synthetase with 5-Fluorodeoxyuridylate</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1974</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">471</span><span class="NLM_x">–</span> <span class="NLM_lpage">481</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi00700a012" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=1974&pages=471-481&author=D.+V.+Santiauthor=C.+S.+McHenryauthor=H.+Sommer&title=Mechanism+of+Interaction+of+Thymidylate+Synthetase+with+5-Fluorodeoxyuridylate"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1021%2Fbi00700a012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi00700a012%26sid%3Dliteratum%253Aachs%26aulast%3DSanti%26aufirst%3DD.%2BV.%26aulast%3DMcHenry%26aufirst%3DC.%2BS.%26aulast%3DSommer%26aufirst%3DH.%26atitle%3DMechanism%2520of%2520Interaction%2520of%2520Thymidylate%2520Synthetase%2520with%25205-Fluorodeoxyuridylate%26jtitle%3DBiochemistry%26date%3D1974%26volume%3D13%26spage%3D471%26epage%3D481" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Wong, K.-K.</span><span> </span><span class="NLM_article-title">HKI-272 in Non-Small Cell Lung Cancer</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl. 15</span><span class="NLM_x">) </span> <span class="NLM_fpage">4953s</span><span class="NLM_x">–</span> <span class="NLM_lpage">4596s</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2007&pages=4953s-4596s&issue=Suppl.+15&author=K.-K.+Wong&title=HKI-272+in+Non-Small+Cell+Lung+Cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWong%26aufirst%3DK.-K.%26atitle%3DHKI-272%2520in%2520Non-Small%2520Cell%2520Lung%2520Cancer%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2007%26volume%3D13%26issue%3DSuppl.%252015%26spage%3D4953s%26epage%3D4596s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Wissner, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Overbeek, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reich, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Floyd, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mamuya, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosfjord, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Discafani, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rabindran, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gruber, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hallett, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nilakantan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.-F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenberger, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsou, H.-R.</span><span> </span><span class="NLM_article-title">Synthesis and Structure−Activity Relationship of 6,7-Disubstituted 4-Anilinoquinoline-3-carbonitriles. The Design of an Orally Active, Irreversible Inhibitor of the Tyrosine Kinase Activity of the Epidermal Growth Factor Receptor (EGFR) and the Human Epidermal Growth Factor Receptor-2 (HER-2)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">49</span><span class="NLM_x">–</span> <span class="NLM_lpage">63</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm020241c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=49-63&author=A.+Wissnerauthor=E.+Overbeekauthor=M.+Reichauthor=M.+B.+Floydauthor=B.+D.+Johnsonauthor=N.+Mamuyaauthor=E.+C.+Rosfjordauthor=C.+Discafaniauthor=R.+Davisauthor=X.+Shiauthor=S.+K.+Rabindranauthor=B.+C.+Gruberauthor=F.+Yeauthor=W.+A.+Hallettauthor=R.+Nilakantanauthor=R.+Shenauthor=Y.-F.+Wangauthor=L.+M.+Greenbergerauthor=H.-R.+Tsou&title=Synthesis+and+Structure%E2%88%92Activity+Relationship+of+6%2C7-Disubstituted+4-Anilinoquinoline-3-carbonitriles.+The+Design+of+an+Orally+Active%2C+Irreversible+Inhibitor+of+the+Tyrosine+Kinase+Activity+of+the+Epidermal+Growth+Factor+Receptor+%28EGFR%29+and+the+Human+Epidermal+Growth+Factor+Receptor-2+%28HER-2%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1021%2Fjm020241c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm020241c%26sid%3Dliteratum%253Aachs%26aulast%3DWissner%26aufirst%3DA.%26aulast%3DOverbeek%26aufirst%3DE.%26aulast%3DReich%26aufirst%3DM.%26aulast%3DFloyd%26aufirst%3DM.%2BB.%26aulast%3DJohnson%26aufirst%3DB.%2BD.%26aulast%3DMamuya%26aufirst%3DN.%26aulast%3DRosfjord%26aufirst%3DE.%2BC.%26aulast%3DDiscafani%26aufirst%3DC.%26aulast%3DDavis%26aufirst%3DR.%26aulast%3DShi%26aufirst%3DX.%26aulast%3DRabindran%26aufirst%3DS.%2BK.%26aulast%3DGruber%26aufirst%3DB.%2BC.%26aulast%3DYe%26aufirst%3DF.%26aulast%3DHallett%26aufirst%3DW.%2BA.%26aulast%3DNilakantan%26aufirst%3DR.%26aulast%3DShen%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DY.-F.%26aulast%3DGreenberger%26aufirst%3DL.%2BM.%26aulast%3DTsou%26aufirst%3DH.-R.%26atitle%3DSynthesis%2520and%2520Structure%25E2%2588%2592Activity%2520Relationship%2520of%25206%252C7-Disubstituted%25204-Anilinoquinoline-3-carbonitriles.%2520The%2520Design%2520of%2520an%2520Orally%2520Active%252C%2520Irreversible%2520Inhibitor%2520of%2520the%2520Tyrosine%2520Kinase%2520Activity%2520of%2520the%2520Epidermal%2520Growth%2520Factor%2520Receptor%2520%2528EGFR%2529%2520and%2520the%2520Human%2520Epidermal%2520Growth%2520Factor%2520Receptor-2%2520%2528HER-2%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D49%26epage%3D63" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><div class="note"><p class="first last">Upon removal of the dimethylamino group, no glutathione addition is detected (ref <a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">52</a>, Wissner et al.)</p></div>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Upon+removal+of+the+dimethylamino+group%2C+no+glutathione+addition+is+detected+%28ref+52%2C+Wissner+et+al.%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group">Tsou, H.-R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Overbeek-Klumpers, E. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hallett, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reich, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Floyd, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michalak, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nilakantan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Discafani, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rabindran, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.-F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Upeslacis, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wissner, A.</span><span> </span><span class="NLM_article-title">Optimization of 6,7-Disubstituted-4-(arylamino)quinoline-3-carbonitriles as Orally Active Irreversible Inhibitors of Human Epidermal Growth Factor Receptor-2 Kinase Activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">1107</span><span class="NLM_x">–</span> <span class="NLM_lpage">1131</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm040159c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=1107-1131&author=H.-R.+Tsouauthor=E.+G.+Overbeek-Klumpersauthor=W.+A.+Hallettauthor=M.+F.+Reichauthor=M.+B.+Floydauthor=B.+D.+Johnsonauthor=R.+S.+Michalakauthor=R.+Nilakantanauthor=C.+Discafaniauthor=J.+Golasauthor=S.+K.+Rabindranauthor=R.+Shenauthor=X.+Shiauthor=Y.-F.+Wangauthor=J.+Upeslacisauthor=A.+Wissner&title=Optimization+of+6%2C7-Disubstituted-4-%28arylamino%29quinoline-3-carbonitriles+as+Orally+Active+Irreversible+Inhibitors+of+Human+Epidermal+Growth+Factor+Receptor-2+Kinase+Activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1021%2Fjm040159c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm040159c%26sid%3Dliteratum%253Aachs%26aulast%3DTsou%26aufirst%3DH.-R.%26aulast%3DOverbeek-Klumpers%26aufirst%3DE.%2BG.%26aulast%3DHallett%26aufirst%3DW.%2BA.%26aulast%3DReich%26aufirst%3DM.%2BF.%26aulast%3DFloyd%26aufirst%3DM.%2BB.%26aulast%3DJohnson%26aufirst%3DB.%2BD.%26aulast%3DMichalak%26aufirst%3DR.%2BS.%26aulast%3DNilakantan%26aufirst%3DR.%26aulast%3DDiscafani%26aufirst%3DC.%26aulast%3DGolas%26aufirst%3DJ.%26aulast%3DRabindran%26aufirst%3DS.%2BK.%26aulast%3DShen%26aufirst%3DR.%26aulast%3DShi%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DY.-F.%26aulast%3DUpeslacis%26aufirst%3DJ.%26aulast%3DWissner%26aufirst%3DA.%26atitle%3DOptimization%2520of%25206%252C7-Disubstituted-4-%2528arylamino%2529quinoline-3-carbonitriles%2520as%2520Orally%2520Active%2520Irreversible%2520Inhibitors%2520of%2520Human%2520Epidermal%2520Growth%2520Factor%2520Receptor-2%2520Kinase%2520Activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D1107%26epage%3D1131" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group">Yun, C.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mengwasser, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toms, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woo, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greulich, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, K.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyerson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eck, M. J.</span><span> </span><span class="NLM_article-title">The T790M Mutation in EGFR Kinase Causes Drug Resistance by Increasing the Affinity for ATP</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x">, </span> <span class="NLM_fpage">2070</span><span class="NLM_x">–</span> <span class="NLM_lpage">2075</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Fjm8008597&amp;key=10.1073%2Fpnas.0709662105" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Fjm8008597&amp;key=18227510" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Fjm8008597&amp;key=1%3ACAS%3A528%3ADC%252BD1cXitl2mu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2008&pages=2070-2075&author=C.-H.+Yunauthor=K.+E.+Mengwasserauthor=A.+V.+Tomsauthor=M.+S.+Wooauthor=H.+Greulichauthor=K.-K.+Wongauthor=M.+Meyersonauthor=M.+J.+Eck&title=The+T790M+Mutation+in+EGFR+Kinase+Causes+Drug+Resistance+by+Increasing+the+Affinity+for+ATP"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">The T790M mutation in EGFR kinase causes drug resistance by increasing the affinity for ATP</span></div><div class="casAuthors">Yun, Cai-Hong; Mengwasser, Kristen E.; Toms, Angela V.; Woo, Michele S.; Greulich, Heidi; Wong, Kwok-Kin; Meyerson, Matthew; Eck, Michael J.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2070-2075</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Lung cancers caused by activating mutations in the epidermal growth factor receptor (EGFR) are initially responsive to small mol. tyrosine kinase inhibitors (TKIs), but the efficacy of these agents is often limited because of the emergence of drug resistance conferred by a second mutation, T790M.  Threonine 790 is the "gatekeeper" residue, an important determinant of inhibitor specificity in the ATP binding pocket.  The T790M mutation has been thought to cause resistance by sterically blocking binding of TKIs such as gefitinib and erlotinib, but this explanation is difficult to reconcile with the fact that it remains sensitive to structurally similar irreversible inhibitors.  Here, we show by using a direct binding assay that T790M mutants retain low-nanomolar affinity for gefitinib.  Furthermore, we show that the T790M mutation activates WT EGFR and that introduction of the T790M mutation increases the ATP affinity of the oncogenic L858R mutant by more than an order of magnitude.  The increased ATP affinity is the primary mechanism by which the T790M mutation confers drug resistance.  Crystallog. anal. of the T790M mutant shows how it can adapt to accommodate tight binding of diverse inhibitors, including the irreversible inhibitor HKI-272, and also suggests a structural mechanism for catalytic activation.  We conclude that the T790M mutation is a "generic" resistance mutation that will reduce the potency of any ATP-competitive kinase inhibitor and that irreversible inhibitors overcome this resistance simply through covalent binding, not as a result of an alternative binding mode.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXXP7TBlyrdrVg90H21EOLACvtfcHk0lj1vUVf8wK9wg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXitl2mu7k%253D&md5=f5f5d791a65f73ca628d95e9922b8ea8</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0709662105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0709662105%26sid%3Dliteratum%253Aachs%26aulast%3DYun%26aufirst%3DC.-H.%26aulast%3DMengwasser%26aufirst%3DK.%2BE.%26aulast%3DToms%26aufirst%3DA.%2BV.%26aulast%3DWoo%26aufirst%3DM.%2BS.%26aulast%3DGreulich%26aufirst%3DH.%26aulast%3DWong%26aufirst%3DK.-K.%26aulast%3DMeyerson%26aufirst%3DM.%26aulast%3DEck%26aufirst%3DM.%2BJ.%26atitle%3DThe%2520T790M%2520Mutation%2520in%2520EGFR%2520Kinase%2520Causes%2520Drug%2520Resistance%2520by%2520Increasing%2520the%2520Affinity%2520for%2520ATP%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2008%26volume%3D105%26spage%3D2070%26epage%3D2075" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group">Erlichman, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hidalgo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boni, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martins, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quinn, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zacharchuk, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amorusi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adjei, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowinksy, E. K.</span><span> </span><span class="NLM_article-title">Phase I Study of EKB-569, an Irreversible Inhibitor of the Epidermal Growth Factor Receptor, in Patients with Advanced Solid Tumors</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">2252</span><span class="NLM_x">–</span> <span class="NLM_lpage">2260</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Fjm8008597&amp;key=10.1200%2FJCO.2005.01.8960" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Fjm8008597&amp;key=16710023" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Fjm8008597&amp;key=1%3ACAS%3A528%3ADC%252BD28XlvV2ksLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2006&pages=2252-2260&author=C.+Erlichmanauthor=M.+Hidalgoauthor=J.+P.+Boniauthor=P.+Martinsauthor=S.+E.+Quinnauthor=C.+Zacharchukauthor=P.+Amorusiauthor=A.+A.+Adjeiauthor=E.+K.+Rowinksy&title=Phase+I+Study+of+EKB-569%2C+an+Irreversible+Inhibitor+of+the+Epidermal+Growth+Factor+Receptor%2C+in+Patients+with+Advanced+Solid+Tumors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Phase I study of EKB-569, an irreversible inhibitor of the epidermal growth factor receptor, in patients with advanced solid tumors</span></div><div class="casAuthors">Erlichman, Charles; Hidalgo, Manuel; Boni, Joseph P.; Martins, Patricia; Quinn, Susan E.; Zacharchuk, Charles; Amorusi, Peter; Adjei, Alex A.; Rowinsky, Eric K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">2252-2260</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">American Society of Clinical Oncology</span>)
        </div><div class="casAbstract">The max. tolerated dose (MTD) and the dose-limiting toxicities of EKB-569, a selective, irreversible inhibitor of the epidermal growth factor receptor (EGFR), when administered orally once daily on an intermittent-dose schedule (14 days of a 28-day cycle) or on a continuous-dose schedule (each day of a 28-day cycle), were detd. in patients with advanced solid tumors.  Planned dose escalation was 25, 50, 75, 125, 175, and 225 mg.  Pharmacokinetic sampling was performed on days 1 and 14 for the intermittent-dose cohort and on days 1 and 15 for the continuous-dose cohort.  Thirty patients received a median of two cycles (range, one to 10 cycles) in the intermittent-dose cohort; 29 patients received a median of three cycles (range, one to eight cycles) in the continuous-dose cohort.  Dose-limiting toxicity was grade 3 diarrhea, and the MTD was 75 mg EKB-569 per day for both cohorts.  Other common toxicities included rash, nausea, and asthenia.  Exposure to EKB-569 was dose proportional.  At the MTD, the mean ± std. deviation terminal half-life was 21.7 ± 4.2 h and peak concn. increased 1.2-fold from day 1 to day 14/15.  No major antitumor responses were obsd.  However, one patient with non-small-cell lung cancer and one with cutaneous squamous cell carcinoma had stable disease for 33 and 24 wk, resp.  The MTD of once-daily oral EKB-569 is 75 mg.  The tolerable toxicity profile and long half-life of this irreversible EGFR inhibitor warrant its further evaluation as a single agent and in combination with other drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpoWU_wd20ORbVg90H21EOLACvtfcHk0lgWTT5cq4FJCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XlvV2ksLk%253D&md5=3a7766538e63808314fe4ea73b5f766d</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1200%2FJCO.2005.01.8960&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2005.01.8960%26sid%3Dliteratum%253Aachs%26aulast%3DErlichman%26aufirst%3DC.%26aulast%3DHidalgo%26aufirst%3DM.%26aulast%3DBoni%26aufirst%3DJ.%2BP.%26aulast%3DMartins%26aufirst%3DP.%26aulast%3DQuinn%26aufirst%3DS.%2BE.%26aulast%3DZacharchuk%26aufirst%3DC.%26aulast%3DAmorusi%26aufirst%3DP.%26aulast%3DAdjei%26aufirst%3DA.%2BA.%26aulast%3DRowinksy%26aufirst%3DE.%2BK.%26atitle%3DPhase%2520I%2520Study%2520of%2520EKB-569%252C%2520an%2520Irreversible%2520Inhibitor%2520of%2520the%2520Epidermal%2520Growth%2520Factor%2520Receptor%252C%2520in%2520Patients%2520with%2520Advanced%2520Solid%2520Tumors%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2006%26volume%3D24%26spage%3D2252%26epage%3D2260" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group">Bull, H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia-Calvo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andersson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baginsky, W. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellsworth, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stearns, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bakshi, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rasmusson, G. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tolman, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Myers, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kozarich, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, G. S.</span><span> </span><span class="NLM_article-title">Mechanism-Based Inhibition of Human Steroid 5α-Reductase by Finasteride: Enyzme-Catalyzed Formation of NADP-Dihydrofinasteride, a Potent Bisubstrate Analog Inhibitor</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">118</span><span class="NLM_x">, </span> <span class="NLM_fpage">2359</span><span class="NLM_x">–</span> <span class="NLM_lpage">2365</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja953069t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=1996&pages=2359-2365&author=H.+G.+Bullauthor=M.+Garcia-Calvoauthor=S.+Anderssonauthor=W.+F.+Baginskyauthor=H.+K.+Chanauthor=D.+E.+Ellsworthauthor=R.+R.+Millerauthor=R.+A.+Stearnsauthor=R.+K.+Bakshiauthor=G.+H.+Rasmussonauthor=R.+L.+Tolmanauthor=R.+W.+Myersauthor=J.+W.+Kozarichauthor=G.+S.+Harris&title=Mechanism-Based+Inhibition+of+Human+Steroid+5%CE%B1-Reductase+by+Finasteride%3A+Enyzme-Catalyzed+Formation+of+NADP-Dihydrofinasteride%2C+a+Potent+Bisubstrate+Analog+Inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1021%2Fja953069t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja953069t%26sid%3Dliteratum%253Aachs%26aulast%3DBull%26aufirst%3DH.%2BG.%26aulast%3DGarcia-Calvo%26aufirst%3DM.%26aulast%3DAndersson%26aufirst%3DS.%26aulast%3DBaginsky%26aufirst%3DW.%2BF.%26aulast%3DChan%26aufirst%3DH.%2BK.%26aulast%3DEllsworth%26aufirst%3DD.%2BE.%26aulast%3DMiller%26aufirst%3DR.%2BR.%26aulast%3DStearns%26aufirst%3DR.%2BA.%26aulast%3DBakshi%26aufirst%3DR.%2BK.%26aulast%3DRasmusson%26aufirst%3DG.%2BH.%26aulast%3DTolman%26aufirst%3DR.%2BL.%26aulast%3DMyers%26aufirst%3DR.%2BW.%26aulast%3DKozarich%26aufirst%3DJ.%2BW.%26aulast%3DHarris%26aufirst%3DG.%2BS.%26atitle%3DMechanism-Based%2520Inhibition%2520of%2520Human%2520Steroid%25205%25CE%25B1-Reductase%2520by%2520Finasteride%253A%2520Enyzme-Catalyzed%2520Formation%2520of%2520NADP-Dihydrofinasteride%252C%2520a%2520Potent%2520Bisubstrate%2520Analog%2520Inhibitor%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1996%26volume%3D118%26spage%3D2359%26epage%3D2365" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><div class="note"><p class="first last">Other covalent MAO inhibitors are used to treat depression, albeit using a different chemotype and mechanism. These include the hydrazide isocarboxazid and the hydrazine phenelzine.</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Other+covalent+MAO+inhibitors+are+used+to+treat+depression%2C+albeit+using+a+different+chemotype+and+mechanism.+These+include+the+hydrazide+isocarboxazid+and+the+hydrazine+phenelzine."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group">Salach, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demeterm, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Youdim, M. B. H.</span><span> </span><span class="NLM_article-title">The Reaction of Bovine and Rat Liver Monoamine Oxidase with [<sup>14</sup>C]-Clorgyline and [<sup>14</sup>C]-Deprenyl</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1979</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">234</span><span class="NLM_x">–</span> <span class="NLM_lpage">241</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1979&pages=234-241&author=J.+I.+Salachauthor=K.+Demetermauthor=M.+B.+H.+Youdim&title=The+Reaction+of+Bovine+and+Rat+Liver+Monoamine+Oxidase+with+%5B14C%5D-Clorgyline+and+%5B14C%5D-Deprenyl"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSalach%26aufirst%3DJ.%2BI.%26aulast%3DDemeterm%26aufirst%3DK.%26aulast%3DYoudim%26aufirst%3DM.%2BB.%2BH.%26atitle%3DThe%2520Reaction%2520of%2520Bovine%2520and%2520Rat%2520Liver%2520Monoamine%2520Oxidase%2520with%2520%255B14C%255D-Clorgyline%2520and%2520%255B14C%255D-Deprenyl%26jtitle%3DMol.%2520Pharmacol.%26date%3D1979%26volume%3D16%26spage%3D234%26epage%3D241" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group">Van Houten, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bogdan, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferri, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mariano, P. S.</span><span> </span><span class="NLM_article-title">A New Strategy for the Design of Monoamine Oxidase Inactivators. Exploratory Studies with Tertiary Allylic and Propargylic Amino Alcohols</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">120</span><span class="NLM_x">, </span> <span class="NLM_fpage">5864</span><span class="NLM_x">–</span> <span class="NLM_lpage">5872</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja973978d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=120&publication_year=1998&pages=5864-5872&author=K.+A.+Van+Houtenauthor=J.-M.+Kimauthor=M.+A.+Bogdanauthor=D.+C.+Ferriauthor=P.+S.+Mariano&title=A+New+Strategy+for+the+Design+of+Monoamine+Oxidase+Inactivators.+Exploratory+Studies+with+Tertiary+Allylic+and+Propargylic+Amino+Alcohols"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1021%2Fja973978d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja973978d%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2BHouten%26aufirst%3DK.%2BA.%26aulast%3DKim%26aufirst%3DJ.-M.%26aulast%3DBogdan%26aufirst%3DM.%2BA.%26aulast%3DFerri%26aufirst%3DD.%2BC.%26aulast%3DMariano%26aufirst%3DP.%2BS.%26atitle%3DA%2520New%2520Strategy%2520for%2520the%2520Design%2520of%2520Monoamine%2520Oxidase%2520Inactivators.%2520Exploratory%2520Studies%2520with%2520Tertiary%2520Allylic%2520and%2520Propargylic%2520Amino%2520Alcohols%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1998%26volume%3D120%26spage%3D5864%26epage%3D5872" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group">Peters, J.-U.</span><span> </span><span class="NLM_article-title">11 Years of Cyanopyrrolidines as DPP-IV Inhibitors</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">579</span><span class="NLM_x">–</span> <span class="NLM_lpage">595</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Fjm8008597&amp;key=10.2174%2F156802607780091000" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Fjm8008597&amp;key=17352679" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Fjm8008597&amp;key=1%3ACAS%3A528%3ADC%252BD2sXlsFers78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2007&pages=579-595&author=J.-U.+Peters&title=11+Years+of+Cyanopyrrolidines+as+DPP-IV+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">11 years of cyanopyrrolidines as DPP-IV inhibitors</span></div><div class="casAuthors">Peters, Jens-Uwe</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">579-595</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Cyanopyrrolidines (cyanopyrrolidides, pyrrolidine-2-nitriles, prolinenitriles) as inhibitors of the serine protease dipeptidyl peptidase IV (DPP-IV, DP IV, CD26, EC 3.4.14.5) were first reported in 1995.  The interest in this compd. class grew immensely when DPP-IV was discovered as a target for the treatment of type 2 diabetes.  The research on cyanopyrrolidines cumulated in the discoveries of vildagliptin (LAF237, NVP-LAF237) and saxagliptin (BMS-477118).  These compds. entered Phase III clin. trials in 2004 and 2005, resp., and an application for market approval has been filed for vildagliptin in 2006.  Today cyanopyrrolidines are, as judged by the nos. of patent applications, the most prominent of several series of DPP-IV inhibitors, and have the potential to become valuable medicines for type 2 diabetes in the near future.  This review summarizes some historical aspects of the discovery of cyanopyrrolidine DPP-IV inhibitors, and then focuses mainly on structure-activity-relationships, the evolution of different subseries, the possibilities to improve on the chem. instability that is assocd. with this compd. class, and on the discoveries of vildagliptin and saxagliptin.  Within this context, the properties of individual compds. and results from biol. studies are discussed.  The rationale of DPP-IV inhibition, clin. data, and the relevance of selectivity over related proteases are extensively reviewed in other contributions to this issue of Curr.  Top. Med. Chem., and are therefore only very briefly touched.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMheLlajHi0LVg90H21EOLACvtfcHk0lgWTT5cq4FJCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXlsFers78%253D&md5=1aed687f83d3d35a2a581956ce4b82e0</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.2174%2F156802607780091000&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802607780091000%26sid%3Dliteratum%253Aachs%26aulast%3DPeters%26aufirst%3DJ.-U.%26atitle%3D11%2520Years%2520of%2520Cyanopyrrolidines%2520as%2520DPP-IV%2520Inhibitors%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2007%26volume%3D7%26spage%3D579%26epage%3D595" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group">Kim, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beconi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eiermann, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickey, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kowalchick, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leiting, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyons, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsilio, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCann, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scapin, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roy, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wyvratt, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thornberry, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, A. E.</span><span> </span><span class="NLM_article-title">(2<i>R</i>)-4-Oxo-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-<i>a</i>]pyrazin-7(8<i>H</i>)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine: A Potent, Orally Active Dipeptidyl Peptidase IV Inhibitor for the Treatment of Type 2 Diabetes</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">141</span><span class="NLM_x">–</span> <span class="NLM_lpage">151</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0493156" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=141-151&author=D.+Kimauthor=L.+Wangauthor=M.+Beconiauthor=G.+J.+Eiermannauthor=M.+H.+Fisherauthor=H.+Heauthor=G.+J.+Hickeyauthor=J.+E.+Kowalchickauthor=B.+Leitingauthor=K.+Lyonsauthor=F.+Marsilioauthor=M.+E.+McCannauthor=R.+A.+Patelauthor=A.+Petrovauthor=G.+Scapinauthor=S.+B.+Patelauthor=R.+S.+Royauthor=J.+K.+Wuauthor=M.+J.+Wyvrattauthor=B.+B.+Zhangauthor=L.+Zhuauthor=N.+A.+Thornberryauthor=A.+E.+Weber&title=%282R%29-4-Oxo-4-%5B3-%28trifluoromethyl%29-5%2C6-dihydro%5B1%2C2%2C4%5Dtriazolo%5B4%2C3-a%5Dpyrazin-7%288H%29-yl%5D-1-%282%2C4%2C5-trifluorophenyl%29butan-2-amine%3A+A+Potent%2C+Orally+Active+Dipeptidyl+Peptidase+IV+Inhibitor+for+the+Treatment+of+Type+2+Diabetes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1021%2Fjm0493156&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0493156%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DBeconi%26aufirst%3DM.%26aulast%3DEiermann%26aufirst%3DG.%2BJ.%26aulast%3DFisher%26aufirst%3DM.%2BH.%26aulast%3DHe%26aufirst%3DH.%26aulast%3DHickey%26aufirst%3DG.%2BJ.%26aulast%3DKowalchick%26aufirst%3DJ.%2BE.%26aulast%3DLeiting%26aufirst%3DB.%26aulast%3DLyons%26aufirst%3DK.%26aulast%3DMarsilio%26aufirst%3DF.%26aulast%3DMcCann%26aufirst%3DM.%2BE.%26aulast%3DPatel%26aufirst%3DR.%2BA.%26aulast%3DPetrov%26aufirst%3DA.%26aulast%3DScapin%26aufirst%3DG.%26aulast%3DPatel%26aufirst%3DS.%2BB.%26aulast%3DRoy%26aufirst%3DR.%2BS.%26aulast%3DWu%26aufirst%3DJ.%2BK.%26aulast%3DWyvratt%26aufirst%3DM.%2BJ.%26aulast%3DZhang%26aufirst%3DB.%2BB.%26aulast%3DZhu%26aufirst%3DL.%26aulast%3DThornberry%26aufirst%3DN.%2BA.%26aulast%3DWeber%26aufirst%3DA.%2BE.%26atitle%3D%25282R%2529-4-Oxo-4-%255B3-%2528trifluoromethyl%2529-5%252C6-dihydro%255B1%252C2%252C4%255Dtriazolo%255B4%252C3-a%255Dpyrazin-7%25288H%2529-yl%255D-1-%25282%252C4%252C5-trifluorophenyl%2529butan-2-amine%253A%2520A%2520Potent%252C%2520Orally%2520Active%2520Dipeptidyl%2520Peptidase%2520IV%2520Inhibitor%2520for%2520the%2520Treatment%2520of%2520Type%25202%2520Diabetes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D141%26epage%3D151" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group">Gauthier, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chauret, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cromlish, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desmarais, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duong, L. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Falgueyret, J.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimmel, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamontagne, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leger, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LeRiche, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masse, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKay, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicoll-Griffith, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oballa, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palmer, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Percival, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riendeau, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robichaud, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodan, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodan, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seto, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Therien, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Truong, V.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venuti, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wesolowski, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, R. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zamboni, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Black, W. C.</span><span> </span><span class="NLM_article-title">The Discovery of Odanacatib (MK-0822), a Selective Inhibitor of Cathepsin K</span> <span class="citation_source-journal">Biol. Org. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">923</span><span class="NLM_x">–</span> <span class="NLM_lpage">928</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Fjm8008597&amp;key=10.1016%2Fj.bmcl.2007.12.047" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Fjm8008597&amp;key=18226527" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Fjm8008597&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsFWktro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=923-928&author=J.+Y.+Gauthierauthor=N.+Chauretauthor=W.+Cromlishauthor=S.+Desmaraisauthor=L.+T.+Duongauthor=J.-P.+Falgueyretauthor=D.+B.+Kimmelauthor=S.+Lamontagneauthor=S.+Legerauthor=T.+LeRicheauthor=C.+S.+Liauthor=F.+Masseauthor=D.+J.+McKayauthor=D.+A.+Nicoll-Griffithauthor=R.+M.+Oballaauthor=J.+T.+Palmerauthor=M.+D.+Percivalauthor=D.+Riendeauauthor=J.+Robichaudauthor=G.+A.+Rodanauthor=S.+B.+Rodanauthor=C.+Setoauthor=M.+Therienauthor=V.-L.+Truongauthor=M.+C.+Venutiauthor=G.+Wesolowskiauthor=R.+N.+Youngauthor=R.+Zamboniauthor=W.+C.+Black&title=The+Discovery+of+Odanacatib+%28MK-0822%29%2C+a+Selective+Inhibitor+of+Cathepsin+K"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">The discovery of odanacatib (MK-0822), a selective inhibitor of cathepsin K</span></div><div class="casAuthors">Gauthier, Jacques Yves; Chauret, Nathalie; Cromlish, Wanda; Desmarais, Sylvie; Duong, Le T.; Falgueyret, Jean-Pierre; Kimmel, Donald B.; Lamontagne, Sonia; Leger, Serge; LeRiche, Tammy; Li, Chun Sing; Masse, Frederic; McKay, Daniel J.; Nicoll-Griffith, Deborah A.; Oballa, Renata M.; Palmer, James T.; Percival, M. David; Riendeau, Denis; Robichaud, Joel; Rodan, Gideon A.; Rodan, Sevgi B.; Seto, Carmai; Therien, Michel; Truong, Vouy-Linh; Venuti, Michael C.; Wesolowski, Gregg; Young, Robert N.; Zamboni, Robert; Black, W. Cameron</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">923-928</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Odanacatib is a potent, selective, and neutral cathepsin K inhibitor which was developed to address the metabolic liabilities of the Cat K inhibitor L-873724.  Substituting P1 and modifying the P2 side chain led to a metabolically robust inhibitor with a long half-life in preclin. species.  Odanacatib was more selective in whole cell assays than the published Cat K inhibitors balicatib and relacatib.  Evaluation in dermal fibroblast culture showed minimal intracellular collagen accumulation relative to less selective Cat K inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7ytNI-SBgarVg90H21EOLACvtfcHk0lgKI_k1PvGYOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsFWktro%253D&md5=e432a420a3ec99c784117750b9bbeda8</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2007.12.047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2007.12.047%26sid%3Dliteratum%253Aachs%26aulast%3DGauthier%26aufirst%3DJ.%2BY.%26aulast%3DChauret%26aufirst%3DN.%26aulast%3DCromlish%26aufirst%3DW.%26aulast%3DDesmarais%26aufirst%3DS.%26aulast%3DDuong%26aufirst%3DL.%2BT.%26aulast%3DFalgueyret%26aufirst%3DJ.-P.%26aulast%3DKimmel%26aufirst%3DD.%2BB.%26aulast%3DLamontagne%26aufirst%3DS.%26aulast%3DLeger%26aufirst%3DS.%26aulast%3DLeRiche%26aufirst%3DT.%26aulast%3DLi%26aufirst%3DC.%2BS.%26aulast%3DMasse%26aufirst%3DF.%26aulast%3DMcKay%26aufirst%3DD.%2BJ.%26aulast%3DNicoll-Griffith%26aufirst%3DD.%2BA.%26aulast%3DOballa%26aufirst%3DR.%2BM.%26aulast%3DPalmer%26aufirst%3DJ.%2BT.%26aulast%3DPercival%26aufirst%3DM.%2BD.%26aulast%3DRiendeau%26aufirst%3DD.%26aulast%3DRobichaud%26aufirst%3DJ.%26aulast%3DRodan%26aufirst%3DG.%2BA.%26aulast%3DRodan%26aufirst%3DS.%2BB.%26aulast%3DSeto%26aufirst%3DC.%26aulast%3DTherien%26aufirst%3DM.%26aulast%3DTruong%26aufirst%3DV.-L.%26aulast%3DVenuti%26aufirst%3DM.%2BC.%26aulast%3DWesolowski%26aufirst%3DG.%26aulast%3DYoung%26aufirst%3DR.%2BN.%26aulast%3DZamboni%26aufirst%3DR.%26aulast%3DBlack%26aufirst%3DW.%2BC.%26atitle%3DThe%2520Discovery%2520of%2520Odanacatib%2520%2528MK-0822%2529%252C%2520a%2520Selective%2520Inhibitor%2520of%2520Cathepsin%2520K%26jtitle%3DBiol.%2520Org.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D923%26epage%3D928" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group">Palmer, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bryant, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, D.-X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Setti, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rydzewski, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venkatraman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, Z.-Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burrill, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendonca, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Springman, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCarter, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheung, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janc, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGrath, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Somoza, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Enriquez, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, Z. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strickley, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venuti, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Percival, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Falgueyret, J.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prasit, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oballa, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riendeau, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, R. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wesolowski, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodan, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimmel, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodan, G.</span><span> </span><span class="NLM_article-title">Design and Synthesis of Tri-Ring P<sub>3</sub> Benzamide-Containing Aminonitriles as Potent, Selective, Orally Effective Inhibitors of Cathepsin K</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">7520</span><span class="NLM_x">–</span> <span class="NLM_lpage">7534</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm058198r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=7520-7534&author=J.+T.+Palmerauthor=C.+Bryantauthor=D.-X.+Wangauthor=D.+E.+Davisauthor=E.+L.+Settiauthor=R.+M.+Rydzewskiauthor=S.+Venkatramanauthor=Z.-Q.+Tianauthor=L.+C.+Burrillauthor=R.+H.+Mendoncaauthor=E.+Springmanauthor=J.+McCarterauthor=T.+Chungauthor=H.+Cheungauthor=J.+W.+Jancauthor=M.+McGrathauthor=J.+R.+Somozaauthor=P.+Enriquezauthor=Z.+W.+Yuauthor=R.+M.+Strickleyauthor=L.+Liuauthor=M.+C.+Venutiauthor=M.+D.+Percivalauthor=J.-P.+Falgueyretauthor=P.+Prasitauthor=R.+Oballaauthor=D.+Riendeauauthor=R.+N.+Youngauthor=G.+Wesolowskiauthor=S.+B.+Rodanauthor=C.+Johnsonauthor=D.+B.+Kimmelauthor=G.+Rodan&title=Design+and+Synthesis+of+Tri-Ring+P3+Benzamide-Containing+Aminonitriles+as+Potent%2C+Selective%2C+Orally+Effective+Inhibitors+of+Cathepsin+K"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1021%2Fjm058198r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm058198r%26sid%3Dliteratum%253Aachs%26aulast%3DPalmer%26aufirst%3DJ.%2BT.%26aulast%3DBryant%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DD.-X.%26aulast%3DDavis%26aufirst%3DD.%2BE.%26aulast%3DSetti%26aufirst%3DE.%2BL.%26aulast%3DRydzewski%26aufirst%3DR.%2BM.%26aulast%3DVenkatraman%26aufirst%3DS.%26aulast%3DTian%26aufirst%3DZ.-Q.%26aulast%3DBurrill%26aufirst%3DL.%2BC.%26aulast%3DMendonca%26aufirst%3DR.%2BH.%26aulast%3DSpringman%26aufirst%3DE.%26aulast%3DMcCarter%26aufirst%3DJ.%26aulast%3DChung%26aufirst%3DT.%26aulast%3DCheung%26aufirst%3DH.%26aulast%3DJanc%26aufirst%3DJ.%2BW.%26aulast%3DMcGrath%26aufirst%3DM.%26aulast%3DSomoza%26aufirst%3DJ.%2BR.%26aulast%3DEnriquez%26aufirst%3DP.%26aulast%3DYu%26aufirst%3DZ.%2BW.%26aulast%3DStrickley%26aufirst%3DR.%2BM.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DVenuti%26aufirst%3DM.%2BC.%26aulast%3DPercival%26aufirst%3DM.%2BD.%26aulast%3DFalgueyret%26aufirst%3DJ.-P.%26aulast%3DPrasit%26aufirst%3DP.%26aulast%3DOballa%26aufirst%3DR.%26aulast%3DRiendeau%26aufirst%3DD.%26aulast%3DYoung%26aufirst%3DR.%2BN.%26aulast%3DWesolowski%26aufirst%3DG.%26aulast%3DRodan%26aufirst%3DS.%2BB.%26aulast%3DJohnson%26aufirst%3DC.%26aulast%3DKimmel%26aufirst%3DD.%2BB.%26aulast%3DRodan%26aufirst%3DG.%26atitle%3DDesign%2520and%2520Synthesis%2520of%2520Tri-Ring%2520P3%2520Benzamide-Containing%2520Aminonitriles%2520as%2520Potent%252C%2520Selective%252C%2520Orally%2520Effective%2520Inhibitors%2520of%2520Cathepsin%2520K%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2005%26volume%3D48%26spage%3D7520%26epage%3D7534" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><div class="note"><p class="first last">There were no literature reports found indicating adduct formation with a cysteine residue or glutathione, which would be indicative of nonspecific reactivity.</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=There+were+no+literature+reports+found+indicating+adduct+formation+with+a+cysteine+residue+or+glutathione%2C+which+would+be+indicative+of+nonspecific+reactivity."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><div class="note"><p class="first last">Another class of drug that reaches less systematic exposure include topical agents. For examples of topical agents that covalently modulate their target, see the following.</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Another+class+of+drug+that+reaches+less+systematic+exposure+include+topical+agents.+For+examples+of+topical+agents+that+covalently+modulate+their+target%2C+see+the+following."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit66a"><span><span class="NLM_label">(a) </span><div class="note"><p class="first last">Eflornithine (an inhibitor of ornithine decarboxylase) used for facial hair removal:</p></div><span class="NLM_contrib-group">Poulin, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ackermann, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bey, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pegg, A. E.</span><span> </span><span class="NLM_article-title">Mechanism of the Irreversible Inactivation of Mouse Ornithine Decarboxylase by α-Difluoromethylornithine. Characterization of Sequences at the Inhibitor and Coenzyme Binding Sites</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">267</span><span class="NLM_x">, </span> <span class="NLM_fpage">150</span><span class="NLM_x">–</span> <span class="NLM_lpage">158</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=267&publication_year=1992&pages=150-158&author=R.+Poulinauthor=L.+Luauthor=B.+Ackermannauthor=P.+Beyauthor=A.+E.+Pegg&title=Mechanism+of+the+Irreversible+Inactivation+of+Mouse+Ornithine+Decarboxylase+by+%CE%B1-Difluoromethylornithine.+Characterization+of+Sequences+at+the+Inhibitor+and+Coenzyme+Binding+Sites"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPoulin%26aufirst%3DR.%26aulast%3DLu%26aufirst%3DL.%26aulast%3DAckermann%26aufirst%3DB.%26aulast%3DBey%26aufirst%3DP.%26aulast%3DPegg%26aufirst%3DA.%2BE.%26atitle%3DMechanism%2520of%2520the%2520Irreversible%2520Inactivation%2520of%2520Mouse%2520Ornithine%2520Decarboxylase%2520by%2520%25CE%25B1-Difluoromethylornithine.%2520Characterization%2520of%2520Sequences%2520at%2520the%2520Inhibitor%2520and%2520Coenzyme%2520Binding%2520Sites%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1992%26volume%3D267%26spage%3D150%26epage%3D158" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit66c"><span><span class="NLM_label">(b) </span><div class="note"><p class="first last">AN 2690 is an antifungal agent targeting aminoacyl-tRNA synthetase under clinical investigation.</p></div><span class="NLM_contrib-group">Rock, F. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yaremchuck, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tukalo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crepin, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hernandez, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plattner, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shapiro, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinis, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benkovic, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cusack, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alley, M. R. K.</span><span> </span><span class="NLM_article-title">An Antifungal Agent Inhibits an Aminoacyl-tRNA Synthetase by Trapping tRNA in the Editing Site</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">316</span><span class="NLM_x">, </span> <span class="NLM_fpage">1759</span><span class="NLM_x">–</span> <span class="NLM_lpage">1761</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66c&amp;dbid=16&amp;doi=10.1021%2Fjm8008597&amp;key=10.1126%2Fscience.1142189" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66c&amp;dbid=8&amp;doi=10.1021%2Fjm8008597&amp;key=17588934" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66c&amp;dbid=32&amp;doi=10.1021%2Fjm8008597&amp;key=1%3ACAS%3A528%3ADC%252BD2sXms1Wgsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=316&publication_year=2007&pages=1759-1761&author=F.+L.+Rockauthor=W.+Maoauthor=A.+Yaremchuckauthor=M.+Tukaloauthor=T.+Crepinauthor=H.+Zhouauthor=Y.-K.+Zhangauthor=V.+Hernandezauthor=T.+Akamaauthor=S.+J.+Bakerauthor=J.+J.+Plattnerauthor=L.+Shapiroauthor=S.+A.+Martinisauthor=S.+J.+Benkovicauthor=S.+Cusackauthor=M.+R.+K.+Alley&title=An+Antifungal+Agent+Inhibits+an+Aminoacyl-tRNA+Synthetase+by+Trapping+tRNA+in+the+Editing+Site"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit66cR"><div class="casContent"><span class="casTitleNuber">66b</span><div class="casTitle"><span class="NLM_cas:atitle">An Antifungal Agent Inhibits an Aminoacyl-tRNA Synthetase by Trapping tRNA in the Editing Site</span></div><div class="casAuthors">Rock, Fernando L.; Mao, Weimin; Yaremchuk, Anya; Tukalo, Mikhail; Crepin, Thibaut; Zhou, Huchen; Zhang, Yong-Kang; Hernandez, Vincent; Akama, Tsutomu; Baker, Stephen J.; Plattner, Jacob J.; Shapiro, Lucy; Martinis, Susan A.; Benkovic, Stephen J.; Cusack, Stephen; Alley, M. R. K.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">316</span>
        (<span class="NLM_cas:issue">5832</span>),
    <span class="NLM_cas:pages">1759-1761</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Aminoacyl-tRNA synthetases, which catalyze the attachment of the correct amino acid to its corresponding tRNA during translation of the genetic code, are proven antimicrobial drug targets.  We show that the broad-spectrum antifungal 5-fluoro-1,3-dihydro-1-hydroxy-2,1-benzoxaborole (AN2690), in development for the treatment of onychomycosis, inhibits yeast cytoplasmic leucyl-tRNA synthetase by formation of a stable tRNALeu-AN2690 adduct in the editing site of the enzyme.  Adduct formation is mediated through the boron atom of AN2690 and the 2'- and 3'-oxygen atoms of tRNA's 3'-terminal adenosine.  The trapping of enzyme-bound tRNALeu in the editing site prevents catalytic turnover, thus inhibiting synthesis of leucyl-tRNALeu and consequentially blocking protein synthesis.  This result establishes the editing site as a bona fide target for aminoacyl-tRNA synthetase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohcTqC8iispbVg90H21EOLACvtfcHk0lgCX5o3bwCuEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXms1Wgsbo%253D&md5=0da444baf3c2f6e0768fe19febcaee6a</span></div><a href="/servlet/linkout?suffix=cit66c&amp;dbid=16384&amp;doi=10.1126%2Fscience.1142189&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1142189%26sid%3Dliteratum%253Aachs%26aulast%3DRock%26aufirst%3DF.%2BL.%26aulast%3DMao%26aufirst%3DW.%26aulast%3DYaremchuck%26aufirst%3DA.%26aulast%3DTukalo%26aufirst%3DM.%26aulast%3DCrepin%26aufirst%3DT.%26aulast%3DZhou%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DY.-K.%26aulast%3DHernandez%26aufirst%3DV.%26aulast%3DAkama%26aufirst%3DT.%26aulast%3DBaker%26aufirst%3DS.%2BJ.%26aulast%3DPlattner%26aufirst%3DJ.%2BJ.%26aulast%3DShapiro%26aufirst%3DL.%26aulast%3DMartinis%26aufirst%3DS.%2BA.%26aulast%3DBenkovic%26aufirst%3DS.%2BJ.%26aulast%3DCusack%26aufirst%3DS.%26aulast%3DAlley%26aufirst%3DM.%2BR.%2BK.%26atitle%3DAn%2520Antifungal%2520Agent%2520Inhibits%2520an%2520Aminoacyl-tRNA%2520Synthetase%2520by%2520Trapping%2520tRNA%2520in%2520the%2520Editing%2520Site%26jtitle%3DScience%26date%3D2007%26volume%3D316%26spage%3D1759%26epage%3D1761" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit66e"><span><span class="NLM_label">(c) </span><div class="note"><p class="first last">Malathion is an organophosphate used to treat head lice by binding irreversible to acetycholinesterase.</p></div><span class="NLM_contrib-group">Guo, J.-X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J. J.-Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lushington, G. H.</span><span> </span><span class="NLM_article-title">Mechanistic Insight into Acetylcholinesterase Inhibition and Acute Toxicity of Organophosphorus Compounds: A Molecular Modeling Study</span> <span class="citation_source-journal">Chem. Res. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">209</span><span class="NLM_x">–</span> <span class="NLM_lpage">−216</span></span><div class="citationLinks">[<a href="/doi/10.1021/tx050090r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2006&pages=209-%E2%88%92216&author=J.-X.+Guoauthor=J.+J.-Q.+Wuauthor=J.+B.+Wrightauthor=G.+H.+Lushington&title=Mechanistic+Insight+into+Acetylcholinesterase+Inhibition+and+Acute+Toxicity+of+Organophosphorus+Compounds%3A+A+Molecular+Modeling+Study"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66e&amp;dbid=16384&amp;doi=10.1021%2Ftx050090r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx050090r%26sid%3Dliteratum%253Aachs%26aulast%3DGuo%26aufirst%3DJ.-X.%26aulast%3DWu%26aufirst%3DJ.%2BJ.-Q.%26aulast%3DWright%26aufirst%3DJ.%2BB.%26aulast%3DLushington%26aufirst%3DG.%2BH.%26atitle%3DMechanistic%2520Insight%2520into%2520Acetylcholinesterase%2520Inhibition%2520and%2520Acute%2520Toxicity%2520of%2520Organophosphorus%2520Compounds%253A%2520A%2520Molecular%2520Modeling%2520Study%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2006%26volume%3D19%26spage%3D209%26epage%3D%25E2%2588%2592216" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group">Copeland, R. A.</span> Irreversible Enzyme Inactivators in Evaluation of Enzyme Inhibitors. In  <span class="citation_source-book">Drug Discovery. A Guide for Medicinal Chemists and Pharmacologists</span>; <span class="NLM_publisher-name">John Wiley & Sons</span>: <span class="NLM_publisher-loc">New York</span>; Chapter 8, pp  <span class="NLM_fpage">214</span>− <span class="NLM_lpage">248</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Copeland%2C+R.+A.+Irreversible+Enzyme+Inactivators+in+Evaluation+of+Enzyme+Inhibitors.+In+Drug+Discovery.+A+Guide+for+Medicinal+Chemists+and+Pharmacologists%3B+John+Wiley+%26+Sons%3A+New+York%3B+Chapter+8%2C+pp+214%E2%88%92248."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DCopeland%26aufirst%3DR.%2BA.%26btitle%3DDrug%2520Discovery.%2520A%2520Guide%2520for%2520Medicinal%2520Chemists%2520and%2520Pharmacologists%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%26spage%3D214%26epage%3D248" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group">Rybak, M. J.</span><span> </span><span class="NLM_article-title">Pharmacodynamics: Relationship to Antimicrobial Resistance</span> <span class="citation_source-journal">Am. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">119</span><span class="NLM_elocation-id">S37−S44</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=2006&author=M.+J.+Rybak&title=Pharmacodynamics%3A+Relationship+to+Antimicrobial+Resistance"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRybak%26aufirst%3DM.%2BJ.%26atitle%3DPharmacodynamics%253A%2520Relationship%2520to%2520Antimicrobial%2520Resistance%26jtitle%3DAm.%2520J.%2520Med.%26date%3D2006%26volume%3D119" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><div class="note"><p class="first last">For example, see the following:</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=For+example%2C+see+the+following%3A"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit69a"><span><span class="NLM_contrib-group">Chu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rothfuss, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">d’Avignon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeng, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hotchkiss, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mach, R. H.</span><span> </span><span class="NLM_article-title">Isatin Sulfonamide Analogs Containing a Michael Addition Acceptor: A New Class of Caspase 3/7 Inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">3751</span><span class="NLM_x">–</span> <span class="NLM_lpage">3755</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm070506t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=3751-3755&author=W.+Chuauthor=J.+Rothfussauthor=A.+d%E2%80%99Avignonauthor=C.+Zengauthor=D.+Zhouauthor=R.+S.+Hotchkissauthor=R.+H.+Mach&title=Isatin+Sulfonamide+Analogs+Containing+a+Michael+Addition+Acceptor%3A+A+New+Class+of+Caspase+3%2F7+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit69a&amp;dbid=16384&amp;doi=10.1021%2Fjm070506t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070506t%26sid%3Dliteratum%253Aachs%26aulast%3DChu%26aufirst%3DW.%26aulast%3DRothfuss%26aufirst%3DJ.%26aulast%3Dd%25E2%2580%2599Avignon%26aufirst%3DA.%26aulast%3DZeng%26aufirst%3DC.%26aulast%3DZhou%26aufirst%3DD.%26aulast%3DHotchkiss%26aufirst%3DR.%2BS.%26aulast%3DMach%26aufirst%3DR.%2BH.%26atitle%3DIsatin%2520Sulfonamide%2520Analogs%2520Containing%2520a%2520Michael%2520Addition%2520Acceptor%253A%2520A%2520New%2520Class%2520of%2520Caspase%25203%252F7%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D3751%26epage%3D3755" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group">Overall, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kleifeld, O.</span><span> </span><span class="NLM_article-title">Towards Third Generation Matrix Metalloproteinase Inhibitors for Cancer Therapy</span> <span class="citation_source-journal">Br. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">94</span><span class="NLM_x">, </span> <span class="NLM_fpage">941</span><span class="NLM_x">–</span> <span class="NLM_lpage">946</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Fjm8008597&amp;key=10.1038%2Fsj.bjc.6603043" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Fjm8008597&amp;key=16538215" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Fjm8008597&amp;key=1%3ACAS%3A528%3ADC%252BD28XjtFGqt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=2006&pages=941-946&author=C.+M.+Overallauthor=O.+Kleifeld&title=Towards+Third+Generation+Matrix+Metalloproteinase+Inhibitors+for+Cancer+Therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Towards third generation matrix metalloproteinase inhibitors for cancer therapy</span></div><div class="casAuthors">Overall, C. M.; Kleifeld, O.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">941-946</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The failure of matrix metalloproteinase (MMP) inhibitor drug clin. trials in cancer was partly due to the inadvertent inhibition of MMP antitargets that counterbalanced the benefits of MMP target inhibition.  We explore how MMP inhibitor drugs might be developed to achieve potent selectivity for validated MMP targets yet therapeutically spare MMP antitargets that are crit. in host protection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWaFApPMIKRLVg90H21EOLACvtfcHk0liJukPEISzxfA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjtFGqt7g%253D&md5=5e672a6e9495ec2e283856edc6e61a60</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjc.6603043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjc.6603043%26sid%3Dliteratum%253Aachs%26aulast%3DOverall%26aufirst%3DC.%2BM.%26aulast%3DKleifeld%26aufirst%3DO.%26atitle%3DTowards%2520Third%2520Generation%2520Matrix%2520Metalloproteinase%2520Inhibitors%2520for%2520Cancer%2520Therapy%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2006%26volume%3D94%26spage%3D941%26epage%3D946" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group">Arnold, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kosinski, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Estebanez-Perpina, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fletterick, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guy, R. K.</span><span> </span><span class="NLM_article-title">Inhibitors of the Interaction of a Thyroid Hormone Receptor and Coactivators: Preliminary Structure−Activity Relationships</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">5269</span><span class="NLM_x">–</span> <span class="NLM_lpage">5280</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm070556y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=5269-5280&author=L.+A.+Arnoldauthor=A.+Kosinskiauthor=E.+Estebanez-Perpinaauthor=R.+J.+Fletterickauthor=R.+K.+Guy&title=Inhibitors+of+the+Interaction+of+a+Thyroid+Hormone+Receptor+and+Coactivators%3A+Preliminary+Structure%E2%88%92Activity+Relationships"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1021%2Fjm070556y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070556y%26sid%3Dliteratum%253Aachs%26aulast%3DArnold%26aufirst%3DL.%2BA.%26aulast%3DKosinski%26aufirst%3DA.%26aulast%3DEstebanez-Perpina%26aufirst%3DE.%26aulast%3DFletterick%26aufirst%3DR.%2BJ.%26aulast%3DGuy%26aufirst%3DR.%2BK.%26atitle%3DInhibitors%2520of%2520the%2520Interaction%2520of%2520a%2520Thyroid%2520Hormone%2520Receptor%2520and%2520Coactivators%253A%2520Preliminary%2520Structure%25E2%2588%2592Activity%2520Relationships%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D5269%26epage%3D5280" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group">Mor, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lodola, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rivara, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacondio, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duranti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tontini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanchini, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piersanti, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clapper, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarzia, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piomello, D.</span><span> </span><span class="NLM_article-title">Synthesis and Quantitative Structure−Activity Relationship of Fatty Acid Amide Hydrolase Inhibitors: Modulation at the N-Portion of Biphenyl-3-yl Alkylcarbamates</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">3484</span><span class="NLM_x">–</span> <span class="NLM_lpage">3498</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=3484-3498&author=M.+Morauthor=A.+Lodolaauthor=S.+Rivaraauthor=F.+Vacondioauthor=A.+Durantiauthor=A.+Tontiniauthor=S.+Sanchiniauthor=G.+Piersantiauthor=J.+R.+Clapperauthor=A.+R.+Kingauthor=G.+Tarziaauthor=D.+Piomello&title=Synthesis+and+Quantitative+Structure%E2%88%92Activity+Relationship+of+Fatty+Acid+Amide+Hydrolase+Inhibitors%3A+Modulation+at+the+N-Portion+of+Biphenyl-3-yl+Alkylcarbamates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMor%26aufirst%3DM.%26aulast%3DLodola%26aufirst%3DA.%26aulast%3DRivara%26aufirst%3DS.%26aulast%3DVacondio%26aufirst%3DF.%26aulast%3DDuranti%26aufirst%3DA.%26aulast%3DTontini%26aufirst%3DA.%26aulast%3DSanchini%26aufirst%3DS.%26aulast%3DPiersanti%26aufirst%3DG.%26aulast%3DClapper%26aufirst%3DJ.%2BR.%26aulast%3DKing%26aufirst%3DA.%2BR.%26aulast%3DTarzia%26aufirst%3DG.%26aulast%3DPiomello%26aufirst%3DD.%26atitle%3DSynthesis%2520and%2520Quantitative%2520Structure%25E2%2588%2592Activity%2520Relationship%2520of%2520Fatty%2520Acid%2520Amide%2520Hydrolase%2520Inhibitors%253A%2520Modulation%2520at%2520the%2520N-Portion%2520of%2520Biphenyl-3-yl%2520Alkylcarbamates%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D3484%26epage%3D3498" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm8008597&amp;pbContext=%3Barticle%3Aarticle%3A10.1021%2Fjm8008597%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2009.52.issue-5%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm8008597" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                985KB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"677a838b1ab9195b","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
